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explore new possibilities, 
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A. Introduction 
 
A.1 Do we need biomimetic models? 
 
Trace elements are essential for living individuals but their availability in the biomass is 
limited.1 This fact depends not on a low distribution of such metal elements on earth, rather 
on their restricted solubility at ambient aqueous conditions (1 atm, 0-30 °C). Particularly, 
variable pH values and redox potentials in the environment govern the formation of soluble 
salts. Therefore only a few elements are able to be taken up by cells at reasonably low energy 
cost. Some transition metal ions, when placed in a framework of carbon, hydrogen, oxygen, 
nitrogen, and sulphur atoms in the cell, form highly functionalized complexes, which are able 
to manage a broad variety of demanding tasks in the metabolism of the body. But without 
intake of these metals, no life may exist and this clearly indicates how indispensable trace 
elements are. 
 
Current investigations focus on the function of transition metals with respect to their 
environment set by their coordination with ligands. The main questions here are not locating 
the active site in an enzyme or investigating the secondary and tertiary structure; it is rather 
the oxidation state of the metal as well as the catalytic cycle they are able to perform. As early 
as 30 years ago, J. M. Wood realized this fact and made a provocative statement for the 
definition of biochemistry: 
 
“The concept of biological cycles for the elements is logical because organic life on this 
planet evolved on an inorganic matrix. From this inorganic matrix certain metals have 
been selected to catalyze important reactions in living systems. Biochemistry is the 
coordination chemistry of living systems!” 
J. M. Wood, 19752 
 
Wood’s view was a venture in a direction of science which pointed to coordination chemistry 
as a cornerstone between interactions of transition metal ions and biological systems. Today, 
this statement is broadly accepted, but it was revolutionary in 1975! 
 
Iron is one of the most widespread metals in nature and due to that it is precisely tuned and 
regulated in its properties. This has given it the capability of catalyzing a wide array of 
Introduction 
 
9 
chemical transformations (e. g. electron transfer, dioxygen transport, and redox trans-
formations). Thus, a broad spectrum of biological processes involves iron-containing 
enzymes. The diversity of these molecules has resulted in their sub-classifications into heme, 
iron-sulphur, and nonheme proteins:  
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Figure 1. Metalloporphyrinoids: heme and vitamin B12.3 
 
Metalloporphyrinoids (Figure 1) are intensely coloured molecules and are therefore 
sometimes refered to as “pigments of life”.4,5,6 The typical porphyrin core contains four 
pyrroles and four methylene groups as bridges between them. Iron or some other metals, such 
as magnesium, zinc, nickel, or cobalt are found in the centre. The heme unit (Figure 1, left) 
plays an essential role as a cofactor in the mode of action in multiple protein structures, e.g. 
haemoglobin (dioxgygen transport), myoglobin (dioxygen storage), and cytochromes 
(electron transport).7,8,9 Vitamin B12, also named cyanocobalamin (Figure 1, right), is based 
on a corrin ring, which has a cobalt ion in the centre. The relationship to the porphyrin core 
can be clearly seen, but in the corrin ligand system, two oppositely positioned methylene 
bridges contain an additional CH3 group and another methylene bridging group between a 
pair of pyrroles is missing. Vitamin B12 is involved in the methylmalonyl-coenzyme A mutase 
pathway (MUT) as well as in the methionine synthase cycle (MTR, 5-methyltetrahydrofolate-
homocysteine methyltransferase). A reduced availability of vitamin B12 has an negative effect 
on the DNA / RNA synthesis and on the blood cell proliferation.10-12  
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Iron-sulphur clusters, Fe2S2 and Fe4S4, represent the second iron-species. They are one of 
the oldest metal-containing cofactors and are widely distributed in nature, found in anaerobic, 
aerobic, and photosynthetic bacteria, as well as in mammals, plants, and fungi.13 These 
clusters are nonheme prosthetic groups, consisting of iron atoms bonded both to inorganic 
sulphur atoms and to four sulphur atoms located on cysteine residues on the protein. Their 
catalytic activity is used for electron transport and structure-directing tasks. Iron-sulphur 
clusters accept and release electrons one at a time. Typical structural motifs are shown in 
simple Fe-S moieties (Figure 2).14-16 
 
 
 
Figure 2. Three-dimensional structures of some iron-sulphur clusters in electron-transporting proteins: (left) a 
dimeric Fe2S2 cluster; (right) a tetrameric Fe4S4 cluster. 
 
Finally, the last and for this thesis the most important class of iron-containing enzymes is 
predominately based on O- and N-containing ligands. They allow the oxidative utilization of 
dioxygen under ambient conditions when coordinating activated iron ions in their centres. 
These so-called nonheme iron proteins are able to catalyze oxidation reactions of non-
activated C-H bonds, detoxification of biologically harmful radicals and reversible O2-binding 
reactions. Nonheme metalloproteins consist of two different types of active sites, the 
mononuclear and the dinuclear forms. 
 
Many mononuclear iron enzymes feature in their octahedral geometry two coordinated 
histidines and a carboxylate (glutamate or aspartate) residue. On the opposite face, three 
readily displaceable water molecules are bound. This structural formation is typical for an 
enzyme superfamily named 2-His-1-carboxylate facial triad (e.g. deacetoxycephalosporin C 
synthase, Figure 3 a).17  
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Figure 3. Common active-site structures for nonheme iron enzymes; (a) deacetoxycephalosporin C synthase, 
(b) reduced ribonucleotide reductase (RNR R2), (c) methemerythrin (merHr).3 
 
The resulting flexibility around the iron metal permits binding of exogenous ligands such as 
solvent, substrate, cofactors, and / or O2 at three available coordination sites.18 As a general 
example, the mononuclear nonheme iron family that requires an α-keto acid (α-KA) for 
activation was chosen to describe the proposed reaction mechanism between the iron centre 
and the substrate, cofactor, and O2 (Scheme 1): 19,20,21,22 
 
(a)  resting state of a 2-His-1-carboxylate facial triad fashion enzyme; 
(b)  coordination of an α-keto acid (α-KA) to the FeII centre by displacing two water 
ligands and subsequent binding of a substrate (SH) in the outer sphere of the active 
site; this substrate binding leads to a dissociation of the third water molecule and 
results in a penta-coordinated and unsaturated FeII centre; 
(c)  addition of O2 creates a FeIII-superoxo species (FeIII-O2-) which undergoes a 
nucleophilic attack on the carbonyl-C of the bound α-KA; 
(d)  a new metal-peroxo species with a FeIV-O2 oxidation state is formed, and O-O bond 
cleavage in combination with decarboxylation occurs; 
(e)  a formation of a FeIV=O intermediate (oxo-iron(IV) species) leads to substrate 
oxidation and after the catalytic step, product, succinate (RCOO-) and CO2 
dissociate from the active site, releasing the resting enzyme. 
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Scheme 1. Proposed reaction mechanism for α-keto acid-dependent enzymes.3,23 
 
X-ray structures for these activated intermediates have been reported and show clearly the 
ligation of an α-keto acid to the iron centre (Figure 4 a) and the dissociation of the third water 
ligand (Figure 4 b). The activated enzyme can then come into contact with an oxygen 
molecule and perform the oxidation reaction at the substrate as described above. 
 
 
 
Figure 4. Active-site structures of various states of α-KA-dependent enzymes based on X-ray crystallographic 
data: (a) the α-KA is already coordinated on the iron centre, and (b) the third water ligand is dissociated and a 
unsaturated iron(II) centre is exposed.3 
 
In dinuclear nonheme proteins usually two histidine- and four carboxylate-moieties are 
involved in the redox processes of the iron ions and their resulting oxygen-activation (e.g. 
reduced ribonucleotide reductase (RNR R2), Figure 3 b). Histidine residues represent 
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permanent terminal ligands, whereas carboxylates are capable of acting as terminal ligands as 
well as bridging ones between both metal centres.24 These kinds of enzyme belong to a 
subclass of diiron proteins which are called carboxylate-rich, in comparison to histidine-rich 
active site proteins. The latter retain five histidines and only two carboxylates (e.g. 
methemerythrin, another form of hemerytrin, Figure 3 c).25  
 
Hemerytrin (Hr) is a dioxygen carrier (Scheme 2) and therefore displays a completely 
different function in comparison to other diiron nonheme proteins.22,26 This enzyme was only 
found in a limited number of marine invertebrates and it was assumed that it is probably a 
evolutionary dead end because of its low abundance. Nevertheless, the chemistry of 
hemerytrin has been investigated in depth in the past, identifying it as the first diiron nonheme 
enzyme. Today, the knowledge in this field often serves as a platform for other diiron protein 
research. 
 
 
 
Scheme 2. Dioxygen binding at the hemerythrin (Hr) active site.22 
 
Deoxy Hr consists of a (µ-hydroxo)bis(µ-carboxylato)diiron(II) core and binds O2 end-on 
at one of the coordinatively unsaturated iron centres (Scheme 2). The activated oxy Hr is 
formed as a (µ-oxo)bis(µ-carboxylato)diiron(III) complex with a terminal η1-hydroperoxo 
ligand. This oxidized form was for a long time suspected to be the key for all diiron protein 
motifs. Oxo bridges and carboxylato ligands are quite important for building activated 
intermediates and lead to an impressive flexibility in diiron core structures.3 
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The primary function of nonheme diiron enzymes, i.e. the oxygen activation, is discussed 
in detail for each oxidation state of ribonucleotide reductase (RNR R2), starting from its 
reduced form (Scheme 3). 
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Scheme 3. Dioxygen activation mechanism for nonheme diiron enzymes, e.g. type I ribonucleotide reductase 
(RNR R2).19,27-29 
 
The diiron(II) centres of RNR R2red react with O2 and afford a diiron(III) peroxo species. 
This peroxo form undergoes electron transfer and is partly oxidized into a high-valent iron-
oxo intermediate, resulting in a FeIII(µ-O)FeIV core.30 The activated enzyme is able to oxidize 
a phenol group from a closely placed tyrosine residue to generate a catalytically important 
tyrosyl radical. Both the high-valent centres and the radical are responsible for further 
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substrate oxidations (e.g. of methane to methanol). Subsequently, the activated core is 
reduced to a diiron(III) state and can easily be returned to the starting form of the catalytic 
cycle by the cellular machinery. In related protein systems similar mechanisms for oxygen 
activation were observed, differing in the high valent iron-oxo intermediate, which is changed 
from FeIII(µ-O)FeIV to FeIV(µ-O)FeIV. The formation of radical species was also not observed 
in other enzyme mechanisms.22,3 
 
Studying enzyme active sites is challenging with regard to the high complexity of their bio-
frameworks (Figure 5). Thus, it is desirable to scale down the size of protein systems, while 
retaining their functionality. 
 
Figure 5. Three structural levels in MMOM (methane monooxygenase) from M. capsulatus (Bath).24 
 
Investigations in enzyme catalysis are frequently obscured by their complexity and herein lies 
the answer to the title question: yes, biomimetic models are definitely necessary to get a better 
view of activated intermediates and their coordination environment. 
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A.2 Models for nonheme iron enzymes 
 
The ultimate goal in bioinorganic chemistry will be achieved by mimicking structural and 
physical characteristics of complex protein systems with small organic molecules. Based on a 
deeper understanding of these fields, the basic catalytical processes can be investigated in 
more detail. In both mononuclear and dinuclear nonheme iron enzymes the major synthetic 
targets are very similar. The construction of iron(II)- and iron(III)-centres, peroxo 
intermediates, and high-valent oxoiron intermediates are the predominant aims in biomimetic 
science. To achieve this, a variety of polydentate ligands are synthesized to model enzymes 
and their special environments (Scheme 4):21 
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Scheme 4. Collection of biomimetic ligand systems. 
 
Introduction 
 
17 
The following examples are representative for the achievements in biomimetic modelling of 
enzyme properties: 
 
To mimic the 2-His-1-carboxylate facial triad of an α-KA-dependent enzyme, a poly-
dentate ligand like TpPh2 (Scheme 4, Tp = tris(pyrazolyl)borate) was found to be suitable. The 
peripheral phenyl groups of the tridentate ligand hinder access to the metal centre in such a 
way that the α-keto carboxylate (benzoylformate) binds as shown in (Scheme 5, left).23 The 
enzyme-cofactor-model contains a coordinatively unsaturated iron centre, which is suitable 
for O2 binding. With this model, structural as well as spectroscopic features were investigated 
and led to more information about 2-His-1-carboxylate facial triad proteins. 
 
 
 
Scheme 5. Structures of [FeII(TpPh2)(bf)] (Tp = tris(pyrazolyl)borate, bf = benzoylformate) (left) and its 
oxygenated product (right) based on X-ray crystallographic data.23 
 
The most important high-valent oxoiron intermediates in mononuclear enzymes can be 
modelled by a topology of polydentate N4 and N5 ligands. Figure 6 shows two different 
ligand systems, Bn-TPEN ( = N-benzyl-N,N´,N´-tris(2-pyridylmethyl)ethane-1,2-diamine) and 
N4Py ( = N,N-bis(2-pyridylmethyl)-N-bis(2-pyridyl)methylamine) (Scheme 4), which are 
utilized to stabilize the oxoiron(IV) unit in a nonheme environment. These models allow a 
deeper view into the characteristics of highly reactive intermediates by spectroscopic 
investigations, revealing their relevance in catalytic cycles. 
 
 
 
Figure 6. Structures of nonheme oxoiron(IV) complexes based on X-ray crystallographic and spectroscopic 
data.31-35 
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Another aim in the biomimetic chemistry of nonheme diiron proteins is the development 
of a (µ-oxo)bis(µ-carboxylato)diiron(III) core (Figure 7), which can be observed in 
hemerytrin. Mimicking a histidine-rich active site molecule, tridentate ligands such as 
tris(pyrazolyl)borate (Tp) (Scheme 4) and 1,4,7-triazycyclononane (TACN)36 are successful 
candidates to generate self-assembling [L2FeII2(µ-O)(µ-O2CR)2] complexes with the desired 
structure. These FeII-complexes are starting points to investigate the stability and oxidation 
potential of histidine-rich diiron proteins in different oxidation states. 
 
 
 
Figure 7. Structures of [FeII2(µ-O)(µ-O2CCH3)2(TACN)2] (left) and [FeII2(µ-O)(µ-O2CR)2(Tp)2] (right) based on 
X-ray crystallographic data.37,38 
 
Carboxylate-rich models with a structural motif like [Fe2L2(ArCO2)4] (L = nitrogen base) 
mimic an active site common to methane monooxygenase (MMOH) or RNR R2 and are 
realized by bulky terphenyl carboxylates and related benzyl-substituted benzoates.30 Figure 8 
shows an example of such a carboxylate ligand with this sterically demanding functionality.  
 
 
 
Figure 8. Structure of a bulky terphenyl carboxylate.30 
 
Oxygen-activating diiron enzymes can be modelled very well by [FeII(TpiPr2)(O2CR)] 
(R = benzyl) (Figure 9) and their synthetic analogues. These complexes bind O2 reversibly 
and exhibit a 1,2-peroxo-bridged diiron(III) unit. Spectroscopic analysis assigns a high 
similarity to nonheme diiron proteins, permitting study of dioxygen binding. 
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Figure 9. Structure of [FeIII2(µ-1,2-O2)(µ-O2CCH2Ph)2(TpiPr2)] based on X-ray crystallographic data.39 
 
High-valent iron-oxo intermediates are the ultimate oxidative form in nonheme iron 
chemistry. MMOH and RNR R2 are typical enzymes which fulfil their catalytic activity by a 
diiron(IV) core. Diiron(IV) species, however, remain elusive, while a number of 
iron(III)iron(IV) intermediates are easily accessible to study. A member of this group of 
special oxidation-state-molecules with a Fe2(µ-O)2 diamond unit is shown in Figure 10. Here 
a modified tris(2-pyridylmethyl)amine (TPA) ligand serves as a suitable metal environment.40 
 
 
 
Figure 10. Structure of [FeIIIFeIV(µ-O)2(5-Et3-TPA)2]3+ based on X-ray crystallographic data.41 
 
All of these examples of models and many more are necessary to complete the “puzzle” in 
bioinorganic chemistry. There are still many open fields which have to be investigated, e. g. 
mononuclear oxoiron(IV) model complexes catalyze oxidation reactions less impressively 
than their biological counterparts and need therefore more investigation and development.  
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A.3 Aim of this work 
 
The exciting chemistry of oxazolines and bis(oxazolines) has long represented a fruitful 
field for investigations, initiated already many years ago. Also in our group the knowledge 
about bis(oxazolines), in catalysis as well as in structure analysis, was continuously increased. 
Within this work, a former explored ligand model42,43 with excellent binding properties was 
used as a basis to introduce certain functional groups with the aim to improve its structural 
and catalytical behaviour: 
 
The first goal of this thesis was to find a selective way for the synthesis of these promising 
modified bis(oxazolines) (Figure 11) and to obtain important structural data of complexes 
formed by these ligands in combination with iron, ruthenium and zinc salts. The 
investigations in solid state and in solution should make further contributions to mimic 
mononuclear nonheme iron proteins with an octahedral geometry around the metal centre. 
 
 
 
Figure 11. Pentadentate bis(oxazoline) ligand system. 
 
The therefore necessary ligand will be obtained by an asymmetric synthesis, which allows 
to access both stereo isomers (R,R and S,S) by minimal variations in the synthetic strategy and 
affords the C2-symmetric bis(oxazoline) systems. The use of flexible donor-sets (N/O or N/S) 
results in a pentadentate ligand, with the possibility to introduce two sterical demanding alkyl 
groups, placed on two different positions at the ligand, which are assumed to influence the 
space near the stereo centres. Different chromophores (pyridine and phenols) are available for 
liquid-state analysis by using electronic absorption methods (UV/Vis and CD). Newly 
introduced ortho-OH groups on the phenyl rings are envisioned to interact with either an 
iron(III)-peroxo-intermediate or a substrate by pre-coordination, utilizing additional 
hydrogen-bridges (Figure 12). 
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Figure 12. Proposed pentadentate binding model, stabilizing either an iron(III)-peroxo-intermediate or substrate 
– shown on the unsubstituted ether bridged ligand 1. 
 
The second goal for this thesis is directly derived from the synthesis of the bis(oxazoline) 
ligands. The whole oxazoline side chain, which was used as an advanced precursor for the 
bis(oxazoline) synthesis, resembles already the basic structure of desferrithiocin (DFT), a 
very important biological active siderophore (Figure 13). 
 
 
 
Figure 13. Oxazoline moieties as model for a siderophore (DFT) – derived from the bis(oxazoline) synthesis as 
precursor. 
 
This natural product is known to be an excellent iron chelator, and just recently Bouwman 
and co-workers44 reported new data on its binding behaviour by using a similar oxazoline 
model, only in racemic form (see discussion in main part – oxazoline complex analysis C.2.3, 
Figure 13). Realizing the close structural relationship of these chiral oxazoline derivatives 
(Figure 13) to the siderophore DFT and the model of Bouwman, it was of certain interest to 
investigate in detail their chelating properties with different iron salts and other related and 
interesting metals in solid state and especially in solution.  
Aim of this work 
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After the successful synthesis and in combination with the obtained structural data, the 
formed oxazoline and bis(oxazoline) complexes were screened in asymmetric oxidation 
catalysis reactions of non-activated C-H bonds, a still challenging field in organic chemistry 
with high importance not only for industrial applications. 
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B. Main Part – Synthesis 
 
B.1 Ligand Synthesis 
 
B.1.1 General Retrosynthesis of Oxazoline, Bis(oxazoline) Ligands and 
their Derivatives 
 
The retrosynthesis of the desired ligand systems aimed at a flexible entry into a variety of 
derivatives in oxazoline and bis(oxazoline) chemistry. Starting from simple and commercially 
available building blocks like chiral amino acids (L-serine (12), L-cysteine (13)) and an 
aromatic nitrile (2-hydroxybenzonitrile (11)), oxazoline ligands 7a-9 and their thio 
derivative 10 can be synthesized in a few steps (Scheme 1). To access bis(oxazolines) 1-6, an 
additional pyridine linker is utilized to combine both oxazoline moieties to a C2-symmetric 
molecule. Via this flexible synthetic route a number of promising ligands for mimicking 
biological active enzymes may be produced. 
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Scheme 1. Retrosynthesis of oxazoline, bis(oxazoline) ligands and their derivatives. 
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B.1.2 Route to Oxazoline Ligands and their Derivatives 
 
The synthesis follows standard procedures, developed in our group, using nitriles and 
amino alcohols as building blocks to form five-membered oxazoline-ring systems.45 The 
success of these reactions depends on the reactivity of the nitriles used; in some cases they 
have to be activated by transformation to the corresponding imidate, in order to perform the 
desired ring closing reaction. To achieve this, an anhydrous stream of HCl was passed 
through a solution of 2-hydroxybenzonitrile (11) in ethanol/benzene and the imidate 
hydrochloride was formed, which precipitated from the solution over approximately two 
weeks. The hydrochloride was transformed into the free imidate 14 by addition of NaHCO3. 
A subsequent liquid-liquid extraction for 24 h increased the reported yield from 45%43 now 
up to 96% (Scheme 2, top). An esterification of L-serine (12) was the next step on the way to 
the oxazoline ligands. Under conventional conditions (SOCl2, MeOH), the serine methyl ester 
15 was obtained quantitively (Scheme 2, bottom). The reaction between the imidate 14 and 
the chiral amino alcohol 15 resulted in the first precursor 16a in a yield of 90%.  
 
 
 
Scheme 2. Synthesis of oxazoline precursor 16a: a) HCl gas (> 2.0 eq.),46 benzene/EtOH, 0 °C, crystallization: 
14 d, 96%; b) SOCl2 (3.5 eq.), MeOH, rt, 36 h, 99%; c) 14 (1.0 eq.), 15 (1.2 eq.), C2H4Cl2, reflux, 60 h, 90%. 
 
With the ester 16a in hand, two potential oxazoline ligands could be synthesized in the 
next step (Scheme 3). Reduction with LAH at -30 °C formed the oxazoline 7a, which was 
accessible in only 32% in enantiomerically pure form (Table 1, entry 1). Different reagents 
and procedures were tested to improve the reaction without loss of the chiral information, but 
only the more expensive DIBAL-H afforded the corresponding alcohol in 44% while 
retaining the same purity of the product (Table 1, entry 2). The reason for this low yield may 
be the presence of the ortho-OH substitution of the aromatic ring. 
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In contrast to this, reductions using LAH on similar substrates, e. g. oxazoline 16b with 
the OH-group in para-position, resulted in 93% of the corresponding alcohol and an optical 
active form (Table 1, entry 3). Furthermore, the completely unsubstituted oxazoline ester 16c 
was reduced as described in literature47 and the yield was increased to 74% in comparison 
with earlier results reported in our group42 (Table 1, entry 4). 
 
OH
NO
OH
OH
NO
OH
O
NO
OH
O
16a
a
b
7a
8
 
 
Scheme 3. Synthesis of oxazoline ligands 7a and 8: a) LAH (1.3 eq.), THF, -30 °C / 3.5 h – rt, 32%; b) 3.0 M 
MeMgBr (3.0 eq.), Et2O, 0 °C, 5 h, 70% - ORTEP plot at the 50% probability level of ligand 7a and 8. 
 
Table 1. Selected results of reductions of ester 16a-c and similar substrates. 
 
 
 
Entry Substrate Reaction Conditions Yield [%] 
1 R = ortho-OH  16a LAH (1.3 eq.), -30 °C / 3.5 h 32 
2 R = ortho-OH  16a 1 M DIBAL-H (3.5 eq.), 0 °C / 5 h 44 a 
3 R = para-OH   16b LAH (2.5 eq.), -30 °C - 0 °C, 100 min 93 a 
4 R = H  16c LAH (0.55 eq.), -30 °C - 0 °C, 75 min 74 
a
 optimized conditions; pH values were adjusted (pH~7). 
X-ray crystal 
structure of 7a 
X-ray crystal 
structure of 8 
d (N-H)
d (N-H)
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The second oxazoline ligand 8 was synthesized by a nucleophilic attack of a Grignard 
reagent on the ester 16a (Scheme 3). A commercially available MeMgBr-solution gave good 
yields (70%) of the tertiary alcohol 8 in this reaction. Both oxazolines provided crystals, 
which were suitable for X-ray structure determination (Scheme 3, right). They feature an 
almost planar structure between the aromatic- and the oxazoline-ring, indicating a conjugation 
across both systems. The proton of the phenolic OH-group remains in close proximity to the 
nitrogen (d(N-H) 1.9 Å), and it can be presumed that a long distance hydrogen bond may 
exist.  
 
The last oxazoline ligand 9 that was synthesized in this series exhibits similar structural 
characteristics as the ligands 7a and 8, but in this case the two methyl groups are located 
directly on the oxazoline ring and not in the side chain. To achieve this, a change in the 
synthetic strategy was required: 
 
 
 
Scheme 4. Synthesis of oxazoline precursors: a) TBDMSCl (1.5 eq.), NEt3 (3.0 eq.), DMAP (0.1 eq.), DCM, rt, 
72 h, 71%; b) 3.0 M MeMgBr (3.0 eq.), Et2O, 0 °C, 2 h, 89%. 
 
Starting again from serine methyl ester hydrochloride 15 (Scheme 4), the free alcohol is 
protected with TBDMSCl under standard conditions, leading to ester 17 in acceptable yields. 
The subsequent nucleophilic attack of a Grignard reagent (MeMgBr) gave the dimethylated 
amino alcohol 18 in excellent yield.48  
 
In order to access the ligand precursor 19 (Scheme 5), the imidate 11 and the amino 
alcohol 18 were successfully combined in moderate yield. After deprotection with TBAF, the 
desired ligand 9 was isolated in an optical active form in 73% yield. Notably, the modified 
synthetic route offers access to the opposite stereochemistry for the oxazoline 9 (and later on 
of two further bis(oxazolines) 2/5), with the configuration of the stereocentre at the oxazoline 
ring inverted in comparison to ligands 7a and 8. 
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Scheme 5. Synthesis of oxazoline precursor 19 and ligand 9: a) 11 (1.0 eq.), 18 (1.5 eq.), C2H4Cl2, reflux, 4 d, 
62%; b) NEt3 (0.1 eq.), TBAF (1.02 eq.), THF, rt, 20 h, 73%. 
 
The thiazoline (±)-10 is a known natural compound in the class of siderophores.49 Its 
similarity to the oxazoline ligands provides a good base for a further derivatization. Starting 
from L-cysteine 13 instead of L-serine 12 the synthesis of thiazoline (±)-10 follows a similar 
strategy as described above (Scheme 6).  
 
 
 
Scheme 6. Synthesis of thiazoline ligand (±)-10: a) SOCl2 (3.5 eq.), MeOH, rt, 4 d, 94%; b) 11 (1.0 eq.), 
C2H4Cl2, reflux, 48 h, 16%; c) NaBH4 (2.6 eq.), THF, reflux, 10 min, 61%. 
 
The acid 13 was transformed into the cysteine methyl ester hydrochloride 20. Coupling of 
the imidate 11 with the cysteine ester 20 gave a poor yield of 16% of the thiazoline ester 21. 
The last step, a reduction of the ester 21 to the thiazoline alcohol (±)-10, also proved to be 
difficult. Three different procedures were investigated: NaBH4 (Table 2, entry 1) was used as 
described in the literature.50,51 This afforded just a moderate yield of 61% thiazoline (±)-10 in 
racemic form. To improve this result the starting material 21 was also treated with LAH 
(Table 2, entry 2) at -30 °C, but no reaction was observed. Use of DIBAL-H (Table 2, entry 3) 
at -30 °C, 0 °C and rt also did not provide the reduced product. 
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Table 2. Reduction methods of thiazoline methyl ester 21. 
 
Entry Substrate Reaction Conditions Yield [%] 
1 21 NaBH4 (2.6 eq.), reflux / 10 min 61 / 6050 / 4151 
2 21 LAH (0.8 eq.), -30 °C / 3.5 h 0 a 
3 21 DIBAL-H (3.5 eq.), -30 °C / 3.5 h, 
0 °C / 2 h, rt / 12 h 
0 a 
a
 only unreacted starting material recovered. 
 
B.1.3 Route to Bis(oxazoline) Ligands 
 
B.1.3.1 Synthesis of Pyridine Linkers 
 
The bis(oxazoline) ligands 1-6 consist of two oxazoline units which are linked by a 
pyridine bridge. This bridge was synthesized starting from 2,6-pyridinedicarboxylic acid 22, 
which was first transformed into the dimethylester 23 (Scheme 7). 23 was then reduced with 
NaBH4 to the diol 24, followed by dichlorination to 25 using SOCl2. The resulting 
dichloride 25 was further treated with thiourea to afford diisothiourea 26. All reactions, 
starting from 22 to 26 are of high yields (> 90%) and afforded very pure compounds.  
 
 
 
Scheme 7. Synthesis of pyridine linker moieties: a) conc. H2SO4, MeOH, reflux, 5 h, 90%; b) NaBH4 (4.7 eq.), 
EtOH, 0 °C, 1 h, 96%; c) SOCl2 (2.2 eq.), Et2O, 0 °C / 1 h, rt/20 h, 90%; d) thiourea (2.4 eq.), EtOH, reflux, 
30 min, 96%; e) NaOH (5.5 eq.), H2O, reflux, 2 h, 78%. 
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For the preparation of dithiol 27, a nitrogen or argon atmosphere was necessary and all 
solvents were degassed before use. The diisothiourea 26 was treated with NaOH and was 
converted into the air-sensitive dithiol 27 in an improved yield of 78% in comparison with 
earlier results obtained in our group.42,43 The resulting unpleasant-smelling product 27 was 
stable to storage under inert gas at -20 °C for month. 
 
B.1.3.2  Coupling of ether-bridged Bis(oxazolines) 
 
Bis(oxazolines) linked by an ether moiety were prepared by a SN-type reaction of two 
nucleophilic oxazoline units and a dichloride pyridine linker 25 as the electrophile. NaH 
deprotonated both OH-groups of the oxazolines 7a, but only the attack of the primary 
alcoholate at the methylene carbon of 25 was observed, leading to the desired chiral 
bis(oxazoline) ligand 1 in 48% yield (Scheme 8).  
 
 
 
Scheme 8. Synthesis of bis(oxazoline) ligand 1: a) 7a (2.2 eq.), 25 (1.0 eq.), NaH 60% (4.1 eq.), DMF, 
0 °C / 70 °C, 24 h, 48%. 
 
A similar reaction of the dimethylated oxazoline derivative 9 resulted in a bis(oxazoline) 
comparable to 1 in moderate yield. This ligand 2 (Scheme 9) has the additional sterically 
demanding methyl groups on the oxazoline ring, and the stereocentres show an opposite 
configuration because of the changed synthetic strategy for the precursor 9 (Scheme 5). 
Furthermore, this ligand crystallized in colourless plates, which enabled X-ray crystal 
structure analysis, providing the final proof for the desired structure (Figure 1).  
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Scheme 9. Synthesis of bis(oxazoline) ligand 2: a) 9 (2.2 eq.), 25 (1.0 eq.), NaH 60% (4.1 eq.), DMF, 
0 °C / 70 °C, 72 h, 40%. 
 
The X-ray structure of 2 is characteristically stretched42 and shows the pyridine moiety in the 
centre of the molecule, which is flanked by two ether bridges and the linked oxazoline units 
(Figure 1). 
 
Figure 1. ORTEP plot at the 50% probability level of bis(oxazoline) 2.  
 
Attempts were made to couple the third oxazoline building block 8, which contains a 
sterically hindered tertiary alcohol, with the pyridine linker 25, but unfortunately this reaction 
failed to afford bis(oxazoline) 3 (Scheme 10). It is assumed that the methyl groups in the side 
chain prevent the bond formation due to an increased steric demand at the reaction centre.  
 
 
 
Scheme 10. Attempt towards the synthesis of bis(oxazoline) ligand 3: a) 8 (2.2 eq.), 25 (1.0 eq.), NaH 60% 
(4.1 eq.), DMF, 0 °C / 70 °C, 72 h, 0%. 
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B.1.3.3  Coupling of thioether-bridged Bis(oxazolines) 
 
To create a related bis(oxazoline) scaffold, which contains a thioether-bridge instead of an 
ether-bridge, further modification needed to be done before the coupling reaction. The 
conversion of the alcohol in the side chain of the oxazoline units to a leaving group was 
therefore envisioned. The oxazoline alcohol moieties were transformed into an electophile 
(Scheme 11-14) and the dithiol 27 (pyridine-linker) was used as the corresponding 
nucleophile. Differentiation between the aliphatic hydroxy functionality in the side chain and 
a phenolic one at the aromatic ring was necessary: A selective bromination of the primary 
alcohol under Appel-conditions should displace the nucleophilic OH to a good leaving group 
while leaving the phenolic hydroxyl group intact.43,52 PPh3 and CBr4 were used to modify 
oxazoline 7a (Scheme 11, top) and the resulting bromide (±)-28 was isolated in 67% yield, 
but all attempts afforded only a racemic mixture. 
 
 
 
Scheme 11. Synthesis of bis(oxazoline) precursors (±)-28 and 29a/b: a) CBr4 (1.2 eq.), PPh3 (1.2 eq.), DCM, 
0 °C-rt, 20 h, 67%; b) NEt3 (2.5 eq.), TsCl (1.1 eq.), DCM, 0 °C-rt, 20 h, 67%. 
 
To overcome this problem, a tosylation reaction was tested to prevent loss of the chiral 
information. This reaction tends to show no selectivity between both aliphatic and phenolic 
alcohols, but it was assumed that the influence of the sterical hindrance on the ortho-OH 
group would result primarily in the desired isomer 29a (Scheme 11, bottom), if a sterical 
demanding reagent as tosyl is used instead of mesyl. However, the outcome of this reaction 
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was initially unclear. 1H NMR spectra indicated that only the phenolic alcohol 29b was 
tosylated (the phenolic OH-peak at 12 ppm disappeared and the aliphatic OH-peak around 3 
ppm was still present) and therefore the subsequent attempt at the coupling reaction failed. 
The use of a sterical hindered reagent was unfortunately not convenient. A possible 
explanation for the preferential formation of substituted phenol-OH 29b can be found in the 
pKs-values. The pKs-value of a primary alcohol lies around 17, whereas a phenolic alcohol 
has a pKs of approximately 10.53 The base therefore deprotonated the more acidic phenolic-
OH preferentially and this reacted although being sterically more hindered. 
 
A proposed mechanism of the racemization during the Appel-bromination is outlined in 
Scheme 12: Initiated by an attack of PPh3 on CBr4, a Ph3PBr+CBr3- salt is formed. CBr3-
deprotonates oxazoline 7a to oxazoline 7d, and in a nucleopilic substitution reaction the 
primary alcoholate of 7d binds to the phosphane of the salt and forms 7e. The final step in the 
Appel-mechanism (Scheme 12, route a) is fulfilled by a free bromide attack on the 
electrophilic methylene carbon bearing the oxygen in 7e, resulting in the corresponding 
oxazoline bromide S-28. The driving force of this reaction results from the high stability of 
leaving group O=PPh3. However, this final step faces a competing reaction: The free bromide 
is also able to attack the electrophilic carbon (Scheme 12, route b) of the oxazoline ring in 7e 
and initiates a ring opening reaction,54 the bond between the nitrogen and the stereocentre is 
thus free to rotate. The new created oxygen nucleophile from the oxazoline ring subsequently 
reacts with the methylene carbon of the former side chain in a ring closing reaction to R-28, 
releasing O=PPh3. This proposed mechanism shows the generation of both enantiomers of 
bromide 28, therefore explaining why the synthesis results in a racemic mixture. 
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Scheme 12. Proposed mechanism for the racemization during  the Appel-reaction. 
 
To avoid the competing reaction, the electrophilic carbon in the oxazoline ring has to be 
made less accessible.43 This property is present in oxazoline 9 with its two sterical demanding 
methyl groups, which also decrease the electrophilic character of this carbon (Scheme 13). 
Under the same reaction conditions, 90% yield of the bromide 30 was isolated in an optically 
active form. 
 
 
 
Scheme 13. Synthesis of bis(oxazoline) precursor 30: a) CBr4 (1.2 eq.), PPh3 (1.2 eq.), DCM, 0 °C-rt, 24 h, 90%. 
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Also the conversion of oxazoline 8 into its bromide 31 was attempted (Scheme 14). In this 
case, the methylene carbon in the side chain contains two methyl groups, which provide steric 
hindrance. Unfortunately this reaction resulted in no product formation and only starting 
material was recovered. It is presumed that the methyl groups prohibit the initial attack of the 
phosphane of the salt (Scheme 14), and therefore the necessary leaving group was not formed. 
 
 
 
Scheme 14. Attempt towards the synthesis of bis(oxazoline) precursor 31: a) CBr4 (1.2 eq.), PPh3 (1.2 eq.), 
DCM, 0 °C-rt, 24 h, 0%. 
 
The racemic bromide (±)-28 was successfully used in the coupling reaction with the 
dithiol pyridine linker 27 (Scheme 15). The SN-reaction generated the bis(oxazoline) ligand 
mixture (±)-4/(meso)-4 in 78% yield, but due to the use of the racemate of (±)-28, the 
bis(oxazoline) (±)-4/(meso)-4 was not optical active. 
 
 
 
Scheme 15. Synthesis of bis(oxazoline) ligand (±)-4/(meso)-4: a) (±)-28 (2.2 eq.), 27 (1.0 eq.), NaH 60% 
(2.5 eq.), DMF, 0 °C / 70 °C, 24 h, 78%. 
 
The successfully synthesized precursor 30 was also coupled to the dithiol pyridine linker 
27, and the chiral bis(oxazoline) ligand 5 was formed in 78% yield. Notably, bis(oxazoline) 
ligand 5 possesses two inverted stereo centres compared to ligands 1 and 2, and additional 
sterically demanding methyl groups at the oxazoline-rings, which have their origin in the 
different synthesis. 
Main Part – Oxazoline Complex Analysis 
 
35 
 
 
Scheme 16. Synthesis of bis(oxazoline) ligand 5: a) 30 (2.2 eq.), 27 (1.0 eq.), NaH 60% (2.5 eq.), DMF, 
0 °C / 75 °C, 90 h, 78%. 
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In summary, three chiral oxazoline ligands 7a-9 and one racemic thiazoline ligand (±)-10 
were synthesized. Furthermore, two optical active ether-bridge bis(oxazoline) ligands (1, 2) as 
well as two thioether-bridge bis(oxazoline) ligands ((±)-4/(meso)-4, 5) were also generated. 
An overview of all the ligands synthesized is presented in Figure 2: 
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Figure 2. Ligand collection. 
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C. Main part – Oxazoline Complex Analysis 
 
C.1 Determination of Stoichiometry and Equilibrium Constant 
 
C.1.1 Siderophores – A General Introduction 
 
The transition metal iron plays an important role in biological systems. This is based on its 
distribution on earth (approximately 5%) as well as its redox potential Fe2+/Fe3+ 
(+0.77 V / pH 0 and -0.69 V / pH 14) adequate for biological processes. The continuous 
access to iron over millions of years allowed its broad integration by evolution. In spite of its 
high deposition (second most metal abundant), its natural concentration in solution is 
disappearingly low under today`s aerobic conditions (e.g. metal ion Fe3+ in the sea 
10-17 M).3,55 This is caused by a restricted solubility of most iron species, which usually 
consist of insoluble oxides and sulfides. Furthermore, the bioavailability of iron is also limited 
by the solubility of Fe3+ ions (<10-17 M) under physiological conditions (pH 7-8). 
Nevertheless, prokaryotic and eukaryotic cells need an iron concentration of 10-7 M for a well 
working metabolism.1,56 To handle this deficit, nature developed iron-specific chelators to 
supply cells with sufficient amounts of this metal. These chelators are named siderophores 
and are synthesized by microorganisms, e. g. bacteria and fungi, but not from higher 
developed species. The iron transport system in higher eukaryotes is rather based on transfer- 
and storage-proteins (e. g. transferrin and ferritin, respectively).57,58  
 
Around 200 different species of natural siderophores are known and they can be found in 
high concentrations in the ground and in the sea. Siderophores are usually secreted into the 
cell environment to absorb the metal, transport it into the cell, metabolize or store it and 
finally excrete iron out of the cells. Because of the restricted solubility of iron-species, a 
successful binding of iron requires a high binding constant of the formed chelat (iron-
siderophore complexes, log K = 15-50; in comparison: iron(III)-EDTA complex, 
log K = 25).59 They prefer hexadentate binding motifs and can therefore form octahedral 
complexes, a geometry favoured by iron. Furthermore, siderophores highly prefer Fe3+ in 
comparison to transition metals similar in size and charge. Even Fe2+ possesses a noticeable 
lower binding constant. Indeed, this allows the siderophores to bind Fe3+ and to release the 
metal again by reduction. Microorganisms produce low-molecular-weight siderophores 
(~300-2000 Da), which can be classified into three different types of ligands:  
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(1) catecholamides (e. g. parabactin 32),  
 
(2) hydroxamates (e. g. desferrioaxamine DFO 33) and 
 
(3) α–hydroxy/keto-carboxylates (e. g. desferrithiocin DFT 34) (Figure 1).60 
 
 
 
Figure 1. Different types of siderophores. 
 
The necessity of siderophores as potential agents in medicine also becomes clear by the 
fact that in humans just 1 mg of iron can be absorbed and excreted per day. Iron excess leads 
to deposition of the transition metal in heart, liver, pancreas, and other tissues. The enhanced 
risk for iron-overload disease is caused by genetic defects (e. g. hemochromatosis – increased 
absorption of iron through nutrition; or β-thalassemia major and other refractory anemias – 
treatment needs continual blood transfusions and consequently a higher accumulation of iron 
takes place as usual). The harmful build-up of iron in the human body leads directly to other 
diseases like cirrhoses, diabetes, and heart dysfunction.57,58  
 
Furthermore, iron-overloading is also directly associated with significant oxidative damage 
to tissues. The Fenton reaction results here in serious consequences (Scheme 1). Ferrous Fe2+ 
is oxidized by an oxidant (e. g. H2O2) to ferric Fe3+, and a free hydroxyl radical is released. 
Fe3+ is then reduced back to Fe2+ (e. g. by H2O2 or other biological reductants, e. g. ascorbate 
cycle) and produces a further hydrogen peroxide radical.61-63 
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Scheme 1. Fenton reaction. 
 
Free radicals are known as very harmful species in living tissues. After their formation, 
they are able to start radical-mediated chain processes and therefore they can attack 
membranes, DNA, and many other important biological components. Hence, radical reactions 
cause mutations in different phases of the cell, destroy the proliferation and apoptosis rhythm 
and lead finally to a variety of cancer.  
 
The limited physiological mechanisms to excrete iron and the complete lack of efficient 
mechanisms to excrete excess iron require effective therapies.64,65 One of the first iron 
chelators that was shown to be orally active is desferrithiocin (DFT 34, Figure 1). It belongs 
to a unique class of iron-complexing natural compounds and was originally observed as a 
metabolite in the micro-organism of Streptomyces antibioticus.66 DFT is known as a tridentate 
siderophore that forms a stable 1:2 complex with Fe3+ (log K = 29.6). 67,68 In biological tests, 
DFT 34 proved to be a successful chelator and showed good iron-clearing efficiency values 
(ICE-value).69-71 The enormous disadvantage of desferrithiocin 34 lies in its high nephrotoxic 
character.71 Therefore, the medicinal research is strongly interested in finding analogues of 
DFT which possess high ICEs as well as higher compatibility with the kidney.72,73 In addition 
to the medical aspects, the analysis of the binding geometry of siderophores and their 
electronic properties are a current area of research. 
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C.1.2 Stoichiometry Determination by Job`s Plot Analysis 
 
The complex of oxazoline ligand 7a and Fe(ClO4)2•6(H2O) was used as a representative 
oxazoline-iron complex and the stoichiometry was determined by spectrophotometric 
UV/Vis-titration. The typical low-energy absorption maximum around 500 nm served to 
detect the newly formed complex. This spectroscopic feature describes the charge-transfer 
transition (LMCT) from the pπ orbitals of the phenolic oxygens to the half-filled dπ* orbitals 
of the ferric iron(III) ion (Figure 2).74-76 
 
 
 
Figure 2. UV/Vis-titration for ligand 7a and Fe(ClO4)2•6H2O – mole fractions for ligand 7 are shown. 
 
Bergeron and co-workers explored similar ligands (35 and 36, Figure 3), which in analogy 
to the oxazolines 7a-9 form 1:2 complexes with iron.60,77,78 It was assumed that ligand 7a, due 
to its close structural relationship, would exhibit the same stoichiometry.  
 
 
 
Figure 3. Oxazoline ligand 7a and desazadesmethyldesferrithiocin analogues 35 and 36. 
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Theoretically, a 1:2 complex shows a significant maximum in the Job`s Plot at 0.667 for 
the mole fraction of the ligand. To confirm this for the case of ligand 7a, all absorptions at the 
maximum of 506 nm for each concentration were plotted against the corresponding mole 
fraction of the ligand (Figure 4). 
 
 
 
Figure 4. Job`s Plot for ligand 7a and Fe(ClO4)2•6H2O.60,78 
 
Indeed, the Job`s Plot of ligand 7a gave the evidence for a 1:2 complex by showing a 
maximum at 0.69. Due to the high structural similarity within oxazoline ligands (7a-9) and 
thiazoline ((±)-10), it is reasonable to assume that all these ligands will also form a complex 
with 1:2 stoichiometry, which was later confirmed by X-ray structure analysis (see main part 
- oxazoline complex analysis C.2.1–C.2.8). 
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C.1.3 Determination of Equilibrium-Constants  
 
The defining characteristic of siderophores is their high affinity towards iron. Therefore, it 
is of highest interest to compare the affinity of typical siderophores to iron with different new 
model structures. Abdallah and co-workers79 published a UV/Vis-titration experiment to 
determine the equilibrium constant of pyochelin 37 and its analogues (Figure 5). This 
experimental protocol can be used for investigations on the equilibrium constant for the 
complex formation using oxazoline ligand 7a. To obtain a better understanding of the binding 
properties, the closely related thiazoline ligand (±)-10 was also synthesized. With its thiazole 
moiety, (±)-10 serves as a bridge between the oxazoline ligand 7a and the siderophore 
pyochelin 37 and its analogues 38 / 39, which also include a thiazole ring system.  
 
 
 
Figure 5. Bacterial siderophores 37-39 in comparison to oxazoline 7a and thiazoline (±)-10.79 
 
For the investigated ligand 7a it was already shown that the stoichiometry of binding to the 
metal is a 1:2 ratio (Figure 4). In theory, a ligand L is always in equilibrium with the metal M 
and the feasible complexes ML (1:1) and ML2 (1:2). The equilibrium reactions of both 
complexes as well as their equilibrium constant equations (K1 and K2) are outlined in 
Scheme 2. For each ligand attachment, the phenol moiety of the ligand has to be deprotonated 
first and release one proton. To simplify this situation an acetonitrile/H2O (1:1) system, 
buffered with 0.053 M formic acid, was chosen. This gives rise to the assumption that the 
concentration of the protons is constant while the reactions run at the same pH of ~2. 
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Scheme 2. Equilibrium reaction of a ML- and a ML2- complex and the corresponding conditional equilibrium 
constant equations of K1 and K2. 
 
The overall equilibrium constant K3, which is given by the product of K1 and K2, is shown in 
Scheme 3 and points out the tendency of a ligand to build a 1:2 complex. 
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Scheme 3. Overall equilibrium constant equation of K3. 
 
Abdallah and co-workers79 calculated the conditional equilibrium constants for 37–39 
(Table 1) using these known equations. In the case of pyochelin 37 and its derivative 38, the 
equilibrium constants K1 was found to be much higher than K2. However, methyl 
hydoxamate 39 results in similar K1 and K2 values. The value of the overall formation 
constant K3 for all 1:2 complexes is very high and confirms a strong binding to the iron ion.  
 
Table 1. Conditional equilibrium constants (pH~2) determined for the formation of Fe(III) complexes of 
pyochelin and its analogs.79 
 
Entry Ligand K1 [M-1] K2 [M-1] K3 [M-2] 
1 pyochelin 37 6740 
(±4640  69%) 
274 
(±178  65%) 
1.85 • 106 
 
2 3´´-nor-NH-pyochelin 38 33300 
(±4940  15%) 
2630 
(±1070  41%) 
87.6 • 106 
 
3 methyl hydoxamate 39 3010 
(±520  17%) 
2790 
(±779  28%) 
8.40 • 106 
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As already used in for the construction of the Job`s Plot (Figure 4), the same charge-
transfer transition served here also as the detectable absorption band. The titration 
experiments are based on the Lambert-Beers law: 
 
absorbance (λ) = OD = εML (λ) • cML + εML2 (λ) • cML2 
 
The optical density (OD) consists of the absorptions resulting from the ML (1:1) and the 
ML2 (1:2) complexes formed. To obtain the extinction coefficients εML and εML2, different 
titrations were done. In the forward titration a constant concentration of the metal M was used 
and the concentrations of the ligand L were continuously increasing (see experimental part). 
The complex formed at high ligand-to-metal concentration ratios was therefore assumed to 
have a 1:2 complex character. In the reverse titration with a constant concentration of the 
ligand L the concentration of the metal M was increased (see experimental part), and a 
complex at a high metal-to-ligand concentration ratio was expected to form a 1:1 
stoichiometry. 
 
Figure 6 and 7 show the outcome of the forward and reverse titrations of oxazoline 
ligand 7a and the thiazoline ligand (±)-10, respectively, using FeCl3•6H2O as the iron source. 
On the left hand side the ligand-to-metal ratios (L/M) and on the right hand side the metal-to-
ligand ratios (M/L) are given: 
 
 
 
Figure 6. UV/Vis-titration for ligand 7a and FeCl3•6H2O – forward titration: ratios of ligand 7a / FeCl3•6H2O 
(ligand/salt) (left) and reverse titration: ratios of FeCl3•6H2O / ligand 7a (salt/ligand) (right).  
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Figure 7. UV/Vis-titration for ligand (±)-10 and FeCl3•6H2O – forward titration: ratios of ligand 
(±)-10 / FeCl3•6H2O (ligand/salt) (left) and reverse titration: ratios of FeCl3•6H2O / ligand (±)-10 (salt/ligand) 
(right).  
 
The extinction coefficients for oxazoline 7a and thiazoline (±)-10 were calculated by 
Lambert-Beers law under the described conditions and are outlined in Table 2. The 
wavelengths used were chosen around the given maximum. With the extinction coefficients in 
hand, the conditional equilibrium constants for both ligands were accessed and point to an 
eight to eighteen times higher K1 value in comparison to K2 (Table 3, entry 1 and 3). The 
calculated errors of 61% and 38% of oxazoline 7a (Table 3, entry 1) are comparable to the 
results obtained by Abdallah and co-workers (Table 1), but indicate a high variance in the 
calculated data. An attempt to optimize the equilibrium constant calculation for oxazoline 
ligand 7a (Table 3, entry 2) by decreasing the dispersion of the data (excluding data points 
with highest variance) resulted in a K3 value of 0.99 • 106 M-2 and decreased errors of 15% 
and 8% for K1 and K2. Nevertheless, both equilibrium constants K3 (Table 3, entry 1-2) are 
much smaller in comparison to the natural siderophore pyochelin 37 and its analogs 38 and 39 
(Table 1).  
 
Table 2. Extinction coefficients of the ML as well as the ML2 complex of oxazoline 7a and thiazoline 10. 
 
Entry Ligand Wavelength [nm] εML εML2 
1 oxazoline 7a 530 
580 
1448 
1287 
4465 
2762 
2 thiazoline 10 
 
535 
580 
1315 
1386 
2506 
2541 
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Table 3. Conditional equilibrium constants (pH~2) determined for the formation of Fe(III) complexes of 
oxazoline 7a and thiazoline 10. 
 
Entry Ligand K1 [M-1] K2 [M-1] K3 [M-2] 
1 oxazoline 7a 1134 
(±690  61%) 
144 
(±55  38%) 
0.158 • 106 
(±0.899  57%) 
2 oxazoline 7a a 748 
(±111  15%) 
131 
(±8  6%) 
0.989 • 106 
(±0.208  21%) 
3 thiazoline (±)-10 1855 
(±1996  108%) 
100 
(±103  102%) 
0.116 • 106 
(±0.125  108%) 
a
 decreasing the dispersion of the data by excluding data points with highest variance. 
 
With regard to the thiazoline (±)-10 titration, the calculated errors indicate that the attempt 
to obtain the equilibrium constants by UV/Vis-titration completely failed (Table 3, entry 3). 
Even an optimization was not feasible and the reason for the unsuccessful approach is 
probably found in the simplified nature of the experiment. Because a racemic ligand was 
used, at least two complex species (R,R / S,S and R,S) might form and this was not paid 
attention to in the calculation. An improvement might be possible by a more sophisticated and 
multivariable data analysis program for modelling and fitting chemical kinetics, as well as 
expanding the theory of the complex formation kinetics. 
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C.2 Characterization of Oxazoline-Metal-Complexes 
 
C.2.1 Formation of Iron(III) Complexes using Fe(ClO4)2•6(H2O) 
 
The series of oxazoline derivatives 7a-9 were utilized to form complexes with 
Fe(ClO4)2•6(H2O) as an iron source (Scheme 4). As already demonstrated above (see main 
part - oxazoline complex analysis C.1.2, Figure 4), this type of ligands will form 
1:2 complexes. Therefore, two equivalents of ligand 7a-9 were dissolved in THF and were 
transferred into a solution of one equivalent Fe(ClO4)2•6(H2O) in THF. The colour 
immediately changed from slightly yellow to dark purple, indicating a rapid complex 
formation. In addition to that, the iron(II) complexes formed seem to be highly sensitive to air 
and get immediately oxidized from Fe2+ to Fe3+ (the dark purple colour originates from a 
charge-transfer transition from the phenolic oxygen to a iron(III) ion).74  
 
OH
NO
OH
OH
NO
OH
OH
NO
OH
Fe(ClO4)2 6H2O
Fe(ClO4)2 6H2O
Fe(ClO4)2 6H2O
7a
9
8
2
2
2
63%
15%
48%
THF, rt, 12h, air
THF, rt, 12h, air
THF, rt, 12h, air
ClO4
-
N
O
O
N
O
O
FeIII
OHHO
[FeIII(7a)2] (ClO4)
ClO4
-
N
O
O
N
O
O
FeIII
OH
O
ClO4
-
N
O
O
N
O
O
FeIII
OH
O
[FeIII(8)2] (ClO4)
[FeIII(9)2] (ClO4)
 
 
Scheme 4. Synthesis of iron(III) complexes [FeIII(7a-9)2]•(ClO4) using Fe(ClO4)2•6H2O. 
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The non-coordinating nature of the counterpart anion, ClO4-, leads to the assumption that the 
hydroxymethylene alcohols also coordinate to the iron(III) centre, to form the preferred 
octahedral geometry, which was later proven by X-ray analysis (Figure 8). 
 
C.2.2 Solid-State-Analysis of Iron(III) Complexes – [FeIII(7a-9)2]•(ClO4) 
 
Typical features of the complexes [FeIII(7a-9)2]•(ClO4) were identified by investigating the 
IR spectra. A broad alcohol stretch at 3250 - 3400 cm-1 and the shift of an attributed strong 
band from 1644 cm-1 (uncoordinated and unsaturated C=N stretch) to 1612 cm-1 for a 
coordinating ligand C=N vibration are seen. Furthermore, a characteristic broad and very 
strong band at 1080 cm-1 as well as a sharp band at 619 cm-1 indicated the presence of a 
perchlorate.80 
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Figure 8. ORTEP plot at the 50% probability level of [FeIII(7a)2]•(ClO4) – (not important hydrogen atoms and 
ClO4- are omitted for clarity). 
 
In the crystallographic measurement of [FeIII(7a)2]•(ClO4) the two ligands are bound 
meridionally to the metal centre (Figure 8). This class of oxazoline-phenolates chelats iron 
with their nitrogen atoms of the oxazoline-ring systems, the deprotonated phenolates and the 
protonated hydroxymethylene groups of the side chain. In the resulting bis(tridentate) iron(III) 
complex [FeIII(7a)2]•(ClO4), the iron(III) ion equalizes two negative charges on the phenolates 
and one perchlorate in the outer environment of the complex to give a neutral compound. The 
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distance of the two oppositely placed nitrogen atoms to the octahedral chelated metal has the 
typical length of 2.00 to 2.03 Å (Table 4), which was also observed in a similar crystal 
structure (Figure 13) obtained by Bouwman and co-workers,44 who used a comparable ligand 
system ((±)-46, see main part - catalysis E.1.1, Figure 1). The bond lengths between the iron 
centre and the phenolate oxygen atoms (Fe(1)-O(1), Fe(1)-O(4)) of 1.88 Å and the 
hydroxymethylene group (Fe(1)-O(3), Fe(1)-O(6)) of 2.23 / 2.26 Å to the metal centre fit also 
to these published data.44 A trans-oriented alignment of N(1)-Fe(1)-N(2) was confirmed by an 
angle of 159°, leading to a slightly distorted octahedral geometry. Characteristic for a 
meridional ligand is also the angle between both oxygen binding sites (O(1)-Fe(1)-O(3)), 
spanning 159°, which indicates a nearly opposite position. The orientation of both ligands is 
described by the angle between O(1)-Fe(1)-O(6) with 92°, showing the ligands in a nearly 
perpendicular alignment (Table 4). The complex [FeIII(7a)2]•(ClO4) was identified as a 
mer-(O,N,O-∆) isomer (Figure 9).  
 
 
 
Figure 9. Meridional octahedral binding models Λ and ∆ for two tridentate ligands.81 
 
 
An overview of all obtained iron(III) oxazoline X-ray structures is given in experimental part 
– F.11, Figure 8. 
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Table 4. Selected bond distances (Å) and angles (°) of [FeIII(7a)2]•(ClO4). 
 
 Bond Distances [Å]  Angles [°] 
Fe(1)-O(1) 1.881(7) O(1)-Fe(1)-O(3) 158.7(3) 
Fe(1)-O(3) 2.255(9) O(1)-Fe(1)-O(4) 103.2(3) 
Fe(1)-O(4) 1.881(8) O(1)-Fe(1)-O(6) 91.8(3) 
Fe(1)-O(6) 2.227(8) O(1)-Fe(1)-N(1) 87.0(4) 
Fe(1)-N(1) 2.003(10) O(1)-Fe(1)-N(2) 106.7(4) 
Fe(1)-N(2) 2.023(9) O(3)-Fe(1)-O(4) 89.2(3) 
  O(3)-Fe(1)-O(6) 82.0(3) 
  O(3)-Fe(1)-N(1) 72.9(3) 
  O(3)-Fe(1)-N(2) 91.0(3) 
  O(4)-Fe(1)-O(6) 158.1(3) 
  O(4)-Fe(1)-N(1) 104.9(4) 
  O(4)-Fe(1)-N(2) 87.3(3) 
  O(6)-Fe(1)-N(1) 91.6(3) 
  O(6)-Fe(1)-N(2) 73.0(3) 
  N(1)-Fe(1)-N(2) 159.3(4) 
 
 
Furthermore, the mass spectrometry (ESI) shows for all complexes [FeIII(7a-9)2]•(ClO4) a 
significant mass peak corresponding to the 1:2-iron(III) complex ([FeIII(L)2]+) of the specific 
ligand. Additionally in two spectra the mass for the free ligand (L) was detected. The 
elemental analysis confirmed for all three compounds the proposed complex system, 
including two ligands with deprotonated phenols, one iron metal and one perchorate ion 
(Scheme 4).  
 
C.2.3 Liquid-State-Analysis of Iron(III) Complexes – [FeIII(7a-9)2]•(ClO4) 
 
The UV/Vis spectra of the complexes [FeIII(7a-9)2]•(ClO4) were measured between 200 
and 750 nm in acetonitrile at room temperature (Figure 10). All three iron(III) compounds 
show the same absorption bands indicating the same structure in solution, which was also 
strengthened by comparing the UV/Vis spectra of further iron(III) complexes with a different 
binding motive (see experimental part F.9.2, Figure 7). To differentiate which absorption 
maximum belongs to the metal, the ligand or to the complex, each of them was explored 
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separately under the same conditions (see experimental part F.9.2, Figure 1 and 4) and so an 
assignment of the high energy maxima at 240 nm and 300 nm was possible. They characterize 
ligand based transitions (n → π* or π → π*) and are probably caused by the chromophore of 
the conjugated system in the ligand. The shoulder between 350 and 400 nm as well as the 
absorption at 475 nm are identified as complex specific. These features in the electronic 
spectra are the relatively intense charge-transfer (CT) bands responsible for the dark purple 
colour and they can be assigned to a transition from the pπ orbital on the phenolate oxygen to 
the half-filled dπ* orbitals on the ferric iron(III) ion.74-76 
 
 
 
Figure 10. UV/Vis spectra for the [FeIII(7a-9)2]•(ClO4) series. 
 
The circular dichroism spectra (CD) of the [FeIII(7a-9)2]•(ClO4) series exhibit a high 
similarity in behaviour under the influence of circularly polarized light (Figure 11), and are 
not comparable to the CD spectra of further iron(III) complexes. An example for this, 
including ligand 7a is shown in experimental part F.9.2, Figure 7.  
 
The specific features of this class of iron(III) complexes reach from 200 to 750 nm, 
measured in acetonitrile at room temperature. Complex [FeIII(7a)2]•(ClO4) (Figure 11, black 
line), for which the crystallographic data are known, was identified as an octahedral ∆-isomer 
with two tridentate meridional ligands, and it is presumed that [FeIII(7a)2]•(ClO4) has the same 
conformation in solution. Following this assumption, the CD spectra of the complexes 
[FeIII(8/9)2]•(ClO4) (Figure 11, light and dark grey line), can be interpreted as their mirror 
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imaged curves in comparison to [FeIII(7a)2]•(ClO4), what leads to the reasonable assumption 
that [FeIII(8/9)2]•(ClO4) will form the opposite meridional Λ-isomer. However, this 
conclusion, obtained from the CD, means that two stereo chemical analogue ligands 7a and 8, 
differing only in the substituted methylene alcohols, are able to control both complex 
geometry formations. Within this thesis, this effect was observed only by using 
Fe(ClO4)2•6(H2O) and might be caused by its unique meridional complex binding ability.  
 
The CD spectra of the ligands 7a-9 (see experimental part F.9.2, Figure 4) are still in 
agreement with their stereo chemical information. 
 
 
 
Figure 11. CD spectra for the [FeIII(7a-9)2]•(ClO4) series. 
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The observation that ligands with identical absolute configuration of the chiral carbon atom 
are able to form both enantiomeric metal coordination geometries was already reported by 
Hahn and co-workers.68 In the anionic chromium(III) complex including ligand 34 (DFT, 
desferrithiocin) the counter cation controls the meridional isomer formation. The Λ-isomer 
was crystallized as the tetramethylammonium salt, and the ∆-isomer was obtained as the 
potassium salt (Figure 12). 
 
 
 
Figure 12. Two chromium(III) complexes, including the S-configurated ligand 34 and different counter cations, 
are able to form different metal geometries.68 
 
The proposed structure model of the siderophore desferrithiocin (DFT), chelating an Fe3+ 
ion, predicted a meridional octahedral iron(III) complex formation (Figure 13, top).77 
Bouwman and co-workers44 reported recently a structurally-characterized analog for an 
iron(III) sidereophore complex, using a very similar ligand structure to DFT, which contains 
instead of a chiral thiazoline system a racemic oxazoline moiety (±)-46 (Figure 13, bottom, 
right). The crystallized complex consists only of the (S)-configurated ligand and shows an 
anionic isomer of (HNEt3)2•[FeIII((S)-46)2]•(ClO4). 
 
The comparability of the proposed structure formation as well as the model of Bouwman to 
the X-ray structure of complex [FeIII(7a)2]•(ClO4) (Figure 13, bottom, left), which resulted 
from a DFT related enantiopure ligand 7a, provides a further suitable model system to mimic 
the binding characteristic of this important siderophore. Both obtained crystal structures for 
(HNEt3)2•[FeIII((S)-46)2]•(ClO4) and [FeIII(7a)2]•(ClO4) show the same metal geometry 
(Figure 13, bottom). Due to the enantiopure ligands 7a-9, the CD spectroscopy of the 
corresponding iron(III) complexes offers further information on the complex behaviour in 
solution.  
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Figure 13. Proposed structure of desferrithiocin diastereomeric 1:2 complexes with Fe3+ (top); X-ray structure of 
the anionic isomer mer-[FeIII(S)-46)2]- (bottom, left) and determined structure of [FeIII(7a)2]•(ClO4) (bottom, 
right).68,77 
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C.2.4 Formation of Iron(III) Complexes using Fe(OAc)2 
 
Many nonheme iron enzymes are based on N- and O-containing ligands, and therefore 
carbonic acids plays an important role as oxygen source. To investigate this on the oxazoline 
ligand systems, Fe(OAc)2 was choosen to test the effect of an acetate residue on the metal 
centre. The preparation of the [FeIII(7a-9)2(OAc)] complex series required a change of the 
solvent. Fe(OAc)2 proved to be highly insoluble in THF and only the use of a very polar 
solvent led to a homogenous solution, which is necessary for a successful complex formation. 
Two equivalents of ligand 7a-9 were therefore dissolved in N,N-dimethylacetamide (DMA) 
and transferred into a solution of Fe(OAc)2 in DMA (Scheme 5), which was accompanied by 
an immediate colour change from slightly yellow into a dark orange-red complex. This 
intensive colour is significant for these complex formations and it is assumed that the iron(II) 
complex initially formed is not stable on air and is oxidized.74  
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Scheme 5. Synthesis of iron(III) complexes [FeIII(7a-9)2(OAc)] using Fe(OAc)2. 
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C.2.5 Solid-State-Analysis of Iron(III) Complexes – [FeIII(7a-9)2(OAc)] 
 
IR analysis of all three [FeIII(7a-9)2(OAc)] complexes revealed a typical stretch of the free 
alcohols at 3340 - 3410 cm-1 and the shifted strong stretch from 1644 cm-1 (uncoordinated and 
unsaturated C=N stretch) to 1604 cm-1 for a coordinating ligand C=N vibration The bound 
acetate is detected by two characteristic bands at 1580 cm-1 and at 1240 cm-1. 
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Figure 14. ORTEP plot at the 50% probability level of [FeIII(7a)2(OAc)] – (not important hydrogen atoms are 
omitted for clarity). 
 
For complex [FeIII(7a)2(OAc)] a crystal structure was obtained (Figure 14). The iron(III) 
centre is chelated by two bidentate oxazoline ligands 7a and one bidentate acetate. The 
positive charge of the metal is in balance with two deprotonated phenolates as well as with the 
negative charge of the acetate. The distorted octahedral binding structure is given by the 
trans-oriented nitrogen atoms with an angle of 179° (N(1)-Fe(1)-N(2)) and a bond distance of 
2.09 Å (Fe(1)-N(1)/(2)) (Table 5). Furthermore, the nearly planar orientation of the four 
oxygens of the phenolates and the acetate around the iron are in agreement with this 
geometry. The bond lengths of O(1) and O(4) to the metal Fe(1) are shorter (1.92 Å) as 
compared to the distance of O(7) and O(8) to Fe(1) (2.11 Å). The angles between O(1)-Fe(1)-
O(4) and O(7)-Fe(1)-O(8) span 104° and 62°, respectively, resulting in a strong distortion of 
the octahedral geometry. Nevertheless, the complex [FeIII(7a)2(OAc)] can be identified as the 
Λ-isomer (Figure 15).  
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Based on the strong counter anion acetate, the meridional bis(tridentate) structure 
formation, found for the perchlorat complex [FeIII(7a)2]•(ClO4), was not able to form in this 
case. Because of this, the unbound hydroxymethylene groups are both aligned to be anti to the 
acetate ligand and the distances between Fe(1)-O(3)/O(6) are measured as 3.82 / 3.80 Å 
(values not given in Table 5). 
 
Table 5. Selected bond distances (Å) and angles (°) of [FeIII(7a)2(OAc)]. 
 
 Bond Distances [Å]  Angles [°] 
Fe(1)-O(1) 1.927(2) O(1)-Fe(1)-O(4) 103.86(11) 
Fe(1)-O(4) 1.914(3) O(1)-Fe(1)-O(7) 99.63(11) 
Fe(1)-O(7) 2.122(3) O(1)-Fe(1)-O(8) 160.24(11) 
Fe(1)-O(8) 2.106(3) O(1)-Fe(1)-N(1) 86.47(11) 
Fe(1)-N(1) 2.091(3) O(1)-Fe(1)-N(2) 92.19(12) 
Fe(1)-N(2) 2.095(3) O(4)-Fe(1)-O(7) 155.56(11) 
  O(4)-Fe(1)-O(8) 95.48(11) 
  O(4)-Fe(1)-N(1) 93.80(12) 
  O(4)-Fe(1)-N(2) 86.78(12) 
  O(7)-Fe(1)-O(8) 61.78(11) 
  O(7)-Fe(1)-N(1) 94.28(12) 
  O(7)-Fe(1)-N(2) 85.67(12) 
  O(8)-Fe(1)-N(1) 88.28(12) 
  O(8)-Fe(1)-N(2) 92.89(12) 
  N(1)-Fe(1)-N(2) 178.64(12) 
 
 
An overview of all obtained iron(III) oxazoline X-ray structures is given in experimental part 
– F.11, Figure 8. 
 
 
 
Figure 15. Octahedral binding models ∆ and Λ for three bidentate ligands. 
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Figure 16. ORTEP plot at the 50% probability level of [FeIII(8)2(OAc)] – (not important hydrogen atoms are 
omitted for clarity). 
 
The crystallographic results of complex [FeIII(8)2(OAc)] show two bidentate oxazolines 
around the iron centre and an additional third bidentate acetyl ligand (Figure 16). Both 
phenolates as well as the acetate compensate the charge of the Fe3+ centre, forming a neutral 
complex. Both nitrogen atoms are placed in a trans-position (178°) with a bond length to the 
metal of 2.12 Å (Table 6).44,82 The deprotonated oxygens of the phenolate groups also bind 
with the typical length of 1.98 Å, comparable to the other crystal structures obtained in this 
series. The angle between these oxygen atoms (O(1)/O(4)) and iron is stretched (106°) as 
usual by the planar coordinating bidentate acetyl ligand (61° for O(7)-Fe(1)-O(8)), to a highly 
distorted octahedral structure. The average bond length of an acetate oxygen to the metal was 
found to be 2.13 Å. The two substituted hydroxymethylene side chains are not involved in the 
complexation and point away from the metal centre, resulting in an average distance for the 
hydroxymethylene oxygen to the iron of 3.73 Å (value not given in Table 6). The complex 
structure could be identified as the Λ-isomer (Figure 15).  
The oxazoline ligands 7a and 8, which are equipped with a simple hydroxymethylene 
group as well as with a dimethylated hydroxymethylene group, caused a similar binding motif 
in both structures. The substitution on the side chain of ligand 8 leads to no sterical hindrance, 
while the use of the strong coordinating counter anion OAc- prevents the formation of the 
third bond of the ligand to the metal.  
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Table 6. Selected bond distances (Å) and angles (°) of [FeIII(8)2(OAc)]. 
 
 Bond Distances [Å]  Angles [°] 
Fe(1)-O(1) 1.892(4) O(1)-Fe(1)-O(4) 105.92(15) 
Fe(1)-O(4) 1.902(4) O(1)-Fe(1)-O(7) 157.31(15) 
Fe(1)-O(7) 2.117(4) O(1)-Fe(1)-O(8) 97.28(15) 
Fe(1)-O(8) 2.135(4) O(1)-Fe(1)-N(1) 86.36(17) 
Fe(1)-N(1) 2.117(5) O(1)-Fe(1)-N(2) 95.17(17) 
Fe(1)-N(2) 2.085(5) O(4)-Fe(1)-O(7) 96.08(14) 
  O(4)-Fe(1)-O(8) 156.49(15) 
  O(4)-Fe(1)-N(1) 94.18(17) 
  O(4)-Fe(1)-N(2) 86.78(17) 
  O(7)-Fe(1)-O(8) 61.32(14) 
  O(7)-Fe(1)-N(1) 86.57(16) 
  O(1)-Fe(1)-O(8) 91.49(16) 
  O(8)-Fe(1)-N(1) 90.99(16) 
  O(8)-Fe(1)-N(2) 87.41(16) 
  N(1)-Fe(1)-N(2) 177.92(17) 
 
 
An overview of all obtained iron(III) oxazoline X-ray structures is given in experimental part 
– F.11, Figure 8. 
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Figure 17. ORTEP plot at the 50% probability level of [FeIII(9)2]2 – (not important hydrogen atoms are omitted 
for clarity). 
 
A further iron(III) complex [FeIII(9)2]2 with an unexpected diiron core in the solid sate 
(Figure 17) was obtained by complexation fo 9 with Fe(OAc)2. Characteristic features of this 
complex include an involvement of four ligands as well a two-iron cluster containing two oxo 
bridges. In this complex the charge is balanced without the necessity of counter anions. In 
both metal centres, the iron is chelated in an octahedral binding geometry and shows a C2 axis 
along the Fe-Fe vector.83 The metal core is bridged by two oxygen atoms coming from two 
hydroxymethylene groups of two separate ligands. Two hydroxymethylene groups of two 
further ligands do not coordinate to the iron centres in this structure. Starting from the right 
hand side metal centre (Figure 17), the phenolate oxygen atoms bind to the iron with an 
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average bond length of 1.96 Å and span an angle of 93° (O(1)-Fe(1)-O(4)) (Table 7). 
Meridional coordination on this iron is indicated by an 156° angle of both phenolate oxygens 
over the iron centre to the hydroxymethylene oxygens (O(1)-Fe(1)-O(3) and 
O(4)-Fe(1)-O(6)). These hydroxymethylene oxygens bridge both iron metals with unequal 
bond distances. Fe(1)-O(6) and Fe(1)-O(3) show an average bond length of 2.03 Å. However, 
Fe(2) is bound with a bond of length 2.01 Å to O(6) and 2.04 Å to O(3). The corresponding 
nitrogen atoms around Fe(1) differ slightly from each other in their bonding with bond lengths 
of 2.06 Å and 2.10 Å, and are placed directly in opposite positions, spanning an angle of 175°. 
Switching to the second iron centre Fe(2), its octahedral environment is formed by two 
bidentate oxazoline ligands and both oxygen bridges. In comparison to the Fe(1) data, the 
phenolate oxygens bind to the left hand iron centre with similar bond distances (1.92 Å and 
1.95 Å). The angle of O(7)-Fe(2)-O(10) was observed to be 97°. The two nitrogen atoms 
(N(3) and N(4)) are nearly aligned in trans-position (172°) and the distances to the Fe(2) 
metal centre are longer than on the Fe(1) side (2.12 Å and 2.09 Å, respectively). For both iron 
metals the isomer geometry is determined as the ∆-form (Figure 18). 
 
An explanation for the favoured formation of the dinuclear iron(III) complex [FeIII(9)2]2 is 
probably based on a concentration gradient during the crystallization process. As described 
later in detail, the liquid-state analysis was not able to answer the question of whether the 
dinuclear structure also exists in solution. Furthermore, it should be mentioned that the 
dinuclear complex (∆) was formed with a different geometry than both mononuclear 
complexes (Λ), a fact, which is in agreement with the absolute configuration of the chiral 
carbon atom of the ligands. This might be caused by an energetically more stable dinuclear ∆-
isomer compared to a mononuclear ∆-isomer, with the monomer possessing more stability in 
the Λ-form. 
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Table 7. Selected bond distances (Å) and angles (°) of [FeIII(9)2]2. 
 
 Bond Distances [Å]  Angles [°] 
Fe(1)-O(1) 1.9687(19) O(1)-Fe(1)-O(3) 155.49(8) 
Fe(1)-O(3) 2.0281(19) O(1)-Fe(1)-O(4) 93.15(8) 
Fe(1)-O(4) 1.9527(19) O(1)-Fe(1)-O(6) 98.38(7) 
Fe(1)-O(6) 2.0295(19) O(1)-Fe(1)-N(1) 82.90(9) 
Fe(1)-N(1) 2.063(2) O(1)-Fe(1)-N(2) 92.09(9) 
Fe(1)-N(2) 2.097(2) O(3)-Fe(1)-O(4) 100.47(8) 
Fe(2)-O(3) 2.0387(19) O(3)-Fe(1)-O(6) 76.81(7) 
Fe(2)-O(6) 2.0110(18) O(3)-Fe(1)-N(1) 75.67(9) 
Fe(2)-O(7) 1.9243(19) O(3)-Fe(1)-N(2) 109.52(9) 
Fe(2)-O(10) 1.9495(19) O(4)-Fe(1)-O(6) 156.50(9) 
Fe(2)-N(3) 2.094(2) O(4)-Fe(1)-N(1) 95.36(9) 
Fe(2)-N(4) 2.120(2) O(4)-Fe(1)-N(2) 83.49(9) 
  O(6)-Fe(1)-N(1) 106.31(9) 
  O(6)-Fe(1)-N(2) 75.72(8) 
  N(1)-Fe(1)-N(2) 174.80(9) 
  O(3)-Fe(2)-O(6) 76.98(7) 
  O(3)-Fe(2)-O(7) 168.66(8) 
  O(3)-Fe(2)-O(10) 92.67(8) 
  O(3)-Fe(2)-N(3) 87.62(8) 
  O(3)-Fe(2)-N(4) 99.56(9) 
  O(6)-Fe(2)-O(7) 94.96(8) 
  O(6)-Fe(2)-O(10) 165.34(8) 
  O(6)-Fe(2)-N(3) 99.52(9) 
  O(6)-Fe(2)-N(4) 86.26(8) 
  O(7)-Fe(2)-O(10) 96.62(8) 
  O(7)-Fe(2)-N(3) 85.86(9) 
  O(7)-Fe(2)-N(4) 87.72(9) 
  O(10)-Fe(2)-N(3) 90.27(9) 
  O(10)-Fe(2)-N(4) 85.25(9) 
  N(3)-Fe(2)-N(4) 171.70(9) 
  Fe(1)-O(3)-Fe(2) 102.59(8) 
  Fe(1)-O(6)-Fe(2) 103.53(8) 
 
 
An overview of all obtained iron(III) oxazoline X-ray structures is given in experimental part 
– F.11, Figure 8. 
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Figure 18. Dinuclear octahedral binding models ∆ / Λ and ∆Λ / Λ∆ for two bidentate ligands and two tridentate 
ligands. 
 
Finally, all the data obtained for the three complexes were confirmed by mass analysis 
(ESI), having each a significant mass peak of a 1:2-iron(III) complex ([FeIII(L)2]+) and a peak 
for the corresponding ligand (L). These measurement conditions probably cause cleavage of 
the dimer into the mononuclear form, and it was not surprising that the dinuclear mass peak 
was not detectable. The elemental analysis fit very well for all three complex systems with a 
1:2-iron(III) oxazoline structure including acetate as third ligand, and even for the dinuclear 
sample an acetate ion was calculated, whereas in the solid state structure no counter anion is 
seen (Scheme 5).  
 
C.2.6 Liquid-State-Analysis of Iron(III) Complexes – [FeIII(7a-9)2(OAc)] 
 
The UV/Vis spectra of the [FeIII(7a-9)2(OAc)] series were measured between 200 and 
750 nm in acetonitrile at room temperature (Figure 19). The complexes [FeIII(7a)2(OAc)] and 
[FeIII(9)2(OAc)] show the same absorption bands which indicate a similar structure in 
solution, whereas [FeIII(8)2(OAc)] differs in its absorption curve. Starting from the absorption 
maximum at 310 nm, which is for all complexes the same and based on ligand specific 
transitions (n → π* or π → π*) (see experimental part F.9.2, Figure 1 and 4), the 
extraordinary width of this band for complex [FeIII(7a)2(OAc)] and [FeIII(9)2(OAc)] reach 
from 275 to 400 nm. In the spectra of complex [FeIII(8)2(OAc)] a shoulder is clearly 
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recognized between 340 and 400 nm. The complex specific and distinct maximum at 460 nm 
for complex [FeIII(7a)2(OAc)] and [FeIII(9)2(OAc)] was also not observed for [FeIII(8)2(OAc)], 
only a small increase in the band is detected around this wavelength. The width of the bands, 
the shoulder as well as the absorption at 460 nm led to the assumption of relatively intense 
charge-transfer transitions of the ligand to the metal (LMCT). The changes between the 
spectra of the acetate complexes and the perchlorate complexes were also reflected by a 
colour change form dark purple to now dark orange-red.74-76 
 
 
 
Figure 19. UV/Vis spectra for the [FeIII(7a-9)2(OAc)] series. 
 
In the circular dichroism spectra (CD) of the [FeIII(7a-9)2(OAc)] series, slightly different 
results were observed under the influence of circularly polarized light (Figure 20). Complex 
[FeIII(8)2(OAc)] (Figure 20, light grey line), exhibit an small shift of its curve in the CD 
graph, but it is still comparable to the complexes [FeIII(7a/9)2(OAc)]. As already indicated in 
the UV/Vis measurements this complex generates a non-typical electronic absorption spectra 
for this series. The CD curve for complex [FeIII(7a)2(OAc)] exhibits a mirror imaged 
behaviour to the graph of complex [FeIII(9)2(OAc)] (Figure 20, black and dark grew line), 
indicating a similar complex structure with opposite geometry in solution. In addition to that, 
the identification by crystallographic data of complex [FeIII(7a)2(OAc)] to form the Λ-isomer 
and for complex [FeIII(9)2(OAc)] to form the ∆-isomer (dinuclear structure in the 
crystallographic measurement) is in a good agreement with this. However, no evidence was 
found for the dinuclear nature of complex [FeIII(9)2(OAc)]. Therefore, it is presumed that 
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[FeIII(9)2(OAc)] exists in solution only in a monomeric form. The already mentioned CD 
graph of complex [FeIII(8)2(OAc)] (Figure 20, light grey line) shows similar positive and 
negative features as complex [FeIII(7a)2(OAc)] (Figure 20, black line) and in combination 
with its crystal structure discussed above (Figure 16) confirms the Λ-isomer for both 
complexes. 
 
Furthermore, in the [FeIII(7a-9)2(OAc)] series it is possible to infer the influence of the 
stereo centre within the ligand on the stereo chemical outcome of the complexes. This fact 
becomes very interesting, because the hydroxymethylen side chains are not directly bound on 
the metal and influence the metal geometry only in a secondary way. This is in direct contrast 
to the above statement for the perchlorate complexes. As outlined in Figure 20, the CD 
spectra of the complexes [FeIII(7a-9)2(OAc)] are in agreement with their stereo chemical 
information of their corresponding ligands 7a-9 (see experimental part F.9.2, Figure 4). 
 
 
 
Figure 20. CD spectra for the [FeIII(7a-9)2(OAc)] series. 
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C.2.7 Formation of Iron(III) Complexes using Fe(acac)3 
 
Iron(III) acetylacetonate, Fe(acac)3, was the third salt explored in this series. In this salt 
iron resides already in the +3 oxidation state, and acetylacetonate is a coordinating anion of 
similar strength to acetate. As before, the iron salt and the oxazoline derivatives 7a-9 were 
used in a ratio of 1:2 to form the desired complexes (Scheme 6). The ligands were dissolved 
in THF and were transferred into a solution of Fe(acac)3 in THF. The observed colour change 
from a slightly yellow into a dark blood-red, indicates a successful complex formation, but 
took place significantly slower than observed for the Fe(OAc)2 or Fe(ClO4)2•6H2O salts 
(Scheme 4 and 5).74 The newly formed iron(III) complexes appear to be stable on air. 
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Scheme 6. Synthesis of iron(III) complexes [FeIII(7a-9)2(acac)] using Fe(acac)3. 
 
Features typical for [FeIII(7a-9)2(acac)] complexes were observed by IR analysis. A broad 
alcohol stretch was found between 3430 and 3350 cm-1, and a typical strong band around 
1360 cm-1 was assigned to the acetylacetonate group. The shifted strong band of an 
uncoordinated and unsaturated C=N stretch from 1644 cm-1 to 1604 cm-1 indicated a 
coordinating ligand C=N vibration. 
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In all three cases the mass spectrometry was able to detect a significant mass peak for a 
1:2-iron(III) complex ([FeIII(L)2]+), which contained two oxazoline ligands (L) and an 
iron(III) metal. Furthermore, an 1:1:1-iron(III) complex ([FeIII(L)(acac)]+) with two different 
kinds of ligands, an oxazoline (L) and an acetylacetonate (acac), bound to an iron(III) metal 
was observed as well as a mass peak of the corresponding free oxazoline ligand (L) 
(Figure 21). These results can be interpreted that the expected [FeIII(7a-9)2(acac)] complexes 
were formed (Scheme 6) and under the measurement conditions used (ESI) these complexes 
were ionized differently by losing either an oxazoline ligand or an acetylacetonate ligand. The 
elemental analysis confirmed for all three complex systems the expected [FeIII(7a-9)2(acac)] 
formation.  
 
 
Figure 21. Mass spectrum of [FeIII(9)2(acac)], representative for all three iron(III) acetylacetonate complexes. 
 
C.2.8 Liquid-State-Analysis of Iron(III) Complexes – [FeIII(7a-9)2(acac)] 
 
Unfortunately, all attempts to obtain crystals of this series suitable for X-ray analysis 
failed. The UV/Vis spectra of the [FeIII(7a-9)2(acac)] series were measured between 200 and 
750 nm in acetonitrile at room temperature (Figure 22). The assignment of the absorption 
bands from 360 nm to higher energies was not easy to make. It is assumed that most of them 
are representative for the complexes, since they are not present in the spectra of the free 
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ligands nor of the pure salt (see experimental part F.9.2, Figure 2 and 4). Clear evidence for 
the newly formed complexes [FeIII(7a-9)2(acac)] is found in the observed maximum from 450 
to 470 nm. A similar band around 430 nm is already found in the UV/Vis spectra of the pure 
salt, but a shift of between 20 to 50 nm to lower energies indicates a significant charge-
transfer transitions of the ligand to the metal (LMCT).74-76 This small difference originates 
from a CT transition of the phenolic oxygen to an iron(III) ion and accompanies the darkening 
of the complex solution. 
 
 
 
Figure 22. UV/Vis spectra for the [FeIII(7a-9)2(acac)] series. 
 
The [FeIII(7a-9)2(acac)] series exhibit in their CD spectra a strong similarity in the 
progression of their curves in the circular dichroism spectra (Figure 23). The complexes 
[FeIII(7a-9)2(acac)] showed very distinct graphs, which are comparable in their stereo 
chemical information to the corresponding ligand spectra (see experimental part F.9.2, 
Figure 4). This feature is in agreement with the CD results of the [FeIII(7a-9)2(OAc)] 
complexes (Figure 20). On the basis of this correspondence, both CD spectra of 
[FeIII(7a-9)2(OAc)] and [FeIII(7a-9)2(acac)] were compared: In both graphs around 300 nm 
and 500 nm a similar behaviour of the curves for the related complexes was recognized, 
because all maxima or minima on these wavelengths match together. Furthermore, the zero 
crossings in both complex series are seen at the same points at 340 and 450 nm. These facts 
and the proposed structure (Figure 24) based on the other analysis give rise to the speculation 
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that the [FeIII(7a-9)2(acac)] complex series might have the identical complex geometry as the 
corresponding [FeIII(7a-9)2(OAc)] complexes (Figure 15). This would mean that 
[FeIII(7a)2(acac)] and [FeIII(8)2(acac)] form the Λ-isomer similar to [FeIII(7a)2(OAc)] and 
[FeIII(8)2(OAc)], respectively. In contrast to this, [FeIII(9)2(acac)] forms the ∆-isomer like 
[FeIII(9)2(OAc)]. 
 
 
 
Figure 23. CD spectra for the [FeIII(7a-9)2(acac)] series. 
 
Due to the unsuccessful crystallization experiments, resulting in the lack of structural data 
in the solid state, all spectroscopic results as well as the high analogy to the 
[FeIII(7a-9)2(OAc)] complexes (see main part – oxazoline complex analysis C.2.4-C.2.6) were 
used to propose a possible structure model, including the assumed complex geometry 
(Figure 24). 
 
 
Figure 24. Proposed structures for the complexes [FeIII(7a-9)2(acac)]. 
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C.2.9 Formation of Ruthenium(III) Complexes using [RuCl2(benzene)]2 
 
To test the effect of an iron related metal, ruthenium was chosen, because many of its 
chemical properties are similar and it is located in the periodic table directly under iron. The 
ruthenium salt, [RuCl2(benzene)]2 was selected as suitable metal source.84 One equivalent of 
it was suspended in ethanol and two equivalents of the dissolved ligand 7a-9 in ethanol were 
transferred into the suspension (Scheme 7). The reaction mixture was heated to reflux for 
48 h. During this time the colour slowly changed from a green-brown ruthenium(II) complex 
to a dark purple ruthenium(III) complex. As already seen in the other complexation reactions, 
this indicates an air sensitive oxidation step of the ruthenium(II) metal into a ruthenium(III) 
complex and the probability of a charge-transfer transition from the phenolic oxygen to a 
ruthenium(III) ion.74  
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Scheme 7. Synthesis of ruthenium(III) complexes [RuIII(7a-9)3] using [RuCl2(benzene)]2. 
 
The three ruthenium(III) complexes [RuIII(7a-9)3] feature typical IR bands: the free alcohol 
was detected between 3355 and 3300 cm-1 and the shift of the strong band of an 
uncoordinated and unsaturated C=N stretch from 1644 cm-1 to 1604 cm-1 indicated a 
coordinating ligand C=N vibration. 
Main Part – Oxazoline Complex Analysis 
 
71 
The mass spectrometry showed the same results for all three measured compounds 
[RuIII(7a-9)3]. A significant peak for a 1:3-ruthenium(III) complex ([RuIII(L)3]+), including 
three oxazoline ligands (L) and a ruthenium(III) metal, a 1:2-ruthenium(III) complex 
([RuIII(L)2]+), with only two ligands (L) and one metal, and finally the mass peak of the 
corresponding free ligand (L) were observed (Figure 25). It is assumed that under the used 
measurement conditions (ESI) the complexes are partly ionized and so the third ligand was 
cleaved off, presenting only one species of the ruthenium(III) complexes [RuIII(7a-9)3] 
(Scheme 7). For all three complex systems, also the elemental analysis fitted best for the 
formation of the 1:3-ruthenium(III) complexes [RuIII(7a-9)3].  
 
 
Figure 25. Mass spectrum of [RuIII(9)3], representive for all three ruthenium(III) complexes. 
 
C.2.10 Liquid-State-Analysis of Ruthenium(III) Complexes – [RuIII(7a-9)3] 
 
The UV/Vis spectra of the [RuIII(7a-9)3] series were measured between 200 and 750 nm in 
acetonitrile at room temperature (Figure 26). The complexes [RuIII(7a)3] and [RuIII(9)3], 
showed similar features in their absorption behaviour and indicate therefore a comparable 
structure for the complexes in solution (Figure 26, black and dark grey line). In spite of this, 
complex [RuIII(8)3] significantly absorbed at 290 nm in a different way to the others 
(Figure 26, light grey line). The typical absorption properties of [RuIII(7a)3] and [RuIII(9)3] are 
comparable to the already discussed UV/Vis spectra of the iron(III) perchlorate complexes 
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(Figure 10). Transitions of higher energies until 270 nm usually result from the salt as well as 
from the ligand. The absorption maximum at 300 nm is clearly identified as ligand specific 
transitions (n → π* or π → π*) (see experimental part F.9.2, Figure 2 and 4), whereas the 
shoulder between 340 to 400 nm and the maximum at 525 nm can be assigned as complex 
specific transitions. The flat curve around the last discussed maxima is dependent on the 
concentration used for all three complex solutions, which is reflected in a very high extinction 
coefficient in the spectra. All attempts to obtain a suitable UV/Vis spectra for complex 
[RuIII(8)3] by changing the concentration were unsuccessful. Nevertheless, these specific 
complex based absorptions and the observed dark purple colour in the case of the iron(III) 
perchlorate complexes (see main part – oxazoline complex analysis C.2.1-C.2.3), lead to the 
assumption of there being distinct charge-transfer transitions from the ligand to the metal 
(LMCT).74-76,85 
 
 
 
Figure 26. UV/Vis spectra for the [RuIII(7a-9)3] series. 
 
The failed crystallization experiments and the resulting lack of crystal structure data of this 
complex type demand a variety of speculations. The elemental analysis tends to a 1:3-
ruthenium(III) complex system (Figure 27), which contains three oxazoline ligands, each 
probably bound via the nitrogen and a deprotonated phenolate.  
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Figure 27. Proposed structure models of the complexes [RuIII(7a-9)3]. 
 
These proposed, but unconfirmed structures allow no conclusion to be formulated from the 
CD spectra of the obtained ruthenium(III) complexes. It is only worth mentioning that the CD 
curves of the complexes (Figure 28) include the same stereo chemical information as seen for 
the pure ligands (see experimental part F.9.2, Figure 4). 
 
 
 
Figure 28. CD spectra for the [RuIII(7a-9)3] series. 
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C.2.11 Formation of Zinc(II) Complexes using Zn(ClO4)2•6H2O 
 
The [ZnII(7a-9)2]2•(ClO4)2 complexes were prepared using two equivalents of ligand 7a-9 
and one equivalent of Zn(ClO4)2•6H2O dissolved in THF (Scheme 8). The ligands were 
transferred to the salt and a cloudy solution immediately formed. After a 12 h reaction time, 
two complexes [ZnII(7a/8)2]2•(ClO4)2 were obtained as slightly orange oils and one complex 
[ZnII(9)2]2•(ClO4)2 as a colourless solid.  
 
OH
NO
OH
OH
NO
OH
OH
NO
OH
7a
9
8
Zn(ClO4)2 6H2O
Zn(ClO4)2 6H2O
Zn(ClO4)2 6H2O
2
2
2
53%
34%
83%
THF, rt, 12h, air
THF, rt, 12h, air
THF, rt, 12h, air
N
O
O
HO
N
O
O OH
ZnII
N
O
O
HO
ZnII
N
O
O OH
H H
ZnII ZnII
N
O
HO O
N
O
HO O
N
O
OH
O
N
O
H
O
O
H
H
N
O
O
HO
N
O
O OH
ZnII
N
O
O
HO
ZnII
N
O
O OH
H H
2 ClO4
-
2 ClO4
-
2 ClO4
-
[ZnII(7a)2]2 (ClO4)2
[ZnII(8)2]2 (ClO4)2
[ZnII(9)2]2 (ClO4)2
 
 
Scheme 8. Synthesis of zinc(II) complexes [ZnII(7a-9)2]2•(ClO4)2 using Zn(ClO4)2•6H2O. 
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C.2.12 Solid-State-Analysis of Zinc(II) Complexes – [ZnII(7a/9)2]2•(ClO4)2 
 
Typical IR features of the [ZnII(7a-9)2]2•(ClO4)2 complex series are detected around 3470 
cm-1 (weak band, identified as the alcohol stretch), at 1620 cm-1 (for a coordinating ligand 
C=N vibration), and a characteristic broad and very strong band around 1065 cm-1 as well as a 
sharp band at 620 cm-1, which indicates the presence of a perchlorate anion.80  
 
    
 
Figure 29. ORTEP plot at the 50% probability level of [ZnII(7a)2]2•(ClO4)2 – (not important hydrogen atoms and 
ClO4- are omitted for clarity). 
 
Investigations on the crystal of the zinc(II) complex [ZnII(7a)2]2•(ClO4)2 exposed an 
extraordinary structural unit (Figure 29). Two monomeric zinc moieties are attached together 
by two hydrogen bonds86 and two π–stacking interactions between two anti parallel aligned 
phenol-oxazoline units. The hydrogen bonds (H(1)-O(10) and H(7)-O(4) show a very short 
length of 1.61 Å and 1.62 Å to the oppositely placed deprotonated phenolate (Figure 29 and 
30) and in combination with angles around 171° (O(1)-H(1)-O(10) and O(4)-H(7)-O(7)) 
indicate very strong hydrogen bridges. In addition, π–stacking interactions are feasible by a 
distance of 3.62 Å to 4.17 Å between the planes of the corresponding aromatic systems 
(Figure 29).87,88 Each zinc metal is characteristically coordinated by two tridentate oxazoline 
ligands, and each unit includes one deprotonated phenolate and one perchlorate for its own 
charge balance. The strongly distorted octahedral structures feature both trans-oriented 
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nitrogen pairs, spanning angles between 162° and 165° (N(1)-Zn(1)-N(2) and N(3)-Zn(2)-
N(4)) with a bond length of 1.98 Å to Zn(1) and Zn(2) (Table 8). All four hydoxymethylene 
alcohole side chains point into the outer environment and are still protonated. The distances of 
these oxygen atoms to Zn(1) and Zn(2) are comparable and measured 2.22 Å / 2.19 Å (O(3)-
Zn(1) / O(9)-Zn(2)) or 2.46 Å / 2.40 Å (O(6)-Zn(1) / O(12)-Zn(2)). The angles between them 
are nearly perpendicular, with 86° and 80° (O(3)-Zn(1)-O(6) and O(9)-Zn(2)-O(12). All four 
phenol oxygens are oriented into the inner sphere of the whole unit and one of each zinc 
subunit is still protonated. The bond distances between O(1)/O(4)-Zn(1) are given with 
2.12 Å and 2.03 Å, and for O(7)/O(10)-Zn(2) with 2.16 Å and 2.08 Å. It becomes obvious, 
that each zinc moiety possesses a significant longer Zn-O bond to the protonated oxygens 
(O(1) and O(7)), and a shorter one to the deprotonated oxygens (O(4) and O(10)). The four 
meridional coordinating ligands describe angles between 158° to 161° (O(1)-Zn(1)-O(3), 
O(4)-Zn(1)-O(6), (O(7)-Zn(2)-O(9), O(10)-Zn(2)-O(12)). For each zinc(II) centre in complex 
[ZnII(7a)2]2•(ClO4)2 the isomer geometry is determined as the ∆-form (Figure 31). 
 
 
 
Figure 30. ORTEP plot at the 50% probability level of [ZnII(7a)2]2•(ClO4)2 – (unimportant hydrogen atoms and 
ClO4- are omitted for clarity).  
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Table 8. Selected bond distances (Å) and angles (°) of [ZnII(7a)2]2•(ClO4)2. 
 
 Bond Distances [Å]  Angles [°] 
Zn(1)-O(1) 2.122(3) O(3)-Zn(1)-O(4) 91.93(14) 
Zn(1)-O(3) 2.224(4) O(3)-Zn(1)-O(6) 85.81(14) 
Zn(1)-O(4) 2.031(4) O(3)-Zn(1)-N(1) 76.51(16) 
Zn(1)-O(6) 2.461(4) O(3)-Zn(1)-N(2) 98.09(17) 
Zn(1)-N(1) 1.978(5) O(4)-Zn(1)-O(6) 160.05(15) 
Zn(1)-N(2) 1.975(5) O(4)-Zn(1)-N(1) 109.95(18) 
Zn(2)-O(10) 2.043(4) O(4)-Zn(1)-N(2) 87.73(18) 
Zn(2)-O(12) 2.398(5) O(6)-Zn(1)-N(1) 88.83(18) 
Zn(2)-O(3) 1.988(5) O(6)-Zn(1)-N(2) 73.02(18) 
Zn(2)-O(4) 1.972(5) O(1)-Zn(1)-N(2) 99.46(17) 
Zn(2)-O(7) 2.164(4) O(1)-Zn(1)-O(4) 97.00(14) 
Zn(2)-O(9) 2.187(4) O(1)-Zn(1)-O(6) 91.41(14) 
Zn(2)-N(3) 1.988(4) O(1)-Zn(1)-O(3) 160.58(15) 
Zn(2)-N(4) 1.972(4) O(1)-Zn(1)-N(1) 84.22(17) 
  N(1)-Zn(1)-N(2) 161.5(2) 
  O(7)-Zn(2)-O(9) 158.68(16) 
  O(7)-Zn(2)-O(10) 98.98(16) 
  O(7)-Zn(2)-O(12) 94.65(16) 
  O(7)-Zn(2)-N(3) 82.01(18) 
  O(7)-Zn(2)-N(4) 92.22(18) 
  O(9)-Zn(2)-O(10) 93.23(17) 
  O(9)-Zn(2)-O(12) 79.50(18) 
  O(9)-Zn(2)-N(3) 77.74(19) 
  O(9)-Zn(2)-N(4) 105.73(19) 
  O(10)-Zn(2)-O(12) 158.21(16) 
  O(10)-Zn(2)-N(3) 106.90(19) 
  O(10)-Zn(2)-N(4) 87.79(18) 
  O(12)-Zn(2)-N(3) 91.72(19) 
  O(12)-Zn(2)-N(4) 74.71(19) 
  N(3)-Zn(2)-N(4) 164.8(2) 
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Figure 31. Meridional octahedral binding models Λ and ∆ for two tridentate ligands. 
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Figure 32. ORTEP plot at the 50% probability level of [ZnII(9)2]2•(ClO4)2 – (not important hydrogen atoms and 
ClO4- are omitted for clarity). 
 
Further investigations of a second zinc(II) crystal for the complex [ZnII(9)2]2•(ClO4)2 
revealed analogous results (Figure 32). Two monomeric zinc moieties are fixed together by 
two short and strong hydrogen bonds (H(7)-O(1) 1.60 Å and H(10)-O(4) 1.58 Å)86 and two 
π-stacking interactions resulting from the anti parallel aligned phenol-oxazolines (3.96 Å -
 4.27 Å) (Figure 32 and 33).87,88 Each zinc metal is again characteristically coordinated by 
two tridentate oxazoline ligands. The whole unit includes two deprotonated phenolates and 
two perchlorates for its charge balance. The strongly distorted octahedral structures feature 
both trans-oriented nitrogen pairs, which span angles between 160° and 164° (N(1)-Zn(1)-
N(2) and N(3)-Zn(2)-N(4)) with a bond length of 1.96 Å to Zn(1) and of 2.00 Å to Zn(2) 
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(Table 9). All four hydoxymethylene alcohole side chains are aligned into the outer 
environment and are still protonated. The distance of these oxygen atoms to Zn(1) are 
measured to be 2.49 Å and 2.54 Å (O(3)/O(6)-Zn(1)) and to Zn(2) to be 2.23 Å and 2.31 Å 
(O(9)/O(12)-Zn(2)). The angles between them are nearly perpendicular, at 81° and 87° (O(3)-
Zn(1)-O(6) and O(9)-Zn(2)-O(12). All four phenol oxygens are oriented into the inner sphere 
of the whole unit, but in contrast to the crystal structure of complex [ZnII(7a)2]2•(ClO4)2 
discussed above (Figure 29), the two bound to Zn(2) atom are still protonated, whereas on 
Zn(1) only deprotonated phenolates are coordinated. The bond distances between O(1)/O(4)-
Zn(1) are found to be 2.06 Å long, and for O(7)/O(10)-Zn(2) to be 2.12 Å and 2.08 Å. It is 
clear to see, that the bonds from the Zn(2) centres to the still protonated oxygens O(7)/O(10) 
are slightly longer than to the unprotonated oxygens O(1)/O(4) and are probably effected by 
the presence of hydrogen bridges. All four meridional coordinating ligands describe 
comparable angles of 160° (O(1)-Zn(1)-O(3), O(4)-Zn(1)-O(6) and (O(7)-Zn(2)-O(9), O(10)-
Zn(2)-O(12)). For both zinc(II) centres in complex [ZnII(9)2]2•(ClO4)2 the isomer geometry is 
determined as the Λ-form (Figure 31). 
 
 
 
Figure 33. ORTEP plot at the 50% probability level of [ZnII(9)2]2•(ClO4)2 – (not important hydrogen atoms and 
ClO4- are omitted for clarity). 
 
Main Part – Oxazoline Complex Analysis 
 
80 
Table 9. Selected bond distances (Å) and angles (°) of [ZnII(9)2]2•(ClO4)2. 
 
 Bond Distances [Å]  Angles [°] 
Zn(1)-O(1) 2.056(4) O(3)-Zn(1)-O(4) 93.41(16) 
Zn(1)-O(3) 2.489(4) O(3)-Zn(1)-O(6) 81.04(15) 
Zn(1)-O(4) 2.057(4) O(3)-Zn(1)-N(1) 72.66(16) 
Zn(1)-O(6) 2.536(4) O(3)-Zn(1)-N(2) 91.79(16) 
Zn(1)-N(1) 1.956(4) O(4)-Zn(1)-O(6) 160.05(13) 
Zn(1)-N(2) 1.968(4) O(4)-Zn(1)-N(1) 104.83(18) 
Zn(2)-O(7) 2.118(4) O(4)-Zn(1)-N(2) 88.26(16) 
Zn(2)-O(9) 2.234(4) O(6)-Zn(1)-N(1) 91.87(18) 
Zn(2)-O(10) 2.083(4) O(6)-Zn(1)-N(2) 72.88(18) 
Zn(2)-O(12) 2.308(4) O(1)-Zn(1)-N(2) 105.17(16) 
Zn(2)-N(3) 2.001(4) O(1)-Zn(1)-O(4) 96.45(15) 
Zn(2)-N(4) 2.003(4) O(1)-Zn(1)-O(6) 94.76(14) 
  O(1)-Zn(1)-O(3) 160.58(13) 
  O(1)-Zn(1)-N(1) 88.63(16) 
  N(1)-Zn(1)-N(2) 160.0(2) 
  O(7)-Zn(2)-O(9) 160.31(14) 
  O(7)-Zn(2)-O(10) 93.80(15) 
  O(7)-Zn(2)-O(12) 92.51(17) 
  O(7)-Zn(2)-N(3) 109.05(18) 
  O(7)-Zn(2)-N(4) 84.08(15) 
  O(9)-Zn(2)-O(10) 93.37(15) 
  O(9)-Zn(2)-O(12) 86.90(17) 
  O(9)-Zn(2)-N(3) 89.99(19) 
  O(9)-Zn(2)-N(4) 76.34(15) 
  O(10)-Zn(2)-O(12) 160.04(14) 
  O(10)-Zn(2)-N(3) 83.19(16) 
  O(10)-Zn(2)-N(4) 105.44(15) 
  O(12)-Zn(2)-N(3) 76.86(16) 
  O(12)-Zn(2)-N(4) 94.03(16) 
  N(3)-Zn(2)-N(4) 164.08(19) 
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The mass spectrometry (ESI) detected significant peaks of each 1:2-zinc(II) complex 
([ZnII(L)2]+) and its corresponding free ligand (L). Furthermore, for ligand 8 an addition 
second complex species with a Zn2L3-stoichiometry was detected, which is not surprising 
with regard to the crystal structures obtained and probably caused by an usual fragmentation 
in the ESI method. The elemental analysis also confirmed a ZnL2-stoichiometry, 
([ZnII(L)2]•(ClO4), which also agrees with the dimeric structure.  
 
C.2.13 Liquid-State-Analysis of Zinc(II) Complexes – [ZnII(7a-9)2]2•(ClO4)2 
 
UV/Vis measurements of the [ZnII(7a-9)2]2•(ClO4)2 complex series results in three very 
similar spectra (Figure 34). Absorptions before 280 nm are ligand or salt specific (see 
experimental part F.9.2, Figure 3 and 4), but the bands between 280 and 380 nm seem to be 
significant for the complex. It is assumed that here two different absorptions are overlapped. 
It is highly probable that the right hand side of this absorption, starting around 330 nm to 
lower energies, results from a complex-specific-transition (LMCT), whereas the left hand side 
of the broad band comes from a ligand-specific-transition.  
 
 
 
Figure 34. UV/Vis spectra for the [ZnII(7a-9)2]2•(ClO4)2 series. 
 
The circular dichroism spectra (CD) of the [ZnII(7a-9)2]2•(ClO4)2 series were measured 
using circularly polarized light in a range of 200 to 400 nm (Figure 35) in acetonitrile at room 
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temperature. Complex [ZnII(7a)2]2•(ClO4)2 (Figure 35, black line), which was identified to 
form a octahedral ∆-isomer, and complex [ZnII(8)2]2•(ClO4)2 (Figure 35, light grey line), 
showed exactly the same CD graphs and it is reasonable to assume that [ZnII(8)2]2•(ClO4)2 
possesses also ∆-conformation. On the other hand, complex [ZnII(9)2]2•(ClO4)2 (Figure 35, 
dark grey line), already known to form a Λ-isomer, shows completely different features. The 
CD spectra of the ligands 7a-9 (see experimental part F.9.2, Figure 4) are in an agreement in 
their stereo chemical information with the zinc(II) complexes [ZnII(7a-9)2]2•(ClO4)2. 
 
 
 
Figure 35. CD spectra for the [ZnII(7a-9)2]2•(ClO4)2 series. 
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C.2.14 Formation of a Manganese(III) Complex using Mn(ClO4)2•6H2O28 
 
Manganese was used as the last 3d-transition metal in the complex formation reaction with 
ligand 7a. Two equivalents of oxazoline ligand 7a were dissolved in THF and were 
transferred into a solution of one equivalent Mn(ClO4)2•6(H2O) in THF (Scheme 9). The 
colour immediately changed without further adducts (base, e. g. NEt3)89 from slightly yellow 
into dark green. This colour change was already observed by Bouwman and co-workers and 
indicates the successful complex formation as well as an oxidation from Mn2+ to Mn3+.89 
Further investigations (see below) revealed similar binding characteristics between the 
manganese and the iron metal. Two oxazoline ligands coordinate the metal via the nitrogen 
atoms as well as the deprotonated phenolate oxygen and two THF molecules complete an 
octahedral geometry. This is in contrast to the observed meridional structure of 
[FeIII(7a)2]•(ClO4) (Figure 8), where the octahedral geometry is fulfilled by the tridentate 
coordinating ligands. 
 
 
 
Scheme 9. Synthesis of the manganese(III) complex [MnIII(7a)2(THF)2]•(ClO4) using Mn(ClO4)2•6H2O. 
 
C.2.15 Solid-State-Analysis of a Manganese(III) Complex – 
[MnIII(7a)2(THF)2]•(ClO4) 
 
Typical IR features of the complex [MnIII(7a)2(THF)2]•(ClO4) are a free alcohol stretch 
around 3480 cm-1 and the shift of a strong band from 1644 cm-1 (uncoordinated and 
unsaturated C=N stretch) to 1604 cm-1 for a coordinating ligand C=N vibration. Furthermore, 
a characteristic broad and very strong band at 1086 cm-1 as well as a sharp band at 619 cm-1 
indicate the presence of a perchlorate.80,89 
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Crystallographic investigations of complex [MnIII(7a)2(THF)2]•(ClO4) showed an 
octahedral coordination of the manganese(III) metal utilizing two bis(didentate) oxazoline 
ligands 7a and two solvent molecules (THF) directly coordinated in a trans-orientation 
(Figure 36 and 37). The positive charge is balanced by two deprotonated phenolate oxygens 
of the ligands and one perchlorate molecule bound in the outer environment. Both nitrogen 
atoms are positioned in a typical trans-orientation (172°) and their distances to the manganese 
are between 1.95 and 1.98 Å (Table 10). The deprotonated oxygens of the phenols and the 
nitrogens are placed in a nearly quadratic planar manner as shown by the significant angle of 
O(1)-Mn(1)-O(4), spanning exactly 178°. The angles between O(1)-Mn(1)-N(1) with 90° and 
between O(4)-Mn(1)-N(1) with 88° complete this statement. The two THF molecules 
spanning an angle of 178° (O(7)-Mn(1)-O(8)) are located on the left hand and right hand side 
of the structure, while their orientation is almost perpendicular. The bond lengths of the two 
oxygens in the oxazoline ring are measured to 1.86 Å (O(1)/O(4)-Mn(1)), whereas the THF 
oxygens differ in their distance to the metal, from 2.21 ((O(7)-Mn(1)) to 2.32 Å ((O(8)-
Mn(1)). All these features give rise to a nearly perfect octahedral complex.  
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Figure 36. ORTEP plot at the 50% probability level of [MnIII(7a)2(THF)2]•(ClO4) – (not important hydrogen 
atoms and ClO4- are omitted for clarity).  
 
With two oxazoline ligands with the same chirality and their trans-orientation, both 
hydroxymethylen side chains are aligned in one direction (Figure 37).89 These oxygens are 
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not involved in the coordination to the metal, and are found on a straight line (176° (O(3)-
O(7)-O(6), not shown in Table 10) together with the THF (O(7)) oxygen. The corresponding 
lengths are measured as 3.83 Å (O(6)-O(7) and 3.66 Å (O(3)-O(7) (not shown in Table 10). 
The complex structure was identified as the trans-isomer (Figure 38).  
 
 
 
Figure 37. ORTEP plot at the 50% probability level of [MnIII(7a)2(THF)2]•(ClO4) – (not important hydrogen 
atoms and ClO4- are omitted for clarity). 
 
 
 
 
Figure 38. Octahedral binding model cis / trans-form for two didentate ligands and two solvent molecules. 
 
Bouwman and co-workers already reported a similar complex system,89 using the racemic 
ligand (±)-46 and obtained the complex (HNEt3)•trans-[MnIII((R)-46)((S)-46)(H2O)2] 
(Figure 39, left). Due to the racemic ligand (±)-46 used, both carbonic acid side chains are 
directed in opposite half spaces, each pointing to a trans-oriented H2O molecule.  
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Figure 39. Manganese(III) complex, reported by Bouwman.89 
 
Table 10. Selected bond distances (Å) and angles (°) of [MnIII(7a)2(THF)2]•(ClO4). 
 
 Bond Distances [Å]  Angles [°] 
Mn(1)-O(1) 1.866(5) O(1)-Mn(1)-O(4) 178.3(2) 
Mn(1)-O(4) 1.858(5) O(1)-Mn(1)-O(7) 91.39(17) 
Mn(1)-O(7) 2.211(4) O(1)-Mn(1)-O(8) 90.54(17) 
Mn(1)-O(8) 2.322(4) O(1)-Mn(1)-N(1) 90.0(2) 
Mn(1)-N(1) 1.981(6) O(1)-Mn(1)-N(2) 91.7(2) 
Mn(1)-N(2) 1.952(5) O(4)-Mn(1)-O(7) 88.97(17) 
  O(4)-Mn(1)-O(8) 89.14(17) 
  O(4)-Mn(1)-N(1) 88.3(2) 
  O(4)-Mn(1)-N(2) 90.0(2) 
  O(7)-Mn(1)-O(8) 177.8(2) 
  O(7)-Mn(1)-N(1) 95.3(2) 
  O(7)-Mn(1)-N(2) 92.70(18) 
  O(8)-Mn(1)-N(1) 85.9(2) 
  O(8)-Mn(1)-N(2) 86.09(17) 
  N(1)-Fe(1)-N(2) 171.8(2) 
 
 
The mass spectrometry (ESI) shows significant mass peaks for a 1:2-manganese(III) 
complex ([MnIII(L)2]+) and for its corresponding free ligand (L). Additionally a second 
complex species with a Mn2L3-stoichiometry was detected. This was previously seen in the 
mass analysis of zinc(II) complex [ZnII(8)2]2•(ClO4)2 and leads to further speculation. This 
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manganese-ligand-system might be also able to form dimers, if no solvent is present to 
stabilize the complex.82 Nevertheless, the elemental analysis prepared from a dried sample of 
the manganese(III) complex confirmed a MnL2-stoichiometry, which might be also in a good 
agreement for a dimeric structure without further stabilizations by solvent molecules.  
 
C.2.16 Liquid-State-Analysis of a Manganese(III) Complex – 
[MnIII(7a)2(THF)2]•(ClO4) 
 
The UV/Vis spectra of the manganese(III) complex shows an significant difference in 
comparison to the ligand as well as the pure salt spectra (see experimental part F.9.2, Figure 3 
and 4). The shoulder between 330 and 390 nm definitely arise from a complex-specific-
transition (LMCT) (Figure 40).  
 
 
 
Figure 40. UV/Vis spectra of [MnIII(7a)2(THF)2]•(ClO4). 
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The CD spectra of the manganese(III) complex [MnIII(7a)2(THF)2]•(ClO4) is shown in 
Figure 41. As determined by X-ray crystallography the complex geometry was identified as 
an octahedral trans-isomer, and it is reasonable to assume that this is conserved in solution. 
 
 
 
Figure 41. CD spectra of [MnIII(7a)2(THF)2]•(ClO4). 
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C.2.17 Summary 
 
In conclusion, for all three oxazoline derivatives (7a-9) it can be predicted that complexation 
reactions with salts having weak counter anions (e. g. Fe(ClO4)2•6H2O and Zn(ClO4)2•6H2O) 
usually form a meridional bis(tridentate) binding structure (Table 11, entry 1/(4)/5). In 
counterpart to this, metals with strong counter anions (e. g. Fe(OAc)2 and Fe(acac)3) prefer a 
tri(didentate) structural formation (Table 11, entry 2 and 3). Furthermore, the structural 
geometry of the complexes is controlled by the stereo centre of the ligands as well as the 
nature of the counter anion. 
 
All obtained crystallographic structures possess a distorted octahedral geometry with slightly 
varying angles from ideally 90° or 180°, but in spite of this fact, a C2-symmetric formation for 
all complexes can be concluded. 
 
Table 11. Summery of all structural geometries for the salts used. 
 
Entry Salt Ligand 7a Ligand 8 Ligand 9 Ligand 
Coordination 
1 Fe(ClO4)2•6H2O ∆     (X-ray) Λ     (CD) Λ     (CD) meridional - 
bis(tridentate) 
2 Fe(OAc)2 Λ     (X-ray) Λ     (X-ray) ∆   (X-ray) tri(didentate) 
 
3 Fe(acac)3 (Λ)     (CD) (Λ)     (CD) (∆)     (CD) tri(didentate) 
 
4 [RuCl2(benzene)2]2 - - - (meridional) 
 
5 Zn(ClO4)2•6H2O ∆     (X-ray) ∆     (CD)  Λ     (X-ray) meridional - 
bis(tridentate) 
6 Mn(ClO4)2•6H2O trans-form - - di(didentate) 
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D. Main part – Bis(oxazoline) Complex Analysis 
 
D.1 Characterization of Bis(oxazoline)-Metal-Complexes 
 
D.1.1 Formation of Iron(III) Complexes using Fe(ClO4)2•6(H2O) 
 
The bis(oxazoline) derivatives (1, 2, (±)-4/(meso)-4, 5) were utilized as a second ligand 
series to chelate Fe(ClO4)2•6(H2O) (Scheme 1 and 2). This type of ligand is known to form 
1:1 complexes,42,43 and so one equivalent of a bis(oxazoline) ligand was dissolved in THF and 
was transferred into a solution of one equivalent Fe(ClO4)2•6(H2O) in THF. The colour 
immediately changed from slightly red to dark purple, indicating a rapid complex formation 
as well as a spontaneous oxidation of Fe2+ to Fe3+ (significant dark purple colour originates 
from a charge-transfer transition from the phenolic oxygen to a iron(III) ion).74  
 
 
 
Scheme 1. Synthesis of the complexes [FeIII(1)(H2O)2]•(ClO4)2 and [FeIII(2)(H2O)2]•(ClO4)2. 
 
Further investigations (see below) revealed a different binding characteristic than assumed 
from results of former investigations in our group,42,43 which predicted a pentadentate chelate 
system, using the nitrogen atom of the pyridine ring, both nitrogen atoms of the oxazoline 
rings and two oxygen or sulphur atoms of the ether or thioether bridges, respectively. 
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Instead of this, evidence was found for two further binding motifs: A tetradentate 
chelation, using both oxazoline nitrogen atoms and the newly introduced oxygens of the 
phenolates, which stabilizes the iron(III) centre (Figure 3, proposed) and a pseudo-
pentadentate (Scheme 2) coordination. In the latter the tetradentate complexation is expanded 
by a peculiarity, which is outlined in Figure 1. The structure exhibits an unexpected sulfoxide 
bridge, which resulted from an oxidation of the sulphur atom, and serves as new fifth 
coordination position. This was only observed when using the sulphur containing ligands 
(±)-4/(meso)-4 and 5. 
 
Furthermore, earlier complexation reactions between iron(II) salts and bis(oxazoline) 
ligands performed in our group resulted in air stable iron(II) complexes.42 Due to the newly 
introduced ortho-OH groups in the ligand, the changed binding motifs led to an unstable 
iron(II) species, which was immediately oxidized. This observation was also made for the 
oxazoline ligands 7a-9 (see main part – oxazoline complex analysis C.2.1-C.2.8).  
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Scheme 2. Synthesis of the complexes [FeIII((meso)-4)ox(H2O)]•(ClO4) and [FeIII(5)ox(H2O)]•(ClO4). 
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D.1.2 Solid-State-Analysis of Iron(III) Complexes – 
FeIII((meso)-4)ox(H2O)]•(ClO4) 
 
The IR spectra of all four iron(III) bis(oxazoline) complexes showed the same typical 
features. A broad alcohol stretch around 3300 cm-1, a strong band at 1603 cm-1 indicating a 
coordinating ligand C=N vibration, and a characteristic broad and very strong band around 
1070 cm-1 as well as a sharp band at 619 cm-1 for the perchlorate, were detected.80 
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Figure 1. ORTEP plot at the 50% probability level of [FeIII((meso)-4)ox(H2O)]•(ClO4) – (not important hydrogen 
atoms and ClO4- are omitted for clarity). 
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In this series, suitable crystals for X-ray crystallography were obtained only for complex 
[FeIII((meso)-4)ox(H2O)]•(ClO4), formed by the (meso)-4 ligand with mixed configurated 
stereo centres (R,S). Here, the bis(oxazoline) (R,S)-4 chelates an iron metal in a pseudo-
pentadentate fashion and forms with a sixth coordination (H2O) an octahedral geometry 
(Figure 1). As already mentioned above, both deprotonated oxygens of the phenolates and 
two oxazoline nitrogens are involved in the binding structure. Furthermore, the oxygen of the 
sulfoxide and a H2O molecule complete the octahedral geometry around the metal, while the 
pyridine nitrogen does not take part in the complexation. The positive charges of the Fe3+ are 
neutralized by two deprotonated phenolates and one perchlorate that is not coordinated at the 
metal. The distance of the two opposite placed nitrogen atoms (N(1) and N(3)) have the 
typical length of 2.11 Å (Table 1), which is comparable to the distances in the di-/tridentate 
oxazoline iron(III) complexes (see main part – oxazoline complex analysis C.2.1-C.2.8). The 
bond lengths of the phenolate oxygen atoms (Fe(1)-O(1) and Fe(1)-O(5)) were determined to 
be 1.92 Å and are significantly shorter than the distance of the sulfoxide oxygen (Fe(1)-O(3) 
with 2.08 Å) and the oxygen of the water molecule (Fe(1)-O(6) with 2.13 Å) to the metal 
centre. A trans-alignment of N(1)-Fe(1)-N(3) was confirmed by an angle of 179°, leading to a 
slightly distorted octahedral geometry. This was also characterized by the nearly square-
planar location of the coordinated oxygen atoms, which span angles between 87° and 100° 
(O(1)-Fe(1)-O(5), O(3)-Fe(1)-O(5), O(3)-Fe(1)-O(6), O(1)-Fe(1)-O6)). In keeping the 
preferred octahedral geometry around the metal, the ligand system becomes strongly distorted 
by the bond interaction between the sulfoxide oxygen and the iron ion (Figure 1). Due to this 
unexpected complex formation, the determination of the complex isomer was not possible. 
 
The expected formation of the complexes [FeIII(1/2)(H2O)2]•(ClO4)2 was confirmed by 
mass analysis (ESI and LSIMS), having each a significant mass peak corresponding to a 
1:1-iron(III) complex. Furthermore, the elemental analysis fit very well for a complex system 
containing one bis(oxazoline) ligand, an iron(III) metal, two H2O molecules and finally two 
perchlorates. Based on the X-ray structure of complex [FeIII((meso)-4)ox(H2O)]•(ClO4) and the 
information collected for [FeIII(1/2)(H2O)2]•(ClO4)2, the complex formation as outlined in 
Figure 2 was proposed. 
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Table 1. Selected bond distances (Å) and angles (°) of [FeIII((meso)-4)ox(H2O)]•(ClO4). 
 
 Bond Distances [Å]  Angles [°] 
Fe(1)-O(1) 1.920(2) O(1)-Fe(1)-O(3) 166.37(9) 
Fe(1)-O(3) 2.079(2) O(1)-Fe(1)-O(5) 99.77(9) 
Fe(1)-O(5) 1.915(2) O(1)-Fe(1)-O(6) 87.35(10) 
Fe(1)-O(6) 2.132(2) O(1)-Fe(1)-N(1) 86.16(10) 
Fe(1)-N(1) 2.110(2) O(1)-Fe(1)-N(3) 93.85(10) 
Fe(1)-N(3) 2.105(3) O(3)-Fe(1)-O(5) 92.91(9) 
S(1)-O(3) 1.523(2) O(3)-Fe(1)-O(6) 80.47(9) 
  O(3)-Fe(1)-N(1) 88.45(9) 
  O(3)-Fe(1)-N(3) 91.77(9) 
  O(5)-Fe(1)-O(6) 171.42(10) 
  O(5)-Fe(1)-N(1) 91.96(9) 
  O(5)-Fe(1)-N(3) 86.98(9) 
  O(6)-Fe(1)-N(1) 93.30(10) 
  O(6)-Fe(1)-N(3) 87.78(10) 
  N(1)-Fe(1)-N(3) 178.93(10) 
 
 
The mass analysis of the complexes [FeIII((±)-4/(meso)-4/5)ox(H2O)]•(ClO4) showed a 
significant mass peak for a 1:1-iron(III) complex as well as it oxidized species, but the 
elemental analysis indicated only the presence of the oxidized 1:1-iron(III) complex 
(Scheme 2).  
 
 
 
Figure 2. Proposed binding structure of the complexes [FeIII(1/2)(H2O)2]•(ClO4)2. 
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D.1.3 Liquid-State-Analysis of Iron(III) Complexes – 
[FeIII(1/2)(H2O)2]•(ClO4)2 and [FeIII((±)-4/(meso)-4/5)ox(H2O)]•(ClO4) 
 
The UV/Vis spectra were measured between 200 and 750 nm in acetonitrile at room 
temperature for the [FeIII(1/2)(H2O)2]•(ClO4)2 and [FeIII((±)-4/(meso)-4/5)ox(H2O)]•(ClO4) 
complexes (Figure 3). All iron(III) compounds exhibited the same features in their absorption 
spectra, indicating similar structures in solution. To differentiate which absorption maximum 
belongs to the specific compounds (ligand, salt, complex), each of them was explored 
separately under the same conditions (see experimental part F.9.2, Figure 1 and 5). With this 
knowledge in hand, an assignment of the maxima at 290 nm and 340 nm was possible. They 
characterize ligand-based transitions (n → π* or π → π*), which are probable caused by the 
chromophores of the conjugated system in the ligand. The shoulder between 340 and 420 nm 
as well as the absorption at 525 nm for [FeIII(1/2)(H2O)2]•(ClO4)2 or at 540 nm for 
[FeIII((±)-4/(meso)-4/5)ox(H2O)]•(ClO4) are identified as complex specific. These transitions 
detected in the electronic spectra are the relatively intense charge-transfer (CT) bands 
responsible for the dark purple colour. They can be assigned to a transition from the pπ orbital 
on the phenolate oxygen to the half-filled dπ* orbitals on the ferric iron(III) ion.74-76 
 
 
 
Figure 3. UV/Vis spectra of [FeIII(1/2)(H2O)2]•(ClO4)2 (left) and [FeIII((±)-4/(meso)-4/5)ox(H2O)]•(ClO4) (right) 
complexes. 
 
The circular dichroism spectra (CD) of the [FeIII((±)-4/(meso)-4)ox(H2O)]•(ClO4) complex 
was not detectable, because of the use of the (±)-4/(meso)-4 ligand mixture. The resulting 
multiple complex geometries were not CD active in mixture. The enantiopure 
[FeIII(1/2)(H2O)2]•(ClO4)2 and the [FeIII(5)ox(H2O)]•(ClO4) complexes exhibit a high 
similarity in their behaviour under the influence of circularly polarized light (Figure 4). The 
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samples were dissolved in acetonitrile and the measurements were made from 200 to 750 nm 
at room temperature. The graphs of complex [FeIII(2)(H2O)2]•(ClO4)2 and 
[FeIII(5)ox(H2O)]•(ClO4) (Figure 4, light grey line and dark grey line), which both contain the 
same methylated oxazoline rings and stereochemistry, but differ in their ether/thioether 
bridges, show a very similar curve progression and are comparable in their stereo chemical 
information to the pure ligand spectra (see experimental part F.9.2, Figure 6). Only small 
features are seen, which indicate no structural homology between [FeIII(2)(H2O)2]•(ClO4)2 and 
[FeIII(5)ox(H2O)]•(ClO4). At 220 nm the ether bridged iron(III) complex 
[FeIII(2)(H2O)2]•(ClO4)2 shows a significant maximum which was not observed in the graph 
of [FeIII(5)ox(H2O)]•(ClO4) (thioether bridged). Furthermore, the positive curve at 330 nm of 
complex [FeIII(2)(H2O)2]•(ClO4)2 was slightly shifted to 380 nm for complex 
[FeIII(5)ox(H2O)]•(ClO4). The CD graph of the unmethylated complex [FeIII(1)(H2O)2]•(ClO4)2 
(ether bridged) (Figure 4, black line) exhibits an mirror image progression in comparison to 
the complexes [FeIII(2)(H2O)2]•(ClO4)2 and [FeIII(5)ox(H2O)]•(ClO4), and therefore confirms 
the different stereochemistry obtained in the complex as well as in the pure ligand. 
Unfortunately, the geometric information from the crystal of [FeIII((meso)-4)ox(H2O)]•(ClO4) 
was not useful, because of the meso-character of the ligand. The complex geometry of the 
complexes [FeIII(1/2)(H2O)2]•(ClO4)2 and [FeIII(5)ox(H2O)]•(ClO4) could not be assigned 
based on their CD spectra (Figure 4). 
 
 
 
Figure 4. CD spectra of [FeIII(1/2)(H2O)2]•(ClO4)2 and [FeIII(5)ox(H2O)]•(ClO4) complexes. 
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D.1.4 Formation of Ruthenium(II) and Ruthenium(III) Complexes using 
[RuCl2(benzene)]2 
 
The effect on the complex formation of an iron-related metal was already described (see 
main part - oxazoline complex analysis C.2.9-C.2.10). The ruthenium salt [RuCl2(benzene)]2 
was selected and also serves here as a suitable metal source for the complexation experiments 
of the bis(oxazoline) ligands (1, 2, (±)-4/(meso)-4, 5).84 One equivalent of the ligand (1, 2, 
(±)-4/(meso)-4, 5), dissolved in ethanol, was transferred into an ethanol suspension of one 
equivalent ruthenium salt (Scheme 3 and 4) and the reaction mixture was heated to reflux for 
16-24 h. For the ether bridged ligands 1 and 2 (Scheme 3) the colour slowly changed from a 
green-brown ruthenium(II) salt to a dark purple ruthenium(III) complex, and for the thioether 
bridged ligands (±)-4/(meso)-4 and 5 (Scheme 4) only the dark green colour of a 
ruthenium(II) complex became visible.  
 
 
 
Scheme 3. Synthesis of the complexes [RuIII(1)(Cl)(solvent)] and [RuIII(2)(Cl)(solvent)]. 
 
The colour indicates that in the case of the complexes [RuIII(1/2)(Cl)(solvent)] (Scheme 3) 
an oxidation of the ruthenium(II) salt into a ruthenium(III) complex, presumably by air, 
occurred. In contrast to this, the complexes [RuII((±)-4/(meso)-4/5)(Cl)2] (Scheme 4) proved 
to be stable on air and so a ruthenium(II) complex was isolated. It is assumed that a charge-
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transfer transition from the phenolic oxygen to a ruthenium(III) ion is responsible for the dark 
purple colour of the complexes [RuIII(1/2)(Cl)(solvent)]74 and the therefore observed colour 
variation indicates different product formation by using either an ether (1, 2) or thioether 
((±)-4/(meso)-4, 5) bridged ligand.  
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Scheme 4. Synthesis of the complexes [RuII((±)-4/(meso)-4)(Cl)2] and [RuII(5)(Cl)2]. 
 
The broad alcohol stretch around 3200 cm-1 was detected for the ruthenium(III) complexes 
[RuIII(1/2)(Cl)(solvent)] as well as for the ruthenium(II) complexes 
[RuII((±)-4/(meso)-4/5)(Cl)2] using IR spectroscopy. However, the IR features strongly differ 
in the significant strong band at 1600 cm-1, which is characterized as a coordinating ligand 
C=N vibration. For [RuIII(1/2)(Cl)(solvent)] the band was still sharp and intensive at 
1617 cm-1, but for [RuII((±)-4/(meso)-4/5)(Cl)2], the extra broad band was divided into two 
signals at 1633 and 1600 cm-1. This might also indicate a different complex formation. 
 
The mass spectrometry (ESI or LSIMS) of the complexes [RuIII(1/2)(Cl)(solvent)] (ether 
bridged ligands) both showed a significant peak for a 1:1-ruthenium(III) complex, and in 
addition the spectra of complex [RuIII(1)(Cl)(solvent)] showed a second mass for the same 
complex, binding one chloride. The elemental analysis confirmed the 1:1 complex formation 
and also suggested one bound chloride and one solvent molecule. This information led to the 
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proposed binding motif for the complexes [RuIII(1/2)(Cl)(solvent)], including a tetradentate 
ligand system (Figure 5, top). The complexes [RuII((±)-4/(meso)-4/5)(Cl)2] (thioether bridged 
ligands) were also detected in the mass analysis (ESI) as a 1:1-ruthenium(II) compound and a 
corresponding complex binding one additional chloride. In the elemental analysis of 
[RuII((±)-4/(meso)-4/5)(Cl)2] a 1:1 complex with two bound chlorides was also confirmed. 
The resulting binding motif contains a pentadentate ligand system, which is shown in Figure 5 
(bottom). 
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Figure 5. Two proposed binding motifs (tetradentate and pentadentate) of the complexes 
[RuIII(1/2)(Cl)(solvent)] and [RuII((±)-4/(meso)-4/5)(Cl)2]. 
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D.1.5 Liquid-State-Analysis of Ruthenium(II) and Ruthenium(III) 
Complexes – [RuIII(1/2)(Cl)(solvent)] and [RuII((±)-4/(meso)-4/5)(Cl)2]  
 
It is not surprising that the assumed binding motifs of the complexes 
[RuIII(1/2)(Cl)(solvent)] and [RuII((±)-4/(meso)-4/5)(Cl)2] are distinguishable by their 
different UV/Vis spectra (Figure 6 and 7). Measured in acetonitrile at room temperature 
between 200 and 750 nm, complexes [RuIII(1)(Cl)(solvent)] (Figure 6, black line) and 
[RuIII(2)(Cl)(solvent)] (Figure 6, light grey line) showed similar features in their absorption 
behaviour and indicate therefore a comparable structure of the complexes in solution. The 
lower concentration used for complex [RuIII(2)(Cl)(solvent)] caused a very weak absorption 
band. The section between 450 nm to 700 nm was enlarged and exhibits also a noticeable 
maximum at 560 nm in both graphs (Figure 6, right). These absorptions as well as the 
shoulders between 350 to 430 nm of the complexes [RuIII(1/2)(Cl)(solvent)] are assigned as 
complex-specific transitions and can be interpreted in combination with the observed dark 
purple colour as a distinct charge-transfer transition from the pπ orbital on the phenolate 
oxygen of the ligand to the half-filled dπ* orbitals of the ruthenium(III) ion (LMCT).74-76,85 
The absorption maximum around 300 nm is clearly identified as due to ligand-specific 
transitions (n → π* or π → π*) (see experimental part F.9.2, Figure 2 and 5).  
 
 
 
Figure 6. UV/Vis spectra of [RuIII(1/2)(Cl)(solvent)] complexes (left) and offset 450 to 700 nm (right). 
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Compared to the ruthenium(III) species, the [RuII((±)-4/(meso)-4/5)(Cl)2] complexes 
showed also ligand specific absorptions around 300 nm and complex-based transitions 
between 350 nm and 475 nm (Figure 7). In contrast to this, the significant absorption 
maximum at 560 nm was not detectable and confirmed again a different binding motif of the 
ruthenium(II) species without interaction of a phenolate oxygen to the metal (Figure 5). 
 
 
 
Figure 7. UV/Vis spectra of the [RuII((±)-4/(meso)-4/5)(Cl)2] complexes.  
 
The circular dichroism (CD) spectra of the complexes [RuIII(1/2)(Cl)(solvent)] and 
[RuII(5)(Cl)2] were measured between 200 to 750 nm in acetonitrile at room temperature 
(Figure 8). Both ruthenium(III) species [RuIII(1/2)(Cl)(solvent)], which are formed by ether 
bridged ligands with a different stereochemistry, exhibit curves with an opposite progression 
(Figure 8, black and light grey line). They possess a minimum or maximum at 240 nm and 
325 nm and the behaviour is comparable to the CD spectra of their corresponding ligands, 
including their stereo chemical information (see experimental part F.9.2, Figure 6). The 
ruthenium(II) complex [RuII(5)(Cl)2] (Figure 8, dark grey line) behaved differently under the 
influence of circularly polarized light than the ruthenium(III) complexes and this indicates a 
significant change in the metal coordination, e. g. from an assumed tetradentate into a 
pentadentate chelation.  
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Figure 8. CD spectra of the [RuIII(1/2)(Cl)(solvent)] and [RuII(5)(Cl)2] complexes.  
 
The attempt to compare these newly obtained results with a similar ruthenium(II) complex 
40, synthesized by M. Seitz (Figure 9)42,90 is difficult, because of the lack of X-ray data of this 
complex. 40 contains a bis(oxazoline) ligand, without ortho-positioned hydroxyl groups and 
without methylated oxazoline rings. The CD spectra of 40 was measured only from 200 to 
300 nm (see experimental part F.9.2, Figure 8). Nevertheless, in this short wavelength range 
both complexes also exhibit different features. The curve progression of 40 is detected only 
on the positive side, whereas the comparable complex [RuII(5)(Cl)2] (Figure 8) shows a 
negative one in this area. 
 
 
 
Figure 9. Proposed binding motifs of two ruthenium(II) complexes – M. Seitz 40 (left) and complex 
[RuII(5)(Cl)2]  (right). 
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D.1.6 Formation of Zinc(II) Complexes using Zn(ClO4)2•6H2O 
 
The [ZnII(1, 2, (±)-4/(meso)-4, 5)]•(ClO4)2 complexes were prepared using one equivalent 
of the bis(oxazoline) ligand (1, 2, (±)-4/(meso)-4, 5) and one equivalent of Zn(ClO4)2•6H2O 
dissolved in THF (Scheme 5 and 6).  
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Scheme 5. Synthesis of the complexes [ZnII(1)]•(ClO4)2 and [ZnII(2)]•(ClO4)2. 
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Scheme 6. Synthesis of the complexes [ZnII((S,S)-4)]•(ClO4)2 and [ZnII(5)]•(ClO4)2. 
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The ligands were transferred to the salt and a precipitate immediately formed in each 
reaction. After a 4-12 h reaction time, the ether bridged complexes [ZnII(1)]•(ClO4)2 and 
[ZnII(2)]•(ClO4)2 were obtained as a slightly pink or a colourless solid, respectively. Both 
thioether bridged complexes [ZnII((±)-4/(meso)-4, 5)]•(ClO4)2 gave yellow solid complexes. 
Previous investigations42 predicted a pentadendate 1:1-zinc(II) complex formation, including 
two non-coordinated perchlorates, which was confirmed by the following observed data.  
 
D.1.7 Solid-State-Analysis of Zinc(II) Complexes – [ZnII(1/2)]•(ClO4)2 and 
[ZnII((S,S)-4/5)]•(ClO4)2 
 
The IR spectra of all four bis(oxazoline) zinc(II) complexes featured the same typical 
properties: a weak alcohol stretch around 3300 cm-1, a strong band at 1620 cm-1 indicating a 
coordinating ligand C=N vibration, and a characteristic broad and very strong band around 
1070 cm-1 as well as a sharp band at 620 cm-1 for the perchlorate.80 
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Figure 10. ORTEP plot at the 50% probability level of [ZnII((S,S)-4)]•(ClO4)2 – (not important hydrogen atoms 
and ClO4- are omitted for clarity). 
 
From the complex mixture [ZnII((±)-4/(meso)-4)]•(ClO4)2 a crystal was obtained with two 
stereo centres of the ligand in the same configuration (S,S). The crystallographic data of 
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[ZnII((S,S)-4)]•(ClO4)2 shows a pentadentate coordinated Zn2+ ion surrounded by an (S,S)-
isomer of the bis(oxazoline) ligand (Figure 10 and 11) and neutralized by two non-
coordinated perchlorates. The crystal structure is C2-symmetric and exhibits a strongly 
distorted square-pyramidal geometry. The nitrogens N(1) and N(3) of the oxazoline ring and 
both sulphurs S(1)/(2) of the thioether bridges form a nearly planar square at the bottom of 
this structure. The distance of the two almost oppositely placed nitrogen atoms (161°) has the 
typical length of 2.00 Å to the metal (Zn(1)-N(1)/(3)) (Table 3), which is comparable to the 
distances in the dimeric oxazoline zinc(II) complexes (see main part – oxazoline complex 
analysis C.2.11-C.2.13). The bond between the pyridine nitrogen N(2) on the top of the 
pyramid and the zinc centre is significantly longer and measured to 2.25 Å. The bond lengths 
of the sulphur atoms to the metal are 2.56 Å and the nearly trans-oriented alignment of 
S(1)-Zn(1)-S(2) was confirmed by an angle of 159°.  
 
         
 
Figure 11. ORTEP plot at the 50% probability level of [ZnII((S,S)-4)]•(ClO4)2 – (not important hydrogen atoms 
and ClO4- are omitted for clarity). 
 
A special feature that should be mentioned is that both phenolates are still protonated and 
point into the complex centre (Figure 11). Their distances to zinc measure exactly 2.60 Å (not 
shown in Table 3) and confirm a weak interaction between the hydroxyl group and the metal. 
The complex geometry of [ZnII((S,S)-4)]•(ClO4)2 was identified as the ∆-isomer (Figure 12). 
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The mass spectrometry (ESI, LSIMS) as well as the elemental analysis of all four zinc(II) 
complexes confirmed a 1:1 stoichiometry, in which two positive charges from the zinc are 
equilized by two perchlorate anions (Scheme 5 and 6).  
 
Table 3. Selected bond distances (Å) and angles (°) of [ZnII((S,S)-4)]•(ClO4)2. 
 
 Bond Distances [Å]  Angles [°] 
Zn(1)-S(1) 2.5588(12) S(1)-Zn(1)-N(1) 83.61(10) 
Zn(1)-S(2) 2.5588(12) S(1)-Zn(1)-N(2) 79.61(4) 
Zn(1)-N(1) 1.997(4) S(1)-Zn(1)-S(2) 159.22(6) 
Zn(1)-N(2) 2.250(5) S(1)-Zn(1)-N(3) 99.78(10) 
Zn(1)-N(3) 1.997(4) N(1)-Zn(1)-N(2) 99.36(11) 
  S(2)-Zn(1)-N(1) 99.78(10) 
  N(1)-Zn(1)-N(3) 161.29(16) 
  S(2)-Zn(1)-N(2) 79.61(4) 
  N(3)-Zn(1)-N(2) 99.36(11) 
  S(2)-Zn(1)-N(1) 83.61(10) 
 
 
 
 
Figure 12. Pentadentate binding model for a square pyramidal geometry. 
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D.1.8 Liquid-State-Analysis of Zinc(II) Complexes – [ZnII(1/2)]•(ClO4)2 and 
[ZnII((±)-4/(meso)-4/5)]•(ClO4)2 
 
Although two different ligand systems were used, the UV/Vis measurements of the 
[ZnII(1/2/(±)-4/(meso)-4/5)]•(ClO4)2 complex series resulted in similar electronic spectra 
(Figure 13). Absorptions with energy higher than 280 nm are ligand or salt specific (see 
experimental part F.9.2, Figure 3 and 5), whereas the bands between 280 and 380 nm are 
identified as overlapping transitions of the ligand and the newly formed zinc(II) complex. It is 
assumed that the right hand side of this broad absorption, starting around 330 nm to lower 
energies, results from a complex-specific transition (LMCT), and the left hand side indicates a 
ligand-specific transition.  
 
 
 
Figure 13. UV/Vis spectra of the complexes [ZnII(1/2)]•(ClO4)2 and [ZnII((±)-4/(meso)-4/5)]•(ClO4)2. 
 
The circular dichroism spectra (CD) of the [ZnII(1/2/5)]•(ClO4)2 complex series were 
measured using circularly polarized light in a range of 200 to 750 nm in acetonitrile at room 
temperature (Figure 15), but only in the range between 200 to 450 nm complex specific 
curves are seen. The complexes [ZnII((±)-4/(meso)-4)]•(ClO4)2 were only obtained in a 
mixture of multiple geometries and was therefore not CD active. Starting from the methylated 
complexes, [ZnII(2)]•(ClO4)2 (Figure 15, light grey line) and [ZnII(5)]•(ClO4)2 (Figure 15, 
dark grey line) respectively, a clear opposite curve progression is seen, which is in contrast to 
the spectra of the corresponding ligands (see experimental part F.9.2, Figure 6). This is an 
unusual effect for ligand systems with two stereo centres of the same configuration, which 
form different geometric structures in combination with a zinc(II) metal. It might be caused 
by the varied bridging atom (oxygen or sulphur) in the ligand. The phenomenon of two non-
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stereogenic atoms, like oxygen and sulphur, being responsible for a different geometry 
formation in the complex was already seen by M. Seitz, using a similar ligand system 
(Figure 14). But the CD spectra of the complexes 41/42 (see experimental part F.9.2, 
Figure 7) and [ZnII(1)]•(ClO4)2 (Figure 15, black line) show significant differences against 
one another and were not directly comparable. 
 
 
 
Figure 14. Two zinc(II) complexes – left ether bridged (M. Seitz 41) and right thioether bridged (M. Seitz 42). 
 
 
 
Figure 15. CD spectra of the complexes [ZnII(1/2)]•(ClO4)2 and [ZnII(5)]•(ClO4)2. 
 
The unmethylated ether bridged complex [ZnII(1)]•(ClO4)2 (Figure 15, black line), with a 
different stereochemistry in comparison to the complexes [ZnII(2)]•(ClO4)2 and 
[ZnII(5)]•(ClO4)2, confirmed its ligand spectra in this point (see experimental part F.9.2, 
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Figure 6). Furthermore, its CD graph resembles more the curve of complex [ZnII(5)]•(ClO4)2 
(thioether bridged) and exhibits an opposite curve progression with regard to complex 
[ZnII(2)]•(ClO4)2 (ether bridged). These untypical behaviours, where same stereo 
configurations in the ligands form different geometric isomers in the complexes, and that 
ether bridged complexes are not comparable with each other but behave similarly to thioether 
bridged complexes, led to the following proposal: The obtained information for the 
enantiopure crystallized zinc(II) complex isomer [ZnII((S,S)-4)]•(ClO4)2, was identified as a 
∆-complex. On the basis of the probably oppositely formed geometry by different bridging 
atoms, complex [ZnII(1)]•(ClO4)2 was assumed to be a Λ-isomer. Corresponding to these 
assumptions, complex [ZnII(2)]•(ClO4)2 might have the ∆- and [ZnII(5)]•(ClO4)2 the 
Λ-geometry (Figure 16). 
 
 
 
Figure 16. Proposed binding motif of the complexes [ZnII(1/2)]•(ClO4)2. 
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D.1.9 Summary 
 
In conclusion, for all iron(III) complexes two different binding motifs have been suggested, 
depending on whether an ether or thioether bridged ligand is used, and whether tetradentate or 
pseudo-pentadentate chelation occurs. For the ruthenium based complexes two binding motifs 
were also assumed. In addition to this, the ligand seems to control the oxidation of Ru2+ to 
Ru3+ in the case of the ether bridged bis(oxazolines). The determination of the iron and 
ruthenium complex geometry was not possible due to the lack of X-ray structures, including a 
chiral ligand. 
 
The crystal obtained in the zinc series allowed the identification of all complex isomers and 
confirmed all expectations with respect to reported literature. 
 
Table 4. Summery of all structural geometries for the complexes obtained. 
 
Entry Salt Ligand 
1 
Ligand 
2 
Ligand 
(±)-4/ 
(meso)-4 
Ligand 
5 
1 Fe(ClO4)2•6H2O Fe(III) 
tetra-
dentate 
Fe(III) 
tetra-
dentate 
Fe(III) 
pseudo-
penta-
dentate 
Fe(III) 
pseudo-
penta-
dentate 
2 [RuCl2(benzene)2]2 Ru(III) 
tetra-
dentate 
Ru(III) 
tetra-
dentate 
Ru(II) 
penta- 
dentate 
Ru(II) 
penta-
dentate 
3 Zn(ClO4)2•6H2O Λ (CD) 
penta-
dentate 
∆ (CD) 
penta-
dentate 
∆ (X-ray) 
penta-
dentate 
Λ (CD) 
penta-
dentate 
 
 
With regard to the aim of this work, to create a defined complex geometry including 
secondary pre-coordination functionalities, the obtained data let to a variety of results: For all 
observed iron(III) complexes, the postulated active intermediate stabilization is not possible 
on the base of the changed binding situation. But for the zinc(II) complexes, the proposed 
binding motif of the bis(oxazolines) with the possibility for additional hydrogen bridge 
formation was confirmed. 
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E. Main Part – Catalysis 
 
E.1 Catalysis 
 
E.1.1 Functionalization of Alkanes by C-H Bond Activation  
 
The generation of ketones and alcohols from simple hydrocarbons is an important aim in 
organic chemistry, but the functionalization of non-activated C-H bonds by oxidation still 
requires drastic conditions and toxic metals.91,92 Many investigations have been devoted to 
develop new mild and efficient methods for oxidation reactions to functionalize saturated 
hydrocarbons. In the past, iron played only a minor role in catalytic approaches. However, 
iron has been the subject of increased interest in recent years due to its non-toxic and 
inexpensive nature. 
 
Bolm and co-workers screened different iron-salts without addition of any ligand for 
reactivity with ethylbenzene (43) and reported an iron-catalyzed oxidation of alkylarenes by 
hydrogen peroxide.93 The reactions were performed under ambient conditions (e.g. room 
temperature), using catalytic amounts of iron-salts and 30% aqueous H2O2 in acetonitrile 
(Scheme 1). The results indicated a rapid decomposition of hydrogen peroxide using 
Fe(OAc)2 and Fe(acac)2, therefore leading to no conversion of the starting material. However, 
Fe(ClO4)2•6H2O (10 mol%) was able to oxidize ethylbenzene in 65% yield, with 
acetophenone (44) being the major product, and no significant decomposition of hydrogen 
peroxide was observed. In addition to this, carboxylic acids have been shown to be effective 
additives in iron-catalyzed oxidations,94-96 presumably by forming the corresponding peracid 
intermediates. Bolm and co-workers tested the addition of various carboxylic acids (e. g. 
acetic acid) under the same reaction conditions and obtained acetophenone as the only product 
at a similar conversion rate as before. The catalyst/substrate/H2O2/acid molar ratio of 
1/10/50/2 has been employed. 
 
 
 
 
Scheme 1. General oxidation of ethylbenzene. 
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Bouwman and co-workers44 studied the catalytic effect of an iron complex containing a 
phenol-oxazoline ligand (±)-46 (Figure 1, left), which has high similarity to the ligands 
described in this thesis (Figure 3). Fe(ClO4)2•6H2O was used to form the catalytically active 
species with this ligand and the oxidation of ethylbenzene under ambient conditions was 
investigated. An excess of substrate with respect to hydrogen peroxide should reduce the 
ketone-formation and minimize the uncontrolled decomposition of H2O2. A molar ratio of 
1/1000/100 (catalyst/substrate/H2O2) resulted in a 0.8/1 mixture of acetophenone and racemic 
1-phenylethanol (45) with TONs of 8.8 and 11.0, respectively (Table 1, entry 2). 
 
 
 
Figure 1. Phenol-oxazoline ligand (±)-46 of Bouwman et al.44 (left) and tpoen ligand 47 ( = N-(2-
pyridylmethoxyethyl)-N,N-bis(2-pyridylmethyl)amine)) of Sun et al.97 (right). 
 
Sun and co-workers97 investigated the catalytic properties of a multidentate N4O ligand 47 
(tpoen = N-(2-pyridyl-methoxyethyl)-N,N-bis(2-pyridylmethyl)amine) (Figure 1, right). 
Depending on the salt added, the corresponding complex is formed with different binding 
motifs. FeCl2•H2O was used to generate a pentadentate complex 48, FeCl3•6H2O to form a 
tridentate complex 49, and Fe(ClO4)2•6H2O was able to form a µ-oxo dinuclear iron complex 
50 (Figure 2). The catalytic activity of the species formed was subsequently tested in the 
oxidation of ethylbenzene in acetonitrile, using a molar ratio of 1/1000/200 
(catalyst/substrate/H2O2) under a N2 atmosphere at room temperature.  
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As outlined in Table 1, all three catalysts generated similar ratios of the products obtained, 
showing a slight preference for the ketone 44 (Table 1, entry 3-5). All TONs reported by Sun 
and co-workers are increased in comparison to those obtained by Bolm and Bouwman, which 
might be explained by the higher ratio of hydrogen peroxide used. Furthermore, it should be 
pointed out that the tridentate complex 49 achieved a TON of 17.2 for the ketone (Table 1, 
entry 4), a result which was improved by the pentadentate complex 48 (Table 1, entry 3). The 
highest reported TON so far was observed under these conditions with the dinuclear iron 
complex 50 (Table 1, entry 5).  
 
Table 1. Comparison of reported oxidations of ethylbenzene. 
 
Entry Catalyst TON d 
acetophenone 
44 
TON d 
phenylethanol 
45 
Ratio 
44 / 45 
1  Fe(ClO4)2•6H2O a 5.0 - 5.0 / 0 
2  (HNEt3)2[Fe((±)-46)2](ClO4) b 8.8 11.0 0.8 / 1 
3  [Fe(47)Cl]PF6 c 22.7 15.7 1.4 / 1 
4  Fe(47)Cl3  c 17.2 12.7 1.4 / 1 
5  [Fe(47)2(µ-O)](ClO4)4  c 26.2 16.4 1.6 / 1 
a reaction conditions: 1.0 mmol ethylbenzene, 0.1 mmol iron-salt, 0.2 mmol HOAc, 5.0 mmol H2O2, 
5 mL acetonitrile, nitrobenzene (0.2 eq., internal standard) – 5 h / rt; b reaction conditions: 5.0 mmol 
ethylbenzene, 5 µmol iron-complexe, 0.5 mmol H2O2, 5 mL acetonitrile – 3 h / rt; c reaction conditions: 
5.0 mmol ethylbenzene, 5 µmol iron-complexe, 1.0 mmol H2O2, 4 mL acetonitrile, 1,2-
dichlorobenzene (internal standard) – 1.5 h / rt; d TON = turnover number of the product in mole 
product per mole catalyst. 
 
 
 
 
Figure 2. Three crystal structures of Sun and co-workers.97 
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E.1.2 Oxidation of Ethylbenzene by Oxazoline / Bis(oxazoline) 
Complexes 
 
To investigate the oxidation of ethylbenzene (Scheme 1) by oxazoline and bis(oxazoline) 
complexes, conditions were chosen on the basis of a number of reported protocols. 
Acetonitrile was envisioned to be a suitable solvent for all oxidation reactions because of the 
good solubility of the ligands, iron salts and the complexes formed by them. Furthermore, the 
substrate was added in a high excess as described by Bouwman et al. Two different iron-salts 
as well as three oxazoline and two bis(oxazoline) derivatives (Figure 3) were used to form the 
catalytically active species as 2:1- or 1:1-complexes. The molar ratio of 
catalyst/substrate/H2O2 was set to 1/100/50, 1/1000/100, or 1/1000/500. The effect of a 
carboxylic acid (HOAc) was also tested. All reactions were performed under ambient 
conditions and samples for GC-analysis were taken at a reaction time of 3 h, 5 h or 24 h. 
 
N
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Figure 3. Oxazoline ligands 7a-9 and bis(oxazoline) ligands 1 and (±)-4/(meso)-4 used for the catalysis. 
 
In the first series of experiments the oxidation of ethylbenzene was performed using 
Fe(ClO4)2•6H2O and Fe(OAc)2. Table 2 summarizes the results obtained after 3 h reaction 
time. Higher TONs are seen for Fe(ClO4)2•6H2O (Table 2, entry 1) in comparison to 
Fe(OAc)2 (Table 2, entry 5) without addition of a ligand. These values show the same 
tendency reported by Bolm and co-workers,93 but here acetophenone was not the only product 
which was obtained.  
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The best results for a 3 h reaction time were achieved by ligand 8 in combination with 
Fe(ClO4)2•6H2O (Table 2, entry 3). A TON of 5.3 was obtained for the ketone and a ratio of 
44 / 45 - 1.6 / 1 shows a slight preference for the ketone. An enantiomeric excess of 28%ee 
was determined for the chiral alcohol. The results for a 24 h reaction time are given in 
Table 3. Here the complex of ligand 8 with Fe(ClO4)2•6H2O (Table 3, entry 3) afforded a 
TON of 10.8 for the ketone, which is comparable to the blank (ligand free) reaction for the 
same reaction time (Table 3, entry 1). Moreover, the selectivity of ligand 8 after 24 h was 
increased to a ratio of 2.3 / 1 towards the ketone (Table 3, entry 3), but at the same time the 
enantiomeric excess for the alcohol observed after 3 h had disappeared. 
 
Table 2. Oxidation of ethylbenzene after 3 h. a 
 
Entry Salt Ligand TON  
acetophenone  
44 
TON 
phenylethanol  
45 
Ratio 
44 / 45 
1 Fe(ClO4)2•6H2O - 7.9 7.5 1.0 / 1 
2 Fe(ClO4)2•6H2O 7a 4.0 2.5 1.6 / 1 
3 Fe(ClO4)2•6H2O 8 5.3 3.3 b 1.6 / 1 
4 Fe(ClO4)2•6H2O 9 4.0 2.7 1.5 / 1 
5 Fe(OAc)2 - 2.4 0.8 3.0 / 1 
6 Fe(OAc)2 7a 3.2 1.7 1.9 / 1 
7 Fe(OAc)2 8 3.0 1.3 2.3 / 1 
8 Fe(OAc)2 9 3.0 1.4 2.1 / 1 
a
 reaction conditions:  10.0 mmol ethylbenzene, 0.01 mmol catalyst, 1.0 mmol H2O2, 5 mL acetonitrile, 
bromobenzene (0.1 eq., internal standard) – 3 h / rt; b 28%ee determined by chiral GC. 
 
Table 3. Oxidation of ethylbenzene after 24 h. a 
 
Entry Salt Ligand TON  
acetophenone 
44 
TON 
phenylethanol 
45 
Ratio 
44 / 45 
1 Fe(ClO4)2•6H2O - 11.4 10.9 1.1 / 1 
2 Fe(ClO4)2•6H2O 7a 5.2 3.0 1.8 / 1 
3 Fe(ClO4)2•6H2O 8 10.8 4.8 b 2.3 / 1 
4 Fe(ClO4)2•6H2O 9 6.9 5.0 1.4 / 1 
5 Fe(OAc)2 - 3.0 1.0 3.1 / 1 
6 Fe(OAc)2 7a 3.9 2.0 1.9 / 1 
7 Fe(OAc)2 8 3.7 1.6 2.4 / 1 
8 Fe(OAc)2 9 4.0 1.8 2.2 / 1 
a
 reaction conditions:  10.0 mmol ethylbenzene, 0.01 mmol catalyst, 1.0 mmol H2O2, 5 mL 
acetonitrile, bromobenzene (0.1 eq., internal standard) – 24 h / rt; b 0%ee determined by chiral GC. 
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Due to the generally lower TONs for Fe(OAc)2 in the oxidation of ethylbenzene, the focus 
for further investigations was shifted to the more promising Fe(ClO4)2•6H2O complexes. The 
addition of a carboxylic acid (e.g. HOAc) and use of a higher amount of hydrogen peroxide 
was also explored in the next experiments. It was assumed that the rapid decomposition of 
H2O2 plays an important role for the observed low TON values and could be avoided by 
continuous addition of the oxidizing agent. The following 5 h and 24 h reactions were 
performed by a portion-wise addition of 1 mmol oxidant each hour during the first 5 h up to a 
total of 5 mmol hydrogen peroxide. 
The results obtained after 5 h are shown in Table 4. The addition of acetic acid resulted in 
a higher blank value (TON 14.4 for the ketone) as well as in a better ratio of 44 / 45 - 2 / 1 
(Table 4, entry 1-2). Furthermore, the continuous addition of five equivalents H2O2 with an 
elongated reaction time of 5 h improved all TONs (Table 4). Ligand 8 performed well under 
these conditions. A TON of 8.8 for the ketone and a selectivity of 44 / 45 - 2.2 / 1 was reached 
(Table 4, entry 6), while only 9%ee for the chiral alcohol was obtained. The corresponding 
complexes of the bis(oxazoline) ligands 1 and (±)-4/(meso)-4 were also investigated, but they 
catalyzed the oxidation reaction less well in comparison to all the oxazolines 7a-9. The 
complex of ligand 1 was able to form the ketone only with a TON of 5.0 (Table 4, entry 10), 
but the selectivity for the ketone is improved (2.8 / 1). While the addition of acetic acid 
resulted in slightly higher TONs for the oxazoline ligands 7a-9, no detectible influence for the 
bis(oxazoline) catalysts was observed.  
 
Table 4. Oxidation of ethylbenzene after 5 h. a 
 
Entry Ligand TON  
acetophenone  
44 
TON 
phenylethanol 
45 
Ratio 
44 / 45 
1 - 12.9 10.3 1.3 / 1 
2 - b 14.4 7.1 2.0 / 1 
3 7a 4.7 2.6 1.8 / 1 
4 7a b 6.2 3.2 1.9 / 1 
5 8 4.9 2.4 2.0 / 1 
6 8 b 8.8 4.0 c 2.2 / 1 
7 9 5.3 2.7 2.0 / 1 
8 9 b 7.2 3.9 2.0 / 1 
9 1 5.3 2.2 2.4 / 1 
10 1 b 5.0 1.8 2.8 / 1 
11 (±)-4/(meso)-4 3.4 1.6 2.1 / 1 
12 (±)-4/(meso)-4  b 3.2 1.8 1.8 / 1 
a reaction conditions: 10.0 mmol ethylbenzene, 0.01 mmol catalyst, 5 x 1.0 mmol H2O2, 
5 mL acetonitrile, bromobenzene (0.1 eq., internal standard) – 5 h / rt; b 0.2 mmol 
HOAc; c 9%ee determined by chiral GC. 
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A TON of 8.8 for the ketone obtained using ligand 8 after 5 h (Table 4, entry 6) is 
comparable with the results reported by Bouwman and co-workers (TON 8.8 for the ketone) 
(Table 1, entry 2).44 In contrast to this, a ratio of 2.2 / 1 was observed, indicating a higher 
preference for the ketone, while Bouwman et al. achieved only a ratio of 0.8 / 1. The higher 
TONs of Sun and co-workers97 were not reached using our catalytic system. Their three 
complexes catalyzed the oxidation reaction to a high degree (TON 17.2 – 26.2 for the ketone) 
(Table 1, entry 3-5), but the selectivity of their catalytic species is lower. 
 
The data obtained from the 24 h-samples are summarized in Table 5 and indicate a further 
increase of the blank values (Table 5, entry 1-2) as well as a higher TON using ligand 8 
(Table 5, entry 5-6). In addition to these improved results the enantiomeric excess of the 
alcohol was increased to 16% (Table 5, entry 6). Furthermore, after 24 h ligand 7a afforded 
results quite similar to ligand 8 (Table 5, entry 4), but no enantiomeric excess could be 
detected. The best result for the bis(oxazoline) complexes was obtained with ligand 1 
(Table 5, entry 10), but did not reach the TONs of ligand 7a and 8. 
 
Table 5. Oxidation of ethylbenzene after 24 h. a 
 
Entry Ligand TON  
acetophenone  
44 
TON 
phenylethanol 
45 
Ratio 
44 / 45 
1 - 15.0 8.4 1.8 / 1 
2 - b 19.2 7.8 2.5 / 1 
3 7a 10.0 8.8 1.1 / 1 
4 7a b 11.7 4.2 c 2.8 / 1 
5 8 8.00 2.9 2.7 / 1 
6 8 b 11.6 4.5 d 2.6 / 1 
7 9 9.2 3.9 2.3 / 1 
8 9 b 14.1 6.2 2.3 / 1 
9 1 6.2 2.6 2.4 / 1 
10 1 b 7.8 3.1 2.5 / 1 
11 (±)-4/(meso)-4 4.0 1.8 2.2 / 1 
12 (±)-4/(meso)-4  b 3.5 1.6 2.1 / 1 
a reaction conditions: 10.0 mmol ethylbenzene, 0.01 mmol catalyst, 5 x 1.0 mmol H2O2, 
5 mL acetonitrile, bromobenzene (0.1 eq., internal standard) – 24 h / rt; b 0.2 mmol HOAc; c 
0%ee determined by chiral GC; d 16%ee determined by chiral GC. 
 
Finally, an increase of the catalyst loading from 1 mol% to 10 mol% leads to the results 
shown in Table 6 and 7. In general, after 5 h as well as after 24 h, in all cases only very low 
TONs were observed. Even the blank values reached only TONs of 3.8 and 5.1 for the ketone 
after 5 h and 24 h, respectively (Table 6, entry 2, Table 7, entry 2). All complex-catalyzed 
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reactions showed TONs lower than 3.5 and the selectivity is in the same range as for the blank 
reactions.  
 
Table 6. Oxidation of ethylbenzene after 5 h. a 
 
Entry Ligand TON  
acetophenone 
44 
TON 
phenylethanol 
45 
Ratio 
44 / 45 
1 - 3.3 1.9 1.7 / 1 
2 - b 3.8 2.3 1.7 / 1 
3 7a 0.9 0.8 1.0 / 1 
4 7a b 1.1 1.0 1.0 / 1 
5 8 1.6 1.0 1.6 / 1 
6 8 b 2.7 1.7 1.6 / 1 
7 9 2.0 1.3 1.5 / 1 
8 9 b 2.1 1.4 1.5 / 1 
9 1 1.1 0.9 1.2 / 1 
10 1 b 1.3 0.6 2.2 / 1 
11 (±)-4/(meso)-4 0.5 0.5 1.0 / 1 
12 (±)-4/(meso)-4  b 0.6 0.6 1.0 / 1 
a reaction conditions: 10.0 mmol ethylbenzene, 0.1 mmol catalyst, 5 x 1.0 mmol H2O2, 
5 mL acetonitrile, bromobenzene (0.1 eq., internal standard) – 5 h / rt; b 0.2 mmol HOAc. 
 
Table 7. Oxidation of ethylbenzene after 24 h. a 
 
Entry Ligand TON  
acetophenone 
44 
TON 
phenylethanol 
45 
Ratio 
44 / 45 
1 - 3.9 2.2 1.8 / 1 
2 - b 5.1 2.7 1.9 / 1 
3 7a 1.0 0.9 1.1 / 1 
4 7a b 1.0 0.9 1.1 / 1 
5 8 2.1 1.5 1.5 / 1 
6 8 b 3.3 2.2 1.5 / 1 
7 9 2.6 1.6 1.6 / 1 
8 9 b  2.9 1.8 1.6 / 1 
3 1 0.9 0.5 1.8 / 1 
4 1 b 1.3 0.7 2.0 / 1 
5 (±)-4/(meso)-4 0.2 0.4 0.5 / 1 
6 (±)-4/(meso)-4  b 0.3 0.4 0.8 / 1 
a reaction conditions: 10.0 mmol ethylbenzene, 0.1 mmol catalyst, 5 x 1.0 mmol H2O2, 
5 mL acetonitrile, bromobenzene (0.1 eq., internal standard) – 24 h / rt; b 0.2 mmol HOAc. 
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E.1.3 Preparation of Optical Active Sulfoxides 
 
Many sulfoxides are known to have high biological activity.98 Their preparation involves 
the use of chiral auxiliaries or reagents in enantioselective oxidations of prochiral sulfides.99 
The utilization of chiral transition metal complexes in combination with an oxidizing agent is 
a powerful method to generate optically active sulfoxides. Recently Bolm and co-workers 
reported a highly selective catalytic process using iron96,100-103 (as one of the most inexpensive 
and user-friendly metals) in combination with Schiff bases (Figure 4) as chiral ligands, and 
very simple and mild reaction conditions. 
 
 
 
Figure 4. Schiff base ligand 51 used by Bolm et al. in comparison with oxazoline 7a and thiazoline 10. 
 
The most successful Schiff base 51 (Figure 4), bearing iodine substituents in para- and 
ortho-positions to the hydroxyl group, generated promising ee-values in the oxidation of 
methyl phenyl sulfide (52) (Scheme 2), but only moderate yields (Table 8, entry 1).100 This 
reaction was performed in dichloromethane at room temperature, using Fe(acac)3 and 
30% aqueous H2O2 as oxidant in a molar ratio of catalyst/substrate/H2O2 of 1/50/60. 
 
 
 
 
Scheme 2. Oxidation of methyl phenyl sulfide by Bolm et al. 
 
Further investigations revealed that the addition of various carboxylic acids and their 
lithium salts improved the yields as well as the enantiomeric excess. Table 8 shows an 
increase of the ee-value from 59% (Table 8, entry 1, no additive) to 77%ee (Table 8, entry 2, 
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addition of 4-metoxybenzoic acid) and to an excellent 90%ee (Table 8, entry 3, addition of 
lithium salt of 4-metoxybenzoic acid), while the low yield of 36% was nearly doubled to 63% 
(Table 8, entry 1-3). In all the oxidation reactions of methyl phenyl sulfide reported by Bolm 
and co-workers, no sulfone 54 as further oxidation product was observed. 
 
Table 8. Comparison of reported oxidations of methyl phenyl sulfide by Bolm et al.d 
 
Entry Ligand Yield [%] ee [%] 
1  51 a 36 59 
2   51 a, b 61 77 
3   51 a, c 63 90 
a reaction conditions: 1.0 mmol methyl phenyl sulfide, 0.02 mmol 
Fe(acac)3, 0.04 mmol Schiff base 51, 1.2 mmol H2O2, 2 mL 
dichloromethane – 16 h / rt; b 0.01 mmol 4-methoxybenzoic acid; 
c
 0.01 mmol lithium salt of 4-methoxybenzoic acid; d isolated yield, 
ee-values determined by cHPLC. 
 
E.1.4 Asymmetric Sulfide Oxidation 
 
The high structural similarity between the Schiff base ligand 51 and oxazoline ligand 7a 
(Figure 4) gave rise to speculation that they could also have comparable catalytic properties. 
It was assumed that on the basis of the comparable metal binding sites104 the sulfide oxidation 
may also be successful using oxazoline complexes. Further evidence for the catalytic activity 
of oxazoline and bis(oxazoline) iron complexes is provided by the crystal structure of 
complex [FeIII((meso)-4)ox(H2O)]•(ClO4) (see main part – bis(oxazoline) complex analysis 
D.1.2, Figure 1), which resulted from a self oxidation reaction of the ligand. When the 
complex with Fe(ClO4)2•6H2O was formed, one of the thioether bridges of the bis(oxazoline) 
ligand (meso)-4 was oxidized by air into the corresponding sulfoxide. This self oxidation is 
promising for further investigations into the complexes potential as a catalyst for sulfide 
oxidations.  
 
Applying the method reported by Bolm and co-workers,96 oxazoline ligands 7a-9 and 
bis(oxazolines) 1 and (±)-4/(meso)-4 were tested in combination with Fe(acac)3 or 
Fe(ClO4)2•6H2O in the oxidation of methyl phenyl sulfide. A 2:1 ratio of ligand to salt for 
oxazolines 7a-9 and a 1:1 ratio of ligand to salt for bis(oxazolines) 1 and (±)-4/(meso)-4 were 
used (Scheme 2). Fe(acac)3 and Fe(ClO4)2•6H2O were explored in dichloromethane as solvent 
under ambient conditions over 16 h reaction time. Unfortunately, the first attempts of the 
sulfide oxidation resulted in only very low conversions. During the course of the reaction 
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(approximately 2 h after the addition of H2O2), a solid began to precipitate from the reaction 
mixture. It is assumed that the low solubility of the intermediate species might be a problem 
and is the reason for these disappointing results. 
 
To overcome this solubility problem, a new solvent was chosen. The precipitation of the 
catalyst intermediate should be avoidable by using acetonitrile, a solvent which is known to 
be suitable for all oxazoline and bis(oxazoline) complexes as described above (see main part 
– catalysis E.1.2). In addition to this, Fe(OAc)2 as a third salt was also tested and 
4-methoxybenzoic acid was added to all reactions because of its reported positive effect.96,101 
Furthermore, the thiazoline ligand (±)-10 (Scheme 4) was also explored for its catalytic 
activity in the sulfide oxidation reaction. 
 
The summarized results under these conditions are presented in Table 9-11. In general, the 
yields obtained for the Fe(acac)3- (Table 10) and Fe(OAc)2-based (Table 11) complexes 
reached only a maximum of 55% for the corresponding sulfoxide 53 and the determined 
ee-values were also extremely low. In contrast to this, Fe(ClO4)2•6H2O-based complexes 
achieved the best yields of up to 73% by using ligand 8 (Table 9, entry 5), which are 
comparable to the results reported by Bolm and co-workers. Unfortunately, the ee-values did 
not exceed 23%.  
 
Table 9. Oxidation of methyl phenyl sulfide.a, b 
 
Entry Salt  Ligand Ligand 
[mol%]  
Sulfoxide 53 
Yield [%]b 
ee [%]c 
1 Fe(ClO4)2•6H2O - - 26 / 10 d - 
2 Fe(ClO4)2•6H2O 1 2.0 57 / 28 d 14.5 
3 Fe(ClO4)2•6H2O (±)-4/(meso)-4 2.0 36 1 
4 Fe(ClO4)2•6H2O 7a 4.0 52 23 
5 Fe(ClO4)2•6H2O 8 4.0 73 9 
6 Fe(ClO4)2•6H2O 9 4.0 65 3.5 
7 Fe(ClO4)2•6H2O 10 4.0 66 3 
a reaction conditions: 1.0 mmol methyl phenyl sulfide, 0.02 mmol catalyst, 1.2 mmol H2O2, 0.01 eq. 
4-methoxybenzoic acid, 2.5 mL acetonitrile – 16 h / rt; b determined by 1H-NMR; c ee-values 
determined by cHPLC, d yield determined after complete solvent removal. 
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Table 10. Oxidation of methyl phenyl sulfide. a 
 
Entry Salt  Ligand Ligand 
[mol%] 
Sulfoxide 53 
Yield [%] 
ee [%] 
1 Fe(acac)3 - - n.r. / 16 d - 
2 Fe(acac)3 1 2.0 41 / 20 d 3 
3 Fe(acac)3 (±)-4/(meso)-4 2.0 22 1 
4 Fe(acac)3 7a 4.0 40 <1 
5 Fe(acac)3 8 4.0 36 <1 
6 Fe(acac)3 9 4.0 55 5.5 
7 Fe(acac)3 10 4.0 37 3 
a reaction conditions: 1.0 mmol methyl phenyl sulfide, 0.02 mmol catalyst, 1.2 mmol H2O2, 
0.01 eq. 4-methoxybenzoic acid, 2.5 mL acetonitrile – 16 h / rt; b determined by 1H-NMR; c ee-
values determined by cHPLC, d yield determined after complete solvent removal. 
 
Table 11. Oxidation of methyl phenyl sulfide. a 
 
Entry Salt Ligand Ligand 
[mol%]  
Sulfoxide 53 
Yield [%]b 
ee [%]c 
1 Fe(OAc)2 - - 18 - 
2 Fe(OAc)2 1 2.0 19 2 
3 Fe(OAc)2 (±)-4/(meso)-4 2.0 16 2 
4 Fe(OAc)2 7a 4.0 37 4 
5 Fe(OAc)2 8 4.0 43 <1 
6 Fe(OAc)2 9 4.0 47 16.5 
7 Fe(OAc)2 10 4.0 32 6 
a reaction conditions: 1.0 mmol methyl phenyl sulfide, 0.02 mmol catalyst, 1.2 mmol H2O2, 
0.01 eq. 4-methoxybenzoic acid, 2.5 mL acetonitrile – 16 h / rt; b determined by 1H-NMR; c ee-
values determined by cHPLC, d yield determined after complete solvent removal. 
 
 
To prevent a possible source of error, based on the strong solvent excess in each sample, in 
four reactions (Table 9 and 10, entry 1 and 2) the solvent was completely removed. Because 
of this variation in the work-up, a reduced yield in each sample was detected, but the positive 
effect of the ligand was nevertheless observed. 
 
 
In conclusion, for both oxidation reactions explored, the oxazoline ligands were able to 
generate better results compared to the bis(oxazoline) ligands. Ligand 8 in particular exhibited 
the best performance in all catalytic oxidations. All the results obtained were not able to 
match those already published, but do provide the basis for further investigations. Variations 
of substrates and reaction conditions are feasible. 
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F. Experimental Part 
 
F.1 General 
 
1H NMR-Spectra were recorded on Bruker Avance 300, Bruker Avance 400, Bruker Avance 
600, Varian Inova 600, Bruker DRX-400 with a H/C/P/F QNP gradient probe and Bruker Avance 
500 with a dual carbon/proton CPDUL cryoprobe. The chemical shift δ is given in [ppm], 
calibration was set on chloroform-d1 (7.26 ppm) or tetramethylsilane (0.00 ppm) as internal 
standard. The spectra were evaluated in 1st order and the coupling constants are given in Hertz 
[Hz]. The following abbreviations for the spin multiplicity were used: s = singlet, d = doublet, t = 
triplet, q = quartet, qt = quintet, m = multiplet, dt = doublet of a triplet, dd = double doublet, ddd 
= doublet of a double doublet, sept = septet. The used deuterated solvents are given separately.  
 
13C NMR-Spectra were recorded on Bruker Avance 300, Bruker Avance 400, Bruker Avance 
600, Varian Inova, Bruker DRX-400 with a H/C/P/F QNP gradient probe and Bruker Avance 500 
with a dual carbon/proton CPDUL cryoprobe. The chemical shift δ is given in [ppm], calibration 
was set on chloroform-d1 (77.16 ppm), or tetramethylsilane (0.00 ppm) as internal standard. 
 
Melting points were measured on a Büchi SMP 20 in a silicon oil bath. The melting points are 
uncorrected. 
 
Infrared-Spectra were recorded on a Bio-Rad Excalibur Series or Mattson Genesis Series FT-
IR. Solid compounds were measured in KBr, liquid compounds as a neat film between NaCl-
plates. The wave numbers are given in [cm-1]. 
 
Masspectrometry was performed on Varian MAT 311A, Finnigan MAT 95, Thermoquest 
Finnigan TSQ 7000, Nermag quadrupoles, VG ZAB high-resolution double-focusing and VG 
Autospec-Q tandem hybrid with EBEqQ configuration. The percentage set in brackets gives the 
peak intensity related to the basic peak (I = 100%). High resolution mass spectrometry (HRMS): 
The molecular formula was proven by the calculated precise mass. 
 
Elemental analysis was prepared by the micro analytic section of the University of 
Regensburg using a Vario EL III or Mikro-Rapid CHN (Heraeus). 
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Optical rotation was measured at rt on a 241 MC Perkin-Elmer polarimeter at a wavelength of 
589 nm (Na-D) in a 1 dm or 0.1 dm cell. The concentration is given in [g/100 ml]. 
 
X-ray analysis was performed by the crystallography laboratory of the University of 
Regensburg (STOE-IPDS, Stoe & Cie GmbH) and the crystallography laboratory of the 
University of Kansas. 
 
Chiral HPLC was performed in the analytic department of the University of Regensburg or on 
a Kontron Instruments 325 System (HPLC 335 UV detector, λ = 254 nm, Chiracel OD/OD-H 
column (50x4.6 mm, 10 µm, flow rate: 1 mL/min, 20 °C, n-heptane/ethanol 99:1). 
 
Gaschromatography (GC) was measured in the analytic department of the University of 
Regensburg or on Fisons Instruments GC 8000 series (Data Jet Integrator, CP-chiralsil-DEX-CP 
column). 
 
Thin layer chromatography (TLC) was prepared on TLC-aluminium sheets (Merck, silica 
gel 60 F254, 0.2 mm). Detection in UV-light λ = 254 nm, staining with I2, mostain, 
molybdatophosphoric-acid (5% in ethanol), KMnO4 solution or vanillin-sulfuric acid. 
 
Column chromatography was performed in glass columns (G2 or G3). As a stationary phase 
silica gel Merck-Geduran 60 (0.063-0.200 mm) or flash silica gel Merck 60 (0.040-0.063 mm) 
was used. 
 
CD-spectra were measured on a JASCO model J-710/720 at the Institute of Bioanalytic and 
Sensoric of the University of Regensburg in the specified solvent. The background was subtracted 
to each spectrum and the absorption value is measured as molare ellipticity (deg•cm2•dmol-1). The 
spectra were smoothed by adjacent averaging algorithm with Origin 6.0. 
 
UV/Vis spectra were recorded on a Varian Cary BIO 50 UV/VIS/NIR spectrophotometer 
equipped with a jacketed cell holder using 1-cm cuvettes (quartz or glass) from Hellma 
 
Solvents: Abs. solvents were prepared according to usual lab procedures or taken from the 
MB-SPS solvent purification system. Ethylacetate, hexanes (40-60 °C) and dichloromethane were 
purified by distillation before use. Further solvents and reagents were of p.a. quality. 
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Reactions with oxygen- and moisture sensitive reactants were performed in oven dried and in 
vacuo heated reaction flasks under a pre-dried inert gas (nitrogen or argon) atmosphere. For 
cooling to temperatures < -40 °C a cryostat Haake EK 90 or dry ice/iso-propanol mixture was 
used. 
 
F.2  Abbreviations 
 
α-KA α-keto acid 
abs absolute 
acac acetylacetonate 
bf benzoylformate 
cat catalytic 
CD circular dichroism 
CI chemical ionization 
DCM dicholormethane 
DFO desferrioaxamine 
DFT desferrithiocin 
dr diastereomeric ratio 
DMA N,N-dimethylacetamide 
DMAP N,N-dimethylamino pyridine 
DMF dimethyl formamide 
ee enantiomeric excess 
EE eth 
eq equivalents 
EI electronic ionization 
Et ethyl 
GC gas-chromatograph 
h hour 
HPLC high pressure liquid  
 Chromatography 
HR hemerythrin 
HRMS high resolution mass  
 Spectrometry 
ICE iron clearing efficiency 
iPr iso-propyl 
IR infra red 
L ligand 
LAH lithium aluminium hydride 
M metal 
Me methyl 
MeCN acetonitrile 
Mes mesyl 
min minute 
MMOM methane monooxygenase 
MRT 5-methyltetrahydrofolate-
homocystein methyltransferase 
MS molecular sieve 
nm nano meters 
NMR nuclear magnetic resonance 
Nu nucleophile 
OAc acetate 
OD optical density 
Ph phenyl 
PPLE porcine pancreas lipase enzyme 
pyr pyridine 
RNR R2 ribonucleotide reductase type I 
rt room temperature 
TBDMS tert-butyldimethylsily 
TBAF tetrabutylammonium fluoride 
tBu tert-butyl 
THF tetrahydrofuran 
TMS trimethylsilyl 
Tp tris(pyrazolyl)borate 
Ts tosyl 
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F.3 Oxazoline and Thiazoline Ligands 
 
OH
NO
OH
 
 
(R)-2-(4-(hydroxymethyl)-4,5-dihydrooxazol-2-yl)phenol (7a) 
 
(S)-methyl-2-(2-hydroxyphenyl)-4,5-dihydrooxazole-4-carboxylate 16a (8.09 g, 36.57 mmol, 
1.0 equiv.) was dissolved in dry THF (100 mL) under N2 and cooled to -30 °C. LiAlH4 (1.80 g, 
47.54 mmol, 1.3 equiv.) was added in portions and the mixture was stirred for 3.5 h at -30 °C. 
After addition of sat. aqueous KNa-tartrate-solution (200 mL) and Et2O (200 mL) the mixture 
was continuously stirred over night at rt. The layers were separated and the aqueous layer was 
extracted with EtOAc (3 x 150 mL) and all combined organic layers were dried (Na2SO4). The 
solvent was evaporated under reduced pressure and the crude product was purified by flash 
column chromatography (SiO2, hexanes/EtOAc 5:1 to 3:1 to EtOAc) to yield the product as 
slightly yellow solid (2.24 g, 11.61 mmol, 32%), which can be further recrystallized from Et2O 
to afford a colourless solid.  
 
Rf  0.14 (hexanes/EtOAc 5:1); m.p. 85 °C; [ ]20Dα = +23.65 (c = 0.99, EtOH); 1H NMR 
(300 MHz, CDCl3): δ 11.90 (bs, OH, 1H), 7.68-7.64 (m, CHa, 1H), 7.43-7.33 (m, CHa, 1H), 
7.03-6.98 (m, CHa, 1H), 6.91-6.84 (m, CHa, 1H), 4.56-4.44 (m, CH2-OH, 2H), 4.41-4.31 (m, 
CH, 1H), 3.90 (dd, J = 3.7, 11.4 Hz, CH-CH2, 1H), 3.71 (dd, J = 11.4, 3.7 Hz, CH-CH2, 1H); 
13C NMR (75.5 MHz, CDCl3): δ 167.0 (Cq), 159.8 (Cq), 133.8 (Ca), 128.3 (Ca), 118.8 (Ca), 
116.8 (Ca), 110.4 (Cq), 68.6 (CH2), 66.8 (CH), 64.0 (CH2); IR (KBr): ν~  3299, 2870, 1643, 
1616, 1580, 1489, 1410, 1364, 1303, 1257, 1224, 1157, 1126, 1066, 1029, 982, 952, 860, 828, 
788, 750 cm-1; MS (CI, NH3): m/z (%) = 194.1 (100, [MH]+); elemental analysis calcd (%) for 
C10H11NO3 (256.1): C 62.17, H 5.74, N 7.25, found: C 62.08, H 6.21, N 7.23. 
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(R)-2-(4-(hydroxymethyl)-4,5-dihydrooxazol-2-yl)phenol (7a) 
(ppm)
1.02.03.04.05.06.07.08.09.010.011.012.0
 
(ppm)
0102030405060708090100110120130140150160170180190
 
OH
NO
OH
Experimental Part 
 
128 
 
OH
NO
OH
 
 
(S)-2-(4-(hydroxymethyl)-5,5-dimethyl-4,5-dihydrooxazol-2-yl)phenol (9) 
 
(S)-2-(4-((tert-butyldimethylsilyloxy)methyl)-5,5-dimethyl-4,5-dihydrooxazol-2-yl)phenol 19 
(2.75 g, 8.20 mmol, 1.0 equiv.) was dissolved in dry THF (50 mL), dry NEt3 (115 µL, 83 mg, 
0.82 mmol, 0.1 equiv.) and TBAF (2.64 g, 8.36 mmol, 1.02 equiv.) were added at rt and the 
mixture was stirred for 20 h. The solvent was evaporated and the crude product was purified by 
column chromatography (SiO2, hexanes/EtOAc 1:1) to yield the product as slightly orange oil 
(1.32 g, 5.97 mmol, 73%). 
 
Rf  0.67 (hexanes/EtOAc 1:1); [ ]20Dα = -33.39 (c = 1.11, EtOH); 1H NMR (300 MHz, CDCl3): δ 
7.67-7.60 (m, CHa, 1H), 7.40-7.32 (m, CHa, 1H), 7.02-6.96 (m, CHa, 1H), 6.89-6.81 (m, CHa, 
1H), 3.99 (t, J = 5.6 Hz, CH, 1H), 3.82 (d, J = 6.0 Hz, CH2, 2H), 1.51 (s, CH3, 3H), 1.49 (s, 
CH3, 3H); 13C NMR (75.5 MHz, CDCl3): δ 165.5 (Cq), 160.0 (Cq), 133.5 (Ca), 128.3 (Ca), 
118.7 (Ca), 116.8 (Ca), 110.9 (Cq), 85.6 (Cq), 73.9 (CH), 62.3 (CH2), 29.0 (CH3), 21.4 (CH3); 
IR (film): ν~  3425, 2975, 1633, 1491, 1365, 1307, 1256, 1153, 1127, 1074, 1037, 946, 893, 
850, 801, 757, 692 cm-1; MS (EI, 70 eV): m/z (%) = 121.1 (100, [C7H5O2+]), 190.1 (38, 
[C11H12NO2+]), 221.1 (52, [M]+); HRMS (EI, 70 eV): calcd for C12H15NO3 [M+] 221.1052, 
found 221.1055. 
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(S)-2-(4-(hydroxymethyl)-5,5-dimethyl-4,5-dihydrooxazol-2-yl)phenol (9) 
(ppm)
0.01.02.03.04.05.06.07.08.09.010.011.012.0
 
(ppm)
0102030405060708090100110120130140150160170180190
 
OH
NO
OH
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OH
NO
OH
 
 
(S)-2-(4-(2-hydroxypropan-2-yl)-4,5-dihydrooxazol-2-yl)phenol (8) 
 
(S)-methyl-2-(2-hydroxyphenyl)-4,5-dihydrooxazole-4-carboxylate 16a (15.58 g, 70.43 mmol, 
1.0 equiv.) was dissolved in dry Et2O (300 mL) and cooled to 0 °C under N2. A 3.0 M-solution 
of MeMgBr (69.50 mL, 208.5 mmol, 2.96 equiv.) was added dropwise. The mixture was 
stirred for 5 h at 0 °C. After addition of sat. NH4Cl-solution (200 mL) stirring was continued 
until both layers were clear. After layer separation, the aqueous layer was extracted with Et2O 
(5 x 100 mL) and the combined organic layers were dried (Na2SO4). The solvent was 
evaporated under reduced pressure and the crude product was purified by flash column 
chromatography (SiO2, hexanes/EtOAc 3:1) to yield the product as yellow solid (10.90 g, 
49.27 mmol, 70%).  
 
Rf 0.49 (hexanes/EtOAc 3:1); m.p. 45 - 47 °C; [ ]20Dα = -7.98 (c = 1.02, EtOH); 1H NMR 
(300 MHz, CDCl3): δ 12.00 (bs, OH, 1H), 7.64-7.58 (m, CHa, 1H), 7.38-7.30 (m, CHa, 1H), 
7.00-6.94 (m, CHa, 1H), 6.87-6.80 (m, CHa, 1H), 4.42-4.36 (m, CH2, 2H), 4.38 (dd, 
J = 8.2 Hz, CH, 1H), 1.50 (bs, C(CH3)2-OH, 1H), 1.31 (s, CH3, 3H), 1.19 (s, CH3, 3H); 
13C NMR (75.5 MHz, CDCl3): δ 166.8 (Cq), 159.9 (Cq), 133.7 (Ca), 128.3 (Ca), 118.8 (Ca), 
116.8 (Ca), 110.4 (Cq), 74.4 (CH), 71.3 (Cq), 68.0 (CH2), 26.8 (CH3), 25.8 (CH3); IR (KBr): ν~  
3428, 3398, 2963, 1643, 1618, 1581, 1491, 1464, 1420, 1363, 1311, 1253, 1232, 1150, 1130, 
1075, 1039, 955, 829, 793, 761 cm-1; MS (EI, 70 eV): m/z (%) = 121.1 (100, [C7H5O2+]), 221.2 
(20, [M+]); HRMS (EI, 70 eV): calcd for C12H15NO3 [M+] 221.1052, found 221.1051. 
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(S)-2-(4-(2-hydroxypropan-2-yl)-4,5-dihydrooxazol-2-yl)phenol (8) 
(ppm)
0.01.02.03.04.05.06.07.08.09.010.011.012.0
 
(ppm)
0102030405060708090100110120130140150160170180190
 
OH
NO
OH
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OH
NS
OH
 
 
(±)-2-(4-(hydroxymethyl)-4,5-dihydrothiazol-2-yl)phenol (±)-(10) 
 
(R)-methyl-2-(2-hydroxyphenyl)-4,5-dihydrothiazole-4-carboxylate 21 (340 mg, 1.43 mmol, 
1.0 equiv.) was dissolved in dry THF (15 mL). NaBH4 (141 mg, 3.73 mmol, 2.6 equiv.) was 
added at once and the mixture started refluxing. MeOH (3 mL) was added over 15 min. and the 
solution was cooled down to 15 °C. H2O (1 mL) was added and stirring was continued for 10 
min., before additional H2O (10 mL) was added. The layers were separated and the aqueous 
layer was extracted with Et2O (3 x 20 mL) and all combined organic layers were washed with 
brine (30 mL) and dried (Na2SO4). The solvent was evaporated under reduced pressure and the 
crude product was purified by column chromatography (SiO2, hexanes/EtOAc 2:1) to yield the 
product as yellow oil in racemic form (182 mg, 0.87 mmol, 61%).  
 
Rf  0.37 (hexanes/EtOAc 2:1); [ ]20Dα = +1.38 (c = 1.01, CHCl3); 1H NMR (300 MHz, CDCl3): δ 
12.3 (bs, OH, 1H), 7.39-7.27 (m, CHa, 2H), 6.97-6.91 (m, CHa, 1H), 6.87-6.80 (m, CHa, 1H), 
4.88-4.77 (m, CH, 1H), 3.94 (dd, J = 11.3, 5.2 Hz, CH2-OH, 1H), 3.79 (dd, J = 11.3, 4.7 Hz, 
CH2-OH, 1H), 3.38 (dd, J = 11.0, 8.8 Hz, CH-CH2, 1H), 3.30 (dd, J = 11.0, 8.2 Hz, CH-CH2, 
1H); 13C NMR (75.5 MHz, CDCl3): δ 172.5 (Cq), 158.0 (Cq), 132.2 (Ca), 129.7 (Ca), 118.5 
(Ca), 116.1 (Ca), 111.9 (Cq), 76.7 (CH), 63.1 (CH2), 31.7 (CH2); IR (film): ν~  3409, 2918, 
2871, 1617, 1590, 1566, 1489, 1456, 1406, 1290, 1254, 1219, 1154, 1118, 1034, 953, 816, 749 
cm-1; MS (EI, 70 eV): m/z (%) = 178.1 (100, [M-CO2H]), 209.1 (42, [M+]); HRMS (EI, 
70 eV): calcd for C10H11NO2S [M+] 209.0511, found 209.0511. 
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(±)-2-(4-(hydroxymethyl)-4,5-dihydrothiazol-2-yl)phenol (±)-(10) 
(ppm)
0.01.02.03.04.05.06.07.08.09.010.011.012.0
 
(ppm)
0102030405060708090100110120130140150160170180190
 
OH
NS
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F.5 Bis(oxazoline) ligands  
 
N
O O
N
O O
N
OH HO
 
 
2,2'-(4R,4'R)-4,4'-(pyridine-2,6-diylbis(methylene))bis(oxy)bis(methylene)bis(4,5-di-
hydrooxazole-4,2-diyl)diphenol (1) 
 
(R)-2-(4-(hydroxymethyl)-4,5-dihydrooxazol-2-yl)phenol 7a (1.756 g, 9.10 mmol, 2.2 equiv.) 
was dissolved in dry DMF (25 mL) under N2 and cooled to 0 °C. NaH (60% suspension in 
mineral oil) (0.678 g, 16.96 mmol, 4.1 equiv.) was added in portions and the mixture was 
stirred for 20 min. 2,6-bis(chloromethyl)pyridine 25 (0.729 g, 4.14 mmol, 1.0 equiv.) was 
added as a solid and the ice-bath was removed. Stirring was continued at 70 °C for 24 h. DMF 
was evaporated, water (15 mL) and CHCl3 (20 mL) were added and the layers were separated. 
The aqueous layer was extracted with CHCl3 (5 x 20 mL) and the combined organic layers 
were dried (Na2SO4). After removal of the solvent in vacuo, the residue was purified by flash 
column chromatography (SiO2, hexanes/EtOAc 5:1 to EtOAc/MeOH 4:1) to yield the product 
as red oil (0.966 g, 1.98 mmol, 48%). 
 
Rf  0.05 (hexanes/EtOAc 5:1); [ ]20Dα = +12.12 (c = 1.00, EtOH); 1H NMR (300 MHz, CDCl3): δ 
12.0 (bs, OH, 2H), 7.69-7.62 (m, CHa, 3H), 7.41-7.33 (m, CHa, 2H), 7.31-7.25 (m, CHa, 2H), 
7.03-6.97 (m, CHa, 2H), 6.90-6.83 (m, CHa, 2H), 4.66 (s, Oside-CH2-Ca, 4H), 4.63-4.54 (m, 
CH, 2H), 4.50 (dd, J = 8.9, 8.6 Hz, Ooxa-CH2-CH, 2H), 4.39 (dd, J = 8.0, 8.2 Hz, Ooxa-CH2-
CH, 2H), 3.82 (dd, J = 9.6, 4.1 Hz, Oside-CH2-CH, 2H), 3.62 (dd, J = 9.6, 6.3 Hz, Oside-CH2-
CH, 2H); 13C NMR (75.5 MHz, CDCl3): δ 166.5 (Cq), 159.9 (Cq), 157.5 (Cq), 137.5 (Ca), 
133.5 (Ca), 128.2 (Ca), 120.2 (Ca), 118.7 (Ca), 116.8 (Ca), 110.6 (Cq), 74.2 (CH2), 72.5 (CH2), 
69.7 (CH2), 65.2 (CH); IR (film): ν~  2906, 1641, 1595, 1490, 1454, 1367, 1305, 1260, 1232, 
1128, 1064, 961, 755 cm-1; MS (EI, 70 eV): m/z (%) = 177.1 (35, [C10H11NO2+]), 313.1 (100, 
[C17H17N2O4+]), 489.1 (11, [M+]); HRMS (EI, 70 eV): calcd for C27H27N3O6 [M+] 489.1900, 
found 489.1895. 
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2,2'-(4R,4'R)-4,4'-(pyridine-2,6-diylbis(methylene))bis(oxy)bis(methylene)bis(4,5-di-
hydrooxazole-4,2-diyl)diphenol (1) 
(ppm)
1.02.03.04.05.06.07.08.09.010.011.012.0
 
(ppm)
0102030405060708090100110120130140150160170180190
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N
S S
N
O O
N
OH HO
 
 
(±)-2,2'-(4,4'-(pyridine-2,6-diylbis(methylene))bis(sulfanediyl)bis(methylene)bis(4,5-di-
hydrooxazole-4,2-diyl)diphenol (±)-(4) 
 
NaH (60% suspension in mineral oil) (70 mg, 1.75 mmol, 2.5 equiv.) was suspended in dry 
DMF (5 mL) under N2 and cooled to 0 °C. 2,6-bis(mercaptomethyl)pyridine 27 (120 mg, 
0.70 mmol, 1.0 equiv.) was added dropwise as a solution in dry DMF (3 mL) and the mixture 
was stirred until the evolution of hydrogen had ceased. (±)-2-(4-(bromomethyl)-4,5-
dihydrooxazol-2-yl)phenol (±)-28 (394 mg, 1.54 mmol, 2.2 equiv.) was dissolved in dry DMF 
(3 mL) and was also added dropwise. The ice-bath was removed and stirring was continued at 
70 °C for 24 h. DMF was evaporated, water (10 mL) and CHCl3 (20 mL) were added and the 
layers were separated. The aqueous layer was extracted with CHCl3 (4 x 20 mL) and the 
combined organic layers were dried (Na2SO4). After removal of the solvent in vacuo, the 
residue was purified by column chromatography (SiO2, hexanes/EtOAc 1:1) to yield the 
product as red oil in racemic form (285 mg, 0.546 mmol, 78%).  
 
Rf  0.77 (hexanes/EtOAc 1:1); [ ]20Dα = -0.69 (c = 1.02, EtOH); 1H NMR (300 MHz, CDCl3): δ 
12.00 (bs, OH, 2H), 7.64-7.58 (m, CHa, 3H), 7.40-7.32 (m, CHa, 3H), 7.23 (s, CHa, 1H), 7.00-
6.95 (m, CHa, 2H), 6.88-6.81 (m, CHa, 2H), 4.61-4.50 (m, CH, 2H), 4.48-4.38 (m, O-CH2-CH, 
2H), 4.25-4.18 (m, O-CH2-CH, 2H), 3.89 (s, S-CH2-Ca, 4H), 2.96 (dd, J = 13.3, 4.5 Hz, S-
CH2-CH, 2H), 2.66 (dd, J = 13.3, 7.8 Hz, S-CH2-CH, 2H); 13C NMR (75.5 MHz, CDCl3): δ 
166.1 (Cq), 159.9 (Cq), 158.1 (Cq), 137.8 (Ca), 133.6 (Ca), 128.2 (Ca), 121.5 (Ca), 118.7 (Ca), 
116.8 (Ca), 110.5 (Cq), 71.2 (CH2), 65.1 (CH), 38.1 (CH2), 36.4 (CH2); IR (film): ν~  3427, 
2914, 1639, 1574, 1491, 1452, 1419, 1365, 1309, 1275, 1230, 1155, 1129, 1068, 1034, 958, 
916, 825, 755, 684 cm-1; MS (ESI): m/z (%) = 522.3 (100, [MH+]); elemental analysis calcd 
(%) for C27H27N3O4S2 (521.65): C 62.17, H 5.22, N 8.06, S 12.29, found: C 61.92, H 5.07, N 
7.83, S 12.11. 
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(±)-2,2'-(4,4'(pyridine-2,6-diylbis(methylene))bis(sulfanediyl)bis(methylene)bis(4,5-di-
hydrooxazole-4,2-diyl)diphenol (±)-(4) 
 
(ppm)
1.02.03.04.05.06.07.08.09.010.011.012.013.0
 
 
(ppm)
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2,2'-(4S,4'S)-4,4'-(pyridine-2,6-diylbis(methylene))bis(oxy)bis(methylene)bis(5,5-di-
methyl-4,5-dihydrooxazole-4,2-diyl)diphenol (2) 
 
Under a N2 atmosphere, (S)-2-(4-(hydroxymethyl)-5,5-dimethyl-4,5-dihydrooxazol-2-yl)-
phenol 9 (300 mg, 1.36 mmol, 2.2 equiv.) was dissolved in dry DMF (15 mL) and cooled to 
0 °C. NaH (60% suspension in mineral oil) (102 mg, 2.54 mmol, 4.1 equiv.) was added in 
portions and the mixture was stirred for 30 min. 2,6-bis(chloromethyl)pyridine 25 (109 mg, 
0.62 mmol, 1.0 equiv.) was added as a solid and the ice-bath was removed. Stirring was 
continued at 70 °C for 72 h. DMF was evaporated, water (30 mL) and CHCl3 (40 mL) were 
added and the layers were separated. The aqueous layer was extracted with CHCl3 (5 x 40 mL) 
and the organic layer was dried (Na2SO4). After removal of the solvent in vacuo, the residue 
was purified by flash column chromatography (SiO2, hexanes/EtOAc 2:1 to EtOAc to 
EtOAc/MeOH 1:4) and recrystallized from MeCN to yield the product as colourless solid 
(139 mg, 0.25 mmol, 40%).  
 
Rf  0.49 (hexanes/EtOAc 2:1); m.p. 123 °C; [ ]20Dα = -29.03 (c = 1.03, CHCl3); 1H NMR 
(300 MHz, CDCl3): δ 12.2 (bs, OH, 2H), 7.75-7.68 (m, CHa, 1H), 7.65-7.59 (m, CHa, 2H), 
7.39-7.30 (m, CHa, 4H), 7.02-6.95 (m, CHa, 2H), 6.89-6.81 (m, CHa, 2H), 4.66 (s, O-CH2-Ca, 
4 H), 4.18 (dd, J = 8.4, 4.8 Hz, O-CH2-CH, 2H), 3.88 (dd, J = 9.9, 4.7 Hz, O-CH2-CH, 2H), 
3.70 (dd, J = 9.7, 8.4 Hz, CH, 2H), 1.57 (s, CH3, 6H), 1.48 (s, CH3, 6H); 13C NMR (75.5 MHz, 
CDCl3): δ 165.1 (Cq), 160.0 (Cq), 157.6 (Cq), 137.4 (Ca), 133.3 (Ca), 128.1 (Ca), 120.1 (Ca), 
118.5 (Ca), 116.8 (Ca), 111.0 (Cq), 86.0 (Cq), 74.2 (CH2), 72.0 (CH), 70.2 (CH2), 28.8 (CH3), 
21.4 (CH3); IR (KBr): ν~  2980, 2871, 1634, 1611, 1488, 1458, 1363, 1331, 1306, 1257, 1236, 
1143, 1102, 1069, 1058, 1037, 933, 849, 749 cm-1; MS (EI, 70 eV): m/z (%) = 121.0 (60, 
[C7H5O2+]), 341.1 (100, [C19H21N2O4+]), 545.2 (22, [M+]); HRMS (EI, 70 eV): calcd for 
C31H35N3O6 [M+] 545.2526, found 545.2513. 
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2,2'-(4S,4'S)-4,4'-(pyridine-2,6-diylbis(methylene))bis(oxy)bis(methylene)bis(5,5-
dimethyl-4,5-dihydrooxazole-4,2-diyl)diphenol (2) 
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2,2'-(4S,4'S)-4,4'-(pyridine-2,6-diylbis(methylene))bis(sulfanediyl)bis(methylene)bis 
(5,5-dimethyl-4,5-dihydrooxazole-4,2-diyl)diphenol (5) 
 
NaH (60% suspension in mineral oil) (46 mg, 1.15 mmol, 2.5 equiv.) was suspended in dry 
DMF (5 mL) under N2 and cooled to 0 °C. 2,6-bis(mercaptomethyl)pyridine 27 (79 mg, 
0.46 mmol, 1.0 equiv.) was added dropwise as a solution in dry DMF (3 mL) and the mixture 
was stirred until the evolution of hydrogen had ceased. (R)-2-(4-(bromomethyl)-5,5-dimethyl-
4,5-dihydrooxazol-2-yl)phenol 30 (287 mg, 1.01 mmol, 2.2 equiv.) was dissolved in dry DMF 
(3 mL) and also added dropwise. The ice-bath was removed and stirring was continued at 
75 °C for 90 h. DMF was evaporated, water (30 mL) and CHCl3 (40 mL) were added and the 
layers were separated. The aqueous layer was extracted with CHCl3 (4 x 20 mL) and the 
combined organic layers were dried (Na2SO4). After removal of the solvent in vacuo, the 
residue was purified by flash column chromatography (SiO2, hexanes/EtOAc 2:1) to yield the 
product as red oil (205 mg, 0.36 mmol, 78%).  
 
Rf  0.50 (hexanes/EtOAc 2:1); [ ]20Dα = -3.47 (c = 1.44, CHCl3); 1H NMR (300 MHz, CDCl3): δ 
12.15 (bs, OH, 2H), 7.67-7.50 (m, CHa, 3H), 7.38-7.30 (m, CHa, 2H), 7.28-7.33 (m, CHa, 2H), 
7.01-6.93 (m, CHa, 2H), 6.88-6.78 (m, CHa, 2H), 4.05 (dd, J = 8.0, 6.6 Hz, CH, 2H), 3.90 (s, 
S-CH2-Ca, 4H), 2.87 (dd, J = 13.3, 6.5 Hz, S-CH2-CH, 2H), 2.72 (dd, J = 13.2, 8.0 Hz, S-CH2-
CH, 2H), 1.50 (s, CH3, 6H), 1.36 (s, CH3, 6H); 13C NMR (75.5 MHz, CDCl3): δ 164.4 (Cq), 
160.0 (Cq), 158.2 (Cq), 137.6 (Ca), 133.3 (Ca), 128.1 (Ca), 121.4 (Ca), 118.5 (Ca), 116.8 (Ca), 
110.9 (Cq), 86.1 (Cq), 72.4 (CH), 38.7 (CH2), 32.6 (CH2), 28.7 (CH3), 21.5 (CH3); IR (film): 
ν~  3379, 2927, 1739, 1638, 1615, 1590, 1491, 1453, 1364, 1311, 1259, 1236, 1153, 1124, 755, 
cm-1; MS (EI, 70 eV): m/z (%) = 204.2 (100, [C12H14NO2+]), 374.3 (83, [C19H22N2O2S2+]), 
577.4 (30, [MH+]); HRMS (LSI, MeOH/Glycerin): calcd for C31H35N3O4S2 [M+] 577.2069, 
found 577.2068. 
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2,2'-(4S,4'S)-4,4'-(pyridine-2,6-diylbis(methylene))bis(sulfanediyl)bis(methylene)bis 
(5,5-dimethyl-4,5-dihydrooxazole-4,2-diyl)diphenol (5) 
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F.5 Precursor for Oxazoline and Bis(oxazoline) Ligands 
 
OH
NO
OTs
 
 
(S)-(2-(2-hydroxyphenyl)-4,5-dihydrooxazol-4-yl)methyl-4-methylbenzenesulfonate (29b) 
 
(R)-2-(4-(hydroxymethyl)-4,5-dihydrooxazol-2-yl)phenol 7a (100 mg, 0.518 mmol, 1.0 equiv.) 
was dissolved in dry CH2Cl2 (3 mL) under nitrogen, dry NEt3 (182 µL, 131 mg, 1.294 mmol, 
2.5 equiv.) was added and cooled to 0 °C. Fresh recrystallized tosyl chloride (109 mg, 
0.569 mmol, 1.1 equiv.) was added in one portion and the mixture was stirred for 20 h at rt. 
The reaction mixture was washed with H2O (1 mL) and then with sat. aqueous NaHCO3 
(1 mL). All combined organic layers were dried (Na2SO4). The solvent was evaporated under 
reduced pressure, and the crude product was purified by column chromatography (SiO2, 
hexanes/EtOAc 1:1 to EtOAc) to afford the product as colourless solid (120 mg, 0.346 mmol, 
67%). 
 
Rf  0.35 (hexanes/EtOAc 1:1); m.p. 108 °C; [ ]20Dα = +118.0 (c = 1.00, CHCl3); 1H NMR 
(300 MHz, CDCl3): δ 7.83-7.76 (m, CHa, 1H), 7.71-7.62 (m, CHa, 2H), 7.35-7.20 (m, CHa, 
4H), 6.88-6.81 (m, CHa, 1H), 4.39-4.19 (m, CH/OTs-CH2-CH, 3H), 3.86 (dd, J = 11.5, 2.7 Hz, 
Ooxa-CH2-CH, 1H), 3.57 (dd, J = 11.3, 2.7 Hz, Ooxa-CH2-CH, 1H), 2.90 (bs, OH, 1H), 2.38 (s, 
CH3, 3H); 13C NMR (75.5 MHz, CDCl3): δ 162.5 (Cq), 147.5 (Cq), 145.5 (Cq), 132.7 (Cq), 
132.2 (Ca), 131.4 (Ca), 129.8 (Ca), 128.5 (Ca), 127.2 (Ca), 123.6 (Ca), 122.8 (Cq), 69.0 (CH2), 
68.5 (CH), 64.1 (CH2), 21.7 (CH3); IR (KBr): ν~  2899, 1647, 1597, 1448, 1342, 1293, 1170, 
1095, 1038, 962, 850, 815, 777, 729, 613, 562 cm-1; MS (EI, 70 eV): m/z (%) = 91.1 (100, 
[C7H7+]), 316.1 (37, [C17H18NO3S+]), 317.2 (39, [C17H19NO3S+]), 347.2 (2, [M+]); HRMS (EI, 
70 eV): calcd for C17H17NO5S [M+] 347.0824, found 347.0824. 
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(S)-(2-(2-hydroxyphenyl)-4,5-dihydrooxazol-4-yl)methyl-4-methylbenzenesulfonate (29b) 
(ppm)
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(±)-2-(4-(bromomethyl)-4,5-dihydrooxazol-2-yl)phenol (±)-(28) 
 
(R)-2-(4-(hydroxymethyl)-4,5-dihydrooxazol-2-yl)phenol 7a (0.502 g, 2.60 mmol, 1.0 equiv.) 
was dissolved in dry CH2Cl2 (20 mL) and cooled to 0 °C. CBr4 (1.035 g, 3.12 mmol, 
1.2 equiv.) was added in portions and the mixture was stirred for 15 min. Subsequently PPh3 
(0.818 g, 3.12 mmol, 1.2 equiv.) was added and the ice-bath was removed. Stirring was 
continued at rt for 20 h. Addition of brine (20 mL) followed and the layers were separated. The 
aqueous layer was extracted with CH2Cl2 (2 x 20 mL) and all combined organic layers were 
dried (Na2SO4). The solvent was evaporated under reduced pressure, and the crude product 
was purified by column chromatography (SiO2, hexanes/EtOAc 4:1 to EtOAc) to afford the 
product as slightly pink solid in racemic form (0.447 g, 1.75 mmol, 67%). 
 
Rf  0.73 (hexanes/EtOAc 4:1); m.p. 98 °C; [ ]20Dα = -2.40 (c = 1.04, EtOH); 1H NMR (300 MHz, 
CDCl3): δ 11.7 (bs, OH, 1H), 7.68-7.63 (m, CHa, 1H), 7.43-7.36 (m, CHa, 1H), 7.05-7.00 (m, 
CHa, 1H), 6.92-6.85 (m, CHa, 1H), 4.79-4.68 (m, CH, 1H), 4.54 (dd, J = 9.1, 9.1 Hz, O-CH2-
CH, 1H), 4.36 (dd, J = 8.8, 6.9 Hz, O-CH2-CH, 1H), 3.65 (dd, J = 10.2, 3.8 Hz, Br-CH2-CH, 
1H), 3.44 (dd, J = 10.2, 7.7 Hz, Br-CH2-CH, 1H); 13C NMR (75.5 MHz, CDCl3): δ 167.0 (Cq), 
160.0 (Cq), 134.0 (Ca), 128.3 (Ca), 118.9 (Ca), 116.9 (Ca), 110.1 (Cq), 70.9 (CH2), 66.0 (CH), 
34.9 (CH2); IR (KBr): ν~  2904, 1635, 1492, 1425, 1372, 1306, 1259, 1160, 1130, 1072, 1029, 
964, 796, 757, 602 cm-1; MS (CI, NH3): m/z (%) = 256.0 (100, [MH]+(79Br)), 258.0 (95, 
[MH]+(81Br)); elemental analysis calcd (%) for C10H10BrNO2 (256.1): C 46.90, H 3.94, N 5.47, 
found: C 47.06, H 4.14, N 5.37. 
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(R)-2-(4-(bromomethyl)-5,5-dimethyl-4,5-dihydrooxazol-2-yl)phenol (30) 
 
(S)-2-(4-(hydroxymethyl)-5,5-dimethyl-4,5-dihydrooxazol-2-yl)phenol 9 (300 mg, 1.36 mmol 
1.0 equiv.) was dissolved in dry CH2Cl2 (15 mL) and cooled to 0 °C. CBr4 (540 mg, 
1.63 mmol, 1.2 equiv.) was added and the mixture was stirred for 10 min at 0 °C. After the 
addition of PPh3 (428 mg, 1.63 mmol, 1.2 equiv.) the mixture was allowed to warm up to rt 
and stirred for 24 h. Addition of brine (15 mL) stopped the reaction and the layers were 
separated. The aqueous layer was extracted with CH2Cl2 (2 x 15 mL) and the combined 
organic layers were dried (Na2SO4). After removal of the solvent in vacuo, the residue was 
purified by column chromatography (SiO2, hexanes/EtOAc 4:1) to yield the product as red oil 
(347.3 mg, 1.222 mmol, 90%). 
 
Rf  0.82 (hexanes/EtOAc 4:1); [ ]20Dα = -9.13 (c = 1.03, EtOH); 1H NMR (300 MHz, CDCl3): δ 
12.0 (bs, OH, 1H), 7.65-7.60 (m, CHa, 1H), 7.41-7.34 (m, CHa, 1H), 7.03-6.97 (m, CHa, 1H), 
6.90-6.82 (m, CHa, 1H), 4.25 (dd, J = 8.9, 5.1 Hz, CH2, 1H), 3.66 (dd, J = 10.6, 5.1 Hz, CH2, 
1H), 3.45 (dd, J = 10.6, 8.9 Hz, CH, 1H), 1.61 (s, CH3, 3H), 1.52 (s, CH3, 3H); 13C NMR 
(75.5 MHz, CDCl3): δ 165.0 (Cq), 160.0 (Cq), 133.7 (Ca), 128.3 (Ca), 118.7 (Ca), 116.9 (Ca), 
110.6 (Cq), 86.1 (Cq), 73.7 (CH), 30.2 (CH2), 29.1 (CH3), 20.9 (CH3); IR (film): ν~  2976, 
2928, 1637, 1614, 1490, 1462, 1365, 1343, 1309, 1257, 1237, 1154, 1124, 1069, 1034, 960, 
852, 756 cm-1; MS (EI, 70 eV): m/z (%) = 92.1 (28, [CH2Br+]), 121.1 (100, [C7H5O2+]), 190.1 
(22, [C11H12NO2+]), 285.1 (23, [M+]); HRMS (EI, 70 eV): calcd for C12H14NO2Br [M+] 
283.0208, found 283.0203. 
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(S)-methyl-2-(2-hydroxyphenyl)-4,5-dihydrooxazole-4-carboxylate (16a) 
 
Ethyl-2-hydroxybenzimidate 14 (33.43 g, 202.6 mmol, 1.0 equiv.) was dissolved in dry 
C2H4Cl2 (300 mL) under N2 and (S)-methyl-2-amino-3-hydroxypropanoate hydrochloride 15 
(38.31 g, 243.1 mmol, 1.2 equiv.) was added to the solution. The reaction mixture was stirred 
under reflux for 60 h. After coming to rt the mixture was filtered and concentrated. Addition of 
Et2O (100 mL), storing at 4 °C for some hours and a final filtration purified the product and 
afford a gold-brown oil (40.19 g, 181.7 mmol, 90%). 
 
Rf 0.92 (EtOAc); [ ]20Dα = +62.49 (c = 1.13, EtOH); 1H NMR (300 MHz, CDCl3): δ 11.6 (bs, 
OH, 1H), 7.70-7.63 (m, CHa, 1H), 7.44-7.35 (m, CHa, 1H), 7.05-6.99 (m, CHa, 1H), 6.92-6.84 
(m, CHa, 1H), 5.02 (dd, J = 10.6, 7.6 Hz, CH, 1H), 4.71 (dd, J = 8.8, 7.4 Hz, CH2, 1H), 4.61 
(dd, J = 10.4, 8.8 Hz, CH2, 1H), 3.81 (s, CH3, 3H); 13C NMR (75.5 MHz, CDCl3): δ 171.0 
(Cq), 167.6 (Cq), 159.9 (Cq), 134.0 (Ca), 128.4 (Ca), 118.9 (Ca), 117.0 (Ca), 110.1 (Cq), 68.9 
(CH2), 67.2 (CH), 52.9 (CH3); IR (film): ν~  2955, 1746, 1637, 1615, 1491, 1437, 1367, 1307, 
1260, 1212, 1156, 1131, 1078, 968, 945, 830, 757 cm-1; MS (EI, 70 eV): m/z (%) = 162.0 (100, 
[C9H8NO2+]), 221.1 (57, [M+]); HRMS (EI, 70 eV): calcd for C11H11NO4 [M+] 221.0688, 
found 221.0689. 
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(R)-methyl-2-(2-hydroxyphenyl)-4,5-dihydrothiazole-4-carboxylate (21) 
 
Ethyl-2-hydroxybenzimidate 14 (1.90 g, 11.52 mmol, 1.0 equiv.) was dissolved in dry C2H4Cl2 
(60 mL) under N2 and (R)-methyl-2-amino-3-mercaptopropanoate hydrochloride (2.96 g, 
17.28 mmol, 1.5 equiv.) was added to the solution. The reaction mixture was stirred under 
reflux for 48 h. After coming to rt the mixture was filtered and concentrated. For the further 
purification a column chromatography (SiO2, hexanes/EtOAc 4:1) was done and was obtained 
as the product as yellow oil (431 mg, 1.82 mmol, 16%). 
 
Rf 0.43 (hexanes/EtOAc 4:1); [ ]20Dα = -11.86 (c = 1.02, EtOH); 1H NMR (300 MHz, CDCl3): δ 
12.3 (s, OH, 1H), 7.45-7.34 (m, CHa, 2H), 7.04-6.99 (m, CHa, 1H), 6.92-6.85 (m, CHa, 1H), 
5.38 (dd, J = 9.3, 8.0 Hz, CH, 1H), 3.82 (s, CH3, 3H), 3.72 (dd, J = 11.4, 8.1 Hz, CH2, 1H), 
3.63 (dd, J = 11.3, 9.3 Hz, CH2, 1H), 13C NMR (75.5 MHz, CDCl3): δ 174.3 (Cq), 170.6 (Cq), 
159.2 (Cq), 133.6 (Ca), 130.8 (Ca), 118.9 (Ca), 117.3 (Ca), 116.0 (Cq), 76.7 (CH), 52.9 (CH3), 
33.7 (CH2); IR (film): ν~  2952, 1743, 1621, 1593, 1566, 1489, 1435, 1404, 1295, 1254, 1221, 
1060, 951, 821, 753, cm-1; MS (EI, 70 eV): m/z (%) = 178.0 (100, [C9H8NOS+]), 237.1 (45, 
[M+]); HRMS (EI, 70 eV): calcd for C11H11NSO3 [M+] 237.0460, found 237.0460. 
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(S)-2-(4-((tert-butyldimethylsilyloxy)methyl)-5,5-dimethyl-4,5-dihydrooxazol-2-yl) phenol 
(19) 
 
Under a N2 atmosphere (S)-3-amino-4-(tert-butyldimethylsilyloxy)-2-methylbutan-2-ol 18 
(6.35 g, 27.21 mmol, 1.5 equiv.) was dissolved in dry C2H4Cl2 (50 mL) and ethyl-2-
hydroxybenzimidate 14 (2.99 g, 18.14 mmol, 1.0 equiv.) was added in one portion. The 
mixture was refluxed for 4 d, filtered and evaporated. The crude product was purified by 
column chromatography (SiO2, hexanes/EtOAc 4:1) to yield the product as red-brown oil 
(3.74 g, 11.15 mmol, 62%). 
 
Rf 0.79 (hexanes/EtOAc 4:1); [ ]20Dα = -9.80 (c = 1.00, EtOH); 1H NMR (300 MHz, CDCl3): δ 
12.2 (bs, OH, 1H), 7.65-7.59 (m, CHa, 1H), 7.39-7.31 (m, CHa, 1H), 7.01-6.95 (m, CHa, 1H), 
6.88-6.81 (m, CHa, 1H), 3.99-3.89 (m, CH2, 2H), 3.74-3.65 (m, CH, 1H), 1.53 (s, CH3, 3H), 
1.48 (s, CH3, 3H), 0.88 (s, C-(CH3)3, 9H), 0.09 (s, Si-CH3, 3H), 0.05 (s, Si-CH3, 3H); 
13C NMR (75.5 MHz, CDCl3): δ 167.0 (Cq), 162.1 (Cq), 135.2 (Ca), 130.1 (Ca), 120.4 (Ca), 
118.7 (Ca), 113.1 (Cq), 88.2 (Cq), 75.8 (CH), 64.4 (CH2), 31.1 (CH3), 27.9 (3 x CH3), 23.2 
(CH3), 20.1 (Cq), -3.5 (CH3), -3.6 (CH3); IR (film): ν~  2954, 2929, 2857, 1639, 1616, 1491, 
1462, 1387, 1364, 1309, 1257, 1153, 1132, 1084, 837, 776, 755 cm-1; MS (EI, 70 eV): 
m/z (%) = 278.2 (100, [C14H20NO3Si+]), 335.2 (32, [M+]); HRMS (EI, 70 eV): calcd for 
C18H29NO3Si [M+] 335.1917, found 335.1916. 
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(S)-2-(4-((tert-butyldimethylsilyloxy)methyl)-5,5-dimethyl-4,5-dihydrooxazol-2-yl)phenol 
(19) 
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F.6 General precursor 
 
 
 
(S)-3-amino-4-(tert-butyldimethylsilyloxy)-2-methylbutan-2-ol48 (18) 
 
(S)-methyl-2-amino-3-(tert-butyldimethylsilyloxy)propanoate 17 (7.05 g, 30.21 mmol, 
1.0 equiv.) was dissolved in dry Et2O (100 mL) and cooled under N2 to 0 °C. A 3.0 M solution 
of MeMgBr (30.21 mL, 90.63 mmol, 3.0 equiv.) was added dropwise. The mixture was stirred 
for 2 h at 0 °C and was quenched with sat. NH4Cl-solution (75 mL) and H2O (25 mL). After 
separation, the aqueous layer was extracted with EtOAc (2 x 100 mL) and dried (Na2SO4). The 
crude product was obtained as a gold-brown gel (6.27 g, 26.86 mmol, 89%), which was pure 
enough to be used in further synthesis. 
 
Rf 0.05 (hexanes/EtOAc 1:1; 0.1 % KMnO4-stain); [ ]20Dα = -10.00 (c = 1.06, EtOH); 1H NMR 
(300 MHz, CDCl3): δ 3.78 (dd, J = 10.1, 4.3 Hz, CH2, 1H), 3.68 (dd, J = 10.1, 6.6 Hz, CH2, 
1H), 2.72 (dd, J = 6.7, 4.2 Hz, CH, 1H), 2.31 (bs, NH2, OH, 3H), 1.22 (s, CH3, 3H), 1.19 (s, 
CH3, 3H), 0.92 (s, C-(CH3)3, 9H), 0.10 (s, Si-(CH3)2, 6H); 13C NMR (75.5 MHz, CDCl3): δ 
71.3 (Cq), 65.0 (CH2), 59.7 (CH), 27.8 (2 x CH3), 25.7 (3 x CH3), 18.2 (Cq), -5.5 (2 x CH3); 
IR (film): ν~  3373, 2955, 2929, 2884, 2857, 1675, 1579, 1467, 1386, 1362, 1256, 1090, 1005, 
939, 836, 776, 756, 665 cm-1; MS (CI): m/z (%) = 234.2 (100, [MH+]). 
 
 
 
 
(S)-methyl-2-amino-3-(tert-butyldimethylsilyloxy)propanoate48 (17) 
 
(S)-methyl-2-amino-3-hydroxypropanoate hydrochloride 15 (10.5 g, 67.49 mmol, 1.0 equiv.) 
was suspended in CH2Cl2 (100 mL) at rt. NEt3 (28.07 mL, 20.49 g, 202.5 mmol, 3.0 equiv.) 
and DMAP (0.825 g, 6.75 mmol, 0.1 equiv.) were added at once. Subsequently TBDMSCl 
(15.25 g, 101.2 mmol, 1.5 equiv.) was added slowly in portions. The mixture was stirred for 
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72 h at rt. H2O (50 mL) was added to dissolve the precipitate and the layers were separated. 
The aqueous layer was extracted with CH2Cl2 (2 x 100 mL) and the combined organic layers 
were extracted with H2O (2 x 100 mL) and finally dried (Na2SO4). The crude product was 
purified by distillation (100-135 °C, 0.1 mbar) to yield the product as colourless oil which 
immediately crystallized (11.25 g, 48.20 mmol, 71%). 
 
[ ]20Dα = +9.06 (c = 1.07, EtOH); 1H NMR (300 MHz, CDCl3): δ 3.90 (dd, J = 4.4 Hz, CH2, 1H), 
3.79 (dd, J = 3.7, 9.7 Hz, CH2, 1H), 3.69 (s, CH3, 3H), 3.49 (t, J = 4.1 Hz CH, 1H), 1.82 (bs, 
NH2, 2H), 0.83 (s, C(CH3)3, 9H), 0.01 (s, Si(CH3)2, 6H); 13C NMR (75.5 MHz, CDCl3): δ 
174.5 (Cq), 65.3 (CH3), 56.5 (CH), 52.0 (CH3), 25.7 (3 x CH3), 18.2 (Cq), -5.4 (2 x CH3); 
IR (film): ν~  3387, 2953, 2930, 2885, 2857, 1745, 1600, 1463, 1436, 1361, 1256, 1105, 833, 
777 cm-1; MS (CI): m/z (%) = 116.0 (100, [C6H16Si+]), 176.0 (78, [M-C4H9+]), 234.2 (2, 
[MH+]). 
 
 
 
 
ethyl-2-hydroxybenzimidate (14) 
 
2-Hydroxybenzonitrile 11 (25.0 g, 210.1 mmol, 1.0 equiv.) was dissolved in dry benzene 
(6 mL) and dry EtOH (14 mL), and the mixture was cooled to 0 °C. A stream of HCl gas was 
saturating the solution until more than 2.0 equiv. of HCl were in the flask. The product was 
given 14 days to precipitate at rt. The solid was suspended in CH2Cl2 (200 mL) and was 
completely dissolved by addition of saturated NaHCO3-solution. A liquid-liquid extractor was 
used to transfer the product into the organic layer within 24 h. Subsequently the solvent was 
evaporated and afforded a slightly brown solid (33.43 g, 202.6 mmol, 96%), which was used 
without further purification. 
 
m.p. 62 °C; 1H NMR (300 MHz, CDCl3): δ 14.00-13.50 (bs, OH, 1H), 7.83-7.77 (m, CHa, 
1H), 7.39-7.31 (m, CHa, 1H), 7.01-6.95 (m, CHa, 1H), 6.86-6.78 (m, CHa, 1H), 4.08 (q, 
J = 7.0 Hz, CH2, 2H), 1.49 (t, J = 7.0 Hz, CH3, 3H); 13C NMR (75.5 MHz, CDCl3): δ 165.7 
(Cq), 161.1 (Cq), 133.2 (Ca), 127.8 (Ca), 118.0 (Ca), 117.3 (Ca), 114.5 (Cq), 60.1 (CH2), 
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13.8 (CH3); IR (KBr): ν~  3307, 2982, 1639, 1598, 1500, 1465, 1408, 1375, 1352, 1269, 1153, 
1093, 841, 756, 653 cm-1; MS (EI, 70 eV): m/z (%) = 119.9 (100, [C7H5NO+]), 165.1 (38, 
[M+]); HRMS (EI, 70 eV): calcd for C9H11NO2 [M+] 165.0790, found 165.0792. 
 
 
 
 
dimethyl-pyridine-2,6-dicarboxylate (23) 
 
2,6-pyridinedicarboxylic acid 22 (100.0 g, 598.4 mmol) was suspended in MeOH (700 mL) 
and treated cautiously with conc. H2SO4 (5 mL). The mixture was heated to reflux for 5 h. The 
product crystallized upon cooling to rt (3 days), then it was filtered and washed with MeOH 
(50 mL) and Et2O (50 mL) and finally dried in vacuo to yield the product as colourless solid 
(105.6 g, 541.2 mmol, 90%).  
 
1H NMR (300 MHz, CDCl3): δ 8.34 (d, J = 7.7 Hz, CHa, 2H), 8.04 (t, J = 7.6 Hz, CHa, 1H), 
4.03 (s, CH3, 6H). 
 
 
 
 
pyridine-2,6-diyldimethanol (24) 
 
Dimethyl-pyridine-2,6-dicarboxylate 23 (35.7 g, 183.0 mmol, 1.0 eq.) was dissolved in dry 
EtOH and cooled down at 0 °C. NaBH4 (32.33 g, 854.6 mmol, 4.67 eq.) was added in portions 
and the mixture was stirred for 1 h at 0 °C. After removal of the ice bath the suspension stirred 
until exothermic reaction has stopped and in additional to that it stirred further 3 h at rt and 
14 h under reflux. The solvent was evaporated and the residue was treated with acetone 
(120 mL) and refluxed for 1 h. Then the solvent was removed and sat. aqueous K2CO3-solution 
(120 mL) was added and refluxed again for 1 h. After a renew evaporation the suspension was 
treated with H2O (500 mL) and CHCl3 (500 mL) and filled in a liquid-liquid extractor to run 
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for 24 h. The obtained organic phase was evaporated and the product yields as colourless solid 
(24.47 g, 175.9 mmol, 96%). 
 
1H NMR (300 MHz, DMSO-d6): δ 7.78 (t, J = 7.7 Hz, CHa, 1H), 7.31 (d, J = 7.7 Hz, CHa, 
2H), 5.36 (t, J = 5.9 Hz, OH, 2H), 4.52 (d, J = 5.8 Hz, CH2, 4H). 
 
 
 
 
2,6-bis(chloromethyl)pyridine (25) 
 
Pyridine-2,6-diyldimethanol 24 (22.24 g, 159.9 mmol, 1.0 eq.) was suspended in dry Et2O 
(200 mL) and cooled down to 0 °C. SOCl2 (25.52 mL, 41.85 g, 351.8 mmol, 2.2 eq.), diluted in 
Et2O (10 mL), was slowly dropped into the mixture and stirred for further 1 h at 0 °C and 20 h 
at rt. The reaction mixture was filtered off, washed with Et2O and dried in vacuo. The crude 
product was suspended in CH2Cl2 (200 mL) and sat. aqueous NaHCO3-solution (200 mL) was 
added in portion. After the development of gas has stopped, the phases were separated, the 
organic phase was extracted with CH2Cl2 (3 x 100 mL) and dried (Na2SO4). The product was 
obtained as colourless solid (25.38 g, 144.1 mmol, 90%). 
 
1H NMR (300 MHz, CDCl3): δ 7.77 (t, J = 7.8 Hz, CHa, 1H), 7.44 (d, J = 7.7 Hz, CHa, 2H), 
4.67 (s, CH2, 4H). 
 
 
 
 
pyridine-2,6-diylbis(methylene)-dicarbamimidothioate-3-hydrochlorid (26) 
 
2,6-bis(chloromethyl)pyridine 25 (22.41 g, 127.2 mmol, 1.0 eq.) was suspended in EtOH 
(325 mL) and thiourea (23.24 g, 305.3 mmol, 2.4 eq.) was added in portion. The mixture was 
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refluxed for 30 min and after cooling down to rt the precipitation was filtered off, washed with 
EtOH and Et2O and dried in vacuo. The product was yielded as slightly brown solid (44.59 g, 
122.2 mmol, 96%). 
 
1H NMR (300 MHz, D2O): δ 7.76 (t, J = 7.8 Hz, CHa, 1H), 7.34 (d, J = 8.0 Hz, CHa, 2H), 4.40 
(s, CH2, 4H). 
 
 
 
 
pyridine-2,6-diyldimethanethiol (27) 
 
All steps were produced under nitrogen!  
Pyridine-2,6-diylbis(methylene)-dicarbamimidothioate-3-hydrochlorid 26 (20.0 g, 54.8 mmol, 
1.0 eq.) was dissolved in degassed H2O (60 mL) and NaOH (12.1 g, 301.4 mmol, 5.5 eq.) was 
added at once. The reaction mixture was refluxed for 2 h. The solution was treated with 
degassed 2 N HCl until the value of the pH has reached 7. The neutral aqueous phase was 
extracted with degassed CHCl3 (5 x 80 mL) and all organic phases were dried (Na2SO4). After 
evaporation the crude product was purified by distillation (0.1 mbar, 92 – 105 °C) to yield a 
colourless liquid (7.28 g, 42.5 mmol, 78%). 
 
1H NMR (300 MHz, CDCl3): δ 7.63 (t, J = 7.7 Hz, CHa, 1H), 7.21 (d, J = 7.7 Hz, CHa, 2H), 
3.82 (d, J = 8.0 Hz, CH2, 4H), 2.01 (t, J = 8.1 Hz, OH, 2H). 
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F.7 Synthesized Complexes of Oxazoline Ligands 
 
F.7.1 Iron Complexes 
 
ClO4
-
N
O
O
N
O
O
Fe3+
OHHO
 
 
[FeIII(7a)2] • (ClO4) • (HClO4) • 4(H2O)   elemental analysis 
 
Ligand 7a (100 mg, 0.518 mmol, 2.0 eq.) and Fe(ClO4)2•6H2O (94 mg, 0.259 mmol, 1.0 eq.) 
were dissolved separately in dry THF (each in 2 mL) and the ligand was transferred to the 
metal. The reaction mixture was stirred for 12 h at rt. The solvent was removed and the residue 
was dried in vacuo and stored at rt. The product was obtained as a dark purple solid (116 mg, 
0.163 mmol, 63%). Recrystallization from acetonitrile / ethylacetate afforded purple needles 
which were suitable for X-Ray structure analysis. 
 
MS (ESI, MeCN): m/z (%) = 193.9 (15, [LH+]), 440.0 (100, [L2Fe3+-2H+]); elemental analysis 
calcd (%) for C20H29Cl2FeN2O18 (711.0): C 33.73, H 4.10, N 3.93, found: C 33.94, H 3.98, N 
3.76; IR (Diamond Single Reflection ATR System): ν~  3409, 1608, 1587, 1542, 1507, 1474, 
1441, 1398, 1329, 1316, 1247, 1080, 1062, 1030, 1001, 925, 853, 755, 618 cm-1. 
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ClO4
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N
O
O
N
O
O
Fe3+
OH
O
 
(proposed structure) 
 
[FeIII(8)2] • (ClO4) • (HClO4) • 4(H2O) • 2(THF)   elemental analysis 
 
Ligand 8 (100 mg, 0.452 mmol, 2.0 eq.) and Fe(ClO4)2•6H2O (82 mg, 0.226 mmol, 1.0 eq.) 
were dissolved separately in dry THF (each in 4 mL) and the ligand was transferred to the 
metal. The reaction mixture was stirred over night at rt. The solvent was removed and the 
residue was dried in vacuo and stored at rt. The product was obtained as a dark purple solid 
(31 mg, 0.034 mmol, 15%).  
 
MS (ESI, MeCN): m/z (%) = 222.0 (7, [LH+]), 496.2 (100, [L2Fe3+-2H+]); elemental analysis 
calcd (%) for C32H53Cl2FeN2O20 (911.2): C 42.12, H 5.85, N 3.07, found: C 41.87, H 5.79, N 
2.93; IR (Diamond Single Reflection ATR System): ν~  3322, 2979, 1612, 1543, 1472, 1439, 
1391, 1326, 1246, 1085, 1031, 927, 851, 755, 666, 619 cm-1. 
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ClO4
-
N
O
O
N
O
O
Fe3+
OH
O
 
(proposed structure) 
 
[FeIII(9)2] • (ClO4) • (HClO4) • 5(H2O) • (THF)   elemental analysis 
 
Ligand 9 (100 mg, 0.452 mmol, 2.0 eq.) and Fe(ClO4)2•6H2O (82 mg, 0.226 mmol, 1.0 eq.) 
were dissolved separately in dry THF (each in 2 mL) and the ligand was transferred to the 
metal. The reaction mixture was stirred over night at rt. The solvent was removed and the 
residue was dried in vacuo and stored at rt. The product was obtained as a dark purple solid 
(93 mg, 0.109 mmol, 48%).  
 
MS (ESI, MeCN): m/z (%) = 496.2 (100, [L2Fe3+-2H+]); elemental analysis calcd (%) for 
C28H47Cl2FeN2O20 (857.1): C 39.18, H 5.52, N 3.26, found: C 38.80, H 5.19, N 3.29; 
IR (Diamond Single Reflection ATR System): ν~  3252, 2891, 1626, 1593, 1545, 1506, 1467, 
1440, 1396, 1378, 1327, 1251, 1082, 1031, 925, 865, 754, 696, 619 cm-1. 
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[FeIII(7a)2(OAc)]   elemental analysis 
 
Ligand 7a (100 mg, 0.518 mmol, 2.0 eq.) and Fe(OAc)2 (45 mg, 0.259 mmol, 1.0 eq.) were 
dissolved separately in DMA (each in 3 mL) and the ligand was transferred to the metal. The 
reaction mixture was stirred over night at rt. The solvent was removed, the residue was 
redissolved in Et2O/THF/hexanes (1:1:5), filtered, dried in vacuo and stored at rt. The product 
was obtained as a dark orange-red solid (16 mg, 0.032 mmol, 12%). Recrystallization from 
THF / Et2O afforded dark red needles which were suitable for X-Ray structure analysis. 
 
MS (ESI, MeCN): m/z (%) = 193.9 (23, [LH+]), 440.0 (100, [L2Fe3+-2H+]); elemental analysis 
calcd (%) for C22H23FeN2O8 (499.1): C 52.92, H 4.64, N 5.61, found: C 53.35, H 5.06, N 6.14; 
IR (Diamond Single Reflection ATR System): ν~  3342, 2932, 2880, 1606, 1584, 1547, 1471, 
1441, 1390, 1328, 1243, 1156, 1076, 1030, 952, 848, 755, 688, 612 cm-1. 
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[FeIII(8)2(OAc)] • (THF)   elemental analysis 
 
Ligand 8 (100 mg, 0.452 mmol, 2.0 eq.) and Fe(OAc)2 (39 mg, 0.226 mmol, 1.0 eq.) were 
dissolved separately in DMA (each in 4 mL) and the ligand was transferred to the metal. The 
reaction mixture was stirred over night at rt. The solvent was removed and the residue was 
redissolved in Et2O/THF (1:1), filtered, dried in vacuo and stored at rt. The product was 
obtained as a dark orange-red solid (126 mg, 0.201 mmol, 89%). Recrystallization from 
acetonitrile / ethylacetate afforded dark red needles which were suitable for X-Ray structure 
analysis. 
 
MS (ESI, MeCN): m/z (%) = 222.0 (100, [LH+]), 496.2 (25, [L2Fe3+-2H+]); elemental analysis 
calcd (%) for C30H39FeN2O9 (627.2): C 57.42, H 6.26, N 4.46, found: C 57.13, H 6.24, N 4.87; 
IR (Diamond Single Reflection ATR System): ν~  3412, 2969, 2922, 1604, 1578, 1547, 1471, 
1440, 1385, 1326, 1236, 1179, 1156, 1080, 1012, 942, 855, 808, 757, 689, 667, 623, 549 cm-1. 
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[FeIII(9)2]2   crystal structure 
[FeIII(9)2(OAc)] • (MeCN) • (H2O) • (THF)   elemental analysis  
 
Ligand 9 (134 mg, 0.607 mmol, 2.0 eq.) and Fe(OAc)2 (53 mg, 0.303 mmol, 1.0 eq.) were 
dissolved separately in DMA (each in 4 mL) and the ligand was transferred to the metal. The 
reaction mixture was stirred over night at rt. The solvent was removed and the residue was 
redissolved in Et2O, filtered, dried in vacuo and stored at rt. The product was obtained as a 
dark orange-red solid (116 mg, 0.169 mmol, 56%). Recrystallization from acetonitrile / Et2O 
afforded dark red needles which were suitable for X-Ray structure analysis. 
 
MS (ESI, MeCN): m/z (%) = 222.0 (23, [LH+]), 496.2 (100, [L2Fe3+-2H+]); elemental analysis 
calcd (%) for C32H44FeN3O10 (686.2): C 55.98, H 6.46, N 6.12, found: C 55.41, H 6.44, N 
6.28; IR (Diamond Single Reflection ATR System): ν~  3381, 2971, 2932, 1604, 1580, 1545, 
1472, 1440, 1398, 1328, 1249, 1190, 1150, 1133, 1078, 1032, 955, 894, 869, 832, 755, 703, 
688, 605 cm-1. 
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(proposed structure) 
 
]FeIII(7a)2(acac)]   elemental analysis 
 
Ligand 7a (100 mg, 0.518 mmol, 2.0 eq.) and Fe(acac)3 (92 mg, 0.259 mmol, 1.0 eq.) were 
dissolved separately in dry THF (each in 2 mL) and the ligand was transferred to the metal. 
The reaction mixture was stirred over night at rt. The solvent was removed and the residue was 
redissolved in Et2O, filtered, dried in vacuo and stored at rt. The product was obtained as a 
blood-red solid (22 mg, 0.041 mmol, 16%). 
 
MS (ESI, MeCN): m/z (%) = 193.9 (12, [LH+]), 347.0 (53, [LFe3+-H++(acac)-]), 440.0 (100, 
[L2Fe3+-2H+]); elemental analysis calcd (%) for C25H27FeN2O8 (539.1): C 55.67, H 5.05, N 
5.19, found: C 55.85, H 5.26, N 4.69; IR (Diamond Single Reflection ATR System): ν~  3351, 
2936, 1607, 1582, 1549, 1523, 1480, 1442, 1389, 1373, 1327, 1242, 1152, 1075, 1034, 1020, 
987, 966, 925, 861, 847, 758, 688, 665, 628, 555, 432 cm-1. 
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(proposed structure) 
 
[FeIII(8)2(acac)]   elemental analysis 
 
Ligand 8 (100 mg, 0.452 mmol, 2.0 eq.) and Fe(acac)3 (80 mg, 0.226 mmol, 1.0 eq.) were 
dissolved separately in dry THF (each in 2 mL) and the ligand was transferred to the metal. 
The reaction mixture was stirred over night at rt. The solvent was removed and the residue was 
redissolved in Et2O/hexanes (1:5), filtered, dried in vacuo and stored at rt. The product was 
obtained as a blood-red solid (117 mg, 0.197 mmol, 87%). 
 
MS (ESI, MeCN): m/z (%) = 222.0 (100, [LH+]), 375.0 (80, [LFe3+-H++(acac)-]), 496.2 (37, 
[L2Fe3+-2H+]); elemental analysis calcd (%) for C29H35FeN2O8 (595.2): C 58.50, H 5.92, N 
4.70, found: C 58.15, H 6.49, N 3.99; IR (Diamond Single Reflection ATR System): ν~  3407, 
2970, 2927, 1641, 1605, 1572, 1519, 1473, 1441, 1360, 1259, 1234, 1154, 1076, 1018, 947, 
927, 854, 755, 665, 611, 518 cm-1. 
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(proposed structure) 
 
[FeIII(9)2(acac)]   elemental analysis 
 
Ligand 9 (100 mg, 0.452 mmol, 2.0 eq.) and Fe(acac)3 (80 mg, 0.226 mmol, 1.0 eq.) were 
dissolved separately in dry THF (each in 2 mL) and the ligand was transferred to the metal. 
The reaction mixture was stirred over night at rt. The solvent was removed and the residue was 
redissolved in Et2O/hexanes (1:6), filtered, dried in vacuo and stored at rt. The product was 
obtained as a blood-red solid (79 mg, 0.132 mmol, 58%). 
 
MS (ESI, MeCN): m/z (%) = 222.0 (50, [LH+]), 375.1 (12, [LFe3+-H++(acac)-]), 496.2 (100, 
[L2Fe3+-2H+]); elemental analysis calcd (%) for C29H35FeN2O8 (595.2): C 58.50, H 5.92, N 
4.70, found: C 58.27, H 6.33, N 4.63; IR (Diamond Single Reflection ATR System): ν~  3433, 
2964, 2929, 1606, 1577, 1545, 1520, 1472, 1441, 1367, 1332, 1251, 1150, 1133, 1079, 1021, 
958, 927, 894, 835, 755, 707, 611, 537 cm-1. 
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F.7.2 Ruthenium Complexes 
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(proposed structures) 
 
[RuIII(7a)3] • 2(EtOH) • (THF)   elemental analysis 
 
Ligand 7a (100 mg, 0.518 mmol, 4.0 eq.) was dissolved in dry EtOH (2 mL) and was added to 
[RuCl2(benzene)]2 (65 mg, 0.130 mmol, 1.0 eq.), suspended in dry EtOH (2 mL). The reaction 
mixture was stirred under reflux for 48 h. The suspension was filtered through Celite and the 
solvent was removed in vacuo. The residue was redissolved in Et2O/THF (1:1), filtered, dried 
in vacuo and stored at rt. The product was obtained as a dark purple solid (48 mg, 0.057 mmol, 
44%).  
 
MS (ESI, MeCN): m/z (%) = 194.0 (100, [LH+]), 486.1 (9, [L2Ru3+-2H+]), 679.3 (30, [L3Ru3+-
2H+]); elemental analysis calcd (%) for C38H50N3O12Ru (842.2): C 54.21, H 5.99, N 4.99, 
found: C 54.16, H 5.89, N 5.83; IR (Diamond Single Reflection ATR System): ν~  3300, 3065, 
2972, 2931, 2873, 1605, 1587, 1541, 1476, 1437, 1391, 1369, 1323, 1303, 1238, 1157, 1079, 
1036, 989, 955, 860, 843, 751 cm-1. 
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(proposed structures) 
 
[RuIII(8)3] • (Et2O)   elemental analysis 
 
Ligand 8 (100 mg, 0.452 mmol, 4.0 eq.) was dissolved in EtOH (2 mL) and was added to 
[RuCl2(benzene)]2 (57 mg, 0.113 mmol, 1.0 eq.), suspended in EtOH (2 mL). The reaction 
mixture was stirred under reflux for 48 h. The suspension was filtered through Celite and the 
solvent was removed in vacuo. The residue was redissolved in Et2O/THF (1:1), filtered, dried 
in vacuo and stored at rt. The product was obtained as a dark purple solid (55 mg, 0.072 mmol, 
64%).  
 
MS (ESI, MeCN): m/z (%) = 222.0 (100, [LH+]), 542.2 (5, [L2Ru3+-2H+]), 763.4 (4, [L3Ru3+-
2H+]); elemental analysis calcd (%) for C40H52N3O10Ru (836.3): C 57.47, H 6.27, N 5.03, 
found: C 57.75, H 6.56, N 5.07; IR (Diamond Single Reflection ATR System): ν~  3355, 2971, 
2923, 1605, 1541, 1470, 1435, 1366, 1324, 1232, 1154, 1131, 1075, 1037, 949, 855, 830, 751 
cm-1. 
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(proposed structures) 
 
[RuIII(9)3] • 2(EtOH)   elemental analysis 
 
Ligand 9 (100 mg, 0.452 mmol, 4.0 eq.) was dissolved in EtOH (2 mL) and was added to 
[RuCl2(benzene)]2 (57 mg, 0.113 mmol, 1.0 eq.), suspended in EtOH (2 mL). The reaction 
mixture was stirred under reflux for 48 h. The suspension was filtered through Celite and the 
solvent was removed in vacuo. The residue was redissolved in Et2O/THF (1:1), filtered, dried 
in vacuo and stored at rt. The product was obtained as a dark purple solid (50 mg, 0.059 mmol, 
52%).  
 
MS (ESI, MeCN): m/z (%) = 222.1 (100, [LH+]), 542.2 (6, [L2Ru2+-2H+]), 763.4 (12, [L3Ru3+-
2H+]); elemental analysis calcd (%) for C40H54N3O11Ru (854.3): C 56.26, H 6.37, N 4.92, 
found: C 55.86, H 5.93, N 4.93; IR (Diamond Single Reflection ATR System): ν~  3304, 2968, 
2931, 1604, 1541, 1471, 1434, 1390, 1369, 1324, 1241, 1151, 1134, 1080, 1035, 958, 869, 
832, 752 cm-1. 
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F.7.3 Zinc Complexes 
 
 
 
[ZnII(7a)2] • (ClO4) • (H2O) elemental analysis  
 
Ligand 7a (50 mg, 0.259 mmol, 2.0 eq.) and Zn(ClO4)2•6H20 (48 mg, 0.130 mmol, 1.0 eq.) 
were dissolved separately in THF (each in 2 mL) and the ligand was transferred to the metal. 
The reaction mixture was stirred over night at rt. The solvent was removed by pipette and the 
arising solid was washed with dry THF (3 x 3 mL), dried in vacuo and stored at rt. The product 
was obtained as a slightly orange oil (39 mg, 0.069 mmol, 53%). Recrystallization from 
THF / Et2O afforded colourless crystals which were suitable for X-Ray structure analysis. 
 
MS (ESI, MeCN): m/z (%) = 194.0 (100, [LH+]), 449.0 (35, [L2Zn2+-2H+]); elemental analysis 
calcd (%) for C20H23ClN2O11Zn (566.0): C 42.27, H 4.08, N 4.93, found: C 42.79, H 4.07, N 
5.37; IR (Diamond Single Reflection ATR System): ν~  3482, 2904, 1613, 1556, 1475, 1388, 
1322, 1235, 1147, 1061, 1040, 947, 927, 893, 836, 776, 751, 692, 659, 620, 573 cm-1. 
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(proposed structure) 
 
[ZnII(8)2] • (ClO4) • 5(H2O)   elemental analysis 
 
Ligand 8 (50 mg, 0.226 mmol, 2.0 eq.) and Zn(ClO4)2•6H20 (42 mg, 0.113 mmol, 1.0 eq.) were 
dissolved separately in THF (each in 2 mL) and the ligand was transferred to the metal. The 
reaction mixture was stirred over night at rt. The solvent was removed and the arising solid 
was washed with dry THF (3 x 3 mL), dried in vacuo and stored at rt. The product was 
obtained as a slightly orange oil (65 mg, 0.094 mmol, 83%). 
 
MS (ESI, MeCN): m/z (%) = 222.0 (57, [LH+]), 505.1 (100, [L2Zn2+-H+]), 790.2 (22, [L3Zn22+-
3H+]); elemental analysis calcd (%) for C24H39ClN2O15Zn (694.1): C 41.39, H 5.64, N 4.02, 
found: C 41.27, H 5.19, N 3.97; IR (Diamond Single Reflection ATR System): ν~  3461, 2979, 
2939, 1626, 1555, 1477, 1383, 1317, 1240, 1067, 957, 932, 838, 753, 620 cm-1. 
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[ZnII(9)2] • (ClO4) • 2(H2O)   elemental analysis  
 
Ligand 9 (100 mg, 0.452 mmol, 2.0 eq.) and Zn(ClO4)2•6H20 (84 mg, 0.226 mmol, 1.0 eq.) 
were dissolved separately in THF (each in 3 mL) and the ligand was transferred to the metal. 
The reaction mixture was stirred over night at rt. The solvent was removed by pipette and the 
arising solid was washed with dry THF (3 x 3 mL). Recrystallization from MeCN afforded the 
product as a colourless solid (49 mg, 0.077 mmol, 34%), which was dried in vacuo and stored 
at rt. Recrystallization from THF / Et2O resulted in colourless crystals which were suitable for 
X-Ray structure analysis. 
 
MS (ESI, MeCN): m/z (%) = 222.0 (23, [LH+]), 505.2 (24, [L2Zn2+-H+])1; elemental analysis 
calcd (%) for C24H33ClN2O12Zn (640.1): C 44.87, H 5.18, N 4.36, found: C 45.12, H 5.20, N 
4.35; IR (Diamond Single Reflection ATR System): ν~  3499, 2986, 1621, 1567, 1463, 1393, 
1372, 1308, 1071, 1031, 964, 908, 857, 841, 777, 758, 696, 621 cm-1. 
 
 
 
 
 
                                                 
1
 Masspectrometry shows an additional peak at 496.2 which indicates the presence of an iron complex. This might 
be caused by minimal amount of iron leaching from the injection needle (corrosion). 
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F.7.4 Manganese Complex 
 
O
ClO4
-
N
O
O
N
O
O
MnIII
H2O
HO
O
HO
 
 
[MnIII(7a)2(THF)2] • (ClO4)   crystal structure  
[MnIII(7a)2] • (ClO4) • 4(H2O)   elemental analysis  
 
Ligand 7a (100 mg, 0.518 mmol, 2.0 eq.) and Mn(ClO4)2•6H20 (94 mg, 0.259 mmol, 1.0 eq.) 
were dissolved separately in THF (each in 2 mL) and the ligand was transferred to the metal. 
The reaction mixture was stirred for 48 h at rt. The solvent was removed and the arising solid 
was washed with dry THF (3 x 3 mL), dried in vacuo and stored at rt. The product was 
obtained as a dark green solid (111 mg, 0.182 mmol, 70%). Recrystallization from Et2O 
afforded colourless crystals which were suitable for X-Ray structure analysis. 
 
MS (ESI, MeCN): m/z (%) = 194.0 (33, [LH+]), 439.1 (100, [L2Mn3+-2H+]), 684 (13, 
[L3Mn23+-5H+]); elemental analysis calcd (%) for C20H28ClMnN2O14 (610.1): C 39.33, H 4.62, 
N 4.59 found: C 39.94, H 4.10, N 4.51; IR (Diamond Single Reflection ATR System): ν~  
3481, 2952, 2896, 1604, 1583, 1546, 1480, 1442, 1406, 1325, 1246, 1086, 1032, 985, 928, 
865, 750, 675, 619 cm-1. 
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F.8 Synthesized Complexes of Bis(oxazoline) Ligands 
 
F.8.1 Iron Complexes 
 
N
O O
O N N O
OH O
FeIII
OH2H2O
2 ClO4
-
 
(proposed structure) 
 
[FeIII(1)(H2O)2] • 2(ClO4) • (THF)   elemental analysis 
 
Ligand 1 (50 mg, 0.102 mmol, 1.0 eq.) and Fe(ClO4)2•6H2O (37 mg, 0.102 mmol, 1.0 eq.) 
were dissolved separately in dry THF (each in 2 mL) and the ligand was transferred to the 
metal. The reaction mixture was stirred for 12 h at rt. The solvent was removed by pipette and 
the arising solid was washed with dry THF (3 x 3 mL), dried in vacuo and stored at rt. The 
product was obtained as a dark purple solid (85 mg, 0.099 mmol, 97%). 
 
MS (ESI, MeCN): m/z (%) = 543.1 (100, [LFe3+-2H+]); elemental analysis calcd (%) for 
C31H38Cl2FeN3O17 (850.1): C 43.73, H 4.50, N 4.94, found: C 43.21, H 4.23, N 5.21; 
IR (Diamond Single Reflection ATR System): ν~  2975, 1604, 1579, 1545, 1475, 1441, 1393, 
1332, 1247, 1064, 964, 930, 853, 757, 694, 666, 619 cm-1. 
 
 
 
 
 
Experimental Part 
 
176 
 
N
O O
O N N O
OH O
FeIII
OH2
2 ClO4
-
H2O
 
(proposed structure) 
 
[FeIII(2)(H2O)2] • 2(ClO4) • (THF) • 3(H2O)   elemental analysis 
 
Ligand 2 (50.0 mg, 0.092 mmol, 1.0 eq.) and Fe(ClO4)2•6H2O (33.0 mg, 0.092 mmol, 1.0 eq.) 
were dissolved separately in dry THF (each in 2 mL) and the ligand was transferred to the 
metal. The reaction mixture was stirred for 5 h at rt. The solvent was removed by pipette and 
the arising solid was washed with dry THF (3 x 3 mL), dried in vacuo and stored at rt. The 
product was obtained as a dark purple solid (61 mg, 0.064 mmol, 70%). 
 
MS (LSIMS, MeOH/CH2Cl2/NBA): m/z (%) = 599.2 (100, [LFe3+-2H+]); elemental analysis 
calcd (%) for C35H52Cl2FeN3O20 (960.2): C 43.72, H 5.45, N 4.37, found: C 43.79, H 5.18, N 
3.92; IR (Diamond Single Reflection ATR System): ν~  3200, 2880, 2975, 1603, 1575, 1542, 
1474, 1440, 1394, 1329, 1255, 1081, 1046, 870, 830, 759, 619 cm-1. 
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N
S S
O N N O
O O
FeIII
O OH2
ClO4
-
 
 
[FeIII((meso)-4)ox(H2O)] • (ClO4)   crystal structure 
[FeIII((±)-4/(meso)-4)ox(H2O)] • (ClO4) • (THF) • 4(H2O)   elemental analysis 
 
Ligand (±)-4/(meso)-4 (50 mg, 0.096 mmol, 1.0 eq.) and Fe(ClO4)2•6H2O (35 mg, 0.096 mmol, 
1.0 eq.) were dissolved separately in dry THF (each in 2 mL) and the ligand was transferred to 
the metal. The reaction mixture was stirred for 4 h at rt. The solvent was removed by pipette 
and the arising solid was washed with dry THF (3 x 3 mL), dried in vacuo and stored at rt. The 
product was obtained as a dark violet solid (72 mg, 0.084 mmol, 88%). Recrystallization from 
acetonitrile / ethylacetate afforded violet needles which were suitable for X-Ray structure 
analysis. 
 
MS (ESI, MeCN): m/z (%) = 575.0 (100, [LFe3+-2H+]), 591.0 (64, [LFe3+-2H++O]); elemental 
analysis calcd (%) for C31H43ClFeN3O15S2 (852.1): C 43.64, H 5.08, N 4.93, S 7.52, found: C 
43.60, H 4.32, N 5.01, S 7.57; IR (Diamond Single Reflection ATR System): ν~  2976, 1603, 
1578, 1543, 1475, 1441, 1393, 1329, 1246, 1075, 963, 931, 856, 756, 692, 664, 619 cm-1. 
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N
S S
O N N O
O O
FeIII
O OH2
ClO4
-
 
(proposed structure) 
 
[FeIII(5)ox(H2O)] • (ClO4) • 4(H2O)   elemental analysis 
 
Ligand 5 (40 mg, 0.069 mmol, 1.0 eq.) and Fe(ClO4)2•6H2O (25 mg, 0.069 mmol, 1.0 eq.) 
were dissolved separately in dry THF (each in 2 mL) and the ligand was transferred to the 
metal. The reaction mixture was stirred over night at rt. The solvent was removed by pipette 
and the arising solid was washed with dry THF (3 x 3 mL), dried in vacuo and stored at rt. The 
product was obtained as a dark purple solid (24 mg, 0.029 mmol, 42%). 
 
MS (ESI, MeCN): m/z (%) = 631.1 (100, [LFe3+-2H+]), 647.2 (7, [LFe3+-2H++O]); elemental 
analysis calcd (%) for C31H43ClFeN3O14S2 (836.1): C 44.48, H 5.18, N 5.02, S 7.66, found: C 
44.82, H 4.90, N 4.59, S 7.03; IR (Diamond Single Reflection ATR System): ν~  2975. 1603, 
1575, 1542, 1473, 1439, 1393, 1329, 1255, 1074, 869, 756, 697, 619 cm-1. 
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F.8.2 Ruthenium Complexes 
 
N
O O
O N N O
O O
RuIII
solvent
Cl
 
(proposed structure) 
 
[RuIII(1)(Cl)(solvent)] • 2(EtOH)   elemental analysis 
 
Ligand 1 (30 mg, 0.061 mmol, 2.0 eq.) was dissolved in dry EtOH (3 mL) and was added to 
[RuCl2(benzene)]2 (15.5 mg, 0.031 mmol, 1.0 eq.), suspended in dry EtOH (3 mL). The 
reaction mixture was refluxed for 16 h, the solvent was removed in vacuo and the residue was 
resuspended in CH2Cl2 (4 mL) and filtered through Celite. The solvent was removed in vacuo, 
the residue was dried and stored at rt. The product was obtained as a dark purple solid (18 mg, 
0.025 mmol, 81%). 
 
MS (ESI, MeCN): m/z (%) = 589.1 (40, [LRu3+-2H+]), 625.1 (100, [LRu3+-H++Cl-]); elemental 
analysis calcd (%) for C31H37ClN3O8Ru (716.1): C 51.99, H 5.21, N 5.87, found: C 52.38, H 
4.79, N 5.82; IR (Diamond Single Reflection ATR System): ν~  3400, 3063, 2961, 2869, 1617, 
1539, 1472, 1438, 1388, 1332, 1298, 1231, 1087, 1070, 1034, 847, 797, 753, 687 cm-1. 
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N
O O
O N N O
O O
RuIII
solvent
Cl
 
(proposed structure) 
 
[RuIII(2)(Cl)(solvent)] • 5(EtOH) • 2(H2O)   elemental analysis 
 
Ligand 2 (50.0 mg, 0.092 mmol, 1.0 eq.) was dissolved in dry EtOH (3 mL) and was added to 
[RuCl2(benzene)]2 (23 mg, 0.046 mmol, 0.5 eq.), suspended in dry EtOH (3 mL). The reaction 
mixture was refluxed for 24 h and filtered. The solvent was removed in vacuo, the residue was 
dried and stored at rt. The product was obtained as a dark purple solid (70 mg, 0.074 mmol, 
80%). 
 
MS (LSIMS, MeOH/Glycerin): m/z (%) = 546.3 (100, [LH+]), 645.2 (20, [LRu3+-2H+]); 
elemental analysis calcd (%) for C41H67ClN3O13Ru (946.3): C 52.03, H 7.13, N 4.44, found: 
C 51.87, H 7.01, N 3.63; IR (Diamond Single Reflection ATR System): ν~  3200, 2963, 2922, 
2853, 1618, 1459, 1434, 1372, 1330, 1257, 1125, 1084, 1042, 795, 753, 684 cm-1. 
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N
S S
O N N O
OH HO
RuII
Cl Cl
 
(proposed structure) 
 
[RuII((±)-4/(meso)-4)(Cl)2] • (EtOH)   elemental analysis 
 
Ligand (±)-4/(meso)-4 (150 mg, 0.288 mmol, 2.0 eq.) was dissolved in dry EtOH (3 mL) and 
was added to [RuCl2(benzene)]2 (71.9 mg, 0.143 mmol, 1.0 eq.), suspended in dry EtOH 
(3 mL). The reaction mixture was refluxed for 16 h, the solvent was removed in vacuo and the 
residue was resuspended in CH2Cl2 (4 mL) and filtered through Celite 535. The solvent was 
removed in vacuo, the residue was dried and stored at rt. The product was obtained as a dark 
green solid (79 mg, 0.107 mmol, 75%). 
 
MS (ESI, MeCN): m/z (%) = 311.4 (68, [LRu2+]), 622.0 (100, [LRu2+-H+]), 658.0 (50, 
[LRu2++Cl-]); elemental analysis calcd (%) for C29H33Cl2N3O5RuS2 (739.0): C 47.09, H 4.50, 
N 5.68, S 8.67, found: C 46.99, H 4.79, N 5.32, S 7.70; IR (Diamond Single Reflection ATR 
System): ν~  3200, 3059, 2962, 1634, 1598, 1538, 1489, 1455, 1442, 1363, 1336, 1303, 1258, 
1235, 1068, 1032, 933, 797, 751, 683, 662 cm-1. 
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N
S S
O N N O
OH HO
RuII
Cl Cl
 
(proposed structure) 
 
[RuII(5)(Cl)2] • 3(EtOH) • 2(CH2Cl2) • (C6H6) • (H2O)   elemental analysis 
 
Ligand 5 (35 mg, 0.061 mmol, 1.0 eq.) was dissolved in dry EtOH (2.5 mL) and was added to  
[RuCl2(benzene)]2 (51 mg, 0.102 mmol, 1.7 eq.), suspended in dry EtOH (2.5 mL). The 
reaction mixture was refluxed for 16 h, the solvent was removed in vacuo and the residue was 
resuspended in CH2Cl2 (4 mL) and filtered through Celite. The solvent was removed in vacuo, 
the residue was dried and stored at rt. The product was obtained as a dark green solid (45 mg, 
0.039 mmol, 64%). 
 
MS (ESI, MeCN): m/z (%) = 678.2 (100, [LRu2+-H+]), 714.2 (57, [LRu2++Cl-]); elemental 
analysis calcd (%) for C45H65Cl6N3O8RuS2 (1151.1): C 46.84, H 5.68, N 3.64, S 5.56, found: C 
46.38, H 5.88, N 3.26, S 5.24; IR (Diamond Single Reflection ATR System): ν~  3355, 3190, 
2922, 2852, 1719, 1633, 1606, 1526, 1492, 1458, 1391, 1375, 1334, 1289, 1259, 1243, 1148, 
1123, 1074, 1031, 753 cm-1. 
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F.8.3 Zinc Complexes 
 
N
O O
O N N O
OH HO
ZnII
2 ClO4
-
 
(proposed structure) 
 
[ZnII(1)] • 2(ClO4) • 2(THF) • (H2O)   elemental analysis 
 
Ligand 1 (33 mg, 0.067 mmol, 1.0 eq.) and Zn(ClO4)2•6H2O (25 mg, 0.067 mmol, 1.0 eq.) 
were dissolved separately in dry THF (each in 2 mL) and the ligand was transferred to the 
metal. The reaction mixture was stirred for 4 h at rt. The solvent was removed and the arising 
solid was washed with dry THF (3 x 3 mL), dried in vacuo and stored at rt. The product was 
obtained as a slightly pink solid (49 mg, 0.058 mmol, 87%). 
 
MS (ESI, MeCN): m/z (%) = 552.1 (7, [LZn2+-H+]), 570.1 (100, [LZn2+-H++H20]); elemental 
analysis calcd (%) for C31H37Cl2N3O16Zn (841.1): C 44.12, H 4.42, N 4.98, found: C 44.15, H 
4.35, N 5.14; IR (Diamond Single Reflection ATR System): ν~  3200, 2900, 1610, 1551, 1476, 
1440, 1390, 1329, 1312, 1239, 1067, 963, 930, 840, 755, 697, 661, 620, 574 cm-1. 
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N
O O
O N N O
OH HO
ZnII
2 ClO4
-
 
(proposed structure) 
 
[ZnII(2)] • 2(ClO4) • 2(THF)   elemental analysis 
 
Ligand 2 (37 mg, 0.068 mmol, 1.0 eq.) and Zn(ClO4)2•6H2O (25 mg, 0.068 mmol, 1.0 eq.) 
were dissolved separately in dry THF (each in 2 mL) and the ligand was transferred to the 
metal. The reaction mixture was stirred for 4 h at rt. The solvent was removed and the arising 
solid was washed with dry THF (3 x 3 mL), dried in vacuo and stored at rt. The product was 
obtained as a colourless solid (17 mg, 0.019 mmol, 28%). 
 
MS (LSIMS, MeOH/CH2Cl2/Glycerin): m/z (%) = 608.2 (100, [LZn2+-H+]); elemental analysis 
calcd (%) for C39H51Cl2N3O16Zn (951.2): C 49.09, H 5.39, N 4.40, found: C 49.83, H 5.00, N 
4.91; IR (Diamond Single Reflection ATR System): ν~  2975, 2877, 1624, 1549, 1472, 1441, 
1370, 1322, 1303, 1244, 1079, 967, 925, 859, 833, 763, 833, 622, 584 cm-1. 
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N
S S
O N N O
OH HO
ZnII
2 ClO4
-
 
 
[ZnII((S,S)-4)] • 2(ClO4)   crystal structure 
[ZnII((±)-4/(meso)-4)] • 2(ClO4) • 2(THF) • 4(H2O)   elemental analysis 
 
Ligand (±)-4/(meso)-4  (80 mg, 0.153 mmol, 1.0 eq.) and Zn(ClO4)2•6H2O (71 mg, 
0.192 mmol, 1.2 eq.) were dissolved separately in dry THF (each in 2 mL) and the ligand was 
transferred to the metal. The reaction mixture was stirred for 3 h at rt. The solvent was 
removed and the arising solid was washed with dry THF (3 x 3 mL), dried in vacuo and stored 
at rt. The product was obtained as a slightly yellow solid (116 mg, 0.116 mmol, 76%). 
Recrystallization from acetonitrile / ethylacetate afforded colourless needles which were 
suitable for X-Ray structure analysis. 
 
MS (LSIMS, MeOH/Glycerin): m/z (%) = 522.3 (35, [LH+]), 584.1 (100, [LZn2+-H+]); 
elemental analysis calcd (%) for C35H51Cl2N3O18S2Zn (999.1): C 41.94, H 5.13, N 4.19, S 6.40, 
found: C 41.40, H 4.42, N 4.07, S 6.03; IR (Diamond Single Reflection ATR System): ν~  
2980, 1620, 1479, 1455, 1389, 1312, 1242, 1076, 1035, 993, 962, 919, 860, 839, 753, 691, 
620, 578 cm-1. 
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N
S S
O N N O
OH HO
ZnII
2 ClO4
-
 
(proposed structure) 
 
[ZnII(5)] • 2(ClO4) • (H2O)   elemental analysis 
 
Ligand 5 (40 mg, 0.069 mmol, 1.0 eq.) and Zn(ClO4)2•6H2O (26 mg, 0.069 mmol, 1.0 eq.) 
were dissolved separately in dry THF (each in 2 mL) and the ligand was transferred to the 
metal. The reaction mixture was stirred over night at rt. The solvent was removed by pipette 
and the arising solid was washed with dry THF (3 x 3 mL), dried in vacuo and stored at rt. The 
product was obtained as a yellow solid (22 mg, 0.026 mmol, 38%). 
 
MS (ESI, MeCN): m/z (%) = 640.2 (100, [LZn2+-H+]); elemental analysis calcd (%) for 
C31H37Cl2N3O13S2Zn (857.0): C 43.29, H 4.34, N 4.89, S 7.46, found: C 43.78, H 4.47, N 4.67, 
S 7.33; IR (Diamond Single Reflection ATR System): ν~  3200, 2982, 1618, 1590, 1557, 1476, 
1440, 1377, 1313, 1242, 1077, 868, 929, 755, 700, 620, 579 cm-1. 
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F.9 UV/Vis-Titrations 
 
F.9.1 UV/Vis-Job`s Plot Titration 
 
A stock solution of ligand 7a (6.0 mM in MeCN) as well as Fe(ClO4)2•6H2O (6.0 mM in 
MeCN) were used for preparing the samples. The allover concentration of the solutions, 
containing different ligand / salt ratios, is given with: [ligand] + [salt] = 0.5 mM. Table 1 
shows the different concentrations of the ligand and the salt in each sample and the resulting 
mole fraction values for ligand 7a. The optical cell path length was for all measurements 
d = 1 cm. 
 
Table 1. Mole fraction for ligand 7a and used concentrations. 
 
Sample No. Mole Fraction Ligand 7a cSalt [mM] cLigand [mM] 
1 0.1 0.45 0.05 
2 0.25 0.375 0.125 
3 0.375 0.3125 0.1875 
4 0.5 0.25 0.25 
5 0.625 0.1875 0.3125 
6 0.675 0.1625 0.3375 
7 0.875 0.0625 0.4375 
8 0.995 0.0025 0.4975 
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F.9.2 UV/Vis-Equilibrium Constant Titration 
 
All titrations were carried out in a solvent mixture of acetonitrile/H2O (1:1), buffered with 
0.053 M formic acid. The optical cell path length was for all measurements d = 1 cm. For all 
equilibrium titrations, FeCl3•6H2O was used as iron source. 
 
Table 2. Forward titration of oxazoline 7a. 
 
No. Ratio L/M OD 
(530 nm) 
OD 
(580 nm) 
cM [mM] cL [mM] 
1 0.15 0.0463313 0.0397601 0.25 0.0375 
2 0.60 0.189063 0.156025 0.25 0.15 
3 1.05 0.312262 0.247508 0.25 0.2625 
4 1.50 0.431260 0.330116 0.25 0.375 
5 1.95 0.522818 0.385927 0.25 0.4875 
6 2.40 0.612041 0.438692 0.25 0.6 
7 2.85 0.701491 0.491547 0.25 0.7125 
8 4.51 0.893168 0.589432 0.25 1.1275 
9 11.3 1.11623 0.690552 0.25 2.825 
 
Table 3. Reverse titration of oxazoline 7a. 
 
No. Ratio M/L OD 
(530 nm) 
OD 
(580 nm) 
cM [mM] cL [mM] 
1 0.16 0.0308677 0.0234003 0.02 0.125 
2 0.64 0.0876823 0.0695113 0.08 0.125 
3 1.12 0.115686 0.0940063 0.14 0.125 
4 1.6 0.133199 0.110158 0.20 0.125 
5 2.08 0.141174 0.117740 0.26 0.125 
6 2.56 0.147343 0.123661 0.32 0.125 
7 3.04 0.151961 0.128437 0.38 0.125 
8 6.4 0.169025 0.146672 0.80 0.125 
9 12 0.180968 0.160897 1.50 0.125 
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Table 4. Forward titration of thiazoline (±)-10. 
 
No. Ratio L/M OD 
(535 nm) 
OD 
(580 nm) 
cM [mM] cL [mM] 
1 0.15 0.0147494 0.0126545 0.125 0.01875 
2 0.60 0.0495793 0.0429302 0.125 0.075 
3 1.05 0.0785201 0.0669466 0.125 0.13125 
4 1.50 0.104655 0.0889260 0.125 0.1875 
5 1.95 0.128978 0.108319 0.125 0.24375 
6 2.40 0.148217 0.123307 0.125 0.3 
7 2.85 0.166323 0.137165 0.125 0.35625 
8 4.51 0.215077 0.172500 0.125 0.56375 
9 11.3 0.317620 0.243837 0.125 1.4125 
 
Table 5. Reverse titration of thiazoline (±)-10. 
 
No. Ratio M/L OD 
(535 nm) 
OD 
(580 nm) 
cM [mM] cL [mM] 
1 0.16 0.0240740 0.0199488 0.02 0.125 
2 0.64 0.0570581 0.0486704 0.08 0.125 
3 1.12 0.0828912 0.0720409 0.14 0.125 
4 1.6 0.0898935 0.0783712 0.20 0.125 
5 2.08 0.0989253 0.0870519 0.26 0.125 
6 2.56 0.102990 0.0906938 0.32 0.125 
7 3.04 0.109526 0.0967431 0.38 0.125 
8 6.4 0.173251 0.154841 0.80 0.125 
9 12 0.141189 0.128324 1.50 0.125 
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F.9.2 General UV/Vis- and CD-Measurements 
 
All complex, ligand and salt measurements were carried out in a 10-5 M solution (UV/Vis) 
or 10-4 M solution (CD) in acetonitrile at rt. The optical cell path length was for all 
measurements d = 1 cm (UV/Vis) or d = 0.1 cm (CD). 
 
Figure 1. UV/Vis spectra of Fe(ClO4)2•6H2O and Fe(OAc)2. 
 
Figure 2. UV/Vis spectra of Fe(acac)3 and [RuCl2(benzene)]2. 
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Figure 3. UV/Vis spectra of Zn(ClO4)2•6H2O and Mn(ClO4)2•6H2O. 
 
Figure 4. UV/Vis spectra (left) and CD spectra (right) of oxazoline ligands 7a-9. 
 
Figure 5. UV/Vis spectra of the bis(oxazoline) ligand 1 and 2 (left) as well as (±)-4/(meso)-4 and 5 (right). 
 
Figure 6. CD spectra of the bis(oxazoline) ligand 1, 2 and 5. 
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Table 6. General CD measurement conditions. 
 
Wavelength range 200 – 750 nm 
Resolution 0.2 nm 
Bandwidth 1.0 nm 
Sensitivity 50 mdeg 
Response 2 sec 
Accumulations 10 
Speed 50 nm/min 
 
 
 
 
Figure 7. UV/Vis and CD spectra of [FeIII(7a)2]•(ClO4) and [FeIII(7a)2(OAc)]. 
 
 
Figure 8. CD spectra of the complexes 40 (ruthenium),41 (zinc) and 42 (zinc). 
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F.10 Catalysis Reactions 
 
F.10.1 Oxidation of ethylbenzene 
 
Ligand and salt were dissolved separately in acetonitrile (each in 2.5 mL). The ligand was 
than added to the salt and was stirred for 15 min at rt to form the complex (1 mol% or 
10 mol%). The addition of HOAc (11.4 µL, 12 mg, 0.20 mmol, 0.2 equiv.) followed and the 
reaction mixture was stirred for further 10 min. Ethylbenzene (1.22 mL, 1.06 g, 10.0 mmol, 
10.0 equiv.). Bromobenzene (internal standard) (10.5 µL, 16 mg, 0.100 mmol, 0.1 equiv.) and 
H2O2 (102 µL, 113 mg, 1.0 mmol, 1.0 equiv.) was added. In the cases, for a total of 5 mmol 
H2O2, a portion-wise addition of 1 mmol oxidant each hour during the first 5 h was carried out. 
The reaction mixture was stirred at rt and after 3 h, 5 h or 24 h, samples for GC detection were 
taken. 0.1 mL reaction mixture was filtered through a plug of silica gel followed by a wash 
with 0.9 mL acetonitrile. 
 
GC parameters:  
- FISON GC 8130, Detektor FID 200 °C 
- 200 °C injector 
- column: J&W Scientific DBWAX; 30 m and 0.25 mm 
- oven temperature: 130 °C / 4 min, 30 K / min to 180 °C, 180 °C / 4 min 
- carrier gas helium 
- retention time: 3.19 min (bromobenzene), 6.32 min (acetophenone) and 7.89 min 
(1-phenylethanol). 
 
Chiral GC parameters: 
- FISON GC 8000 series, Detektor FID 200 °C 
- 200 °C injector 
- column: CP-Chiracil-DEX-CP 
- oven temperature: isotherm 100 °C 
- carrier gas helium 
- retention time: 10.28 min and 11.41 min ((±)-1-phenylethanol). 
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F.10.2 Oxidation of methyl phenyl sulfide 
 
Ligand and salt were dissolved separately in dichloromethane or acetonitrile (each in 
1.0 mL). The ligand was than added to the salt and the reaction mixture was stirred for 15 min 
at rt to form the complex (2 mol%). The complex mixture was than added to a suspension of 
4-methoxybenzoic acid (1.5 mg, 0.01 mmol, 0.01 equiv.) in 0.5 mL dichloromethane or 
acetonitrile and was stirred for further 10 min. Methyl phenyl sulfide (118 µL, 124 mg, 
1.00 mmol 1.0 equilv.) and H2O2 (123 µL, 136 mg, 1.2 mmol, 1.2 equiv.) was added. The 
catalysis reaction was stirred at rt for 16 h. Sat. NaSO3–solution (5 mL) was added. After layer 
separation, the aqueous layer was extracted with dichloromethane (2 x 5 mL) and the 
combined organic layers were dried (Na2SO4). Subsequently the solvent was almost removed 
at reduced pressure (200 mbar, rt), and in comparison in a second series the solvent was 
completely removed under a high vacuum. In each case, the yield of the product was 
determined by 1H NMR spectroscopy: 
 
methyl phenyl sulfide:  (CH3) = 2.51 ppm (300MHz. CDCl3) 
methyl phenyl sulfoxide:  (CH3) = 2.75 ppm (300MHz. CDCl3) 
methyl phenyl sulfon:  (CH3) = 3.08 ppm (300MHz. CDCl3) 
 
The enantiomeric excess of methyl phenyl sulfoxide was determined by chiral HPLC: 
 
HPLC conditions: 
- column: Daicel Chiralcel OD-H, 0.46 cm x 25 cm 
- temperature: 15 °C 
- eluent: n-Hexan / 2-propanol 90:10, 1.0 mL/min, isocratic 
- retention time: 13.3 min and 16.8 min for enantiomers of the methyl phenyl sulfoxide 
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Table 7. Crystal data and structure refinement for (7a). 
 
Crystal Data    
Empirical formula  C10 H11 N O3  
Formula weight  193.20  
Crystal size  0.42 x 0.06 x 0.03 mm  
Crystal description  needle  
Crystal colour  colourless  
Crystal system Monoclinic  
Space group  C 2  
Unit cell dimensions  a = 28.613(4) A alpha = 90 deg.  
  b = 4.6550(5) A beta = 99.358(16) deg.  
  c = 14.035(2) A gamma = 90 deg.  
Volume  1844.5(4) A^3  
Z. Calculated density  8. 1.391 Mg/m^3  
Absorption coefficient  0.104 mm^-1  
F(000)  816 
Data Collection    
Measurement device type  STOE-IPDS diffractometer  
Measurement method  rotation  
Temperature  123(1) K  
Wavelength  0.71073 A  
Monochromator   graphite  
Theta range for data collection  1.89 to 26.83 deg.  
Index ranges  -36<=h<=36; -5<=k<=5; -17<=l<=17 
Reflections collected / unique  10278 / 3938 [R(int) = 0.0849]  
Reflections greater I>2\s(I) 2147 
Absorption correction  None  
Refinement    
Refinement method  Full-matrix least-squares on F^2  
Hydrogen treatment  :  
Data / restraints / parameters  3938 / 1 / 253  
Goodness-of-fit on F^2  0.730  
Final R indices [I>2sigma(I)]  R1 = 0.0397. wR2 = 0.0516  
R indices (all data)  R1 = 0.0959. wR2 = 0.0612  
Absolute structure parameter  -0.4(12)  
Largest diff. peak and hole  0.147 and -0.136 e.A^-3  
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Table 8. Atomic coordinates (x104) and equivalent isotropic displacement parameters (A2x103). 
 
 
Atom x y z U(eq) 
O(1) 5352(1) 9428(5) 9080(1) 34(1) 
O(2) 4823(1) 5395(5) 6101(1) 34(1) 
O(3) 6411(1) 6643(5) 7506(1) 33(1) 
N(1) 5537(1) 6575(6) 7880(2) 29(1) 
C(1) 5678(1) 8362(7) 8555(2) 27(1) 
C(2) 5015(1) 6208(7) 7834(2) 29(1) 
C(3) 4906(1) 8035(8) 8692(2) 36(1) 
C(4) 4757(1) 7287(7) 6868(2) 26(1) 
C(5) 6163(1) 9459(7) 8799(2) 26(1) 
C(6) 6507(1) 8500(7) 8250(2) 27(1) 
C(7) 6969(1) 9565(7) 8473(2) 29(1) 
C(8) 7087(1) 11501(7) 9207(2) 32(1) 
C(9) 6751(1) 12477(7) 9755(2) 33(1) 
C(10) 6294(1) 11403(7) 9540(2) 31(1) 
O(4) 3153(1) 3294(5) 4775(1) 29(1) 
O(5) 4317(1) 3885(4) 4371(1) 25(1) 
O(6) 3988(1) 2982(5) 7538(1) 35(1) 
N(2) 3791(1) 1340(5) 5724(2) 26(1) 
C(11) 3436(1) 3050(7) 5641(2) 24(1) 
C(12) 3796(1) 59(7) 4758(2) 29(1) 
C(13) 3346(1) 1292(8) 4129(2) 32(1) 
C(14) 4256(1) 876(7) 4393(2) 28(1) 
C(15) 3315(1) 4855(7) 6430(2) 25(1) 
C(16) 3603(1) 4733(7) 7343(2) 27(1) 
C(17) 3501(1) 6472(8) 8089(2) 35(1) 
C(18) 3112(1) 8290(8) 7924(2) 39(1) 
C(19) 2817(1) 8372(7) 7031(2) 35(1) 
C(20) 2923(1) 6661(6) 6286(2) 27(1) 
H(1) 4658 9480 8469 44 
H(2) 4796 6802 9186 44 
H(3) 5114 5174 6097 40 
H(4) 4415 7456 6895 31 
H(5) 4877 9221 6739 31 
H(6) 4937 4144 7928 34 
H(7) 6128 6102 7452 40 
H(8) 6064 12020 9913 37 
H(9) 6833 13837 10258 39 
H(10) 7402 12195 9348 38 
H(11) 7203 8938 8112 34 
H(12) 3426 2309 3558 38 
H(13) 3116 -254 3908 38 
H(14) 4430 4474 4926 30 
H(15) 4529 8 4821 33 
H(16) 4249 88 3736 33 
H(17) 3770 -2079 4797 34 
H(18) 4001 1914 7061 42 
H(19) 2727 6726 5672 33 
H(20) 2547 9585 6934 41 
H(21) 3045 9500 8430 47 
H(22) 3696 6417 8705 42 
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Table 9. Crystal data and structure refinement for (8). 
 
Crystal Data    
Empirical formula  C12 H15 N O3  
Formula weight  221.25  
Crystal size  0.44 x 0.28 x 0.08 mm  
Crystal description  Rectangular  
Crystal colour  Pale  
Crystal system Monoclinic  
Space group  C 2  
Unit cell dimensions  a = 20.7412(18) A alpha = 90 deg.  
  b = 14.1137(12) A beta = 101.928(2) deg.  
  c = 8.1408(7) A gamma = 90 deg.  
Volume  2331.6(3) A3  
Z. Calculated density  8. 1.261 Mg/m3  
Absorption coefficient  0.091 mm-1  
F(000)  944 
Data Collection    
Measurement device type  CCD area detector  
Measurement method  phi and omega scans  
Temperature  153(2) K  
Wavelength  0.71073 A  
Monochromator   graphite  
Theta range for data collection  2.56 to 30.53 deg.  
Index ranges  -29<=h<=29; -19<=k<=20; -11<=l<=11 
Reflections collected / unique  14376 / 6837 [R(int) = 0.0394]  
Reflections greater I>2\s(I) 5411 
Absorption correction  :  
Refinement    
Refinement method  Full-matrix least-squares on F2  
Hydrogen treatment  :  
Data / restraints / parameters  6837 / 1 / 409  
Goodness-of-fit on F^2  0.912  
Final R indices [I>2sigma(I)]  R1 = 0.0447. wR2 = 0.0841  
R indices (all data)  R1 = 0.0569. wR2 = 0.0879  
Absolute structure parameter  0.6(7)  
Largest diff. peak and hole  0.298 and -0.191 e.A-3  
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Table 10. Atomic coordinates (x104) and equivalent isotropic displacement parameters (A2x103). 
 
    x    y     z  U(eq)  
O(1) 2091(1) 4593(1) 2187(2) 41(1)  
O(2) 2099(1) 6848(1) 3997(2) 41(1)  
O(3) 3958(1) 5541(1) 1722(2) 43(1)  
N(1) 2699(1) 5822(1) 1597(2) 32(1)  
C(1) 1611(1) 5343(1) 1668(3) 39(1)  
C(2) 2018(1) 6184(1) 1241(2) 34(1)  
C(3) 1947(1) 7078(1) 2247(2) 38(1)  
C(4) 2684(1) 4968(1) 2084(2) 32(1)  
C(5) 3251(1) 4336(1) 2498(2) 31(1)  
C(6) 3866(1) 4650(1) 2231(2) 34(1)  
C(7) 4397(1) 4033(1) 2517(2) 40(1)  
C(8) 4334(1) 3137(1) 3126(3) 44(1)  
C(9) 3735(1) 2831(1) 3448(3) 44(1)  
C(10) 3203(1) 3427(1) 3133(2) 38(1)  
C(11) 2397(1) 7855(2) 1846(3) 51(1)  
C(12) 1227(1) 7410(2) 1868(3) 53(1)  
O(21) -775(1) 3544(1) -1409(2) 33(1)  
O(22) -1566(1) 1862(1) -4427(1) 33(1)  
O(23) 742(1) 2479(1) -3527(1) 33(1)  
N(21) -295(1) 2255(1) -2259(2) 25(1)  
C(21) -1199(1) 2759(1) -1123(2) 32(1)  
C(22) -865(1) 1872(1) -1646(2) 25(1)  
C(23) -1314(1) 1275(1) -3001(2) 26(1)  
C(24) -298(1) 3154(1) -2089(2) 26(1)  
C(25) 181(1) 3796(1) -2580(2) 28(1)  
C(26) 680(1) 3421(1) -3317(2) 27(1)  
C(27) 1128(1) 4027(1) -3842(2) 32(1)  
C(28) 1093(1) 4986(1) -3593(2) 39(1)  
C(29) 610(1) 5364(1) -2827(3) 42(1)  
C(30) 155(1) 4772(1) -2348(2) 36(1)  
C(31) -1918(1) 926(1) -2386(2) 34(1)  
C(32) -935(1) 445(1) -3491(2) 36(1)  
H(1A) 1278(10) 5096(14) 670(30) 47(5)  
H(1B) 1426(9) 5463(13) 2640(20) 41(5)  
H(2) 1890(8) 6338(12) 20(20) 32(4)  
H(2O) 2474(11) 6822(17) 4300(30) 61(7)  
H(3O) 3600(11) 5809(16) 1580(30) 61(7)  
H(7) 4785(9) 4222(12) 2280(20) 31(4)  
H(8) 4707(9) 2729(14) 3320(20) 40(5)  
H(9) 3695(9) 2245(14) 3920(20) 42(5)  
H(10) 2779(9) 3233(12) 3400(20) 35(5)  
H(11A) 2865(10) 7643(13) 2110(20) 39(5)  
H(11B) 2282(11) 8022(16) 590(30) 67(7)  
H(11C) 2332(11) 8428(18) 2470(30) 73(7)  
H(12A) 938(11) 6908(17) 2080(30) 61(6)  
H(12B) 1071(11) 7551(15) 640(30) 65(6)  
H(12C) 1205(10) 8010(17) 2490(30) 57(6)  
H(21A) -1612(8) 2897(11) -1820(20) 25(4)  
H(21B) -1219(8) 2779(13) 70(20) 38(5)  
H(22) -706(7) 1451(11) -750(20) 24(4)  
H(22O) -1262(9) 1966(14) -4880(20) 39(5)  
H(23O) 439(10) 2204(15) -3270(30) 53(6)  
H(27) 1459(8) 3771(11) -4330(20) 27(4)  
H(28) 1404(8) 5402(12) -3950(20) 32(4)  
H(29) 576(8) 6034(13) -2730(20) 37(5)  
H(30) -190(9) 5045(13) -1910(20) 37(5)  
H(31A) -1784(9) 488(13) -1440(20) 39(5)  
H(31B) -2175(8) 574(12) -3300(20) 37(5)  
H(31C) -2176(8) 1439(12) -2040(20) 32(5)  
H(32A) -776(9) 4(13) -2510(20) 39(5)  
H(32B) -1209(9) 75(13) -4350(20) 35(4)  
H(32C) -548(10) 648(14) -3960(20) 50(6)  
Experimental Part 
 
199 
     
N
O O
N
O O
N
OH HO
2
 
 
Table 11. Crystal data and structure refinement for (2). 
 
Crystal Data    
Empirical formula  C31 H35 N3 O6  
Formula weight  545.62  
Crystal size  0.360 x 0.270 x 0.080 mm  
Crystal description  prism  
Crystal colour  translucent colourless  
Crystal system Monoclinic  
Space group  P 21  
Unit cell dimensions  a = 7.13738(17) A alpha = 90 deg.  
  b = 12.3186(2) A beta = 90.701(2) deg.  
  c = 15.9754(4) A gamma = 90 deg.  
Volume  1404.49(5) A^3  
Z. Calculated density  2. 1.290 Mg/m^3  
Absorption coefficient  0.734 mm^-1  
F(000)  580 
Data Collection  
Measurement device type  Oxford Diffraction Gemini Ultra  
Measurement method  omega-scan  
Temperature  123 K  
Wavelength  1.54184 A  
Monochromator  graphite  
Theta range for data collection  2.77 to 62.13 deg.  
Index ranges  -8<=h-=7; -14<=k<=13; -18<=l<=15 
Reflections collected / unique  4904 / 3355 [R(int) = 0.0210]  
Reflections greater I>2\s(I) 2793 
Absorption correction  Semi-empirical from equivalents  
Max. and min. transmission  1.00000 and 0.83170  
Refinement  
Refinement method  Full-matrix least-squares on F^2  
Hydrogen treatment  :  
Data / restraints / parameters  3355 / 1 / 367  
Goodness-of-fit on F^2  0.951  
Final R indices [I>2sigma(I)]  R1 = 0.0338. wR2 = 0.0760  
R indices (all data)  R1 = 0.0411. wR2 = 0.0779  
Absolute structure parameter  -0.09(18)  
Largest diff. peak and hole  0.165 and -0.167 e.A^-3  
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Table 12. Atomic coordinates (x104) and equivalent isotropic displacement parameters (A2x103). 
 
 
Atom x y z U(eq) 
O(1) 7250(2) 2313(1) 2485(1) 35(1) 
O(2) 11092(2) 1991(1) 386(1) 31(1) 
O(3) 13927(3) 4784(2) 1225(1) 47(1) 
O(4) -1263(2) 2007(1) 4738(1) 36(1) 
O(5) -5448(3) 666(1) 6403(1) 34(1) 
O(6) -7970(3) 3703(1) 6701(1) 41(1) 
N(1) 3007(3) 2579(2) 3651(1) 32(1) 
N(2) 11496(3) 3226(2) 1415(1) 34(1) 
N(3) -5326(3) 2449(2) 6090(1) 33(1) 
C(1) 4323(3) 2091(2) 3195(2) 30(1) 
C(2) 4292(4) 995(2) 3020(2) 33(1) 
C(3) 2814(4) 384(2) 3317(2) 36(1) 
C(4) 1431(4) 879(2) 3789(2) 34(1) 
C(5) 1594(4) 1977(2) 3957(2) 31(1) 
C(6) 5821(4) 2862(2) 2916(2) 37(1) 
C(7) 8576(4) 3059(2) 2172(2) 36(1) 
C(8) 10099(4) 2442(2) 1731(2) 32(1) 
C(9) 9488(3) 1789(2) 951(2) 30(1) 
C(10) 9378(4) 585(2) 1117(2) 41(1) 
C(11) 7770(4) 2208(2) 505(2) 35(1) 
C(12) 11945(3) 2892(2) 681(2) 28(1) 
C(13) 13302(3) 3442(2) 153(2) 28(1) 
C(14) 13655(3) 3081(2) -657(2) 32(1) 
C(15) 14873(4) 3637(2) -1170(2) 42(1) 
C(16) 15746(4) 4556(2) -867(2) 46(1) 
C(17) 15444(4) 4934(2) -69(2) 41(1) 
C(18) 14226(4) 4377(2) 450(2) 35(1) 
C(19) 314(4) 2615(2) 4503(2) 38(1) 
C(20) -2320(4) 2556(2) 5350(2) 35(1) 
C(21) -4089(4) 1914(2) 5482(2) 31(1) 
C(22) -3835(4) 752(2) 5821(2) 30(1) 
C(23) -4083(4) -102(2) 5152(2) 37(1) 
C(24) -2103(4) 565(2) 6352(2) 39(1) 
C(25) -6017(4) 1691(2) 6539(2) 31(1) 
C(26) -7496(4) 1853(2) 7156(2) 30(1) 
C(27) -8013(4) 1019(2) 7694(2) 33(1) 
C(28) -9488(4) 1149(2) 8236(2) 36(1) 
C(29) -10452(4) 2121(2) 8241(2) 38(1) 
C(30) -9935(4) 2963(2) 7729(2) 37(1) 
C(31) -8453(4) 2848(2) 7185(2) 32(1) 
H(2) 5260 669 2705 39 
H(3) 2745 -371 3198 43 
H(3O) 13050(40) 4370(30) 1503(18) 56 
H(4) 399 474 3992 41 
H(6A) 5258 3420 2544 44 
H(6B) 6368 3235 3410 44 
H(6O) -7030(40) 3520(20) 6375(18) 49 
H(7A) 9124 3488 2638 44 
H(7B) 7955 3566 1776 44 
H(8) 10727 1941 2140 38 
H(10A) 8483 448 1565 49 
H(10B) 10617 315 1286 49 
H(10C) 8961 210 606 49 
H(11A) 7994 2953 316 42 
H(11B) 6708 2199 888 42 
H(11C) 7488 1745 21 42 
H(14) 13051 2444 -860 39 
H(15) 15104 3390 -1722 50 
H(16) 16581 4940 -1218 55 
H(17) 16064 5570 125 49 
H(19A) 1008 2849 5012 45 
H(19B) -104 3275 4200 45 
H(20A) -2627 3299 5158 42 
H(20B) -1594 2608 5881 42 
H(21) -4776 1869 4934 38 
H(23A) -3170 18 4708 44 
H(23B) -5354 -56 4915 44 
H(23C) -3888 -823 5397 44 
H(24A) -2127 1045 6840 47 
H(24B) -987 720 6021 47 
H(24C) -2069 -193 6538 47 
H(27) -7344 352 7688 40 
H(28) -9835 577 8601 43 
H(29) -11487 2209 8603 45 
H(30) -10600 3630 7749 44 
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Figure 8. All iron(III) oxazoline complexes, [FeIII(7a)2]•(ClO4), [FeIII(7a)2(OAc)], [FeIII(8)2(OAc)] and 
[FeIII(9)2]2. 
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Table 13. Crystal data and structure refinement for [FeIII(7a)2]•(ClO4). 
 
Crystal Data  
Empirical formula  C20 H20 Fe N2 O6, Cl O4  
Formula weight  539.68  
Crystal size  0.270 x 0.080 x 0.010 mm  
Crystal description  needle  
Crystal colour  purple  
Crystal system Orthorhombic  
Space group  P 21 21 21  
Unit cell dimensions               a = 6.3707(2) A   alpha = 90 deg.  
                                         b = 11.7037(5) A beta = 90 deg.  
                                         c = 28.8800(9) A gamma = 90 deg.  
Volume  2153.32(13) A3  
Z, Calculated density  4,  1.665 Mg/m3  
Absorption coefficient  7.326 mm-1  
F(000)  1108 
Data Collection    
Measurement device type    
Measurement method    
Temperature  123 K  
Wavelength  1.54184 A  
Monochromator   graphite  
Theta range for data collection  3.06 to 51.57 deg.  
Index ranges  -6<=h<=4, -10<=k<=11, -27<=l<=29 
Reflections collected / unique  4454 / 2137 [R(int) = 0.0825]  
Reflections greater I>2\s(I) 1631 
Absorption correction  Semi-empirical from equivalents  
Max. and min. transmission  1.00000 and 0.57176  
Refinement    
Refinement method  Full-matrix least-squares on F2  
Hydrogen treatment  :  
Data / restraints / parameters  2137 / 0 / 317  
Goodness-of-fit on F^2  1.115 
Final R indices [I>2sigma(I)]      R1 = 0.0625, wR2 = 0.1235  
R indices (all data)               R1 = 0.0903, wR2 = 0.1362  
Absolute structure parameter  -0.002(16)  
Largest diff. peak and hole  0.553 and -0.505 e.A-3  
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Table 14. Atomic coordinates (x104) and equivalent isotropic displacement parameters (A2x103). 
 
 x y z U(eq) 
Fe(1) 2663(3) 1005(2) 3612(1) 33(1) 
O(1) 688(12) 1172(7) 3133(2) 35(3) 
O(2) 3240(15) 4465(7) 3304(3) 48(4) 
O(3) 4980(13) 1515(7) 4165(3) 38(3) 
O(4) 4735(13) 69(6) 3345(2) 35(3) 
O(5) 2226(14) -1941(6) 4425(3) 44(3) 
O(6) 373(12) 1618(7) 4139(3) 41(3) 
N(1) 3577(15) 2605(8) 3472(3) 35(4) 
N(2) 1769(15) -374(8) 3986(3) 33(4) 
C(1) -190(19) 2096(11) 2965(4) 33(5) 
C(2) -2090(20) 1950(11) 2705(4) 41(5) 
C(3) -3100(20) 2867(12) 2514(4) 45(5) 
C(4) -2320(20) 3957(13) 2558(3) 43(5) 
C(5) -500(20) 4143(11) 2812(4) 44(5) 
C(6) 560(20) 3202(10) 3005(4) 32(5) 
C(7) 2500(20) 3404(11) 3273(4) 34(5) 
C(8) 5050(20) 4422(10) 3632(4) 45(5) 
C(9) 5381(18) 3140(9) 3711(4) 32(5) 
C(10) 5310(20) 2737(10) 4198(4) 35(5) 
C(11) 5640(19) -891(11) 3478(4) 39(5) 
C(12) 7490(20) -1247(9) 3269(4) 35(4) 
C(13) 8489(19) -2235(11) 3385(4) 37(5) 
C(14) 7730(20) -2906(10) 3746(4) 41(5) 
C(15) 5910(20) -2601(10) 3967(4) 39(5) 
C(16) 4808(19) -1597(10) 3842(4) 33(4) 
C(17) 2880(20) -1267(11) 4074(4) 35(5) 
C(18) 430(20) -1341(9) 4626(4) 43(5) 
C(19) 0(20) -330(11) 4316(4) 37(5) 
C(20) 60(20) 857(10) 4526(4) 44(5) 
Cl(1) 204(6) 4645(3) 4615(1) 48(1) 
O(7) 255(16) 3533(7) 4802(3) 67(4) 
O(8) -1693(16) 5099(10) 4552(4) 104(6) 
O(9) 2024(18) 5179(8) 4549(5) 105(6) 
O(10) 200(30) 4187(15) 4116(4) 58(7) 
O(10A) 200(30) 5200(16) 5117(6) 60(8) 
H(2) -2648 1205 2665 50 
H(3) -4366 2747 2348 54 
H(3A) 4923 1233 4432 45 
H(4) -3026 4580 2416 51 
H(5) 23 4896 2855 53 
H(6) 406 2296 4235 49 
H(8A) 4702 4815 3926 54 
H(8B) 6310 4779 3495 54 
H(9) 6723 2891 3562 38 
H(10A) 6642 2908 4360 42 
H(10B) 4140 3106 4368 42 
H(12) 8080 -781 3034 42 
H(13) 9706 -2466 3219 45 
H(14) 8470 -3572 3839 49 
H(15) 5371 -3073 4207 47 
H(18A) 750 -1084 4944 51 
H(18B) -815 -1850 4637 51 
H(19) -1351 -445 4147 44 
H(20A) -1280 1030 4686 52 
H(20B) 1222 926 4751 52 
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Table 15. Crystal data and structure refinement for [FeIII(7a)2(OAc)]. 
 
Crystal Data    
Empirical formula  C22 H23 Fe N2 O8  
Formula weight  499.27  
Crystal size  0.200 x 0.040 x 0.040 mm  
Crystal description  rod  
Crystal colour  brown to red  
Crystal system Monoclinic  
Space group  C 2  
Unit cell dimensions               a = 18.7581(5) A   alpha = 90 deg.  
                                         b = 8.2252(2) A    beta = 91.301(2) deg.  
                                         c = 15.2620(4) A   gamma = 90 deg.  
Volume  2354.15(10) A3  
Z, Calculated density  4,  1.409 Mg/m3  
Absorption coefficient  5.568 mm-1  
F(000)  1036 
Data Collection    
Measurement device type  Oxford Diffraction Gemini Ultra  
Measurement method  omega-scan  
Temperature  123 K  
Wavelength  1.54184 A  
Monochromator   graphite  
Theta range for data collection  4.72 to 62.28 deg.  
Index ranges  -21<=h<=21, -9<=k<=9, 0<=l<=17  
Reflections collected / unique  3621 / 3621 [R(int) = 0.0000]  
Reflections greater I>2\s(I) 2889 
Absorption correction  Semi-empirical from equivalents  
Max. and min. transmission  1.00000 and 0.48031  
Refinement    
Refinement method  Full-matrix least-squares on F2  
Hydrogen treatment  :  
Data / restraints / parameters  3621 / 1 / 304  
Goodness-of-fit on F^2  0.964  
Final R indices [I>2sigma(I)]      R1 = 0.0381, wR2 = 0.0860  
R indices (all data)               R1 = 0.0489, wR2 = 0.0896  
Absolute structure parameter  -0.026(4)  
Largest diff. peak and hole  0.307 and -0.332 e.A-3  
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Table 16. Atomic coordinates (x104) and equivalent isotropic displacement parameters (A2x103). 
 
 x y z U(eq) 
Fe(1) 2995(1) 624(1) 2799(1) 25(1) 
O(1) 2199(1) -835(3) 2638(2) 29(1) 
O(2) 1888(1) 833(4) 5190(2) 32(1) 
O(3) 3736(2) -872(4) 5009(2) 35(1) 
O(4) 3766(1) -773(3) 3148(2) 30(1) 
O(5) 4045(1) -479(4) 441(2) 39(1) 
O(6) 2162(2) -1650(5) 866(2) 53(1) 
O(7) 2523(2) 2807(4) 2324(2) 38(1) 
O(8) 3577(1) 2802(4) 2940(2) 35(1) 
N(1) 2646(2) 945(4) 4078(2) 25(1) 
N(2) 3323(2) 275(4) 1509(2) 28(1) 
C(1) 1557(2) -817(5) 2991(2) 28(1) 
C(2) 989(2) -1579(6) 2552(3) 41(2) 
C(3) 313(2) -1586(6) 2891(3) 43(2) 
C(4) 186(2) -866(6) 3693(3) 41(2) 
C(5) 740(2) -154(6) 4153(3) 36(2) 
C(6) 1433(2) -125(5) 3820(3) 28(1) 
C(7) 2013(2) 603(6) 4340(2) 26(1) 
C(8) 2567(2) 1323(5) 5593(3) 34(1) 
C(9) 3057(2) 1633(5) 4831(3) 31(1) 
C(10) 3788(2) 847(6) 4963(3) 35(1) 
C(11) 4410(2) -924(5) 2800(3) 27(1) 
C(12) 5009(2) -1270(5) 3343(3) 31(1) 
C(13) 5664(2) -1458(5) 2996(3) 39(2) 
C(14) 5773(2) -1325(6) 2099(3) 41(2) 
C(15) 5206(2) -964(6) 1570(3) 39(2) 
C(16) 4513(2) -759(5) 1897(3) 30(1) 
C(17) 3931(2) -307(5) 1306(3) 31(1) 
C(18) 3389(2) -52(6) -19(3) 40(1) 
C(19) 2929(2) 705(7) 686(2) 35(1) 
C(20) 2167(2) 30(7) 678(3) 47(2) 
C(21) 3087(2) 3593(5) 2537(3) 33(1) 
C(22) 3172(3) 5323(6) 2326(3) 56(2) 
H(2) 1069 -2103 2008 49 
H(3) -67 -2089 2573 52 
H(3O) 3730(20) -1180(60) 4490(30) 42 
H(4) -281 -866 3923 49 
H(5) 653 329 4706 43 
H(6O) 2160(30) -1880(60) 1440(40) 63 
H(8A) 2761 450 5976 40 
H(8B) 2509 2322 5946 40 
H(9) 3116 2831 4747 37 
H(10A) 4096 1150 4470 42 
H(10B) 4014 1263 5511 42 
H(12) 4954 -1373 3958 37 
H(13) 6060 -1686 3375 46 
H(14) 6233 -1484 1865 49 
H(15) 5276 -845 959 47 
H(18A) 3157 -1029 -274 48 
H(18B) 3479 736 -494 48 
H(19) 2916 1913 614 42 
H(20A) 1885 615 1119 56 
H(20B) 1940 219 95 56 
H(22A) 2799 5954 2611 67 
H(22B) 3133 5474 1690 67 
H(22C) 3642 5697 2538 67 
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Table 17. Crystal data and structure refinement for [FeIII(8)2(OAc)]. 
 
Crystal Data    
Empirical formula  C26 H31 Fe N2 O8  
Formula weight  555.38  
Crystal size  0.070 x 0.060 x 0.030 mm  
Crystal description  flat prism  
Crystal colour  purple  
Crystal system Orthorhombic  
Space group  P 21 21 21  
Unit cell dimensions               a = 11.7914(3) A   alpha = 90 deg.  
                                         b = 12.0459(3) A    beta = 90 deg.  
                                         c = 36.3297(12) A   gamma = 90 deg.  
Volume  5160.2(3) A3  
Z, Calculated density  8,  1.430 Mg/m3  
Absorption coefficient  5.137 mm-1  
F(000)  2328 
Data Collection    
Measurement device type  Oxford Diffraction Gemini Ultra  
Measurement method  omega-scan  
Temperature  123 K  
Wavelength  1.54178 A  
Monochromator   graphite  
Theta range for data collection  3.87 to 51.45 deg.  
Index ranges  -9<=h<=11, -10<=k<=12, -35<=l<=36 
Reflections collected / unique  9296 / 4829 [R(int) = 0.0421]  
Reflections greater I>2\s(I) 3679 
Absorption correction  Semi-empirical from equivalents  
Max. and min. transmission  1.00000 and 0.82410  
Refinement    
Refinement method  Full-matrix least-squares on F2  
Hydrogen treatment  :  
Data / restraints / parameters  4829 / 0 / 677  
Goodness-of-fit on F^2  0.971  
Final R indices [I>2sigma(I)]      R1 = 0.0382, wR2 = 0.0766  
R indices (all data)               R1 = 0.0574, wR2 = 0.0830  
Absolute structure parameter  0.001(4)  
Largest diff. peak and hole  0.335 and -0.219 e.A-3  
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Table 18. Atomic coordinates (x104) and equivalent isotropic displacement parameters (A2x103). 
 
 x y z U(eq) 
Fe(1) 31(1) 5006(1) 417(1) 23(1) 
O(1) 1062(3) 4264(3) 731(1) 29(2) 
O(2) -1028(3) 1658(3) 374(1) 32(2) 
O(3) -3024(3) 4697(3) 608(1) 51(2) 
O(4) -1002(3) 5760(3) 732(1) 25(1) 
O(5) 1028(3) 8323(3) 292(1) 30(2) 
O(6) 3027(3) 5490(3) 713(1) 49(2) 
O(7) -814(3) 5398(3) -81(1) 25(1) 
O(8) 820(3) 4573(3) -92(1) 25(1) 
N(1) -910(4) 3510(4) 415(1) 22(2) 
N(2) 948(4) 6485(4) 399(1) 21(2) 
C(1) 1332(5) 3204(5) 788(2) 26(3) 
C(2) 2350(5) 2945(5) 968(1) 28(2) 
C(3) 2623(5) 1859(5) 1037(2) 34(2) 
C(4) 1940(6) 1012(5) 918(2) 48(3) 
C(5) 952(6) 1256(5) 739(2) 46(3) 
C(6) 620(5) 2339(4) 668(2) 29(2) 
C(7) -444(5) 2564(5) 485(2) 23(2) 
C(8) -1952(5) 2069(5) 143(2) 33(3) 
C(9) -2054(5) 3295(4) 252(2) 25(2) 
C(10) -3029(5) 3542(5) 526(2) 32(2) 
C(11) -2890(5) 2882(6) 874(2) 48(3) 
C(12) -4163(5) 3347(5) 343(2) 36(3) 
C(13) -1311(5) 6822(5) 742(2) 25(2) 
C(14) -2293(5) 7121(5) 929(1) 26(2) 
C(15) -2657(5) 8217(5) 939(2) 38(2) 
C(16) -2038(5) 9024(5) 754(2) 37(3) 
C(17) -1070(5) 8765(5) 582(2) 32(2) 
C(18) -653(5) 7671(4) 571(2) 23(2) 
C(19) 446(5) 7442(5) 421(2) 26(2) 
C(20) 2019(5) 7860(4) 106(2) 29(2) 
C(21) 2143(5) 6703(4) 269(2) 26(2) 
C(22) 3005(5) 6595(4) 585(2) 29(2) 
C(23) 4201(5) 6795(5) 440(2) 38(2) 
C(24) 2730(5) 7396(5) 899(2) 39(2) 
C(25) -9(6) 4969(4) -265(1) 22(2) 
C(26) -66(5) 4944(5) -673(1) 37(2) 
Fe(2) 2481(1) 7918(1) 2046(1) 25(1) 
O(9) 1449(3) 7184(3) 1733(1) 28(1) 
O(10) 3535(3) 4628(3) 2144(1) 30(2) 
O(11) 5431(3) 7427(3) 1672(1) 44(2) 
O(12) 3461(3) 8739(3) 1732(1) 28(1) 
O(13) 1449(3) 11211(3) 2232(1) 34(2) 
O(14) -591(3) 8261(3) 1845(1) 54(2) 
O(15) 1733(3) 7451(3) 2551(1) 27(1) 
O(16) 3338(3) 8337(3) 2550(1) 26(1) 
N(3) 3445(4) 6460(4) 2031(1) 24(2) 
N(4) 1527(4) 9383(4) 2104(1) 26(2) 
C(27) 1169(5) 6110(5) 1714(1) 22(2) 
C(28) 158(5) 5816(5) 1539(1) 26(2) 
C(29) -168(5) 4737(5) 1508(2) 32(2) 
C(30) 471(6) 3894(5) 1663(2) 36(3) 
C(31) 1452(6) 4159(5) 1837(2) 35(3) 
C(32) 1849(5) 5260(4) 1860(2) 25(2) 
C(33) 2936(5) 5491(5) 2012(2) 23(2) 
C(34) 4528(5) 5106(5) 2328(2) 34(2) 
C(35) 4637(5) 6263(4) 2152(2) 27(2) 
C(36) 5472(5) 6327(5) 1827(2) 34(3) 
C(37) 5210(6) 5485(5) 1532(2) 49(3) 
C(38) 6688(5) 6197(5) 1971(2) 47(3) 
C(39) 3817(5) 9783(5) 1773(2) 28(3) 
C(40) 4861(5) 10080(5) 1625(1) 28(2) 
C(41) 5248(5) 11148(5) 1662(2) 37(2) 
C(42) 4616(6) 11958(5) 1847(2) 36(3) 
C(43) 3592(6) 11668(5) 1990(2) 34(3) 
C(44) 3151(5) 10597(5) 1957(2) 25(2) 
C(45) 2030(5) 10339(5) 2094(2) 29(3) 
C(46) 453(5) 10753(5) 2407(2) 34(3) 
C(47) 352(5) 9570(4) 2251(2) 28(2) 
C(48) -553(5) 9405(5) 1946(2) 33(2) 
C(49) -1711(5) 9614(5) 2110(2) 41(3) 
C(50) -336(5) 10130(6) 1618(2) 49(3) 
C(51) 2521(6) 7918(4) 2728(2) 24(2) 
C(52) 2451(5) 8010(5) 3134(2) 36(2) 
H(2A) 2850 3522 1043 34 
H(3) -2407 4867 709 62 
H(3A) 3296 1691 1169 41 
H(4A) 2153 261 959 58 
H(5A) 477 664 661 55 
H(6) 2387 5321 798 58 
H(8A) -2665 1665 194 40 
H(8B) -1764 1992 -122 40 
H(9) -2153 3758 26 30 
H(11A) -2161 3065 989 57 
H(11B) -2912 2087 817 57 
H(11C) -3507 3063 1045 57 
H(12A) -4774 3537 514 43 
H(12B) -4228 2565 272 43 
H(12C) -4222 3815 123 43 
H(14A) -2723 6566 1051 32 
H(15A) -3323 8412 1071 46 
H(16A) -2305 9768 750 44 
H(17A) -652 9336 463 39 
H(20A) 2702 8314 155 35 
H(20B) 1894 7822 -164 35 
H(21) 2342 6166 69 32 
H(23A) 4750 6673 638 46 
H(23B) 4265 7560 350 46 
H(23C) 4358 6279 237 46 
H(24A) 1988 7209 1003 47 
H(24B) 2712 8158 804 47 
H(24C) 3312 7335 1090 47 
H(26A) 622 4596 -770 45 
H(26B) -127 5703 -767 45 
H(26C) -731 4514 -750 45 
H(11) 4780 7548 1587 53 
H(14) 29 8077 1749 64 
H(28A) -312 6381 1439 31 
H(29A) -844 4560 1378 39 
H(30A) 227 3144 1647 43 
H(31A) 1885 3584 1948 42 
H(34A) 5215 4654 2282 40 
H(34B) 4404 5163 2597 40 
H(35) 4852 6820 2344 33 
H(37A) 4430 5589 1446 59 
H(37B) 5296 4736 1633 59 
H(37C) 5735 5584 1325 59 
H(38A) 7227 6364 1774 57 
H(38B) 6804 5433 2056 57 
H(38C) 6810 6711 2177 57 
H(40A) 5305 9544 1499 33 
H(41A) 5962 11342 1559 45 
H(42A) 4896 12694 1871 44 
H(43A) 3161 12214 2116 40 
H(46A) -228 11196 2346 41 
H(46B) 547 10735 2678 41 
H(47) 203 9038 2457 34 
H(49A) -2296 9439 1928 50 
H(49B) -1774 10396 2182 50 
H(49C) -1814 9142 2327 50 
H(50A) 362 9890 1495 59 
H(50B) -254 10903 1698 59 
H(50C) -974 10072 1446 59 
H(52A) 3204 8175 3234 43 
H(52B) 2177 7307 3237 43 
H(52C) 1926 8608 3200 43 
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Table 19. Crystal data and structure refinement for [FeIII(9)2]2. 
 
Crystal Data   
Empirical formula  C48 H54 Fe2 N4 O12 
Formula weight  990.65 
Crystal size  0.050 x 0.020 x 0.020 mm 
Crystal description  prism 
Crystal colour  ruby-coloured 
Crystal system Monoclinic 
Space group  P 21 
Unit cell dimensions               a = 13.9286(2) A   alpha = 90 deg. 
                                         b = 24.2175(3) A    beta = 92.3362(12) deg. 
                                         c = 14.2035(2) A   gamma = 90 deg. 
Volume  4787.08(11) A3 
Z, Calculated density  4,  1.375 Mg/m3 
Absorption coefficient  5.405 mm-1 
F(000)  2072 
Data Collection   
Measurement device type  Oxford Diffraction Gemini Ultra 
Measurement method  omega-scan 
Temperature  123 K 
Wavelength  1.54184 A 
Monochromator  graphite 
Theta range for data collection  3.11 to 51.59 deg. 
Index ranges  -14<=h<=14, -24<=k<=24, 0<=l<=14 
Reflections collected / unique  8533 / 8533 [R(int) = 0.0000] 
Reflections greater I>2\s(I) 5626 
Absorption correction  Semi-empirical from equivalents 
Max. and min. transmission  1.00000 and 0.76099 
Refinement   
Refinement method  Full-matrix least-squares on F2 
Hydrogen treatment  : 
Data / restraints / parameters  8533 / 1 / 1219 
Goodness-of-fit on F^2  0.966 
Final R indices [I>2sigma(I)]      R1 = 0.0484, wR2 = 0.1088 
R indices (all data)               R1 = 0.0764, wR2 = 0.1162 
Absolute structure parameter  -0.012(5) 
Largest diff. peak and hole  1.185 and -0.657 e.A-3 
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Table 20. Atomic coordinates (x104) and equivalent isotropic displacement parameters (A2x103). 
 
 x y z U(eq) 
Fe(1) 6034(1) 8438(1) 9967(1) 31(1) 
Fe(2) 7895(1) 8359(1) 8757(1) 32(1) 
O(1) 5866(1) 8679(1) 11274(1) 29(1) 
O(2) 5139(2) 10079(1) 9608(2) 46(1) 
O(3) 6457(1) 8514(1) 8624(1) 36(1) 
O(4) 4665(1) 8293(1) 9742(1) 36(1) 
O(5) 5732(1) 7012(1) 11506(2) 46(1) 
O(6) 7456(1) 8255(1) 10076(1) 29(1) 
O(7) 9176(1) 8090(1) 9026(1) 35(1) 
O(8) 7880(1) 6690(1) 7751(1) 41(1) 
O(10) 8119(2) 8630(1) 7492(1) 43(1) 
O(11) 8859(1) 10031(1) 9133(1) 39(1) 
O(12) 10302(2) 8952(1) 9919(2) 58(1) 
O(39) 7557(3) 7707(2) 6247(3) 55(1) 
N(1) 5943(2) 9273(1) 9696(2) 34(1) 
N(2) 6075(2) 7603(1) 10362(2) 29(1) 
N(3) 7602(2) 7570(1) 8215(2) 31(1) 
N(4) 8385(2) 9148(1) 9213(2) 34(1) 
C(1) 5386(2) 9097(1) 11589(2) 36(1) 
C(2) 5079(2) 9076(1) 12530(2) 28(1) 
C(3) 4624(2) 9500(1) 12932(2) 37(1) 
C(4) 4429(2) 9999(1) 12430(2) 39(1) 
C(5) 4703(2) 10019(1) 11519(2) 39(1) 
C(6) 5164(2) 9583(1) 11092(2) 25(1) 
C(7) 5441(2) 9629(1) 10101(2) 29(1) 
C(8) 5342(2) 9941(1) 8616(2) 41(1) 
C(9) 6052(2) 9467(1) 8720(2) 35(1) 
C(10) 5997(3) 8959(2) 8121(2) 53(1) 
C(11) 5831(3) 10456(2) 8232(3) 95(2) 
C(12) 4413(3) 9802(2) 8122(3) 76(2) 
C(13) 4110(2) 8010(1) 10289(2) 29(1) 
C(14) 3135(2) 8160(1) 10323(2) 37(1) 
C(15) 2535(2) 7881(2) 10891(2) 58(1) 
C(16) 2845(3) 7458(2) 11463(2) 59(1) 
C(17) 3779(2) 7281(2) 11435(2) 48(1) 
C(18) 4425(2) 7571(1) 10851(2) 37(1) 
C(19) 5430(2) 7400(1) 10890(2) 32(1) 
C(20) 6800(2) 6957(1) 11448(2) 40(1) 
C(21) 7025(2) 7375(1) 10609(2) 38(1) 
C(22) 7709(2) 7847(1) 10772(2) 32(1) 
C(23) 7238(2) 7124(2) 12399(2) 55(1) 
C(24) 7007(3) 6358(2) 11230(3) 69(2) 
C(25) 9641(2) 7624(1) 8906(2) 34(1) 
C(26) 10609(2) 7584(1) 9163(2) 31(1) 
C(27) 11128(2) 7104(1) 9070(2) 37(1) 
C(28) 10665(2) 6626(1) 8698(2) 40(1) 
C(29) 9713(2) 6661(1) 8466(2) 37(1) 
C(30) 9190(2) 7145(1) 8525(2) 26(1) 
C(31) 8216(2) 7157(1) 8173(2) 29(1) 
C(32) 6827(2) 6770(1) 7542(3) 48(1) 
C(33) 6710(2) 7397(1) 7675(2) 46(1) 
C(34A) 6607(2) 7752(2) 6771(2) 50(1) 
C(35) 6301(2) 6458(2) 8287(2) 59(1) 
C(36) 6626(2) 6534(1) 6529(2) 51(1) 
C(37) 8219(2) 9129(1) 7149(2) 43(1) 
C(38) 8155(2) 9185(2) 6140(2) 54(2) 
C(39) 8251(2) 9700(2) 5751(2) 55(1) 
C(40) 8424(2) 10180(2) 6278(2) 45(1) 
C(41) 8499(2) 10116(2) 7227(2) 45(1) 
C(42) 8420(2) 9609(1) 7679(2) 33(1) 
C(43) 8566(2) 9568(1) 8694(2) 34(1) 
C(44) 8814(2) 9936(1) 10174(2) 49(1) 
C(45) 8688(3) 9290(1) 10205(2) 52(1) 
C(46) 9571(2) 8959(1) 10535(2) 54(2) 
C(47) 7933(2) 10233(2) 10495(2) 52(1) 
C(48) 9768(2) 10145(2) 10603(2) 53(1) 
O(9) 5543(4) 7646(2) 6409(4) 55(1) 
C(34) 6607(2) 7752(2) 6771(2) 50(1) 
Fe(3) 1074(1) 7931(1) 4349(1) 35(1) 
Fe(4) 2967(1) 8067(1) 5680(1) 36(1) 
O(13) 865(1) 7709(1) 3025(1) 41(1) 
O(14) 340(1) 6263(1) 4554(1) 38(1) 
O(15) 1567(1) 7832(1) 5717(1) 39(1) 
O(16) -286(1) 8041(1) 4596(1) 43(1) 
O(17) 497(1) 9447(1) 3056(2) 48(1) 
O(18) 2478(1) 8172(1) 4329(1) 31(1) 
O(19) 4222(1) 8424(1) 5592(1) 36(1) 
O(20) 2512(2) 9767(1) 6358(2) 50(1) 
O(21) 2528(3) 8743(2) 8081(3) 71(1) 
O(22) 3284(2) 7756(1) 6917(1) 45(1) 
O(23) 4134(2) 6466(1) 5156(1) 42(1) 
O(24) 5498(2) 7593(1) 4571(2) 72(1) 
N(5) 1049(2) 7091(1) 4568(2) 30(1) 
N(6) 1005(2) 8760(1) 4032(2) 33(1) 
N(7) 2505(2) 8840(1) 6170(2) 32(1) 
N(8) 3584(2) 7325(1) 5155(2) 31(1) 
C(51) 478(2) 7268(1) 2627(2) 35(1) 
C(52) 222(2) 7290(1) 1663(2) 29(1) 
C(53) -132(2) 6834(1) 1190(2) 44(1) 
C(54) -279(2) 6348(1) 1660(2) 37(1) 
C(55) -64(2) 6309(2) 2619(2) 40(1) 
C(56) 336(2) 6775(1) 3103(2) 24(1) 
C(57) 581(2) 6733(1) 4091(2) 34(1) 
C(58) 454(2) 6417(1) 5598(2) 39(1) 
C(59) 1191(2) 6880(1) 5552(2) 41(1) 
C(60) 1141(2) 7387(1) 6184(2) 46(1) 
C(61) -555(2) 6599(2) 5879(2) 51(1) 
C(62) 805(3) 5896(2) 6126(2) 55(2) 
C(63) -909(2) 8323(1) 4139(2) 41(1) 
C(64) -1903(2) 8190(2) 4144(2) 50(1) 
C(65) -2560(2) 8507(2) 3643(2) 62(2) 
C(66) -2373(2) 8965(2) 3146(3) 56(1) 
C(67) -1434(2) 9113(2) 3129(2) 53(1) 
C(68) -699(2) 8814(2) 3606(3) 52(2) 
C(69) 284(2) 9006(2) 3588(2) 44(1) 
C(70) 1569(2) 9470(1) 3028(2) 40(1) 
C(71) 1877(2) 9057(1) 3833(2) 35(1) 
C(72) 2635(2) 8621(1) 3664(2) 35(1) 
C(73) 1839(2) 10051(1) 3234(3) 62(1) 
C(74) 1830(2) 9283(2) 2077(2) 54(1) 
C(75) 4494(2) 8927(1) 5514(2) 26(1) 
C(76) 5434(2) 9062(2) 5243(2) 45(1) 
C(77) 5749(2) 9603(1) 5103(2) 38(1) 
C(78) 5135(2) 10030(2) 5214(2) 46(1) 
C(79) 4221(2) 9936(1) 5514(2) 38(1) 
C(80) 3918(2) 9394(1) 5669(2) 27(1) 
C(81) 2959(2) 9303(1) 6065(2) 35(1) 
C(82) 1551(2) 9595(1) 6683(2) 42(1) 
C(83) 1605(2) 8957(1) 6664(2) 39(1) 
C(84) 1613(2) 8650(2) 7595(2) 49(1) 
C(85) 801(2) 9837(2) 5981(2) 60(2) 
C(86) 1464(2) 9870(2) 7632(2) 58(2) 
C(87) 3465(2) 7247(1) 7220(2) 45(1) 
C(88) 3451(2) 7149(2) 8198(2) 45(1) 
C(89) 3567(2) 6633(2) 8557(2) 58(1) 
C(90) 3711(2) 6196(2) 7958(2) 59(2) 
C(91) 3779(2) 6283(2) 6992(2) 47(1) 
C(92) 3679(2) 6810(1) 6632(2) 33(1) 
C(93) 3782(2) 6889(1) 5616(2) 25(1) 
C(94) 4082(2) 6615(1) 4132(2) 32(1) 
C(95) 3860(2) 7244(1) 4158(2) 35(1) 
C(96) 4712(2) 7637(1) 3947(2) 47(1) 
C(97) 3270(2) 6303(1) 3718(2) 42(1) 
C(98) 5050(2) 6444(1) 3755(2) 38(1) 
O(41) 554(4) 8730(2) 7862(4) 71(1) 
C(84A) 1613(2) 8650(2) 7595(2) 49(1) 
H(9) 6714 9624 8680 42 
H(3) 4429 9466 13562 44 
H(4) 4123 10303 12715 47 
H(5) 4573 10344 11163 47 
H(10A) 5317 8865 7968 64 
H(10B) 6321 9025 7523 64 
H(2) 5200 8750 12889 33 
H(39) 8196 9732 5085 66 
H(11C) 6478 10491 8525 114 
H(12) 10765 9140 10141 70 
H(12A) 4132 9478 8419 91 
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H(12B) 4522 9721 7459 91 
H(12C) 3972 10116 8163 91 
H(14) 2894 8458 9948 44 
H(15) 1878 7985 10888 70 
H(16) 2416 7287 11877 71 
H(17) 3993 6971 11797 57 
H(21) 7243 7155 10062 45 
H(22A) 7649 8000 11414 38 
H(22B) 8380 7722 10704 38 
H(23A) 6961 7477 12592 65 
H(11A) 5453 10784 8380 114 
H(11B) 5876 10423 7548 114 
H(24A) 6684 6121 11677 82 
H(24B) 7702 6293 11284 82 
H(24C) 6770 6273 10587 82 
H(26) 10929 7901 9413 38 
H(27) 11791 7094 9255 44 
H(28) 11009 6292 8614 48 
H(29) 9387 6337 8253 45 
H(33) 6144 7467 8070 55 
H(34C) 6481 8142 6937 60 
H(34D) 6063 7617 6364 60 
H(35A) 6472 6066 8262 71 
H(35B) 5607 6499 8171 71 
H(35C) 6485 6606 8911 71 
H(36A) 6923 6774 6068 61 
H(36B) 5931 6518 6394 61 
H(36C) 6897 6162 6490 61 
H(38) 8049 8871 5749 65 
H(39) 8018 7804 6609 66 
H(40) 8486 10531 5988 54 
H(41) 8612 10435 7604 54 
H(45) 8149 9200 10623 62 
H(46A) 9820 9113 11142 65 
H(46B) 9371 8573 10651 65 
H(47A) 7948 10618 10285 62 
H(47B) 7923 10221 11185 62 
H(47C) 7356 10052 10226 62 
H(48A) 10298 9985 10260 64 
H(48B) 9829 10034 11266 64 
H(48C) 9791 10548 10557 64 
H(23B) 7935 7165 12354 65 
H(23C) 7102 6840 12865 65 
H(9) 5433 7821 5906 66 
H(34A) 7067 7633 6299 60 
H(34B) 6714 8148 6915 60 
H(21A) 2765 8440 8255 85 
H(53) -275 6855 531 52 
H(54) -530 6037 1326 45 
H(55) -182 5976 2948 48 
H(59) 1849 6717 5627 49 
H(60A) 463 7475 6309 55 
H(24) 5389 7768 5067 86 
H(52) 295 7626 1330 35 
H(61B) -528 6721 6537 61 
H(61C) -1001 6288 5804 61 
H(62A) 314 5607 6061 66 
H(62B) 922 5982 6795 66 
H(62C) 1402 5765 5860 66 
H(64) -2112 7881 4494 60 
H(65) -3212 8392 3647 74 
H(66) -2866 9172 2827 67 
H(67) -1267 9431 2780 64 
H(71) 2083 9274 4405 42 
H(72A) 2572 8483 3008 42 
H(72B) 3286 8778 3771 42 
H(73A) 1460 10297 2817 74 
H(60B) 1489 7317 6794 55 
H(61A) -777 6905 5473 61 
H(74A) 1580 8909 1964 65 
H(74B) 2531 9280 2039 65 
H(74C) 1551 9535 1600 65 
H(76) 5874 8769 5152 54 
H(77) 6390 9670 4930 46 
H(78) 5336 10396 5086 55 
H(79) 3800 10237 5614 46 
H(83) 1052 8818 6261 47 
H(84A) 1086 8786 7981 59 
H(84B) 1516 8250 7482 59 
H(85A) 922 10233 5901 72 
H(85B) 158 9783 6219 72 
H(85C) 845 9650 5372 72 
H(86A) 1979 9738 8065 70 
H(86B) 840 9778 7886 70 
H(86C) 1515 10271 7559 70 
H(88) 3357 7450 8613 54 
H(89) 3550 6574 9217 69 
H(90) 3764 5832 8204 71 
H(91) 3894 5981 6584 56 
H(95) 3299 7329 3720 41 
H(96A) 4923 7558 3304 56 
H(96B) 4476 8022 3954 56 
H(97A) 3367 5908 3841 50 
H(97B) 3223 6367 3037 50 
H(97C) 2675 6424 4000 50 
H(98A) 5570 6617 4135 46 
H(98B) 5085 6563 3098 46 
H(98C) 5115 6041 3791 46 
H(73B) 2524 10103 3129 74 
H(73C) 1711 10136 3892 74 
H(41A) 230 8848 7392 85 
H(84C) 2066 8818 8067 59 
H(84D) 1773 8255 7517 59 
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Table 21. Crystal data and structure refinement for [ZnII(7a)2]2•(ClO4)2. 
 
Crystal Data    
Empirical formula  2(C20 H21 N2 O6 Zn), 3(C4 H8 O), 2(Cl O4)  
Formula weight  1317.34  
Crystal size  0.28 x 0.20 x 0.14 mm  
Crystal description  prism  
Crystal colour  colourless  
Crystal system Monoclinic  
Space group  P 21  
Unit cell dimensions               a = 9.7188(3) A   alpha = 90 deg.  
                                         b = 22.5542(5) A    beta = 101.576(4) deg.  
                                         c = 13.3670(6) A   gamma = 90 deg.  
Volume  2870.44(17) A3  
Z, Calculated density  2,  1.524 Mg/m3 
Absorption coefficient  2.611 mm-1  
F(000)  1369 
Data Collection    
Measurement device type  Oxford Diffraction Gemini Ultra  
Measurement method  omega-scan  
Temperature  150 K  
Wavelength  1.54178 A  
Monochromator   graphite  
Theta range for data collection  3.90 to 58.93 deg.  
Index ranges  -5<=h<=10, -25<=k<=24, -14<=l<=14 
Reflections collected / unique  11212 / 6836 [R(int) = 0.0347]  
Reflections greater I>2\s(I) 5597 
Absorption correction  Semi-empirical from equivalents  
Max. and min. transmission  1.00000 and 0.41459  
Refinement    
Refinement method  Full-matrix least-squares on F2  
Hydrogen treatment  :  
Data / restraints / parameters  6836 / 1 / 757  
Goodness-of-fit on F^2  0.957  
Final R indices [I>2sigma(I)]      R1 = 0.0450, wR2 = 0.1076  
R indices (all data)               R1 = 0.0544, wR2 = 0.1113  
Absolute structure parameter  0.00(2)  
Largest diff. peak and hole  0.644 and -0.553 e.A-3  
 
Experimental Part 
 
212 
Table 22. Atomic coordinates (x104) and equivalent isotropic displacement parameters (A2x103).
    x y z U(eq) 
Zn(1) 5585(1) 9300(1) 6864(1) 33(1) 
O(1) 7773(3) 9285(2) 7483(3) 33(1) 
O(2) 6857(4) 10964(2) 6099(3) 46(1) 
O(3) 3480(4) 9624(2) 6087(3) 39(1) 
O(4) 4929(3) 9178(2) 8200(3) 35(1) 
O(5) 4118(4) 7582(2) 6490(3) 47(1) 
O(6) 5995(4) 9106(2) 5136(3) 41(1) 
N(1) 5899(4) 10153(2) 6653(4) 32(2) 
N(2) 5264(4) 8444(2) 6599(4) 33(2) 
C(1) 8801(5) 9677(3) 7366(4) 34(2) 
C(2) 10204(5) 9504(3) 7702(4) 34(2) 
C(3) 11265(6) 9892(3) 7579(5) 43(2) 
C(4) 10978(6) 10438(3) 7122(5) 46(2) 
C(5) 9572(6) 10605(3) 6777(4) 37(2) 
C(6) 8477(5) 10224(2) 6896(4) 31(2) 
C(7) 7034(6) 10428(3) 6564(4) 34(2) 
C(8) 5334(6) 11037(3) 5722(6) 55(2) 
C(9) 4680(6) 10537(3) 6254(5) 38(2) 
C(10) 3610(6) 10166(3) 5550(5) 42(2) 
C(11) 4108(5) 8750(2) 8433(4) 35(2) 
C(12) 3476(6) 8818(3) 9275(5) 40(2) 
C(13) 2574(7) 8397(3) 9527(5) 46(2) 
C(14) 2246(7) 7900(3) 8949(6) 54(3) 
C(15) 2880(6) 7800(3) 8104(5) 50(2) 
C(16) 3803(6) 8230(3) 7838(5) 36(2) 
C(17) 4444(6) 8103(3) 6971(4) 36(2) 
C(18) 4826(7) 7567(3) 5641(5) 45(2) 
C(19) 5662(6) 8144(3) 5718(4) 38(2) 
C(20) 5320(6) 8551(3) 4808(4) 39(2) 
Zn(2) 8255(1) 9159(1) 10207(1) 41(1) 
O(7) 6536(4) 9730(2) 9519(3) 41(1) 
O(8) 10098(5) 10816(2) 10240(4) 56(2) 
O(9) 10357(4) 8903(2) 11012(4) 55(2) 
O(10) 8352(4) 8638(2) 8972(3) 39(1) 
O(11) 5867(5) 7716(2) 10748(3) 60(2) 
O(12) 8108(5) 9403(2) 11928(4) 62(2) 
N(3) 9369(5) 9884(2) 10081(4) 36(2) 
N(4) 6966(5) 8567(2) 10600(4) 37(2) 
C(21) 6444(6) 10335(3) 9432(4) 37(2) 
C(22) 5136(7) 10598(3) 9104(5) 47(2) 
C(23) 5027(8) 11206(3) 9030(6) 64(3) 
C(24) 6196(8) 11557(3) 9345(7) 70(3) 
C(25) 7496(8) 11304(3) 9667(6) 58(3) 
C(26) 7628(6) 10687(3) 9705(5) 41(2) 
C(27) 9042(6) 10432(3) 10014(4) 39(2) 
C(28) 11370(7) 10481(3) 10597(6) 59(3) 
C(29) 10907(6) 9834(3) 10401(5) 46(2) 
C(30) 11218(7) 9434(3) 11310(5) 53(2) 
C(31) 7934(6) 8079(3) 8787(4) 37(2) 
C(32) 8286(6) 7783(3) 7946(5) 49(2) 
C(33) 7835(8) 7210(3) 7720(6) 62(3) 
C(34) 7000(8) 6908(3) 8279(6) 67(3) 
C(35) 6644(7) 7190(3) 9097(5) 52(2) 
C(36) 7090(6) 7770(3) 9376(5) 39(2) 
C(37) 6667(6) 8041(3) 10236(5) 41(2) 
C(38) 5651(8) 8070(4) 11629(6) 73(3) 
C(39) 6304(7) 8672(3) 11464(5) 55(3) 
C(40) 7386(7) 8916(3) 12329(5) 60(3) 
O(54) 520(10) 8027(5) 2304(8) 69(3) 
C(50) 2039(13) 7870(5) 2878(8) 109(4) 
C(51) 1853(19) 7327(7) 2936(16) 232(9) 
C(52) 730(12) 7028(4) 2225(9) 102(4) 
C(53) 146(13) 7511(4) 1625(10) 127(5) 
C(51A) 1853(19) 7327(7) 2936(16) 232(9) 
O(55) 1381(11) 7922(5) 1756(9) 69(3) 
C(50A) 2039(13) 7870(5) 2878(8) 109(4) 
C(52A) 730(12) 7028(4) 2225(9) 102(4) 
C(53A) 146(13) 7511(4) 1625(10) 127(5) 
O(13) 1741(4) 8843(2) 4939(3) 49(2) 
C(41) 787(6) 9191(4) 4222(5) 53(2) 
C(42) -404(6) 9327(3) 4755(5) 51(2) 
C(43) -548(6) 8730(3) 5255(5) 49(2) 
C(44) 922(7) 8520(3) 5564(5) 56(2) 
O(14) 8428(7) 600(2) 2302(5) 82(2) 
C(45) 7466(11) 1069(5) 2406(8) 98(4) 
C(46) 7941(15) 1276(5) 3494(7) 121(6) 
C(47) 9253(13) 981(7) 3897(8) 125(5) 
C(48) 9684(10) 741(5) 2985(9) 98(4) 
Cl(2) 2290(3) 2063(1) 5845(2) 92(1) 
O(21) 3940(15) 2304(5) 6214(9) 74(5) 
O(22) 2431(11) 1646(5) 6596(9) 142(6) 
O(24) 2467(10) 1607(5) 5054(8) 92(5) 
O(25) 1850(16) 2569(7) 6451(12) 125(8) 
O(27) 1823(16) 2257(8) 4830(13) 154(9) 
O(23) 3054(16) 2448(7) 5900(10) 64(7) 
O(26) 692(14) 2122(7) 5724(11) 91(7) 
Cl(1) 4522(2) 9955(1) 2853(1) 60(1) 
O(15) 3534(8) 10385(4) 2971(4) 124(4) 
O(16) 4727(6) 9985(3) 1831(4) 77(2) 
O(17) 4015(6) 9394(3) 3030(5) 110(3) 
O(18) 5814(5) 10029(3) 3573(4) 75(2) 
H(1) 8065 9069 7993 40 
H(2) 10424 9126 8009 41 
H(3) 12216 9779 7816 52 
H(3O) 3072 9369 5675 46 
H(4) 11720 10697 7042 55 
H(5) 9361 10980 6459 44 
H(6O) 5919 9337 4635 49 
H(8A) 5088 10993 4970 66 
H(8B) 5013 11430 5912 66 
H(9) 4271 10699 6827 45 
H(10A) 2696 10374 5386 51 
H(10B) 3929 10083 4905 51 
H(12) 3673 9163 9687 48 
H(13) 2174 8454 10112 56 
H(14) 1592 7622 9115 65 
H(15) 2690 7445 7716 59 
H(18A) 4140 7546 4986 54 
H(18B) 5461 7220 5692 54 
H(19) 6691 8055 5872 46 
H(20A) 5685 8387 4225 47 
H(20B) 4292 8605 4596 47 
H(7) 5979 9573 9029 49 
H(9O) 9861 8836 11447 66 
H(12O) 7565 9696 11805 74 
H(22) 4319 10358 8933 56 
H(23) 4144 11384 8761 76 
H(24) 6101 11976 9339 84 
H(25) 8303 11548 9862 70 
H(28A) 11738 10552 11333 71 
H(28B) 12103 10587 10211 71 
H(29) 11316 9666 9833 55 
H(30A) 12228 9330 11476 63 
H(30B) 10960 9626 11912 63 
H(32) 8837 7978 7533 59 
H(33) 8105 7014 7160 74 
H(34) 6685 6517 8100 79 
H(35) 6077 6988 9489 63 
H(38A) 6132 7887 12279 87 
H(38B) 4639 8110 11635 87 
H(39) 5536 8970 11267 66 
H(40A) 6928 9062 12880 71 
H(40B) 8067 8603 12613 71 
H(50A) 2757 7968 2474 130 
H(53A) -886 7469 1416 152 
H(53B) 554 7547 1006 152 
H(50B) 2281 8060 3559 130 
H(51A) 1703 7245 3633 280 
H(51B) 2745 7131 2876 280 
H(52A) 1104 6725 1814 122 
H(52B) 42 6842 2583 122 
H(50C) 3045 7980 3028 130 
H(50D) 1526 8101 3317 130 
H(51C) 1703 7245 3633 280 
H(51D) 2745 7131 2876 280 
H(52C) 1104 6725 1814 122 
H(52D) 42 6842 2583 122 
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H(53C) -645 7689 1885 152 
H(53D) -178 7395 901 152 
H(41A) 447 8967 3584 63 
H(41B) 1242 9561 4055 63 
H(42A) -1272 9437 4265 61 
H(42B) -155 9646 5268 61 
H(43A) -992 8774 5855 59 
H(43B) -1113 8451 4765 59 
H(44A) 1284 8602 6298 67 
H(44B) 976 8088 5449 67 
H(45A) 6489 920 2287 118 
H(45B) 7524 1394 1919 118 
H(46A) 8073 1711 3515 145 
H(46B) 7231 1173 3903 145 
H(47A) 9120 659 4373 150 
H(47B) 9958 1264 4260 150 
H(48A) 10272 383 3159 118 
H(48B) 10226 1040 2682 118 
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Table 23. Crystal data and structure refinement for [ZnII(9)2]2•(ClO4)2. 
 
Crystal Data    
Empirical formula  C24 H30 N2 O6 Zn, C24 H28 N2 O6 Zn, 2(Cl O4), 3(H2 O)  
Formula weight  1266.67  
Crystal size  0.19 x 0.17 x 0.08 mm  
Crystal description  flat rod  
Crystal colour  colourless  
Crystal system Orthorhombic  
Space group  P 21 21 21  
Unit cell dimensions               a = 14.0574(2) A   alpha = 90 deg.  
                                         b = 18.0606(3) A    beta = 90 deg.  
                                         c = 22.0306(2) A   gamma = 90 deg.  
Volume  5593.24(13) A3  
Z, Calculated density  4,  1.504 Mg/m3  
Absorption coefficient  2.653 mm-1  
F(000)  2632 
Data Collection    
Measurement device type  Oxford Diffraction Gemini Ultra  
Measurement method  omega-scan  
Temperature  150 K  
Wavelength  1.54184 A  
Monochromator   graphite  
Theta range for data collection  3.16 to 62.24 deg.  
Index ranges  -16<=h<=15, -20<=k<=18, -25<=l<=25 
Reflections collected / unique  24916 / 8633 [R(int) = 0.0395]  
Reflections greater I>2\s(I) 6409 
Absorption correction  Semi-empirical from equivalents  
Max. and min. transmission  1.00000 and 0.71596  
Refinement    
Refinement method  Full-matrix least-squares on F2  
Hydrogen treatment  :  
Data / restraints / parameters  8633 / 2 / 711  
Goodness-of-fit on F^2  0.965  
Final R indices [I>2sigma(I)]      R1 = 0.0478, wR2 = 0.1152  
R indices (all data)               R1 = 0.0642, wR2 = 0.1211  
Absolute structure parameter  -0.01(2)  
Largest diff. peak and hole  1.371 and -0.406 e.A^3  
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Table 24. Atomic coordinates (x104) and equivalent isotropic displacement parameters (A2x103).
 x y z U(eq) 
Zn(2) 1074(1) 7500(1) 1461(1) 30(1) 
O(7) 449(3) 8510(2) 1180(2) 29(1) 
O(8) 351(3) 7083(2) -343(2) 32(1) 
O(9) 1607(3) 6335(2) 1430(2) 53(2) 
O(10) 2436(3) 7947(2) 1524(2) 31(1) 
O(11) 1768(3) 7179(2) 3263(2) 37(1) 
O(12) -374(3) 7013(3) 1753(2) 39(1) 
N(3) 1162(3) 7488(3) 2368(2) 25(1) 
N(4) 915(3) 7212(2) 589(2) 28(2) 
C(25) 6(4) 8703(3) 661(2) 27(2) 
C(26) -443(4) 9381(3) 620(3) 36(2) 
C(27) -895(4) 9603(4) 84(3) 41(2) 
C(28) -903(4) 9137(3) -409(3) 38(2) 
C(29) -477(4) 8454(3) -379(2) 30(2) 
C(30) -16(4) 8221(3) 150(2) 25(2) 
C(31) 434(3) 7499(3) 155(2) 24(2) 
C(32) 1298(4) 6493(3) 391(2) 32(2) 
C(33) 724(4) 6323(3) -191(3) 33(2) 
C(34) 1226(5) 5963(4) 916(3) 48(3) 
C(35) -120(4) 5828(4) -97(3) 38(2) 
C(36) 1335(5) 6099(4) -724(3) 46(2) 
C(37) 3119(4) 7798(3) 1928(2) 24(2) 
C(38) 4068(4) 7897(3) 1773(2) 34(2) 
C(39) 4778(4) 7739(3) 2180(3) 36(2) 
C(40) 4564(4) 7486(4) 2753(2) 35(2) 
C(41) 3629(4) 7377(3) 2918(2) 33(2) 
C(42) 2888(3) 7535(3) 2512(2) 25(2) 
C(43) 1898(4) 7408(3) 2701(2) 27(2) 
C(44) 326(4) 7268(3) 2723(2) 30(2) 
C(45) 737(4) 7001(4) 3336(2) 36(2) 
C(46) -237(4) 6716(4) 2350(3) 43(2) 
C(47) 708(5) 6162(4) 3449(3) 41(2) 
C(48) 396(4) 7449(4) 3868(2) 44(2) 
Zn(1) 2355(1) 9944(1) 1243(1) 33(1) 
O(1) 1164(3) 9576(2) 1693(1) 30(1) 
O(2) 3335(2) 9907(2) 3006(2) 35(1) 
O(3) 3967(3) 10468(3) 1058(2) 46(2) 
O(4) 2671(3) 8957(2) 823(1) 30(1) 
O(5) 1577(3) 10401(2) -526(2) 47(2) 
O(6) 1972(3) 11306(2) 1380(2) 43(2) 
N(1) 3046(3) 9910(3) 2013(2) 30(1) 
N(2) 1888(3) 10313(3) 457(2) 32(2) 
C(1) 1000(4) 9573(3) 2296(2) 26(2) 
C(2) 82(4) 9428(3) 2506(3) 30(2) 
C(3) -133(4) 9423(3) 3106(3) 36(2) 
C(4) 578(4) 9560(3) 3539(3) 35(2) 
C(5) 1488(4) 9704(3) 3351(2) 34(2) 
C(6) 1720(4) 9715(3) 2729(2) 29(2) 
C(7) 2710(4) 9842(3) 2554(2) 31(2) 
C(8) 4089(4) 10001(4) 2049(2) 33(2) 
C(9) 4287(4) 10099(3) 2736(2) 30(2) 
C(10) 4349(5) 10644(4) 1636(2) 40(2) 
C(11) 4530(4) 10870(4) 2956(3) 40(2) 
C(12) 4971(4) 9531(4) 2963(3) 44(2) 
C(13) 2566(4) 8760(3) 237(2) 26(2) 
C(14) 2890(4) 8061(3) 60(2) 28(2) 
C(15) 2802(4) 7832(3) -540(2) 35(2) 
C(16) 2407(4) 8304(3) -975(2) 34(2) 
C(17) 2111(4) 8987(3) -803(2) 35(2) 
C(18) 2184(4) 9241(3) -199(2) 27(2) 
C(19) 1901(4) 9988(4) -60(2) 31(2) 
C(20) 1505(5) 11077(4) 389(2) 40(2) 
C(21) 1516(6) 11183(4) -318(3) 48(2) 
C(22) 2055(5) 11594(3) 773(3) 44(2) 
C(23) 605(7) 11517(4) -540(3) 67(3) 
C(24) 2390(6) 11564(4) -550(3) 67(3) 
Cl(2) 6211(3) 1149(2) 237(1) 58(1) 
O(52) 6642(4) 572(4) -118(3) 86(2) 
O(53) 6552(6) 969(5) 841(4) 123(3) 
O(54) 6492(6) 1802(5) 30(3) 123(3) 
O(55) 5177(6) 1189(5) 204(4) 76(3) 
Cl(3) 6990(4) 1139(3) 292(2) 46(2) 
O(52A) 6642(4) 572(4) -118(3) 86(2) 
O(53A) 6552(6) 969(5) 841(4) 123(3) 
O(54A) 6492(6) 1802(5) 30(3) 123(3) 
O(56) 7865(12) 1478(10) 239(7) 79(5) 
Cl(1) 7588(1) 7950(1) 2590(1) 48(1) 
O(21) 8150(3) 8050(3) 3133(2) 60(2) 
O(22) 7209(3) 7218(3) 2601(2) 57(2) 
O(23) 8175(4) 8055(3) 2064(2) 61(2) 
O(24) 6856(4) 8483(3) 2570(3) 88(3) 
O(57) 7108(4) 9256(3) 3853(2) 77(2) 
O(58) 7255(6) 9976(5) 1879(3) 134(3) 
O(59) 2825(4) 5443(3) 1934(2) 77(2) 
H(7O) 680(40) 8850(20) 1410(20) 35 
H(9) 1578 6055 1735 64 
H(10O) 2590(40) 8290(20) 1280(20) 37 
H(12O) -880(50) 7290(40) 1800(30) 46 
H(26) -445 9703 961 43 
H(27) -1195 10074 60 49 
H(28) -1206 9288 -773 45 
H(29) -496 8136 -722 36 
H(32) 1983 6555 281 38 
H(34A) 554 5826 990 57 
H(34B) 1592 5507 831 57 
H(35A) -490 6005 251 46 
H(35B) 98 5321 -19 46 
H(35C) -520 5834 -461 46 
H(36A) 943 6078 -1092 55 
H(36B) 1614 5611 -647 55 
H(36C) 1845 6464 -780 55 
H(38) 4228 8076 1381 41 
H(39) 5424 7804 2065 44 
H(40) 5060 7387 3034 41 
H(41) 3485 7193 3311 39 
H(44) -77 7715 2797 35 
H(46A) 111 6241 2326 52 
H(46B) -861 6623 2544 52 
H(47A) 964 5902 3094 50 
H(47B) 49 6006 3518 50 
H(47C) 1093 6043 3806 50 
H(48A) 741 7297 4234 53 
H(48B) -287 7367 3927 53 
H(48C) 513 7976 3790 53 
H(2) -408 9330 2220 36 
H(3) -766 9326 3233 43 
H(3O) 4310(50) 10780(40) 790(30) 56 
H(4) 429 9553 3959 42 
H(5) 1969 9797 3644 40 
H(6) 2264 11585 1622 52 
H(8) 4407 9540 1901 40 
H(10A) 4072 11112 1791 48 
H(10B) 5049 10701 1612 48 
H(11A) 4619 10862 3397 48 
H(11B) 4011 11209 2852 48 
H(11C) 5118 11037 2760 48 
H(12A) 5079 9605 3398 53 
H(12B) 5576 9579 2745 53 
H(12C) 4708 9035 2894 53 
H(14) 3171 7740 351 33 
H(15) 3011 7351 -654 41 
H(16) 2347 8149 -1385 40 
H(17) 1844 9306 -1100 42 
H(20) 829 11080 530 48 
H(22A) 2729 11610 644 53 
H(22B) 1787 12101 749 53 
H(23A) 513 12002 -350 81 
H(23B) 73 11191 -433 81 
H(23C) 632 11575 -981 81 
H(24A) 2956 11330 -377 81 
H(24B) 2373 12087 -433 81 
H(24C) 2411 11526 -994 81 
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Table 25. Crystal data and structure refinement for [MnIII(7a)2(THF)2]•(ClO4) 
 
Crystal Data    
Empirical formula  C28 H34 Mn N2 O8, Cl O4  
Formula weight  680.96  
Crystal size  0.330 x 0.080 x 0.080 mm  
Crystal description  rod  
Crystal colour  moss-green to turquoise  
Crystal system Trigonal  
Space group  P 31  
Unit cell dimensions               a = 21.0613(2) A   alpha = 90 deg.  
                                         b = 21.0613(2) A    beta = 90 deg.  
                                         c = 17.70770(10) A   gamma = 120 deg.  
Volume  6802.42(10) A3  
Z, Calculated density  9,  1.496 Mg/m3  
Absorption coefficient  4.945 mm-1  
F(000)  3186 
Data Collection    
Measurement device type  Oxford Diffraction Gemini Ultra  
Measurement method  omega-scan  
Temperature  123 K  
Wavelength  1.54184 A  
Monochromator  graphite  
Theta range for data collection  3.48 to 51.63 deg.  
Index ranges  -21<=h<=21, -21<=k<=15, -17<=l<=17 
Reflections collected / unique  26572 / 9735 [R(int) = 0.0344]  
Reflections greater I>2\s(I) 7678 
Absorption correction  Semi-empirical from equivalents  
Max. and min. transmission  1.00000 and 0.54397  
Refinement    
Refinement method  Full-matrix least-squares on F2  
Hydrogen treatment  :  
Data / restraints / parameters  9735 / 1 / 1005  
Goodness-of-fit on F^2  1.050 
Final R indices [I>2sigma(I)]      R1 = 0.0939, wR2 = 0.1764  
R indices (all data)               R1 = 0.1125, wR2 = 0.1845  
Absolute structure parameter  0.053(5)  
Largest diff. peak and hole  0.808 and -0.831 e.A-3  
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Table 26. Atomic coordinates (x104) and equivalent isotropic displacement parameters (A2x103).
 x y z U(eq) 
Mn(1) -4481(1) 1144(1) 2024(1) 39(1) 
O(1) -5226(2) 1090(2) 1409(3) 41(1) 
O(2) -3897(2) 706(2) -56(3) 65(2) 
O(3) -2669(2) 2221(3) 551(3) 65(2) 
O(4) -3728(2) 1189(2) 2611(3) 44(1) 
O(5) -5366(2) 924(2) 4169(3) 68(2) 
O(6) -5140(2) 2369(2) 3490(3) 68(1) 
O(7) -3870(2) 2354(2) 1954(3) 50(1) 
O(8) -5104(2) -124(2) 2144(3) 49(1) 
N(1) -4008(3) 991(3) 1129(3) 53(2) 
N(2) -4999(2) 1146(2) 2937(3) 34(1) 
C(1) -5340(3) 1041(3) 661(4) 39(2) 
C(2) -5904(3) 1111(3) 377(4) 54(2) 
C(3) -6045(3) 1061(3) -377(4) 50(2) 
C(4) -5618(4) 940(4) -876(5) 66(3) 
C(5) -5031(3) 892(3) -605(4) 46(2) 
C(6) -4883(3) 929(3) 161(4) 41(2) 
C(7) -4245(3) 910(3) 397(4) 42(2) 
C(8) -3313(4) 680(4) 352(4) 78(3) 
C(9) -3274(3) 1030(4) 1135(4) 59(2) 
C(10) -2631(3) 1836(3) 1148(4) 42(2) 
C(11) -3652(3) 1199(3) 3378(3) 27(2) 
C(12) -3003(3) 1281(3) 3645(4) 48(2) 
C(13) -2885(3) 1258(3) 4417(4) 48(2) 
C(14) -3431(4) 1160(4) 4918(5) 63(3) 
C(15) -4087(3) 1080(3) 4618(5) 51(2) 
C(16) -4212(3) 1110(3) 3857(4) 45(2) 
C(17) -4869(3) 1086(3) 3636(4) 36(2) 
C(18) -5994(4) 842(4) 3743(4) 68(2) 
C(19) -5733(3) 1142(3) 2939(4) 54(2) 
C(20) -5555(4) 1936(4) 2848(4) 57(2) 
C(21) -3836(4) 2786(3) 1341(5) 68(2) 
C(22) -3393(4) 3572(4) 1589(7) 103(4) 
C(23) -2905(4) 3539(4) 2207(6) 89(4) 
C(24) -3365(4) 2813(4) 2547(5) 70(3) 
C(25) -5736(4) -523(4) 2750(4) 70(3) 
C(26) -5984(4) -1331(3) 2541(3) 49(2) 
C(27) -5261(4) -1305(3) 2403(4) 65(3) 
C(28) -4763(3) -545(3) 2052(5) 61(2) 
Mn(2) -1070(1) 1120(1) -1325(1) 41(1) 
O(9) -1777(2) 383(2) -696(3) 53(1) 
O(10) -514(2) 2127(2) 776(3) 63(2) 
O(11) 780(3) 1939(3) 239(3) 76(2) 
O(12) -357(2) 1840(2) -1930(3) 46(1) 
O(13) -2000(2) 410(2) -3408(3) 57(1) 
O(14) -1673(2) -735(2) -2743(3) 66(2) 
O(15) -409(3) 562(2) -1309(3) 70(2) 
O(16) -1762(2) 1688(2) -1286(2) 47(1) 
N(3) -567(2) 1713(2) -395(3) 44(2) 
N(4) -1611(2) 575(2) -2225(3) 32(1) 
C(29) -1897(4) 324(4) 61(4) 62(2) 
C(30) -2415(3) -337(4) 301(4) 53(2) 
C(31) -2561(4) -444(3) 1032(5) 60(3) 
C(32) -2133(4) 134(4) 1600(5) 66(2) 
C(33) -1577(3) 782(3) 1278(4) 42(2) 
C(34) -1416(3) 906(3) 563(4) 38(2) 
C(35) -825(3) 1595(3) 264(4) 37(2) 
C(36) 45(4) 2745(4) 344(5) 72(3) 
C(37) 116(3) 2444(3) -395(4) 47(2) 
C(38) 759(3) 2300(4) -412(5) 74(3) 
C(39) -283(3) 1937(3) -2671(3) 35(2) 
C(40) 349(3) 2528(3) -2980(5) 62(3) 
C(41) 440(3) 2686(3) -3735(4) 54(2) 
C(42) -78(3) 2195(4) -4213(4) 58(2) 
C(43) -707(3) 1617(3) -3973(4) 49(2) 
C(44) -813(3) 1436(3) -3191(4) 47(2) 
C(45) -1506(3) 802(3) -2911(4) 47(2) 
C(46) -2595(3) -134(4) -3001(4) 50(2) 
C(47) -2321(3) -165(3) -2257(4) 45(2) 
C(48) -2123(4) -758(3) -2084(4) 62(2) 
C(49) -400(4) 135(4) -702(5) 69(3) 
C(50) -50(4) -270(4) -899(8) 165(5) 
C(51) 466(4) 202(4) -1556(7) 131(5) 
C(52) 71(3) 603(4) -1948(5) 75(3) 
C(53) -1546(3) 2370(3) -918(4) 42(2) 
C(54) -2094(3) 2585(3) -1225(4) 50(2) 
C(55) -2782(3) 1841(3) -1347(4) 52(2) 
C(56) -2484(3) 1369(3) -1618(4) 40(2) 
Mn(3) 2194(1) -2278(1) -822(1) 13(1) 
O(17) 1451(2) -2987(2) -214(2) 18(1) 
O(18) 2825(2) -1319(2) 1295(2) 36(1) 
O(19) 4016(2) -1639(2) 623(2) 47(1) 
O(20) 2937(2) -1585(2) -1411(2) 18(1) 
O(21) 1248(2) -2896(2) -2924(2) 25(1) 
O(22) 1436(2) -4174(2) -2306(2) 53(1) 
O(23) 1620(2) -1589(2) -889(2) 40(1) 
O(24) 2761(2) -2911(2) -803(2) 31(1) 
N(5) 2720(2) -1685(2) 85(2) 22(1) 
N(6) 1628(2) -2789(2) -1733(2) 21(1) 
C(57) 1354(3) -3036(3) 546(3) 22(1) 
C(58) 733(3) -3681(3) 817(3) 28(2) 
C(59) 621(3) -3772(3) 1589(3) 39(2) 
C(60) 1111(3) -3199(3) 2089(4) 35(2) 
C(61) 1672(3) -2605(3) 1828(3) 33(2) 
C(62) 1820(3) -2491(3) 1051(3) 25(2) 
C(63) 2450(3) -1835(3) 763(3) 27(2) 
C(64) 3415(3) -687(3) 878(3) 30(2) 
C(65) 3437(3) -1017(3) 114(3) 22(1) 
C(66) 4036(3) -1174(3) 1(3) 45(2) 
C(67) 3010(2) -1518(3) -2154(3) 20(2) 
C(68) 3675(3) -951(3) -2469(3) 24(1) 
C(69) 3775(3) -851(3) -3231(3) 31(2) 
C(70) 3228(3) -1249(3) -3725(3) 35(2) 
C(71) 2569(3) -1807(3) -3467(3) 28(2) 
C(72) 2477(3) -1909(3) -2670(3) 23(2) 
C(73) 1807(3) -2516(3) -2412(3) 25(1) 
C(74) 588(3) -3452(3) -2512(3) 36(2) 
C(75) 912(3) -3488(3) -1741(3) 24(1) 
C(76) 1045(3) -4128(3) -1668(3) 33(2) 
C(77) 1976(3) -817(3) -768(5) 60(2) 
C(78) 1529(3) -520(4) -1123(4) 52(2) 
C(79) 789(3) -1199(3) -1285(5) 64(2) 
C(80) 1017(3) -1747(3) -1433(4) 52(2) 
C(81) 2778(3) -3350(3) -167(3) 33(2) 
C(82) 3225(3) -3684(3) -438(4) 55(2) 
C(83) 3715(4) -3179(4) -1078(4) 76(3) 
C(84) 3256(3) -2901(3) -1410(3) 28(2) 
Cl(1) -1225(1) 4269(1) 344(1) 70(1) 
O(25) -830(4) 4727(4) 846(5) 268(4) 
O(26) -1918(3) 4138(4) 133(5) 162(3) 
O(27) -1249(3) 3633(3) 428(4) 133(3) 
O(28) -754(3) 4479(5) -333(3) 168(3) 
Cl(2) -4565(1) -2267(1) 843(1) 59(1) 
O(29) -4078(3) -2077(3) 1443(3) 90(2) 
O(30) -5250(3) -2830(3) 1008(4) 108(2) 
O(31) -4233(2) -2377(3) 225(3) 100(2) 
O(32) -4660(3) -1684(3) 563(3) 122(2) 
Cl(3) -929(1) -2113(1) -2913(2) 81(1) 
O(33) -745(5) -2335(4) -2307(4) 159(3) 
O(34) -410(4) -1393(3) -3114(6) 177(4) 
O(35) -1224(4) -2576(4) -3591(4) 125(3) 
O(36) -1612(4) -2049(5) -2765(5) 155(3) 
H(2) -6204 1196 713 64 
H(3) -6443 1110 -559 61 
H(4) -5727 890 -1401 79 
H(5) -4719 833 -951 55 
H(8A) -2841 961 81 93 
H(8B) -3424 167 411 93 
H(9) -3236 735 1556 71 
H(10A) -2647 2074 1624 50 
H(10B) -2159 1839 1133 50 
H(12) -2628 1355 3298 58 
H(13) -2437 1309 4596 58 
H(14) -3366 1147 5448 75 
H(15) -4467 1000 4961 61 
H(18A) -6203 1117 3991 81 
H(18B) -6379 318 3719 81 
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H(19) -6076 813 2541 65 
H(20A) -5269 2145 2380 69 
H(20B) -6016 1950 2805 69 
H(21A) -4336 2671 1191 81 
H(21B) -3601 2694 904 81 
H(22A) -3096 3891 1167 124 
H(22B) -3711 3753 1790 124 
H(23A) -2772 3933 2584 107 
H(23B) -2451 3583 1991 107 
H(24A) -3059 2606 2721 84 
H(24B) -3640 2847 2984 84 
H(25A) -5548 -403 3273 84 
H(25B) -6135 -409 2678 84 
H(26A) -6258 -1668 2961 60 
H(26B) -6294 -1487 2082 60 
H(27A) -5326 -1699 2052 78 
H(27B) -5051 -1359 2882 78 
H(28A) -4279 -304 2305 73 
H(28B) -4688 -596 1508 73 
H(30) -2674 -725 -49 64 
H(31) -2950 -904 1199 72 
H(32) -2227 70 2127 79 
H(33) -1287 1171 1616 50 
H(36A) 519 2978 618 87 
H(36B) -104 3118 263 87 
H(37) 131 2754 -829 56 
H(38A) 714 1999 -860 89 
H(38B) 1223 2773 -457 89 
H(40) 735 2836 -2647 75 
H(41) 850 3122 -3918 65 
H(42) 9 2264 -4741 70 
H(43) -1082 1329 -4326 59 
H(46A) -2795 -614 -3259 60 
H(46B) -2989 -10 -2959 60 
H(47) -2668 -177 -1864 54 
H(48A) -1838 -647 -1609 74 
H(48B) -2570 -1246 -2038 74 
H(49A) -909 -209 -541 83 
H(49B) -139 459 -269 83 
H(50A) -409 -771 -1072 198 
H(50B) 234 -303 -470 198 
H(51A) 532 -114 -1925 156 
H(51B) 953 568 -1357 156 
H(52A) 426 1115 -2089 90 
H(52B) -217 332 -2397 90 
H(53A) -1036 2741 -1050 51 
H(53B) -1586 2309 -362 51 
H(54A) -2183 2884 -854 60 
H(54B) -1919 2860 -1704 60 
H(55A) -3059 1650 -871 62 
H(55B) -3106 1874 -1731 62 
H(56A) -2797 857 -1447 48 
H(56B) -2455 1376 -2176 48 
H(58) 401 -4043 476 34 
H(59) 223 -4210 1787 47 
H(60A) 1024 -3253 2617 42 
H(61A) 1991 -2239 2174 39 
H(64A) 3891 -488 1144 36 
H(64B) 3295 -292 814 36 
H(65) 3461 -679 -295 26 
H(66A) 4513 -712 -7 54 
H(66B) 3973 -1429 -487 54 
H(68) 4060 -633 -2140 29 
H(69) 4241 -492 -3418 37 
H(70) 3299 -1143 -4250 42 
H(71) 2189 -2114 -3806 34 
H(74A) 357 -3932 -2772 44 
H(74B) 221 -3292 -2453 44 
H(75) 593 -3494 -1320 28 
H(76A) 1330 -4070 -1203 39 
H(76B) 569 -4588 -1623 39 
H(77A) 2472 -578 -995 71 
H(77B) 2029 -712 -220 71 
H(78A) 1474 -185 -772 62 
H(78B) 1761 -252 -1595 62 
H(79A) 456 -1338 -844 76 
H(79B) 548 -1128 -1730 76 
H(80A) 1193 -1704 -1959 63 
H(80B) 601 -2250 -1355 63 
H(81A) 2276 -3737 -31 39 
H(81B) 3010 -3036 280 39 
H(82A) 2901 -4188 -629 66 
H(82B) 3528 -3705 -22 66 
H(83A) 4180 -2773 -876 92 
H(83B) 3827 -3457 -1454 92 
H(84A) 2964 -3217 -1836 33 
H(84B) 3568 -2396 -1600 33 
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Table 27. Crystal data and structure refinement for [FeIII((meso)-4)ox(H2O)]•(ClO4). 
 
 Crystal Data    
Empirical formula  C27 H27 Fe N3 O6 S2, Cl O4  
Formula weight  708.96  
Crystal size  0.35 x 0.27 x 0.13 mm  
Crystal description  flat prism  
Crystal colour  dark red  
Crystal system Monoclinic  
Space group  P 21/n  
Unit cell dimensions  a = 9.7199(9) A alpha = 90 deg.  
  b = 26.575(2) A beta = 112.697(11) deg.  
  c = 12.0604(13) A gamma = 90 deg.  
Volume  2874.0(5) A3  
Z, Calculated density  4, 1.638 Mg/m3  
Absorption coefficient  0.827 mm-1  
F(000)  1460 
Data Collection    
Measurement device type  STOE-IPDS diffractometer  
Measurement method  rotation  
Temperature  123(1) K  
Wavelength  0.71073 A  
Monochromator   graphite  
Theta range for data collection  1.98 to 25.84 deg.  
Index ranges  -11<=h<=11 -32<=k<=32 -14<=l<=14 
Reflections collected / unique  30411 / 5525 [R(int) = 0.0915]  
Reflections greater I>2\s(I) 4060 
Absorption correction  Analytical  
Max. and min. transmission  0.8851 and 0.7616  
Refinement    
Refinement method  Full-matrix least-squares on F2  
Hydrogen treatment  :  
Data / restraints / parameters  5525 / 0 / 405  
Goodness-of-fit on F^2  0.940  
Final R indices [I>2sigma(I)]  R1 = 0.0398, wR2 = 0.0948  
R indices (all data)  R1 = 0.0581, wR2 = 0.1006  
Absolute structure parameter  .  
Largest diff. peak and hole  0.715 and -0.461 e.A-3  
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Table 28. Atomic coordinates (x104) and equivalent isotropic displacement parameters (A2x103). 
 x y z U(eq) 
Fe(2) 7125(1) 1249(1) 138(1) 21(1) 
S(1) 7781(1) 241(1) -1245(1) 23(1) 
S(2) 11393(1) 212(1) 3751(1) 24(1) 
O(1) 5814(2) 1671(1) 579(2) 27(1) 
O(2) 3179(2) 1336(1) -3039(2) 28(1) 
O(3) 8214(2) 657(1) -305(2) 23(1) 
O(4) 10700(3) 1895(1) 3059(2) 35(1) 
O(5) 7925(2) 1738(1) -615(2) 29(1) 
O(6) 6554(3) 653(1) 1066(2) 26(1) 
N(1) 5273(3) 1116(1) -1476(2) 23(1) 
N(2) 8235(3) -253(1) 1395(2) 24(1) 
N(3) 8983(3) 1394(1) 1734(2) 24(1) 
C(1) 4744(3) 1973(1) -109(2) 25(1) 
C(2) 4323(4) 2392(1) 411(3) 29(1) 
C(3) 3278(4) 2730(1) -276(3) 34(1) 
C(4) 2557(4) 2667(1) -1524(3) 34(1) 
C(5) 2879(4) 2246(1) -2049(3) 30(1) 
C(6) 3946(3) 1893(1) -1363(2) 24(1) 
C(7) 4205(3) 1439(1) -1928(2) 23(1) 
C(8) 3724(4) 894(1) -3466(2) 28(1) 
C(9) 4926(3) 680(1) -2322(2) 24(1) 
C(10) 6273(3) 489(1) -2546(2) 25(1) 
C(11) 6762(3) -232(1) -756(2) 27(1) 
C(12) 7812(3) -504(1) 338(2) 25(1) 
C(13) 8307(4) -990(1) 253(3) 30(1) 
C(14) 9294(4) -1220(1) 1280(3) 32(1) 
C(15) 9782(4) -956(1) 2358(3) 29(1) 
C(16) 9229(3) -469(1) 2383(2) 25(1) 
C(17) 9736(4) -170(1) 3529(2) 27(1) 
C(18) 10642(3) 674(1) 2562(2) 24(1) 
C(19) 9688(3) 1078(1) 2829(2) 25(1) 
C(20) 10601(4) 1462(1) 3774(3) 35(1) 
C(21) 9675(3) 1825(1) 1942(3) 27(1) 
C(22) 9547(3) 2222(1) 1078(3) 28(1) 
C(23) 10339(4) 2677(1) 1499(3) 34(1) 
C(24) 10375(4) 3043(1) 686(3) 40(1) 
C(25) 9647(4) 2959(1) -531(3) 37(1) 
C(26) 8847(4) 2519(1) -963(3) 33(1) 
C(27) 8740(3) 2148(1) -170(3) 28(1) 
Cl(2) 6074(1) 767(1) 3898(1) 24(1) 
O(7) 6599(3) 295(1) 3610(2) 35(1) 
O(8) 7196(3) 990(1) 4924(2) 51(1) 
O(9) 5739(3) 1097(1) 2872(2) 41(1) 
O(10) 4754(3) 688(1) 4120(3) 52(1) 
H(2) 4774 2439 1256 35 
H(3) 3038 3013 98 40 
H(4) 1861 2910 -1998 41 
H(5) 2369 2193 -2888 35 
H(8A) 4152 990 -4060 34 
H(8B) 2913 647 -3838 34 
H(9) 4495 400 -2006 29 
H(10A) 6667 768 -2880 30 
H(10B) 5935 221 -3164 30 
H(11A) 5967 -66 -566 32 
H(11B) 6286 -477 -1413 32 
H(13) 7972 -1159 -499 36 
H(14) 9634 -1553 1248 39 
H(15) 10481 -1104 3071 34 
H(17A) 9962 -404 4216 32 
H(17B) 8916 53 3516 32 
H(18A) 11479 840 2430 29 
H(18B) 10028 498 1809 29 
H(19) 8910 920 3067 30 
H(20A) 10090 1554 4314 42 
H(20B) 11604 1329 4262 42 
H(23) 10848 2731 2337 40 
H(24) 10897 3350 967 48 
H(25) 9693 3206 -1084 45 
H(26) 8367 2468 -1805 40 
H(27) 6330(50) 724(17) 1520(40) 49(13) 
H(28) 7190(50) 386(18) 1250(30) 55(12) 
Experimental Part 
 
221 
        
N
S S
O N N O
OH HO
ZnII
2 ClO4
-
-[ZnII((S,S)-4)] (ClO4)2
 
 
Table 29. Crystal data and structure refinement for [ZnII((S,S)-4)]•(ClO4)2. 
 
Crystal Data    
Empirical formula  C27 H27 N3 O4 S2 Zn, 2(Cl O4)  
Formula weight  785.95  
Crystal size  0.27 x 0.19 x 0.11 mm  
Crystal description  prism  
Crystal colour  leicht rosa  
Crystal system Monoclinic  
Space group  C 2/c  
Unit cell dimensions  a = 14.4742(12) A alpha = 90 deg.  
  b = 12.9006(12) A beta = 110.552(9) deg.  
  c = 17.5248(14) A gamma = 90 deg.  
Volume  3064.1(5) A3  
Z, Calculated density  4, 1.704 Mg/m3  
Absorption coefficient  1.182 mm-1  
F(000)  1608 
Data Collection    
Measurement device type  STOE-IPDS diffractometer  
Measurement method  rotation  
Temperature  123(1) K  
Wavelength  0.71073 A  
Monochromator   graphite  
Theta range for data collection  2.18 to 26.84 deg.  
Index ranges  =-18<=h<=18 -16<=k<=16 -22<=l<=22 
Reflections collected / unique  16916 / 3275 [R(int) = 0.0463]  
Reflections greater I>2\s(I) 2560 
Absorption correction  Analytical  
Max. and min. transmission  0.9022 and 0.7618  
Refinement    
Refinement method  Full-matrix least-squares on F2  
Hydrogen treatment  :  
Data / restraints / parameters  3275 / 0 / 215  
Goodness-of-fit on F^2  1.041 
Final R indices [I>2sigma(I)]  R1 = 0.0663, wR2 = 0.1647  
R indices (all data)  R1 = 0.0824, wR2 = 0.1734  
Absolute structure parameter  .  
Largest diff. peak and hole  1.344 and -0.817 e.A-3  
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Table 30. Atomic coordinates (x104) and equivalent isotropic displacement parameters (A2x103). 
 x y z U(eq) 
Zn(1) 0 1309(1) 7500 29(1) 
S(1) -627(1) 952(1) 5966(1) 46(1) 
O(1) -77(2) 3053(3) 8218(2) 41(1) 
O(2) -2919(2) 1935(3) 7353(2) 42(1) 
N(1) -1425(3) 1561(3) 7309(2) 34(1) 
N(2) 0 -435(4) 7500 35(2) 
C(1) -639(3) 3149(3) 8690(2) 30(1) 
C(2) -326(4) 3711(4) 9417(3) 35(1) 
C(3) -935(4) 3816(3) 9872(3) 37(1) 
C(4) -1862(4) 3361(4) 9609(3) 38(1) 
C(5) -2173(3) 2792(3) 8895(3) 31(1) 
C(6) -1570(3) 2666(3) 8425(2) 26(1) 
C(7) -1934(3) 2037(4) 7676(2) 30(1) 
C(8) -3131(3) 1314(5) 6610(3) 44(1) 
C(9) -2101(4) 908(5) 6646(3) 45(2) 
C(10) -1910(4) 1046(5) 5877(3) 53(2) 
C(11) -308(4) -408(5) 6015(3) 51(2) 
C(12) -161(3) -975(4) 6801(3) 41(2) 
C(13) -172(4) -2054(5) 6788(4) 56(2) 
C(14) 0 -2591(7) 7500 65(3) 
Cl(1) 7180(1) 9605(1) 8588(1) 52(1) 
O(3) 7362(5) 9449(4) 7877(3) 81(2) 
O(4) 7056(9) 8714(6) 8959(4) 190(5) 
O(5) 6214(5) 10109(11) 8356(5) 175(6) 
O(6) 7876(3) 10281(3) 9126(2) 53(1) 
H(1) 406 3458 8387 50 
H(2) 309 4025 9600 43 
H(3) -716 4201 10366 44 
H(4) -2281 3440 9918 45 
H(5) -2807 2479 8719 37 
H(8A) -3440 1744 6118 53 
H(8B) -3578 730 6604 53 
H(9) -2024 162 6812 53 
H(10A) -2162 1734 5648 63 
H(10B) -2290 516 5483 63 
H(11A) -833 -769 5574 62 
H(11B) 308 -473 5894 62 
H(13) -298 -2416 6290 67 
H(14) 0 -3327 7500 77 
 
References 
 
223 
G. References 
 
 (1) Williams, R. J. P. Coord. Chem. Rev. 2001, 216-217, 583-595. 
 (2) Wood, J. M. Naturwissenschaften 1975, 62, 357-64. 
 (3) Kraatz, H.-B.; Metzler-Nolte, N. Concepts and Models in Bioinorganic Chemistry; 
WILEY-VCH GmbH & Co. KGaA: Weinheim, 2006. 
 (4) Battersby, A. R. Pure Appl. Chem. 1993, 65, 1113-22. 
 (5) Kadish, K. M.; Smith, K. M.; Guilard, R. The Prophyrin Handbook; Elsevier 
Science: Oxford, 2000. 
 (6) Kadish, K. M.; Smith, K. M.; Guilard, R. The Porphyrin Handbook; Elsevier 
Science: Oxford, 2003. 
 (7) Denisov, I. G.; Makris, T. M.; Sligar, S. G.; Schlichting, I. Chem. Rev. 2005, 105, 
2253-2277. 
 (8) Collman, J. P.; Fu, L. Acc. Chem. Res. 1999, 32, 455-463. 
 (9) Messerschmidt, A.; Huber, R.; Poulos, T.; Wieghardt, K. Handbook of 
Metalloproteins; J. Wiley & Sons: Chichester, UK, 2001; Vol. 1. 
 (10) Eschenmoser, A. Angew. Chem. 1988, 100, 5-40. 
 (11) Krauss, G. Biochemistry of Signal Transduction and Regulation; 2nd ed.; Wiley-
VCH GmbH: Weinheim, 2001. 
 (12) Lodish, H.; Berk, A.; Zipursky, S. L.; Matsudaira, P.; Baltimore, D.; Darnell, J. E. 
Moleculare Cell Biology; 4th ed.; W. H. Freeman and Company: New York, 2000. 
 (13) Rees, D. C.; Howard, J. B. Science 2003, 300, 929-931. 
 (14) Beinert, H.; Holm, R. H.; Munck, E. Science 1997, 277, 653-659. 
 (15) Bian, S.; Cowan, J. A. Coord. Chem. Rev. 1999, 190-192, 1049-1066. 
 (16) Orme-Johnson, W. H. Annu. Rev. Biochem 1973, 42, 159-204. 
 (17) Shan, X.; Que, L. J. Inorg. Biochem. 2006, 100, 421-433. 
 (18) Koehntop, K. D.; Emerson, J. P.; Que, L., Jr. J. Biol. Inorg. Chem. 2005, 10, 87-93. 
 (19) Solomon, E. I.; Brunold, T. C.; Davis, M. I.; Kemsley, J. N.; Lee, S.-K.; Lehnert, 
N.; Neese, F.; Skulan, A. J.; Yang, Y.-S.; Zhou, J. Chem. Rev. 2000, 100, 235-349. 
 (20) Solomon, E. I.; Decker, A.; Lehnert, N. PNAS 2003, 100, 3589-3594. 
 (21) Costas, M.; Mehn, M. P.; Jensen, M. P.; Que, L., Jr. Chem. Rev. 2004, 104, 939-
986. 
 (22) Kryatov, S. V.; Rybak-Akimova, E. V.; Schindler, S. Chem. Rev. 2005, 105, 2175-
2226. 
References 
 
224 
 (23) Mehn, M. P.; Fujisawa, K.; Hegg, E. L.; Que, L., Jr. J. Am. Chem. Soc. 2003, 125, 
7828-7842. 
 (24) Merkx, M.; Kopp, D. A.; Sazinsky, M. H.; Blazyk, J. L.; Muller, J.; Lippard, S. J. 
Angew. Chem. Int. Ed. 2001, 40, 2782-2807. 
 (25) Stenkamp, R. E.; Sieker, L. C.; Jensen, L. H. J. Am. Chem. Soc. 1984, 106, 618-22. 
 (26) Stenkamp, R. E. Chem. Rev. 1994, 94, 715-26. 
 (27) Wallar, B. J.; Lipscomb, J. D. Chem. Rev. 1996, 96, 2625-2657. 
 (28) Stubbe, J. Curr. Opin. Chem. Biol. 2003, 7, 183-188. 
 (29) Fontecave, M.; Menage, S.; Duboc-Toia, C. Coord. Chem. Rev. 1998, 178-180, 
1555-1572. 
 (30) Tolman, W. B.; Que, L., Jr. J. Chem. Soc., Dalton Trans. 2002, 653-660. 
 (31) Rohde, J.-U.; In, J.-H.; Lim, M. H.; Brennessel, W. W.; Bukowski, M. R.; Stubna, 
A.; Muenck, E.; Nam, W.; Que, L., Jr. Science 2003, 299, 1037-1039. 
 (32) Klinker, E. J.; Kaizer, J.; Brennessel, W. W.; Woodrum, N. L.; Cramer, C. J.; Que, 
L., Jr. Angew. Chem. Int. Ed. 2005, 44, 3690-3694. 
 (33) Lim, M. H.; Rohde, J.-U.; Stubna, A.; Bukowski, M. R.; Costas, M.; Ho, R. Y. N.; 
Munck, E.; Nam, W.; Que, L., Jr. PNAS 2003, 100, 3665-3670. 
 (34) Jensen, M. P.; Costas, M.; Ho, R. Y. N.; Kaizer, J.; Payeras, A. M.; Muenck, E.; 
Que, L., Jr.; Rohde, J.-U.; Stubna, A. J. Am. Chem. Soc. 2005, 127, 10512-10525. 
 (35) Rohde, J.-U.; Torelli, S.; Shan, X.; Lim, M. H.; Klinker, E. J.; Kaizer, J.; Chen, K.; 
Nam, W.; Que, L., Jr. J. Am. Chem. Soc. 2004, 126, 16750-16761. 
 (36) Brown, C. A.; Remar, G. J.; Musselman, R. L.; Solomon, E. I. Inorg. Chem. 1995, 
34, 688-717. 
 (37) Wieghardt, K.; Pohl, K.; Gebert, W. Angew. Chem. 1983, 95, 739-40. 
 (38) Armstrong, W. H.; Lippard, S. J. J. Am. Chem. Soc. 1983, 105, 4837-8. 
 (39) Kim, K.; Lippard, S. J. J. Am. Chem. Soc. 1996, 118, 4914-15. 
 (40) Que, L., Jr.; Dong, Y. Acc. Chem. Res. 1996, 29, 190-6. 
 (41) Hsu, H.-F.; Dong, Y.; Shu, L.; Young, V. G., Jr.; Que, L., Jr. J. Am. Chem. Soc. 
1999, 121, 5230-5237. 
 (42) Seitz, M. PhD, University of Regensburg, 2004. 
 (43) Kaiser, A. PhD, University of Regensburg, 2004. 
 (44) Godbole, M. D.; Puig, M. P.; Tanase, S.; Kooijman, H.; Spek, A. L.; Bouwman, E. 
Inorg. Chim. Acta 2007, 360, 1954-1960. 
References 
 
225 
 (45) Seitz, M.; Kaiser, A.; Tereshchenko, A.; Geiger, C.; Uematsu, Y.; Reiser, O. 
Tetrahedron 2006, 62, 9973-9980. 
 (46) Estimated by weight. 
 (47) Meyers, A. I.; Schmidt, W.; McKennon, M. J. Synthesis 1993, 250-62. 
 (48) Novachek, K. A.; Myers, A. I. Tetrahedron Lett. 1996, 37, 1743-6. 
 (49) Zunnundzhanov, A.; Bessonova, I. A.; Abdullaev, N. D.; Ogai, D. K. Chem. Nat. 
Compd. 1988, 23. 
 (50) Zamri, A.; Abdallah, M. A. Tetrahedron 2000, 56, 9397. 
 (51) Rinehart, K. L.; Staley, A. L.; Wilson, S. R.; Ankenbauer, R. G.; Cox, C. D. J. Org. 
Chem. 1995, 60, 2786-91. 
 (52) Appel, R. Angew. Chem. 1975, 87, 863-74. 
 (53) Christen, H. R.; Vögtle, F. Organische Chemie - Von den Grundlagen zur 
Forschung; Otto Salle Verlag GmbH & Co. / Sauerländer AG: Frankfurt am Main / 
Aarau, 1992; Vol. 1. 
 (54) Frump, J. A. Chem. Rev. 1971, 71, 483-506. 
 (55) Cox, P. A. The Elements on Earth; Oxford University Press: Oxford, 1995. 
 (56) Bergeron, R. J.; Wiegand, J.; McManis, J. S.; Weimar, W. R.; Park, J.-H.; Eiler-
McManis, E.; Bergeron, J.; Brittenham, G. M. J. Med. Chem. 2005, 48, 821-831. 
 (57) Ponka, P. J. Trace Elem. Exp. Med. 2003, 16, 201-217. 
 (58) Ponka, P. J. Trace Elem. Exp. Med. 2000, 13, 73-83. 
 (59) Hollemann, A. F.; Wiberg, E. Lehrbuch der Anorganischen Chemie; Walter de 
Gruyter: Berlin  New York, 1995; Vol. 101. 
 (60) Bergeron, R. J.; Wiegand, J.; Weimar, W. R.; McManis, J. S.; Smith, R. E.; 
Abboud, K. A. Chirality 2003, 15, 593-599. 
 (61) Graf, E.; Mahoney, J. R.; Bryant, R. G.; Eaton, J. W. J. Biol. Chem. 1984, 259, 
3620-4. 
 (62) Halliwell, B. Nutr. Rev. 1994, 52, 253-65. 
 (63) Halliwell, B. Lancet 1994, 344, 721-4. 
 (64) Olivieri, N. F.; Brittenham, G. M. Blood 1997, 89, 739-61. 
 (65) Giardina, P. J.; Grady, R. W. Semin. Hematol. 2001, 38, 360-6. 
 (66) Naegeli, H. U.; Zaehner, H. Helv. Chim. Acta 1980, 63, 1400-6. 
 (67) Anderegg, G.; Raeber, M. J. Chem. Soc., Chem. Commun. 1990, 1194-6. 
 (68) Hahn, F. E.; McMurry, T. J.; Hugi, A.; Raymond, K. N. J. Am. Chem. Soc. 1990, 
112, 1854-60. 
References 
 
226 
 (69) Bergeron, R. J.; Wiegand, J.; Dionis, J. B.; Egli-Karmakka, M.; Frei, J.; Huxley-
Tencer, A.; Peter, H. H. J. Med. Chem. 1991, 34, 2072-8. 
 (70) Bergeron, R. J.; Streiff, R. R.; Wiegand, J.; Vinson, J. R.; Luchetta, G.; Evans, K. 
M.; Peter, H.; Jenny, H. B. Ann. N. Y. Acad. Sci. 1990, 612, 378-93. 
 (71) Bergeron, R. J.; Streiff, R. R.; Creary, E. A.; Daniels, R. D., Jr.; King, W.; Luchetta, 
G.; Wiegand, J.; Moerker, T.; Peter, H. H. Blood 1993, 81, 2166-73. 
 (72) Bergeron, R. J.; Wiegand, J.; McManis, J. S.; Bharti, N. J. Med. Chem. 2006, 49, 
7032-7043. 
 (73) Bergeron, R. J.; Wiegand, J.; McManis, J. S.; Vinson, J. R. T.; Yao, H.; Bharti, N.; 
Rocca, J. R. J. Med. Chem. 2006, 49, 2772-2783. 
 (74) Tanase, S.; Bouwman, E.; Long, G. J.; Shahin, A. M.; Mills, A. M.; Spek, A. L.; 
Reedijk, J. Eur. J. Inorg. Chem. 2004, 4572-4578. 
 (75) Gaber, B. P.; Miskowski, V.; Spiro, T. G. J. Am. Chem. Soc. 1974, 96, 6868-73. 
 (76) Ainscough, E. W.; Brodie, A. M.; Plowman, J. E.; Brown, K. L.; Addison, A. W.; 
Gainsford, A. R. Inorg. Chem. 1980, 19, 3655-63. 
 (77) Bergeron, R. J.; Liu, C. Z.; McManis, J. S.; Xia, M. X. B.; Algee, S. E.; Wiegand, J. 
J. Med. Chem. 1994, 37, 1411-17. 
 (78) Bergeron, R. J.; Wiegand, J.; Weimar, W. R.; Vinson, J. R. T.; Bussenius, J.; Yao, 
G. W.; McManis, J. S. J. Med. Chem. 1999, 42, 95-108. 
 (79) Tseng, C.-F.; Burger, A.; Mislin, G. L. A.; Schalk, I. J.; Yu, S. S. F.; Chan, S. I.; 
Abdallah, M. A. J. Biol. Inorg. Chem. 2006, 11, 419-432. 
 (80) Sreerama, S. G.; Mukhopadhyay, A.; Pal, S. Inorg. Chem. Commun. 2006, 9, 1083-
1086. 
 (81) Langemann, K.; Heineke, D.; Rupprecht, S.; Raymond, K. N. Inorg. Chem. 1996, 
35, 5663-5673. 
 (82) Godbole, M. D.; Roubeau, O.; Mills, A. M.; Kooijman, H.; Spek, A. L.; Bouwman, 
E. Inorg. Chem. 2006, 45, 6713-6722. 
 (83) Stubna, A.; Jo, D.-H.; Costas, M.; Brenessel, W. W.; Andres, H.; Bominaar, E. L.; 
Muenck, E.; Que, L., Jr. Inorg. Chem. 2004, 43, 3067-3079. 
 (84) Bennett, M. A.; Smith, A. K. J. Chem. Soc. Dalton Trans. 1974, 233-41. 
 (85) Bag, N.; Lahiri, G. K.; Bhattacharya, S.; Falvello, L. R.; Chakravorty, A. Inorg. 
Chem. 1988, 27, 4396-402. 
 (86) Steiner, T. Angew. Chem. Int. Ed. 2002, 41, 48-76. 
 (87) Moriuchi, T.; Nishiyama, M.; Hirao, T. Eur. J. Inorg. Chem. 2002, 447-451. 
References 
 
227 
 (88) Tong, Y.-P.; Zheng, S.-L.; Chen, X.-M. J. Mol. Struct. 2007, 826, 104-112. 
 (89) Godbole, M. D.; Hotze, A. C. G.; Hage, R.; Mills, A. M.; Kooijman, H.; Spek, A. 
L.; Bouwman, E. Inorg. Chem. 2005, 44, 9253-9266. 
 (90) Seitz, M.; Kaiser, A.; Powell, D. R.; Borovik, A. S.; Reiser, O. Adv. Synth. Catal. 
2004, 346, 737-741. 
 (91) Baucherel, X.; Gonsalvi, L.; Arends, I. W. C. E.; Ellwood, S.; Sheldon, R. A. Adv. 
Synth. Catal. 2004, 346, 286-296. 
 (92) Shilov, A. E.; Shul'pin, G. B. Chem. Rev. 1997, 97, 2879-2932. 
 (93) Pavan, C.; Legros, J.; Bolm, C. Adv. Synth. Catal. 2005, 347, 703-705. 
 (94) Lane, B. S.; Burgess, K. Chem. Rev. 2003, 103, 2457-2473. 
 (95) White, M. C.; Doyle, A. G.; Jacobsen, E. N. J. Am. Chem. Soc. 2001, 123, 7194-
7195. 
 (96) Legros, J.; Bolm, C. Angew. Chem. Int. Ed. 2004, 43, 4225-4228. 
 (97) Li, F.; Wang, M.; Ma, C.; Gao, A.; Chen, H.; Sun, L. Dalton Transactions 2006, 
2427-2434. 
 (98) Kalir, A.; Kalir, H. H. Chemistry of Sulphur-Containing Functional Groups 1993, 
957-73. 
 (99) Bolm, C. Coord. Chem. Rev. 2003, 237, 245-256. 
 (100) Legros, J.; Bolm, C. Angew. Chem. Int. Ed. 2003, 42, 5487-5489. 
 (101) Legros, J.; Bolm, C. Chem. Eur. J. 2005, 11, 1086-1092. 
 (102) Korte, A.; Legros, J.; Bolm, C. Synlett 2004, 2397-2399. 
 (103) Bolm, C.; Legros, J.; Le Paih, J.; Zani, L. Chem. Rev. 2004, 104, 6217-6254. 
 (104) No structure analysis of the Schiff base complexed with iron is published until now. 
 
 
 
 
 
Curriculum Vitae 
 
228 
H. Curriculum Vitae 
 
 
Caroline A. Schall 
 
Personal Data 
 
Address Lieblstr. 51 
 93059 Regensburg, Germany 
Phone + 49 - 941 - 2068349 
E-mail caroline.schall@chemie.uni-regensburg.de 
Born June 12th 1977, Schwandorf, Germany 
Nationality German 
 
Education 
 
11/2007 Final defense 
 “Chiral Oxazoline and Bis(oxazoline) Ligands – New biomimetic 
Models for Iron containing nonheme Proteins and their Application 
in Catalysis” 
03/2006 - 05/2006 Exchange program: University of Kansas, Lawrence, USA 
 Research in the group of Prof. A.S. Borovik  
 (Bioinorganic Chemistry) 
Since 08/2004 PhD thesis in the research group of Prof. Dr. O. Reiser  
 University of Regensburg, Germany (Organic Chemistry) 
01/2004 - 07/2004 Research in the group of Prof. Dr. R. Andreesen 
 University of Regensburg, Germany (Heamatology/Oncology) 
 supervisor Prof. Dr. S. Elz 
 
“Investigations on human regulatory T cells” 
12/2003 Diploma in Chemistry - University of Regensburg, Germany 
 (master degree in chemistry) 
03/2003 - 11/2003 Diploma thesis in the research group of Prof. Dr. S. Elz 
 University of Regensburg, Germany (Pharmacology/Physiology) 
 “Regulation of Cyclooxygenase-2 depending on Angiotensin-II in 
cultured mesangial cells of the rat” 
Curriculum Vitae 
 
229 
04/2001 - 02/2003 Study of Chemistry, University of Regensburg, Germany 
08/2000 - 03/2001 Study of Chemistry and Biochemistry, University of Aberdeen, 
Scottland 
01/2001 - 03/2001 Research project in the group of Dr. J. Feldmann 
 University of Aberdeen, Scotland (Organic Chemistry)  
“Synthesis of arsenic sugars“ 
08/2000 Intermediate exam - University of Regensburg, Germany  
04/1999 - 08/2000 Student of general Chemistry, University of Regensburg, Germany 
10/1996 - 03/1999 Student of Technological Chemistry  
 Georg-Simon-Ohm Fachhochschule, Nürnberg, Germany 
09/1994 - 07/1996 Fachoberschule, Schwandorf, Germany 
 (high school graduation) 
 
Professional Experience 
 
09/2005 EU-Project ASIA-Link Medicinal Chemistry, Shanghai, China 
“Sommerschool Medicinal Chemistry” 
07/2002 - 10/2002 Internship in the department of Prof. Dr. D. Männel 
 (Tumor Immunology), University of Regensburg, Germany 
 “Cell culture training” 
08/2001 - 10/2001 Summer Research Internship at BAYER AG, Pharma Research, 
Wuppertal, Germany  
05/2001 - 07/2001  Internship in the department of Prof. Dr. S. Elz, 
 (Pharmaceutical & Medicinal Chemistry I) 
 University of Regensburg, Germany 
 “Ligand-Receptor-Effects on guinea pig trachea” 
03/2000 - 04/2000 Internship at the Max-Planck-Institut of Immunbiology  
 Research group of Prof. Dr. A. Kispert 
 (Development Biology), Freiburg, Germany 
 “Characterization of sFRP-2 Gen in mouse” 
12/1998 Workshop at Roche Diagnostics, Nürnberg, Germany 
 “Basic techniques of enzymatic analysis”  
07/1998 - 08/1998 Internship at Bayerische Landesanstalt für Bodenkultur und 
Pflanzenbau, (Gene analysis in plants), Freising, Germany 
09/1997 Internship at Bayerisches Landesamt für Umweltschutz,  
 (Environmental analytical chemsitry), Schwandorf, Germany  
Curriculum Vitae 
 
230 
Presentations 
 
1) “Pentadentate Bis(oxazoline) Ligands: A Promising Model for C-H-Activation” Caroline 
Wagner, M. Seitz, A. Kaiser, Oliver Reiser; DFG 1118 – “Sekundäre Wechselwirkungen als 
Steuerungsprinzip zur gerichteten Funktionalisierung reaktionsträger Substrate” 2006, 
Schleiden, Germany 
 
2) “Pentadentate Bis(oxazoline) Ligands: A Promising Model for C-H Activation” Caroline 
Wagner, M. Seitz, A. Kaiser, Oliver Reiser; Summerschool Medicinal Chemistry 2005, 
Shanghai, China 
 
3) “Metallkomplexe neuer Bis(oxazolin)liganden als Katalysatoren für die Oxidation von 
Kohlenwasserstoffen” A. Kaiser, M. Seitz, Caroline Wagner, A. Tereshenko, Oliver Reiser; 
DFG meeting, 2005, Germany 
 
4) “Iron(II) metal complexes with pentadentate bis(oxazolines)” Caroline Wagner, M. Seitz, 
A. Kaiser, Oliver Reiser; Workshop on biomimetic metal mediated oxidative transformations 
2005, Marburg, Germany 
 
5) “In vitro expanded CD4+CD25high cells retain regulatory T cell characteristics” Caroline 
Wagner, B. Piseshka, R. Eder, A. Havasi, P. Hoffmann, M. Edinger; Heamatology/Oncology 
department meeting 2004, Hirschberg, Germany 
 
Scholarships 
 
06/2006 – 08/2006  RISE DAAD student exchange tutor 
08/2000 - 03/2001  ERASMUS/SOKRATES student exchange program
Acknowledgement 
 
231 
I. Acknowledgement 
 
 
Für das Gelingen dieser Arbeit möchte ich mich bei folgenden Personen bedanken: 
 
Herrn Prof. Dr. O. Reiser für die Bereitstellung des Themas und die Ermöglichung meines 
Auslandaufenthaltes an der University of Kansas, USA. 
 
Herrn Prof. Dr. A. Borovik für die freundliche Aufnahme in seiner Arbeitsgruppe und allen 
Kollegen in Kansas für ihre hilfsbereite Unterstützung und eine tolle Zeit. 
 
Herrn Prof. Dr. R. Winter für die Benutzung seiner Laborgeräte sowie für seine 
Diskussionsbereitschaft. 
 
Herrn Dr. Zabel und Frau Stempfhuber für die Vermessung meiner zahlreichen 
Kristallstrukturen sowie ihre stete Hilfsbereitschaft. 
 
Herr Dr. Rudi Vasold für seinen starken Einsatz in der Untersuchung meiner Substanzen 
durch GC und HPLC Analytik, sowie zahlreichen informative Gespräche über die 
Geheimnisse des GC Analytik. 
 
Herrn Dr. Burgemeister, Herrn Kastner, Frau Schramm und Frau Stühler für die stete und 
freundliche Unterstützung in allen NMR-Problemen. 
 
Herrn Kiermaier und Herrn Söllner für ihre freundliche Zusammenarbeit und ständige 
Hilfsbereitschaft in der massenspektroskopischen Analyse meiner Substanzen. 
 
Frau W. Krutina und Frau B. Baumann für Ihre freundliche Art und schnelle Durchführung 
meiner Elementaranalysen. 
 
Herrn Dr. Peter Kreitmeier für seine überdurchschnittliche Hilfestellung bei allenen Problem 
rund ums Labor und die Chemie, sowie für nette Frühstückskaffeerunden. 
 
Acknowledgement 
 
232 
Frau Rotermund und Frau Ohli für ihre ebenfalls überdurchschnittliche Hilfsbereitschaft in 
jeder Lebenslage. 
 
Andrea Roithmaier, Georg Adolin, Klaus Döring und Robert Tomahogh für eine sehr 
angenehme und überaus hilfsbereite Zusammenarbeit, sowie für unsere netten 
Frühstückskaffeerunden. 
 
Dominic Laventine, Markus Hager und Dr. Kirsten Zeitler für ihre wertvolle Hilfestellung 
beim Korrekturlesen dieser Arbeit. 
 
Max und Steve, für ihre enorme Unterstützung während ihres Praktikums in meinem Labor. 
 
Allen jetzigen und ehemaligen Mitgliedern der Arbeitsgruppe Reiser für zahllose Grillfestl, 
Kuchengelage und Pläusche. 
 
 
Last but not least, 
 
Ganz besonderer Dank gebührt meiner Familie, die immer an mich geglaubt und mir den 
nötigen Halt für meine Ziele gegeben hat. 
 
Bei meiner Schwester Julia möchte ich mich für ihre aufmunternden Worte bedanken. Du 
schaffst das auch!  
 
Letztendlich möchte ich mich bei meinem Liebsten, Andy, bedanken, der meine Gedanken 
auch ohne Worte kennt, der Nachts die gleichen Träume träumt und der mich spüren lässt, 
jemand ganz besonderen zu sein. Dafür Liebe ich Ihn über alles. Danke mein Schatz!  
 
